0001144204-14-009735.txt : 20140214 0001144204-14-009735.hdr.sgml : 20140214 20140214160224 ACCESSION NUMBER: 0001144204-14-009735 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140214 DATE AS OF CHANGE: 20140214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IsoRay, Inc. CENTRAL INDEX KEY: 0000728387 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411458152 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33407 FILM NUMBER: 14616270 BUSINESS ADDRESS: STREET 1: 350 HILLS STREET, STREET 2: SUITE 106 CITY: RICHLAND STATE: WA ZIP: 99354 BUSINESS PHONE: (509) 375-1202 MAIL ADDRESS: STREET 1: 350 HILLS STREET, STREET 2: SUITE 106 CITY: RICHLAND STATE: WA ZIP: 99354 FORMER COMPANY: FORMER CONFORMED NAME: CENTURY PARK PICTURES CORP DATE OF NAME CHANGE: 19920703 10-Q 1 v367032_10q.htm QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY Report PURSUANT TO Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended December 31, 2013

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________ to ____________

Commission File No. 001-33407

ISORAY, INC.

(Exact name of registrant as specified in its charter)

Minnesota	41-1458152
(State or other jurisdiction of incorporation or	(I.R.S. Employer
organization)	Identification No.)

350 Hills St., Suite 106, Richland, Washington	99354
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code: (509) 375-1202

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o Accelerated filer o Non-accelerated filer o

Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes o No x

Number of shares outstanding of each of the issuer's classes of common equity as of the latest practicable date:

Class	Outstanding as of February 6, 2014
Common stock, $0.001 par value	41,540,982

ISORAY, INC.

Table of Contents

PART I	FINANCIAL INFORMATION

Item 1	Consolidated Unaudited Financial Statements	1

	Consolidated Balance Sheets	1

	Consolidated Statements of Operations (Unaudited)	2

	Consolidated Statements of Cash Flows (Unaudited)	3

	Notes to Unaudited Consolidated Financial Statements	4

Item 2	Management’s Discussion and Analysis of Financial
	Condition and Results of Operations	11

Item 3	Quantitative and Qualitative Disclosures About Market Risk	21

Item 4	Controls and Procedures	21

PART II	OTHER INFORMATION

Item 1A	Risk Factors	22

Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	22

Item 6	Exhibits	23

Signatures		24

PART I – FINANCIAL INFORMATION

IsoRay, Inc. and Subsidiaries

Consolidated Balance Sheets

	(Unaudited)
	December 31,			June 30,
	2013			2013

ASSETS

Current assets:
Cash and cash equivalents	$	4,414,572		$	2,899,927
Accounts receivable, net of allowance for doubtful accounts
of $32,515 and $52,598, respectively		917,222			923,780
Inventory		426,333			405,571
Other receivables		10,064			11,502
Prepaid expenses and other current assets		156,365			202,880

Total current assets		5,924,556			4,443,660

Fixed assets, net of accumulated depreciation and amortization		1,349,469			1,684,282
Restricted cash		181,181			181,149
Inventory, non-current		469,758			469,758
Other assets, net of accumulated amortization		262,698			276,507

Total assets	$	8,187,662		$	7,055,356

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
Accounts payable and accrued liabilities	$	430,293		$	432,566
Accrued protocol expense		46,973			25,305
Accrued radioactive waste disposal		124,000			100,000
Accrued payroll and related taxes		141,082			127,419
Accrued vacation		104,932			107,578

Total current liabilities		847,280			792,868

Warrant derivative liability		23,000			104,000
Asset retirement obligation		828,568			792,242

Total liabilities		1,698,848			1,689,110

Commitments and contingencies (Note 6)

Shareholders' equity:
Preferred stock, $.001 par value; 7,001,671 shares authorized:
Series A: 1,000,000 shares allocated; no shares issued and outstanding		-			-
Series B: 5,000,000 shares allocated; 59,065 shares issued and outstanding		59			59
Series C: 1,000,000 shares allocated; no shares issued and outstanding		-			-
Series D: 1,671 and 0 shares allocated; 1,670 & 0 shares issued and outstanding		2			-
Common stock, $.001 par value; 192,998,329 & 193,000,000 shares authorized;
38,419,502 and 34,618,517 shares issued and outstanding		38,420			34,618
Treasury stock, at cost, 13,200 shares		(8,390	)		(8,390	)
Additional paid-in capital		60,747,935			57,431,293
Accumulated deficit		(54,289,212	)		(52,091,334	)

Total shareholders' equity		6,488,814			5,366,246

Total liabilities and shareholders' equity	$	8,187,662		$	7,055,356

The accompanying notes are an integral part of these consolidated financial statements.

IsoRay, Inc. and Subsidiaries

Consolidated Statements of Operations

(Unaudited)

	Three months ended December 31,						Six months ended December 31,
	2013			2012			2013			2012

Product sales	$	1,085,408		$	975,457		$	2,135,323		$	2,031,689
Cost of product sales		1,119,314			1,134,083			2,246,537			2,210,740

Gross loss		(33,906	)		(158,626	)		(111,214	)		(179,051	)

Operating expenses:
Research and development expenses		170,030			149,176			317,020			290,648
Sales and marketing expenses		326,467			322,094			685,652			638,150
General and administrative expenses		513,964			469,559			1,165,000			1,114,412

Total operating expenses		1,010,461			940,829			2,167,672			2,043,210

Operating loss		(1,044,367	)		(1,099,455	)		(2,278,886	)		(2,222,261	)

Non-operating income (expense):
Interest income		481			128			835			272
Change in fair value of warrant derivative liability		117,000			(55,000	)		81,000			74,000
Financing and interest expense		(86	)		-			(827	)		(6	)

Non-operating income / (expense), net		117,395			(54,872	)		81,008			74,266

Net loss		(926,972	)		(1,154,327	)		(2,197,878	)		(2,147,995	)
Preferred stock deemed dividends (Note 9)		-			-			(726,378	)		-
Preferred stock dividends		(2,658	)		(2,658	)		(5,316	)		(5,316	)

Net loss applicable to common shareholders	$	(929,630	)	$	(1,156,985	)	$	(2,929,572	)	$	(2,153,311	)

Basic and diluted loss per share	$	(0.02	)	$	(0.03	)	$	(0.08	)	$	(0.06	)

Weighted average shares used in computing net loss per share:
Basic and diluted		38,419,502			34,604,605			37,133,875			34,238,401

The accompanying notes are an integral part of these consolidated financial statements.

IsoRay, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(Unaudited)

	Six months ended December 31,
	2013			2012

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(2,197,878	)	$	(2,147,995	)
Adjustments to reconcile net loss to net cash used by operating activities:
Allowance for doubtful accounts		(20,083	)		(13,477	)
Depreciation and amortization of fixed assets		349,232			388,171
Amortization of deferred financing costs and other assets		15,371			14,024
Change in fair value of warrant derivative liability		(81,000	)		(74,000	)
Accretion of asset retirement obligation		36,326			33,211
Share-based compensation		51,786			57,789
Changes in operating assets and liabilities:
Accounts receivable, gross		26,641			222,365
Inventory		(20,762	)		41,433
Other receivables		1,438			1,914
Prepaid expenses and other current assets		46,515			(84,252	)
Accounts payable and accrued expenses		(2,273	)		4,120
Accrued protocol expense		21,668			13,750
Accrued radioactive waste disposal		24,000			24,000
Accrued payroll and related taxes		13,663			9,181
Accrued vacation		(2,646	)		(3,230	)

Net cash used by operating activities		(1,738,002	)		(1,512,996	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of fixed assets		(14,419	)		-
Additions to licenses and other assets		(1,562	)		(13,407	)
Change in restricted cash		(32	)		(84	)

Net cash used by investing activities		(16,013	)		(13,491	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Preferred dividends paid		(10,632	)		(10,632	)
Proceeds from sales of preferred stock, pursuant to underwritten offering, net		1,478,712			-
Proceeds from sales of common stock, pursuant to underwritten offering, net		1,800,580			-
Proceeds from sales of common stock, pursuant to registered direct offering, net		-			3,291,977
Proceeds from sales of common stock, pursuant to exercise of warrants, net		-			1,825
Proceeds from sales of common stock, pursuant to exercise of options		-			11,309

Net cash provided by financing activities		3,268,660			3,294,479

Net increase in cash and cash equivalents		1,514,645			1,767,992
Cash and cash equivalents, beginning of period		2,899,927			2,672,711

CASH AND CASH EQUIVALENTS, END OF PERIOD	$	4,414,572		$	4,440,703

The accompanying notes are an integral part of these consolidated financial statements.

IsoRay, Inc.

Notes to the Unaudited Consolidated Financial Statements

For the three and six months ended December 31, 2013 and 2012

Basis of Presentation

The accompanying consolidated financial statements are those of IsoRay, Inc., and its wholly-owned subsidiaries (IsoRay or the Company). All significant intercompany accounts and transactions have been eliminated in consolidation. Certain amounts in the prior-year financial statements have been reclassified to conform to the current year presentation.

In the opinion of management, the accompanying unaudited interim consolidated financial statements and notes to the interim consolidated financial statements contain all adjustments, consisting of normal recurring items, necessary to present fairly, in all material respects, the financial position of IsoRay, Inc. and its wholly-owned subsidiaries. These unaudited interim consolidated financial statements should be read in conjunction with our audited consolidated financial statements and related footnotes as set forth in the Company’s annual report filed on Form 10-K for the year ended June 30, 2013, as it may be amended from time to time.

The results of operations for the periods presented may not be indicative of those which may be expected for a full year. The unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures are adequate for the information not to be misleading.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, the reported amounts of revenues and expenses during the reporting period and the disclosures of contingent liabilities. Accordingly, ultimate results could differ materially from those estimates.

New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the “FASB”) or other standards setting bodies that are adopted by us as of the specified effective dates. Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.

Loss per Share

Basic earnings per share is calculated by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding, and does not include the impact of any potentially dilutive common stock equivalents. Common stock equivalents, including warrants and options to purchase the Company's common stock, are excluded from the calculations when their effect is antidilutive. At December 31, 2013 and 2012, the calculation of diluted weighted average shares did not include preferred stock, common stock warrants, or options that are potentially convertible into common stock as those would be antidilutive due to the Company’s net loss position.

Securities, presented on an as-converted to common stock basis, not considered in the calculation of diluted weighted average shares, but that could be dilutive in the future as of December 31, 2013 and 2012, were as follows:

	December 31,
	2013		2012
Series B preferred stock		59,065		59,065
Series D preferred stock		3,121,480		-
Common stock warrants		7,605,771		1,957,033
Common stock options		2,370,072		2,312,072

Total potential dilutive securities		13,156,388		4,328,170

Inventory

Inventory consisted of the following at December 31, 2013 and June 30, 2013:

	December 31,		June 30,
	2013		2013
Raw materials	$	168,731	$	167,671
Work in process		212,726		195,323
Finished goods		44,876		42,577

Total inventory	$	426,333	$	405,571

Share-Based Compensation

The following table presents the share-based compensation expense recognized during the three and six months ended December 31, 2013 and 2012:

	Three months				Six months
	ended December 31,				ended December 31,
	2013		2012		2013		2012
Cost of product sales	$	4,499	$	10,164	$	8,921	$	20,328
Research and development expenses		3,482		8,717		6,965		17,435
Sales and marketing expenses		879		1,523		1,757		3,182
General and administrative expenses		4,572		8,422		34,141		16,844
Total share-based compensation	$	13,432	$	28,826	$	51,784	$	57,789

As of December 31, 2013, total unrecognized compensation expense related to stock-based options was $42,626 and the related weighted-average period over which it is expected to be recognized is approximately 0.82 years.

The Company currently provides stock-based compensation under three equity incentive plans approved by the Board of Directors. Options granted under each of the plans have a ten year maximum term, an exercise price equal to at least the fair market value of the Company’s common stock on the date of the grant, and varying vesting periods as determined by the Board. For stock options with graded vesting terms, the Company recognizes compensation cost on a straight-line basis over the requisite service period for the entire award.

A summary of stock options within the Company’s share-based compensation plans as of December 31, 2013 was as follows:

					Weighted
			Weighted		Average
	Average		Remaining		Aggregate
	Number of		Exercise		Contractual		Intrinsic
	Options		Price		Term		Value

Outstanding at December 31, 2013		2,370,072	$	1.79		4.57	$	125,884
Vested and expected to vest at
December 31, 2013		2,278,260	$	1.84		4.50	$	114,801
Vested and exercisable at
December 31, 2013		2,080,064	$	1.90		4.13	$	125,784

There were no options exercised during the six months ended December 31, 2013 and 31,700 options exercised during the six months ended December 31, 2012. The Company’s current policy is to issue new shares to satisfy option exercises. The intrinsic value of the employee options exercised during the six months ended December 31, 2012 was $13,866.

There were 65,000 stock option awards granted and no stock option awards granted during the six months ended December 31, 2013 and 2012, respectively.

There were 50,000 director stock options issued to the Chief Executive Officer and Chairman on September 5, 2013 with an exercise price of $0.58 per share which was the closing price of the Company common stock on the day of issuance. The fair value of the stock options issued on September 5, 2013 using a Black Scholes model is $25,150 utilizing the closing price on the day of grant of $0.58 per share as the grant and exercise price, a five year term, volatility of 132.31% and a discount rate of 1.85%.

There were 15,000 employee stock options issued to three members of management on September 6, 2013 with an exercise price of $0.59 per share which was the closing price of the Company common stock on the day of issuance. The fair value of the stock options issued on September 6, 2013 using a Black Scholes model is $6,906 utilizing the closing price on the day of grant of $0.59 per share as the grant and exercise price, a five year term, volatility of 132.31% and a discount rate of 1.77%.

Commitments and Contingencies

Patent and Know-How Royalty License Agreement

The Company is the holder of an exclusive license to use certain “know-how” developed by one of the founders of a predecessor to the Company and licensed to the Company by the Lawrence Family Trust, a Company shareholder. The terms of this license agreement require the payment of a royalty based on the Net Factory Sales Price, as defined in the agreement, of licensed product sales. Because the licensor’s patent application was ultimately abandoned, only a 1% “know-how” royalty based on Net Factory Sales Price, as defined in the agreement, remains applicable. To date, management believes that there have been no product sales incorporating the “know-how” and therefore no royalty is due pursuant to the terms of the agreement. Management believes that ultimately no royalties should be paid under this agreement as there is no intent to use this “know-how” in the future.

The licensor of the “know-how” has disputed management’s contention that it is not using this “know-how”. On September 25, 2007 and again on October 31, 2007, the Company participated in nonbinding mediation regarding this matter; however, no settlement was reached with the Lawrence Family Trust. After additional settlement discussions, which ended in April 2008, the parties failed to reach a settlement. The parties may demand binding arbitration at any time.

Fair Value Measurements

The table below sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2013 and June 30, 2013, respectively, and the fair value calculation input hierarchy level the Company has determined applies to each asset and liability category.

	Balance at		Balance at		Input
Description	December 31, 2013		June 30, 2013		Hierarchy Level
Assets:
Cash and cash equivalents	$	4,414,572	$	2,899,927	Level 1
Restricted cash		181,181		181,149	Level 1

Liabilities:
Warrant liability	$	23,000	$	104,000	Level 2

Preferred Dividends

On December 19, 2013, the Board of Directors declared a dividend on the Series B Preferred Stock of all currently payable and accrued outstanding and cumulative dividends through December 31, 2013 in the amount of $10,632. Dividends on the Series B Preferred Stock were last paid on December 31, 2012 as declared by the Board of Directors on December 21, 2012 in the amount of $10,632. The dividends outstanding and cumulative through December 31, 2013 of $10,632 and through December 31, 2012 of $10,632 were paid as of those dates.

Shareholders’ Equity

Common and preferred stock transactions

On August 29, 2013, the Company entered into an agreement to sell 3,800,985 common units, each consisting of 1 share of common stock and a warrant to purchase 0.816 shares of common stock (the “Common Units”), and 1,670 preferred units, each consisting of 1 share of Series D Convertible Preferred Stock and a warrant to purchase 1,525.23 shares of common stock (the “Preferred Units”) on a firm commitment underwritten basis. The Common Units were sold at an initial per unit purchase price of $0.535 and the Preferred Units were sold at an initial per unit purchase price of $1,000. The warrants are all exercisable at $0.72 per share, are callable, and have a twenty-four month term, with the exercise price and term subject to reduction if shareholder approval is obtained, and are not exercisable until March 1, 2014. Each share of the Series D Convertible Preferred Stock is convertible into 1,869.15 shares of common stock at any time at the option of the holder, subject to adjustment, provided that the holder will be prohibited from converting Series D Convertible Preferred Stock into shares of the Company's common stock if, as a result of such conversion, the holder, together with affiliates, would own more than 9.99% of the total shares of the Company's common stock then issued and outstanding. The preferred shares which are convertible into shares of common stock contain a beneficial conversion feature of $726,378 which was recognized as a deemed dividend to the Series D preferred shareholders on the date of issuance. This public offering resulted in gross proceeds of $3.7 million. The offering yielded approximately $3,279,292 in cash after expenses.

Series D

Series D convertible preferred shares are entitled to dividends in the same form as dividends actually paid on shares of common stock. Series D convertible preferred shares are convertible into shares of common stock at the rate of 1,869.15 shares of common stock for each share of Series D convertible preferred stock (subject to adjustment as provided in the certificate of designation for the Series D Convertible Preferred Stock), and are subject to conversion limitations if the conversion would result in the holder together with its affiliates, beneficially owning more than 9.99% of the total number of shares of our common stock then issued and outstanding. Series D convertible preferred shareholders shall not have the right to vote on any matter other than those set forth in the Certificate of Designation with the potential to specifically adversely affect the Series D Convertible Preferred Stock.

Upon the execution of a fundamental transaction which effects a merger or other change of control transaction of the Company a holder will have the right to receive, upon any subsequent conversion of a share of Series D Convertible Preferred Stock (in lieu of conversion shares) for each issuable conversion share, the same kind and amount of securities, cash or property as it would have been entitled to receive upon the occurrence of such fundamental transaction if it had been, immediately prior to such fundamental transaction, the holder of the shares of common stock into which such holder's shares of Series D Convertible Preferred Stock is then convertible.

Gross proceeds from public offering	$	3,703,527
Underwriting discount		(185,176	)
Legal and accounting expense		(184,514	)
Listing expense		(48,500	)
Other expense		(6,045	)
Net proceeds		3,279,292

Warrant liability and related offering cost deferral

Based on the guidance contained in ASC 815 “Derivatives and Hedging”, management has concluded that the warrants issued in the October 13, 2011 underwritten registered offering of 2,500,000 shares of common stock should be classified as a derivative liability and has recorded a liability at fair value. The Company determined the fair value of the warrants using the Black-Scholes fair value model. The Company determined the fair value of the warrants on the date of the offering to be as disclosed in the tables below. The Company has recognized a change in fair value as described in the table below:

Change in fair value of the derivative warrant liability for the three months ended December 31, 2013 and 2012, respectively.

	Three months ended			Three months ended
	December 31, 2013			December 31, 2012
Change in fair value	$	(117,000	)	$	55,000

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on October 19, 2011.

	Three months ended					Three months ended
	December 31, 2013					December 31, 2012
	Quantity¹		Amount			Quantity¹		Amount
Balance, beginning of period		650,003	$	127,000			650,003	$	168,000
Change in fair value		650,003		(107,000	)		650,003		50,000
Warrants exercised		-		-			-		-
Balance, end of period		650,003	$	20,000			650,003	$	218,000

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on December 7, 2011.

	Three months ended					Three months ended
	December 31, 2013					December 31, 2012
	Quantity¹		Amount			Quantity¹		Amount
Balance, beginning of period		63,598	$	13,000			63,598	$	17,000
Change in fair value		63,598		(10,000	)		63,598		5,000
Warrants exercised		-		-			-		-
Balance, end of period		63,598	$	3,000			63,598	$	22,000
Total fair value of warrant derivative liability at December 31, 2013 and 2012			$	23,000				$	240,000

Change in fair value of the derivative warrant liability for the six months ended December 31, 2013 and 2012, respectively.

	Six months ended			Six months ended
	December 31, 2013			December 31, 2012
Change in fair value	$	(81,000	)	$	(74,000	)

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on October 19, 2011.

	Six months ended					Six months ended
	December 31, 2013					December 31, 2012
	Quantity¹		Amount			Quantity¹		Amount
Balance, beginning of period		650,003	$	94,000			650,003	$	286,000
Change in fair value		650,003		(74,000	)		650,003		(68,000	)
Warrants exercised		-		-			-		-
Balance, end of period		650,003	$	20,000			650,003	$	218,000

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on December 7, 2011.

	Six months ended					Six months ended
	December 31, 2013					December 31, 2012
	Quantity¹		Amount			Quantity¹		Amount
Balance, beginning of period		63,598	$	10,000			63,598	$	28,000
Change in fair value		63,598		(7,000	)		63,598		(6,000	)
Warrants exercised		-		-			-		-
Balance, end of period		63,598	$	3,000			63,598	$	22,000
Total fair value of warrant derivative liability at December 31, 2013 and 2012			$	23,000				$	240,000

¹ Quantity of warrants either issued or outstanding as of the date of valuation.

Warrants

The following table summarizes the warrants outstanding as of the beginning of the fiscal year, warrants exercised and warrants issued during the year and weighted average prices for each category.

			Weighted average
	Warrants		exercise price
Outstanding as of June 30, 2013		1,957,033	$	1.38
Warrants issued		5,648,738		0.72
Outstanding as of December 31, 2013		7,605,771	$	0.89

Warrants outstanding as of December 31, 2013

Quantity		Expiration date	Exercise price
	6,000	June 8, 2015	$	1.18
	25,000	July 27, 2015		2.00
	5,648,738	August 25, 2015		0.72
	1,207,832	November 21, 2015		1.56
	650,003	October 19, 2016		1.043
	63,198	December 7, 2016		1.043
	5,000	June 27, 2017		0.98
	7,605,771		$	0.89

10.

Related Party Transaction

During the six months ended December 31, 2013 and 2012, the Company continued to engage the services of APEX Data Systems, Inc., owned by Dwight Babcock, the Company’s Chairman and Chief Executive Officer, to modify and maintain the Company’s web interfaced data collection application to aggregate patient data in a controlled environment. The Audit Committee and Board of Directors approved the use of the ongoing services of APEX Data Systems. Mr. Babcock recused himself from the Board vote due to his conflict of interest. The cost recorded during the six months ended December 31, 2013 and 2012 from APEX Data Systems, Inc. for the maintenance of the web interfaced data collection application was $9,720 and $8,960, respectively. An additional $6,000 was spent on the implementation of Customer Relationship Management software in the six months ended December 31, 2013.

11.

Subsequent Event

In January 2014, the holder of the 1,670 shares of Series D convertible preferred stock fully exercised its right to convert the 1,670 shares of Series D convertible preferred stock into 3,121,480 shares of common stock which resulted in an increase in shares of common stock outstanding from 38,419,502 to 41,540,982. Subsequent to the conversion, no shares of Series D convertible preferred stock remain outstanding.

ITEM 2 – MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Caution Regarding Forward-Looking Information

In addition to historical information, this Form 10-Q contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”). This statement is included for the express purpose of availing IsoRay, Inc. of the protections of the safe harbor provisions of the PSLRA.

All statements contained in this Form 10-Q, other than statements of historical facts, that address future activities, events or developments are forward-looking statements, including, but not limited to, statements containing the words "believe," "expect," "anticipate," "intends," "estimate," "forecast," "project," and similar expressions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new products, services, developments or industry rankings; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. These statements are based on certain assumptions and analyses made by us in light of our experience and our assessment of historical trends, current conditions and expected future developments as well as other factors we believe are appropriate under the circumstances. However, whether actual results will conform to the expectations and predictions of management is subject to a number of risks and uncertainties described under “Risk Factors” under Part II, Item 1A below and in the “Risk Factors” section of our Form 10-K for the fiscal year ended June 30, 2013 that may cause actual results to differ materially.

Consequently, all of the forward-looking statements made in this Form 10-Q are qualified by these cautionary statements and there can be no assurance that the actual results anticipated by management will be realized or, even if substantially realized, that they will have the expected consequences to or effects on our business operations. Readers are cautioned not to place undue reliance on such forward-looking statements as they speak only of the Company's views as of the date the statement was made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Critical Accounting Policies and Estimates

The discussion and analysis of the Company’s financial condition and results of operations are based upon its consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities. On an on-going basis, management evaluates past judgments and estimates, including those related to bad debts, inventories, accrued liabilities, and contingencies. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The accounting policies and related risks described in the Company’s annual report on Form 10-K as filed with the Securities and Exchange Commission on September 30, 2013 are those that depend most heavily on these judgments and estimates. As of December 31, 2013, there had been no material changes to any of the critical accounting policies contained therein.

Results of Operations

Three months ended December 31, 2013 compared to three months ended December 31, 2012.

Revenues. During the three months ended December 31, 2013, total revenue increased from the three months ended December 31, 2012. Revenue generated by prostate brachytherapy and non-prostate related treatments which is described below as Product Sales – (Other) both increased. The increase in revenue from prostate brachytherapy treatments is the result of a new physician being added to a key physician group that resulted in nearly doubling of revenue at an existing treatment facility and the addition of a new treatment facility at which the new physician treated a significant volume of patients as well. While the overall revenue produced by Product Sales – (Other) continued to increase in the three months ended December 31, 2013 when compared to the three months ended December 31, 2012, there continued to be significant variances in utilization of the GliaSite^® Radiation Therapy System (the “GliaSite RTS”) and in treating brain cancer and lung cancer with brachytherapy seeds. The newer brachytherapy product sales reported as “other” represent more developmental applications of our product which may not lead to either a long-term revenue source or a significant product line and therefore revenue fluctuation in this segment is expected to be subject to more significant variation from quarter to quarter. Company management intends to actively pursue alternative uses for the Company’s brachytherapy seeds in treatments consistent with the FDA clearance granted permitting the Company to utilize other FDA cleared application methods as a means of administering the treatments. New treatments such as those being initiated by the Company can be expected to experience a staged entry to market in which primary adopters demonstrate the suitability of a treatment, after which wider adoption is possible. The products being implemented by the Company are very dependent on first adopters as a source of revenue which assists in offsetting some of the developmental cost, and there is initially a significant change in revenue period over period that is expected to reach a plateau due to treatment capacity and quantity of cases available to the first adopters until the mainstream adoption occurs, when and if there is favorable publication of the experiences and treatment outcomes of the first adopters. However, to date the Company has only experienced minimal sales to first adopters. Management believes that the overall market for prostate brachytherapy has continued to receive increased pressure from other treatment options with higher reimbursement rates such as Intensity –Modulated Radiation Therapy (IMRT) and Robotics but management believes that combining treatments incorporating brachytherapy with other modalities in the prostate, the addition of new treatment facilities and treatment of other body sites with brachytherapy have the potential to continue to increase revenue. During the three months ended December 31, 2013 and 2012, respectively, all product sales were generated by the brachytherapy seeds and the related methods of application except for the revenue generated by the sales of GliaSite RTS which include the sale of the Iotrex solution, catheter trays and access trays. The conversion of prospects to new GliaSite RTS customers has been a longer process than originally anticipated by the Company. The Company has experienced lengthy timelines in the internal processes of the medical facilities in reviewing and approving the use of the product at the request of their physician(s). These longer than anticipated internal processes are compounded by uncertain timelines and delays in receiving the approval for the requested modification of each facility's nuclear materials license, which is required to begin using GliaSite RTS and is dependent on external government regulators.

Key operating factors
	Three months		Three months
Description	ended 12-31-13		ended 12-31-12		Variance ($)		Variance (%)
Product Sales (Prostate)	$	937,296	$	840,819	$	96,477		11%
Product Sales (Other)		148,112		134,638		13,474		10%
Total product sales	$	1,085,408	$	975,457	$	109,951		11%

Cost of product sales.

Cost of product sales nominally decreased during the three months ended December 31, 2013 compared to the three months ended December 31, 2012.

The two key operating factors that changed significantly in the three months ended December 31, 2013 as compared to the three months ended December 31, 2012 were the addition of the medical device tax and an increase in production costs of the GliaSite RTS. The addition of the medical device tax expense was the result of the implementation of the Affordable Care Act in calendar year 2013. The increase in the GliaSite RTS production costs was the result of additional Iotrex solution required to meet the increased revenue. Additionally, there was a reduction in overall pre-loading costs through a reduction in third-party loading cost, as the Company is loading nearly 100% of its orders in-house, and an improved utilization of pre-loading materials. There was a reduction in other expense as the result of six months property tax expense being recorded during the three months ended December 31, 2012 while there was three months expense recorded during the three months ended December 31, 2013. Nominal changes in other categories of seed production expenses are summarized as Other cost of product sales (Seeds).

Key operating factors

	Three months		Three months
Description	ended 12-31-13		ended 12-31-12		Variance ($)			Variance (%)
Medical device tax expense	$	23,612	$	-	$	23,612			100%
Pre-loading production expense		64,147		80,033		(15,886	)		(20%	)
Other expense		17,784		32,547		(14,763	)		(45%	)
Other cost of product sales (Seeds)		975,589		998,477		(22,888	)		(2%	)
GliaSite RTS		38,182		23,026		15,156			66%
Total cost of product sales	$	1,119,314	$	1,134,083	$	(14,769	)		(1%	)

Gross loss. Gross loss for the three months ended December 31, 2013 decreased compared to the three month period ended December 31, 2012 as a result of increased revenue from product sales reduced by a minimal increase in cost of product sales. Management continued to seek to control variable costs, however, at this time most remaining production costs are of a fixed nature and related to minimum personnel costs to meet peak demand orders.

Key operating factor

	Three months			Three months
Description	ended 12-31-13			ended 12-31-12			Variance ($)		Variance (%)
Gross loss	$	(33,906	)	$	(158,626	)	$	124,720		79%

Gross loss percentage		(3%	)		(16%	)

Research and development. Research and development costs increased during the three months ended December 31, 2013 compared to the three months ended December 31, 2012. The single category which changed materially was protocol expense as the Company continues to invest in aggregating data regarding the performance of the Company products which was offset by a combination of immaterial changes in other cost categories.

Key operating factors

	Three months		Three months
Description	ended 12-31-13		ended 12-31-12		Variance ($)			Variance (%)
Protocol expense	$	53,792	$	24,333	$	29,459			121%
Other research-development expense		116,238		124,843		(8,605	)		(7%	)
Total research and development	$	170,030	$	149,176	$	20,854			14%

Sales and marketing expenses. Sales and marketing expenses were virtually flat in the three months ended December 31, 2013 compared to the three months ended December 31, 2012. The single category which changed materially was travel expense as the Company continues to manage its travel costs as actively as possible which was offset by a combination of nominal changes in other cost categories.

Key operating factors

	Three months		Three months
Description	ended 12-31-13		ended 12-31-12		Variance ($)			Variance (%)
Travel expense	$	46,006	$	69,794	$	(23,788	)		(34%	)
Other sales-marketing expense		280,461		252,300		28,161			11%
Total sales and marketing	$	326,467	$	322,094	$	4,373			1%

General and administrative expenses. General and administrative expenses increased in the three months ended December 31, 2013 compared to the three months ended December 31, 2012. The single category which changed materially was bad debt expense (recovery) which was partially offset by a combination of nominal changes in other cost categories. As of December 31, 2012, there was a significant reduction in the amounts classified by management for inclusion in the allowance for doubtful accounts when compared to the balance as of September 30, 2012. This decrease in allowance for doubtful accounts resulted in an unusually large recovery being recognized in the statement of operations during the three months ended December 31, 2012. The amount included in allowance for doubtful accounts at September 30, 2012 was approximately double the next largest balance in allowance for doubtful accounts during the past eight quarters. The reduction in allowance for doubtful accounts during the three months ended December 31, 2012 was the result of the successful collection of amounts due to the Company from its customers.

Key operating factors

	Three months			Three months
Description	ended 12-31-13			ended 12-31-12			Variance ($)			Variance (%)
Bad debt expense (recovery)		(15,082	)		(64,949	)		49,867			77%
General and administrative (Other)		529,046			534,508			(5,462	)		(1%	)
Total general and administrative	$	513,964		$	469,559		$	44,405			9%

Operating loss. Operating loss for the three months ended December 31, 2013 decreased compared to the three months ended December 31, 2012 primarily as the result of the increase in product sales coupled with the non-material decrease in cost of product sales and the non-material increase in operating expenses.

Key operating factor

	Three months			Three months
Description	ended 12-31-13			ended 12-31-12			Variance ($)		Variance (%)
Operating loss	$	(1,044,367	)	$	(1,099,455	)	$	55,088		5%

Change in fair value of warrant liability. During the three months ended December 31, 2011, there was a warrant derivative liability established upon issuance of warrants during October 2011 to December 2011 to the purchasers in the Company’s registered offering. The warrant liability requires periodic evaluation for changes in fair value. As required at December 31, 2013, the Company evaluated the fair value of the warrant derivative liability using the Black-Scholes option pricing model and applied updated inputs as of those dates. The resulting change in fair value was recorded as of December 31, 2013.

Key operating factor

	Three months		Three months
Description	ended 12-31-13		ended 12-31-12			Variance ($)		Variance (%)
Change in fair value of warrant liability	$	117,000	$	(55,000	)	$	172,000		(313%	)

Six months ended December 31, 2013 compared to six months ended December 31, 2012.

Revenues. Revenue generated by prostate brachytherapy experienced a nominal increase while the industry continued to experience a decrease as a whole. The increase in revenue created was the result of a single physician increasing his volume of treatments by a factor of 2.5 times the prior year while other physician changes offset each other. The strategy implemented by management in prior years of diversifying the number of body sites being actively treated with the Proxcelan Cs-131 brachytherapy seed has increased revenue during the six months ended December 31, 2013 compared to the six months ended December 31, 2012. Company management intends to continue to actively pursue alternative uses for the Company’s brachytherapy seeds in treatments consistent with the FDA clearance granted permitting the Company to utilize other FDA cleared application methods as a means of administering the treatments as previously identified and to continue to search out new applications in coordination with physicians.

Management believes that the overall market for prostate brachytherapy has continued to receive increased pressure from other treatment options with higher reimbursement rates such as IMRT and Robotics but that combination treatments incorporating brachytherapy with other modalities in the prostate and treatment of other body sites with brachytherapy have the potential to continue to increase.

	Six months		Six months
Description	ended 12-31-13		ended 12-31-12		Variance ($)		Variance (%)
Product Sales (Prostate)	$	1,790,049	$	1,722,675	$	67,374		4%
Product Sales (Other)		345,274		309,014		36,260		12%
Total product sales	$	2,135,323	$	2,031,689	$	103,634		5%

Cost of product sales. Cost of product sales related to brachytherapy seed sales decreased by a nominal amount during the six months ended December 31, 2013 compared to the six months ended December 31, 2012 as the result of a combination of individually nominal cost reductions which are described as other cost of product sales (Seeds), partially offset by the addition of the medical device tax incurred as part of the Affordable Care Act. Cost of product sales related to GliaSite RTS increased as the result of increased Iotrex production required to support the increased sales of the product along with the addition of the medical device tax incurred as part of the Affordable Care Act. The net result of the reduced cost of product sales related to brachytherapy seeds was offset by an increased cost of product sales related to GliaSite RTS, which resulted in the overall increase in cost of product sales.

Key operating factors

	Six months		Six months
Description	ended 12-31-13		ended 12-31-12		Variance ($)			Variance (%)
Medical device tax	$	46,404	$	-	$	46,404			100%
GliaSite RTS		81,071		38,266		42,805			112%
Other cost of product sales (Seeds)		2,119,062		2,172,474		(53,412	)		(2%	)
Total cost of product sales	$	2,246,537	$	2,210,740	$	35,797			2%

Gross loss. Gross loss for the six month period ended December 31, 2013 decreased compared to the six month period ended December 31, 2012 primarily as a result of the increased product sales reduced by the nominal increase in cost of product sales.

Key operating factor

	Six months			Six months
Description	ended 12-31-13			ended 12-31-12			Variance ($)		Variance (%)
Gross loss	$	(111,214	)	$	(179,051	)	$	67,837		38%

Gross loss percentage		(5%	)		(9%	)

Research and development. Research and development costs increased by a nominal amount in the six months ended December 31, 2013 compared to the six months ended December 31, 2012 primarily as a result of changes in the key operating factors that net to an overall nominal increase in cost. The single operating factor that increased in research and development expense was the investment in protocol expenses.

Key operating factors

	Six months		Six months
Description	ended 12-31-13		ended 12-31-12		Variance ($)			Variance (%)
Protocol expense	$	87,613	$	41,191	$	46,422			113%
Research and development (Other)		229,407		249,457		(20,050	)		(8%	)
Total research and development	$	317,020	$	290,648	$	26,372			9%

Sales and marketing expenses. Sales and marketing expenses increased in the six months ended December 31, 2013 compared to the six months ended December 31, 2012. Travel expense was reduced as a function of reduced meal expenses being incurred during the six months ended December 31, 2013 when compared to the six months ended December 31, 2012. The overall decrease in travel expense and in particular meals expense is the result of a revision of the travel policy governing reimbursement for these expenses. Payroll, benefits and share-based compensation increased as a function of having an increased number of sales employees in the field. Tradeshows and convention expense increased primarily as the result of increased attendance at society meetings, conventions and tradeshows.

Key operating factors

	Six months		Six months
Description	ended 12-31-13		ended 12-31-12		Variance ($)			Variance (%)
Travel expense	$	113,627	$	135,489	$	(21,862	)		(16%	)
Payroll, benefits and share-based
compensation		452,137		406,921		45,216			11%
Sales and marketing (Other)		119,888		95,740		24,148			25%
Total sales and marketing	$	685,652	$	638,150	$	47,502			7%

General and administrative expenses. General and administrative expenses increased in the six months ended December 31, 2013 compared to the six months ended December 31, 2012 primarily as a result of one key operating factor. The single key operating factor was public company expense that increased as the result of increased SEC filing expenses in combination with increased investor relations expenses.

Key operating factors

	Six months		Six months
Description	ended 12-31-13		ended 12-31-12		Variance ($)		Variance (%)
Public company expense	$	140,854	$	117,340	$	23,514		20%
General and administrative (Other)		1,024,146		997,072		27,074		3%
Total general and administrative	$	1,165,000	$	1,114,412	$	50,588		5%

Operating loss. Operating loss for the six months ended December 31, 2013 increased compared to the six months ended December 31, 2012 primarily as a result of an overall increase in operating expenses and cost of product sales in excess of the increase in revenue from product sales.

Key operating factor

	Six months			Six months
Description	ended 12-31-13			ended 12-31-12			Variance ($)			Variance (%)
Operating loss	$	(2,278,886	)	$	(2,222,261	)	$	(56,625	)		(3%	)

Change in fair value of warrant liability. During the three months ended December 31, 2011, there were warrant liabilities established upon issuance of warrants to the purchasers and underwriters in the Company’s registered offering during October 2011 to December 2011. Per ASC 820, the warrant liability requires periodic evaluation for changes in fair value. As required at December 31, 2013 and December 31, 2012, the Company evaluated the fair value of the warrant liability using the Black-Scholes option pricing model on which the original warrant liability was based and applied updated inputs as of those dates. The resulting change in fair value was recorded as of December 31, 2013 and December 31, 2012.

	Six months		Six months
Description	ended 12-31-13		ended 12-31-12		Variance ($)		Variance (%)
Change in fair value of warrant liability	$	81,000	$	74,000	$	7,000		9%

Liquidity and capital resources. The Company has historically financed its operations through cash investments from shareholders. During the six months ended December 31, 2013 and December 31, 2012, the Company primarily used existing cash reserves to fund its operations and capital expenditures.

Cash flows from operating activities

Cash used by operating activities is the net loss adjusted for non-cash items and changes in operating assets and liabilities. Management continued to reduce cash consumed in operating activities through a combination of cost reductions and operational efficiencies identified in the results of operations that resulted in an increase in the net loss, which when reduced by the non-cash items and non-cash changes in operating assets and liabilities, resulted in an overall increase in net cash used by operating activities for the six months ended December 31, 2013 when compared to the six months ended December 31, 2012.

Key operating factor

	Six months			Six months
Description	ended 12-31-13			ended 12-31-12			Variance ($)			Variance (%)
Net loss	$	(2,197,878	)	$	(2,147,995	)	$	(49,883	)		(2%	)
Non-cash items		351,632			405,718			(54,086	)		(13%	)
Non-cash changes in operating assets and liabilities		108,244			229,281			(121,037	)		(53%	)
Net cash used by operating activities	$	(1,738,002	)	$	(1,512,996	)	$	(225,006	)		(15%	)

Cash flows from investing activities

Cash used by investing activities during the six months ended December 31, 2013 was primarily related to the deployment of new equipment to improve the efficiency of operations and in the six months ended December 31, 2012 was primarily related to the capitalization of costs related to other assets. The amounts recorded to restricted cash in both periods are the accrual of interest earned on certificates of deposit with two financial institutions that are a requirement of the Washington State Department of Health.

Key operating factor

	Six months			Six months
Description	ended 12-31-13			ended 12-31-12			Variance ($)			Variance (%)
Purchases of fixed assets	$	(14,419	)	$	-		$	(14,419	)		100%
Additions to licenses and other assets		(1,562	)		(13,407	)		11,845			(88%	)
Change in restricted cash		(32	)		(84	)		52			(62%	)
Net cash used by investing activities	$	(16,013	)	$	(13,491	)	$	(2,522	)		19%

Cash flows from financing activities

Cash provided by financing activities in the six months ended December 31, 2013 and December 31, 2012 was the result of the sales of common stock through registered direct and underwritten offerings. Cash used during the six months ended December 31, 2013 and 2012 was the result of dividend payments to the preferred shareholders.

Key operating factor

	Six months			Six months
Description	ended 12-31-13			ended 12-31-12			Variance ($)			Variance (%)
Preferred dividend payments	$	(10,632	)	$	(10,632	)	$	-			0%
Proceeds from sale of preferred stock, net		1,478,712			-			1,478,712			100%
Proceeds from sale of common stock		1,800,580			3,305,111			(1,504,531	)		(46%	)
Net cash provided by financing activities	$	3,268,660		$	3,294,479		$	(25,819	)		(1%	)

Projected Fiscal Year 2014 Liquidity and Capital Resources

At December 31, 2013, the Company held cash and cash equivalents of $4,414,572 as compared to $2,899,927 of cash and cash equivalents at June 30, 2013.

The Company had approximately $4.31 million of cash and cash equivalents and no short-term investments as of February 6, 2014. The Company’s monthly required cash operating expenditures were approximately $290,000 in the six months ended December 31, 2013, which represents a 15% increase or approximately $38,000 from average monthly cash operating expenditures of $252,000 in the six months ended December 31, 2012. The increased use of cash in operating activities of approximately $225,000 is primarily the result of the increased net loss of approximately $50,000 which was driven by the increases in cost of product sales and operating expenses in excess of the increase in revenue, a decrease of $54,000 of cash contributed by changes in non-cash expenses and a decrease of approximately $121,000 of cash contributed by changes in operating assets and liabilities. Management believes that there will not be a significant requirement for capital equipment with the exception of the production of liquid cesium-131 for use in the GliaSite RTS which is expected to be less than $50,000, however, there is no assurance that unanticipated needs for capital equipment may not arise for other needs.

Management intends to continue its existing protocol studies and to begin new protocol studies on lung and inter-cranial cancer treatments using Cesium-131 brachytherapy seeds and the GliaSite RTS. The Company continues to believe that approximately $180,000 in expense will be incurred during fiscal year 2014 related to protocol expenses relating to lung cancer, intra-cranial cancer and both dual therapy and mono therapy prostate cancer protocols but there is no assurance that unanticipated needs for additional protocols in support of the development of new applications of our existing products may not arise.

Based on the foregoing assumptions, management believes cash, cash equivalents, and short-term investments of approximately $4.31 million on hand at February 6, 2014 will be sufficient to meet our anticipated cash requirements for operations and capital expenditure requirements through at least the next twelve months assuming both revenue and expenses remain at current levels.

Management plans to attain breakeven and generate additional cash flows by increasing revenues from both new and existing customers (through our direct sales channels and through our distributors), increasing sales of the Company’s GliaSite RTS, and expanding into other market applications which initially will include inter-cranial, head and neck, and lung implants, while maintaining the Company's focus on cost control. However, there can be no assurance that the Company will attain profitability or that the Company will be able to attain increases in its revenue. Sales in the prostate market have not shown the increases necessary to breakeven during the past six fiscal years and showed only a nominal increase during the six months ended December 31, 2013.

For the six months ended December 31, 2013, revenue from other treatment modalities with brachytherapy seeds has decreased by 16% when compared to the six months ended December 31, 2012. When including the revenue from the sale of GliaSite RTS, revenue from non-prostate treatments has increased 12% in the six months ended December 31, 2013 compared to the six months ended December 31, 2012. As management is focused on increasing revenue from head and neck, colorectal, lung and brain applications of Cesium-131 brachytherapy seeds in addition to increasing the number of cases treated with of the GliaSite RTS, management believes the Company has sufficient cash and cash equivalents to sustain protocols, marketing staff, production staff and production equipment as it works to gain market share.

These non-prostate brachytherapy treatments are in the early stages of application in the clinical setting and the purchasing patterns are subject to the influence of a few key physicians which can significantly influence revenue from quarter to quarter.

There was no material change in the use of proceeds from our public offerings as described in our final prospectus supplements filed with the SEC pursuant to Rule 424(b) on July 17, 2012 and August 29, 2013. Through December 31, 2013, the Company had used the net proceeds raised through the July 2012 and August 2013 offerings as described in the table below and held the remaining net proceeds in cash and cash equivalents. No offering expenses were paid directly or indirectly to any of our directors or officers (or their associates) or persons owning ten percent or more of any class of our equity securities or to any other affiliates.

Offering description	Period	Net proceeds		Remaining net proceeds
Registered direct offering	July 2012	$	3,291,977	$	1,133,455
Underwritten offering	August 2013		3,279,292		3,279,292
Total			6,571,269		4,412,747

Management believes that the Company will require additional equity investment to maintain its common stock’s listing status on the NYSE MKT. The Company expects to finance its future cash needs through the conversion of outstanding warrants to purchase common stock, other sales of equity, possible strategic collaborations, debt financing or through other sources that may be dilutive to existing shareholders. Management anticipates that if it raises additional financing that it will be at a discount to the market price and it will be dilutive to shareholders. Of course, funding may not be available to it on acceptable terms, or at all. If the Company is unable to raise additional funds, it may be unable to expand into new applications and may need to curtail operations.

Other Commitments and Contingencies

The Company is subject to various local, state, and federal environmental regulations and laws due to the isotopes used to produce the Company’s product. As part of normal operations, amounts are expended to ensure that the Company is in compliance with these laws and regulations. While there have been no reportable incidents or compliance issues, the Company believes that if it relocates its current production facilities then certain decommissioning expenses will be incurred. An asset retirement obligation was established in the first quarter of fiscal year 2008 for the Company’s obligations at its current production facility. This asset retirement obligation will be for obligations to remove any residual radioactive materials and to remove all leasehold improvements.

The industry that the Company operates in is subject to product liability litigation. Through its production and quality assurance procedures, the Company works to mitigate the risk of any lawsuits concerning its products. The Company also carries product liability insurance to help protect it from this risk.

The Company has no off-balance sheet arrangements.

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, the Company is not required to provide Part I, Item 3 disclosure in this Quarterly Report.

ITEM 4 – CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the design and operation of our disclosure controls and procedures, as such term is defined under Rules 13a-14(c) and 15d-14(c) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of December 31, 2013. Based on that evaluation, our principal executive officer and our principal financial officer concluded that the design and operation of our disclosure controls and procedures were effective. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. However, management believes that our system of disclosure controls and procedures is designed to provide a reasonable level of assurance that the objectives of the system will be met.

Changes in Internal Control over Financial Reporting

There have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

The Company is continuing the process of remediating the single deficiency which constituted a material weakness identified in its Form 10-K for the fiscal year ended June 30, 2013.

Progress made on remediating the single deficiency which constituted a material weakness in the six months ended December 31, 2013 consisted of the following:

The Company promoted its Controller, Principal Financial and Accounting Officer, to the position of Chief Financial Officer effective October 1, 2013.

As a result of ongoing reviews of all significant and non-routine transactions, management believes that there are no material inaccuracies or omissions of material fact and to the best of its knowledge believes that the consolidated financial statements for the three and six months ended December 31, 2013 fairly present in all material respects the financial condition and results of operations for the Company in conformity with U.S generally accepted accounting principles.

PART II - OTHER INFORMATION

ITEM 1A – RISK FACTORS

There have been no material changes for the risk factors disclosed in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended June 30, 2013, except for the following:

Outstanding Warrants May Depress Share Price. Our warrants issued in August 2013 to purchase 5,648,738 shares of our common stock with an exercise price of $0.72 per share (subject to possible reduction to $0.535 per share if Company shareholder approval is obtained at the upcoming annual meeting to be held on March 5, 2014) become exercisable March 1, 2014 and do not expire until August 29, 2015. Until these warrants are fully exercised or expire, it may depress the price of our common stock to the warrants' exercise price.

Failure to Comply with NYSE MKT Listing Standards And Any Resulting Delisting Could Adversely Affect The Market For Our Common Stock. Our common stock is presently listed on the NYSE MKT. The NYSE MKT will consider delisting a company's securities if, among other things, the company fails to maintain minimum stockholder's equity or the company has sustained losses which are so substantial in relation to its overall operations or its existing financial resources, or its financial condition has become so impaired that it appears questionable, in the opinion of the NYSE MKT, as to whether such issuer will be able to continue operations and/or meet its obligations as they mature. There can be no assurance that we will be able to maintain our listing on the NYSE MKT indefinitely. We anticipate falling below the minimum stockholders equity requirement for the quarter ended March 31, 2014. We may need to raise additional capital sooner than anticipated to meet listing standards if the warrants sold in August 2013 are not exercised. If we are unable to raise this capital our shares may become delisted. In the event that our common stock is delisted from the NYSE MKT, trading, if any, in the common stock would be conducted in the over-the-counter market. As a result, our shareholders would likely find it more difficult to dispose of, or to obtain accurate quotations as to the market value of, our common stock.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Use of Proceeds from Registered Securities

On October 27, 2009, we filed a registration statement on Form S-3 to register securities up to $15 million in value for future issuance in our capital raising activities. The registration statement became effective on November 13, 2009, and the Commission file number assigned to the registration statement is 333-162694. The registration statement expired on November 12, 2012.

There was no material change in the use of proceeds from the July 17, 2012 registered public offering as described in our final prospectus filed with the SEC pursuant to Rule 424(b) on July 17, 2012. Through December 31, 2013, we had begun to use the net proceeds from this registered offering as described in our final prospectus filed with the SEC pursuant to Rule 424(b) and had invested all remaining net proceeds in cash and cash equivalents.

On May 13, 2013, we filed a registration statement on Form S-3 to register securities up to $20 million in value for future issuance in our capital raising activities. The registration statement became effective on June 14, 2013 and the Commission file number assigned to the registration statement is 333-188579.

There was no material change in the use of proceeds from the August 29, 2013 public offering closing for the August 2013 underwritten public offering as described in our final prospectus filed with the SEC pursuant to Rule 424(b) on August 29, 2013. Through December 31, 2013, we had not begun to use the net proceeds from this underwritten offering as described in our final prospectus filed with the SEC pursuant to Rule 424(b) and had invested all net proceeds in cash and cash equivalents.

The proceeds used during the three months ended December 31, 2013 were from the July 17, 2012 registered public offering and no proceeds from the August 29, 2013 underwritten offering were used.

Proceeds used in the six months ended December 31, 2013:
Indirect payments to directors and officers for database maintenance and development	$	15,720
Direct payments of compensation to directors		69,000
Direct payments of salaries to officers		332,107
Working capital		1,347,820
Total proceeds used in the six months ended December 31, 2013	$	1,764,647

ITEM 6. EXHIBITS

Exhibits:

31.1*	Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer

31.2*	Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer

32**	Section 1350 Certifications

101.INS***	XBRL Instance Document

101.SCH***	XBRL Taxonomy Extension Document

101.CAL***	XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF***	XBRL Taxonomy Extension Definition Linkbase Document

101.LAB***	XBRL Taxonomy Extension Label Linkbase Document

101.PRE***	XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

** Furnished herewith.

*** Furnished herewith. In accordance with Rule 406T of Regulation S-T, the information in these exhibits shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: February 14, 2014

	ISORAY, INC., a Minnesota corporation

	By	/s/ Dwight Babcock
		Dwight Babcock, Chief Executive Officer (Principal Executive Officer)

	By	/s/ Brien Ragle
		Brien Ragle, Chief Financial Officer (Principal Financial and Accounting Officer)

EX-31.1 2 v367032_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATION

I, Dwight Babcock certify that:

1. I have reviewed this quarterly report on Form 10-Q of IsoRay, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 14, 2014

	/s/ Dwight Babcock
	Dwight Babcock
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2 3 v367032_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATION

I, Brien L. Ragle certify that:

1. I have reviewed this quarterly report on Form 10-Q of IsoRay, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 14, 2014

	/s/ Brien L. Ragle
	Brien L. Ragle
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-32 4 v367032_ex32.htm EXHIBIT 32

Exhibit 32

Section 1350 Certifications

Pursuant to 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of IsoRay, Inc., a Minnesota corporation (the "Company"), hereby certify that:

To my knowledge, the Quarterly Report on Form 10-Q of the Company for the quarterly period ended December 31, 2013 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 14, 2014

		/s/ Dwight Babcock
		DWIGHT BABCOCK
		CHIEF EXECUTIVE OFFICER (Principal Executive Officer)

Dated: February 14, 2014

		/s/ Brien Ragle
		BRIEN RAGLE
		CHIEF FINANCIAL OFFICER (Principal Financial and Accounting Officer)

EX-101.INS 5 isr-20131231.xml XBRL INSTANCE DOCUMENT false --06-30 Q2 2014 2013-12-31 10-Q 0000728387 41540982 Smaller Reporting Company IsoRay, Inc. 5648738 0.72 P24M P24M 0.0999 3703527 185176 184514 48500 6045 0.01 20083 13477 <div> <div> <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 84%; TEXT-ALIGN: justify">Gross proceeds from public offering</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 12%; TEXT-ALIGN: right"> 3,703,527</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Underwriting discount</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(185,176</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Legal and accounting expense</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(184,514</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Listing expense</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(48,500</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify"> Other expense</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (6,045</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> )</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Net proceeds</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">3,279,292</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> </table> </div> </div> 2015-06-08 2015-07-27 2015-08-25 2015-11-21 2016-10-19 2016-12-07 2017-06-27

432566

430293

923780

917222

107578

104932

57431293

60747935

15371

14024

8921

4499

20328

10164

6965

3482

17435

8717

1757

879

3182

1523

34141

4572

16844

8422

51784

13432

57789

28826

52598

32515

7605771

1957033

2670072

2312072

13156388

4328170

59065

3121480

36326

33211

792242

828568

7055356

8187662

4443660

5924556

2672711

2899927

4414572

4440703

2899927

4414572

1514645

1767992

1.38

0.89

0.72

1.18

2.00

0.72

1.56

1.043

0.98

0.816

1525.23

1957033

7605771

650003

63598

6000

25000

5648738

1207832

650003

63198

5000

0.001

193000000

192998329

34618517

38419502

34618517

38419502

41540982

34618

38420

1670

3121480

1869.15

2246537

1119314

2210740

1134083

9720

8960

25150

6906

349232

388171

104000

23000

104000

23000

10632

-0.08

-0.02

-0.06

-0.03

127419

141082

P9M26D

42626

<div> <div> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for the three months ended December 31, 2013 and 2012, respectively.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify" nowrap="nowrap">  </td> <td style="FONT-SIZE: 10pt" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify" colspan="2" nowrap="nowrap">Three months ended</td> <td style="FONT-SIZE: 10pt" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify" colspan="2" nowrap="nowrap">Three months ended</td> <td style="FONT-SIZE: 10pt" nowrap="nowrap"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify" nowrap="nowrap">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt" nowrap="nowrap">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: justify" colspan="2" nowrap="nowrap">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt" nowrap="nowrap">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt" nowrap="nowrap">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: justify" colspan="2" nowrap="nowrap">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt" nowrap="nowrap">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 68%; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 12%; TEXT-ALIGN: right"> (117,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 12%; TEXT-ALIGN: right"> 55,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on October 19, 2011.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Three months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Three months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 44%; TEXT-ALIGN: justify"> Balance, beginning of period</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 650,003</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 127,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 650,003</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 168,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(107,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">50,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify"> Warrants exercised</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Balance, end of period</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">20,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">218,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on December 7, 2011.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Three months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Three months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 44%; TEXT-ALIGN: justify"> Balance, beginning of period</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 63,598</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 13,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 63,598</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 17,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(10,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">5,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify"> Warrants exercised</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Balance, end of period</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">3,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">22,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> Total fair value of warrant derivative liability at<br /> December 31, 2013 and 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 23,000</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 240,000</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for the six months ended December 31, 2013 and 2012, respectively.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 68%; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 12%; TEXT-ALIGN: right"> (81,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 12%; TEXT-ALIGN: right"> (74,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">)</td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on October 19, 2011.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 44%; TEXT-ALIGN: justify"> Balance, beginning of period</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 650,003</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 94,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 650,003</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 286,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(74,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(68,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify"> Warrants exercised</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Balance, end of period</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">20,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">218,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on December 7, 2011.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 44%; TEXT-ALIGN: justify"> Balance, beginning of period</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 63,598</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 10,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 63,598</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 28,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(7,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(6,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify"> Warrants exercised</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Balance, end of period</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">3,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">22,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: justify"> Total fair value of warrant derivative liability at<br /> December 31, 2013 and 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 23,000</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 240,000</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <sup>1</sup> Quantity of warrants either issued or outstanding as of the date of valuation.</p> </div> </div>

1165000

513964

1114412

469559

-111214

-33906

-179051

-158626

-2273

4120

-26641

-222365

13663

9181

20762

-41433

21668

13750

24000

-2646

-3230

-1438

-1914

-46515

84252

827

42577

44876

405571

426333

469758

167671

168731

195323

212726

835

481

272

128

1689110

1698848

7055356

8187662

792868

847280

3268660

3294479

-16013

-13491

-1738002

-1512996

-2197878

-926972

-2147995

-1154327

-2929572

-929630

-2153311

-1156985

81008

117395

74266

-54872

2167672

1010461

2043210

940829

-2278886

-1044367

-2222261

-1099455

25305

46973

276507

262698

100000

124000

11502

10064

10632

1562

13407

14419

5316

2658

5316

2658

0.001

726378

1000000

5000000

1000000

7001671

1671

59065

1670

59065

1670

202880

156365

3291977

1478712

1800580

3279292

11309

1825

1684282

1349469

6000

317020

170030

290648

149176

181149

181181

181149

181181

-52091334

-54289212

2135323

1085408

2031689

975457

685652

326467

638150

322094

51786

57789

P10Y

0.58

0.59

P5Y

1.3231

0.0185

0.0177

2080064

1.90

13866

50000

15000

65000

125884

2370072

1.79

P4Y6M26D

125784

P4Y1M17D

114801

2278260

1.84

P4Y6M

0.58

0.59

0.535

1000

5366246

6488814

<div> <div> <table style="MARGIN-BOTTOM: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-TOP: 0px" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify"> <td style="WIDTH: 0.5in; TEXT-ALIGN: left"><strong>9.</strong></td> <td style="TEXT-ALIGN: justify"><strong>Shareholders' Equity</strong></td> </tr> </table> <p style="COLOR: #943634; TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong> </strong></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <em>Common and preferred stock transactions</em></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> On August 29, 2013, the Company entered into an agreement to sell 3,800,985 common units, each consisting of 1 share of common stock and a warrant to purchase 0.816 shares of common stock (the "Common Units"), and 1,670 preferred units, each consisting of 1 share of Series D Convertible Preferred Stock and a warrant to purchase 1,525.23 shares of common stock (the "Preferred Units") on a firm commitment underwritten basis. The Common Units were sold at an initial per unit purchase price of $0.535 and the Preferred Units were sold at an initial per unit purchase price of $1,000. The warrants are all exercisable at $0.72 per share, are callable, and have a twenty-four month term, with the exercise price and term subject to reduction if shareholder approval is obtained, and are not exercisable until March 1, 2014. Each share of the Series D Convertible Preferred Stock is convertible into 1,869.15 shares of common stock at any time at the option of the holder, subject to adjustment, provided that the holder will be prohibited from converting Series D Convertible Preferred Stock into shares of the Company's common stock if, as a result of such conversion, the holder, together with affiliates, would own more than 9.99% of the total shares of the Company's common stock then issued and outstanding. The preferred shares which are convertible into shares of common stock contain a beneficial conversion feature of $726,378 which was recognized as a deemed dividend to the Series D preferred shareholders on the date of issuance. This public offering resulted in gross proceeds of $3.7 million. The offering yielded approximately $3,279,292 in cash after expenses.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <u>Series D</u></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Series D convertible preferred shares are entitled to dividends in the same form as dividends actually paid on shares of common stock. Series D convertible preferred shares are convertible into shares of common stock at the rate of 1,869.15 shares of common stock for each share of Series D convertible preferred stock (subject to adjustment as provided in the certificate of designation for the Series D Convertible Preferred Stock), and are subject to conversion limitations if the conversion would result in the holder together with its affiliates, beneficially owning more than 9.99% of the total number of shares of our common stock then issued and outstanding. Series D convertible preferred shareholders shall not have the right to vote on any matter other than those set forth in the Certificate of Designation with the potential to specifically adversely affect the Series D Convertible Preferred Stock.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Upon the execution of a fundamental transaction which effects a merger or other change of control transaction of the Company a holder will have the right to receive, upon any subsequent conversion of a share of Series D Convertible Preferred Stock (in lieu of conversion shares) for each issuable conversion share, the same kind and amount of securities, cash or property as it would have been entitled to receive upon the occurrence of such fundamental transaction if it had been, immediately prior to such fundamental transaction, the holder of the shares of common stock into which such holder's shares of Series D Convertible Preferred Stock is then convertible.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 84%; TEXT-ALIGN: justify">Gross proceeds from public offering</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 12%; TEXT-ALIGN: right"> 3,703,527</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Underwriting discount</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(185,176</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Legal and accounting expense</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(184,514</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Listing expense</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(48,500</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify"> Other expense</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> (6,045</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left"> )</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Net proceeds</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">3,279,292</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <em>Warrant liability and related offering cost deferral</em></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Based on the guidance contained in ASC 815 "Derivatives and Hedging", management has concluded that the warrants issued in the October 13, 2011 underwritten registered offering of 2,500,000 shares of common stock should be classified as a derivative liability and has recorded a liability at fair value. The Company determined the fair value of the warrants using the Black-Scholes fair value model. The Company determined the fair value of the warrants on the date of the offering to be as disclosed in the tables below. The Company has recognized a change in fair value as described in the table below:</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for the three months ended December 31, 2013 and 2012, respectively.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify" nowrap="nowrap">  </td> <td style="FONT-SIZE: 10pt" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify" colspan="2" nowrap="nowrap">Three months ended</td> <td style="FONT-SIZE: 10pt" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify" colspan="2" nowrap="nowrap">Three months ended</td> <td style="FONT-SIZE: 10pt" nowrap="nowrap"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify" nowrap="nowrap">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt" nowrap="nowrap">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: justify" colspan="2" nowrap="nowrap">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt" nowrap="nowrap">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt" nowrap="nowrap">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: justify" colspan="2" nowrap="nowrap">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt" nowrap="nowrap">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 68%; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 12%; TEXT-ALIGN: right"> (117,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 12%; TEXT-ALIGN: right"> 55,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on October 19, 2011.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Three months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Three months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 44%; TEXT-ALIGN: justify"> Balance, beginning of period</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 650,003</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 127,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 650,003</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 168,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(107,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">50,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify"> Warrants exercised</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Balance, end of period</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">20,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">218,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on December 7, 2011.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Three months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Three months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 44%; TEXT-ALIGN: justify"> Balance, beginning of period</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 63,598</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 13,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 63,598</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 17,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(10,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">5,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify"> Warrants exercised</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Balance, end of period</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">3,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">22,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left"> Total fair value of warrant derivative liability at<br /> December 31, 2013 and 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 23,000</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 240,000</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for the six months ended December 31, 2013 and 2012, respectively.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 68%; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 12%; TEXT-ALIGN: right"> (81,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 12%; TEXT-ALIGN: right"> (74,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">)</td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on October 19, 2011.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 44%; TEXT-ALIGN: justify"> Balance, beginning of period</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 650,003</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 94,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 650,003</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 286,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(74,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(68,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify"> Warrants exercised</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Balance, end of period</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">20,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">218,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on December 7, 2011.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="6">Six months ended</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2013</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="6">December 31, 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="BORDER-BOTTOM: black 1pt solid; FONT-SIZE: 10pt; TEXT-ALIGN: center" colspan="2">Quantity<sup>1</sup></td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Amount</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: center">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 44%; TEXT-ALIGN: justify"> Balance, beginning of period</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 63,598</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 10,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 63,598</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 10%; TEXT-ALIGN: right"> 28,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Change in fair value</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(7,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">(6,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">)</td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify"> Warrants exercised</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> -</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify">Balance, end of period</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">3,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,598</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">22,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: justify"> Total fair value of warrant derivative liability at<br /> December 31, 2013 and 2012</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 23,000</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: right">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> $</td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> 240,000</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left">  </td> </tr> </table> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <sup>1</sup> Quantity of warrants either issued or outstanding as of the date of valuation.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <em> </em></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <em>Warrants</em></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The following table summarizes the warrants outstanding as of the beginning of the fiscal year, warrants exercised and warrants issued during the year and weighted average prices for each category.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt" colspan="2"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT: 10pt Times New Roman, Times, Serif"> </td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Weighted average</td> <td style="FONT: 10pt Times New Roman, Times, Serif"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: center"> </td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Warrants</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">exercise price</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="WIDTH: 68%; TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif"> Outstanding as of June 30, 2013</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 12%; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 1,957,033</td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="WIDTH: 12%; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 1.38</td> <td style="WIDTH: 1%; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif"> Warrants issued</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 5,648,738</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 0.72</td> <td style="PADDING-BOTTOM: 1pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif"> Outstanding as of December 31, 2013</td> <td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 7,605,771</td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif">  </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 0.89</td> <td style="PADDING-BOTTOM: 2.5pt; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif">  </td> </tr> </table> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">  </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <em>Warrants outstanding as of December 31, 2013</em></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong> </strong></p> <table style="WIDTH: 90%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Quantity</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center"> Expiration date</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center" colspan="2">Exercise price</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 30%; TEXT-ALIGN: right"> 6,000</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 32%; TEXT-ALIGN: right">June 8, 2015</td> <td style="FONT-SIZE: 10pt; WIDTH: 2%"> </td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; WIDTH: 30%; TEXT-ALIGN: right"> 1.18</td> <td style="FONT-SIZE: 10pt; WIDTH: 1%; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">25,000</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">July 27, 2015</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">2.00</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">5,648,738</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">August 25, 2015</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.72</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">1,207,832</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">November 21, 2015</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">1.56</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">650,003</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">October 19, 2016</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">1.043</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">63,198</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">December 7, 2016</td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">1.043</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: rgb(204,255,204)"> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 5,000</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: right"> June 27, 2017</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt"> </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left">  </td> <td style="FONT-SIZE: 10pt; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> 0.98</td> <td style="FONT-SIZE: 10pt; PADDING-BOTTOM: 1pt; TEXT-ALIGN: left">  </td> </tr> <tr style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: white"> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">7,605,771</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: justify"> </td> <td style="FONT-SIZE: 10pt"> </td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left">$</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: right">0.89</td> <td style="FONT-SIZE: 10pt; TEXT-ALIGN: left"> </td> </tr> </table> </div> </div>

2500000

3800985

1670

31700

13200

8390

81000

117000

74000

-55000

74000

107000

68000

-50000

7000

10000

6000

-5000

23000

240000

286000

94000

20000

218000

127000

168000

28000

10000

3000

22000

13000

17000

37133875

38419502

34238401

34604605

xbrli:shares iso4217:USD isr:warrants xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0000728387 us-gaap:SeriesDPreferredStockMember us-gaap:SubsequentEventMember 2014-01-01 2014-01-31 0000728387 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2014-01-01 2014-01-31 0000728387 us-gaap:SellingAndMarketingExpenseMember 2013-10-01 2013-12-31 0000728387 us-gaap:ResearchAndDevelopmentExpenseMember 2013-10-01 2013-12-31 0000728387 isr:OverAllotmentWarrantsMember 2013-10-01 2013-12-31 0000728387 isr:CommonStockPurchaserWarrantsMember 2013-10-01 2013-12-31 0000728387 us-gaap:GeneralAndAdministrativeExpenseMember 2013-10-01 2013-12-31 0000728387 us-gaap:CostOfSalesMember 2013-10-01 2013-12-31 0000728387 2013-10-01 2013-12-31 0000728387 2013-09-04 2013-09-06 0000728387 2013-09-04 2013-09-05 0000728387 us-gaap:SeriesDPreferredStockMember 2013-08-26 2013-08-29 0000728387 isr:PreferredUnitWarrantsMember 2013-08-26 2013-08-29 0000728387 isr:CommonUnitWarrantsMember 2013-08-26 2013-08-29 0000728387 us-gaap:CommonStockMember 2013-08-26 2013-08-29 0000728387 2013-08-26 2013-08-29 0000728387 us-gaap:WarrantMember 2013-07-01 2013-12-31 0000728387 us-gaap:AffiliatedEntityMember 2013-07-01 2013-12-31 0000728387 us-gaap:SeriesBPreferredStockMember 2013-07-01 2013-12-31 0000728387 us-gaap:SeriesBPreferredStockMember 2013-07-01 2013-12-31 0000728387 us-gaap:SeriesDPreferredStockMember 2013-07-01 2013-12-31 0000728387 us-gaap:SellingAndMarketingExpenseMember 2013-07-01 2013-12-31 0000728387 us-gaap:ResearchAndDevelopmentExpenseMember 2013-07-01 2013-12-31 0000728387 isr:RangeOfExercisePriceSevenMember 2013-07-01 2013-12-31 0000728387 isr:RangeOfExercisePriceSixMember 2013-07-01 2013-12-31 0000728387 isr:RangeOfExercisePriceFiveMember 2013-07-01 2013-12-31 0000728387 isr:RangeOfExercisePriceFourMember 2013-07-01 2013-12-31 0000728387 isr:RangeOfExercisePriceThreeMember 2013-07-01 2013-12-31 0000728387 isr:RangeOfExercisePriceTwoMember 2013-07-01 2013-12-31 0000728387 isr:RangeOfExercisePriceOneMember 2013-07-01 2013-12-31 0000728387 isr:OverAllotmentWarrantsMember 2013-07-01 2013-12-31 0000728387 isr:CommonStockPurchaserWarrantsMember 2013-07-01 2013-12-31 0000728387 us-gaap:GeneralAndAdministrativeExpenseMember 2013-07-01 2013-12-31 0000728387 us-gaap:EmployeeStockOptionMember 2013-07-01 2013-12-31 0000728387 us-gaap:CostOfSalesMember 2013-07-01 2013-12-31 0000728387 2013-07-01 2013-12-31 0000728387 us-gaap:SellingAndMarketingExpenseMember 2012-10-01 2012-12-31 0000728387 us-gaap:ResearchAndDevelopmentExpenseMember 2012-10-01 2012-12-31 0000728387 isr:OverAllotmentWarrantsMember 2012-10-01 2012-12-31 0000728387 isr:CommonStockPurchaserWarrantsMember 2012-10-01 2012-12-31 0000728387 us-gaap:GeneralAndAdministrativeExpenseMember 2012-10-01 2012-12-31 0000728387 us-gaap:CostOfSalesMember 2012-10-01 2012-12-31 0000728387 2012-10-01 2012-12-31 0000728387 us-gaap:WarrantMember 2012-07-01 2012-12-31 0000728387 us-gaap:AffiliatedEntityMember 2012-07-01 2012-12-31 0000728387 us-gaap:SeriesBPreferredStockMember 2012-07-01 2012-12-31 0000728387 us-gaap:SeriesBPreferredStockMember 2012-07-01 2012-12-31 0000728387 us-gaap:SeriesDPreferredStockMember 2012-07-01 2012-12-31 0000728387 us-gaap:SellingAndMarketingExpenseMember 2012-07-01 2012-12-31 0000728387 us-gaap:ResearchAndDevelopmentExpenseMember 2012-07-01 2012-12-31 0000728387 isr:OverAllotmentWarrantsMember 2012-07-01 2012-12-31 0000728387 isr:CommonStockPurchaserWarrantsMember 2012-07-01 2012-12-31 0000728387 us-gaap:GeneralAndAdministrativeExpenseMember 2012-07-01 2012-12-31 0000728387 us-gaap:EmployeeStockOptionMember 2012-07-01 2012-12-31 0000728387 us-gaap:CostOfSalesMember 2012-07-01 2012-12-31 0000728387 2012-07-01 2012-12-31 0000728387 us-gaap:CommonStockMember 2011-10-12 2011-10-13 0000728387 2014-02-06 0000728387 us-gaap:SubsequentEventMember 2014-01-31 0000728387 us-gaap:SeriesBPreferredStockMember 2013-12-31 0000728387 us-gaap:SeriesCPreferredStockMember 2013-12-31 0000728387 us-gaap:SeriesDPreferredStockMember 2013-12-31 0000728387 us-gaap:SeriesAPreferredStockMember 2013-12-31 0000728387 isr:RangeOfExercisePriceSevenMember 2013-12-31 0000728387 isr:RangeOfExercisePriceSixMember 2013-12-31 0000728387 isr:RangeOfExercisePriceFiveMember 2013-12-31 0000728387 isr:RangeOfExercisePriceFourMember 2013-12-31 0000728387 isr:RangeOfExercisePriceThreeMember 2013-12-31 0000728387 isr:RangeOfExercisePriceTwoMember 2013-12-31 0000728387 isr:RangeOfExercisePriceOneMember 2013-12-31 0000728387 isr:OverAllotmentWarrantsMember 2013-12-31 0000728387 isr:CommonStockPurchaserWarrantsMember 2013-12-31 0000728387 isr:PatentRightsKnowhowAndLicenseAgreementsMember 2013-12-31 0000728387 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000728387 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000728387 2013-12-31 0000728387 isr:OverAllotmentWarrantsMember 2013-09-30 0000728387 isr:CommonStockPurchaserWarrantsMember 2013-09-30 0000728387 2013-09-06 0000728387 2013-09-05 0000728387 us-gaap:SeriesDPreferredStockMember 2013-08-29 0000728387 isr:PreferredUnitWarrantsMember 2013-08-29 0000728387 isr:CommonUnitWarrantsMember 2013-08-29 0000728387 us-gaap:CommonStockMember 2013-08-29 0000728387 us-gaap:SeriesBPreferredStockMember 2013-06-30 0000728387 us-gaap:SeriesCPreferredStockMember 2013-06-30 0000728387 us-gaap:SeriesDPreferredStockMember 2013-06-30 0000728387 us-gaap:SeriesAPreferredStockMember 2013-06-30 0000728387 isr:OverAllotmentWarrantsMember 2013-06-30 0000728387 isr:CommonStockPurchaserWarrantsMember 2013-06-30 0000728387 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2013-06-30 0000728387 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2013-06-30 0000728387 2013-06-30 0000728387 isr:OverAllotmentWarrantsMember 2012-12-31 0000728387 isr:CommonStockPurchaserWarrantsMember 2012-12-31 0000728387 2012-12-31 0000728387 isr:OverAllotmentWarrantsMember 2012-09-30 0000728387 isr:CommonStockPurchaserWarrantsMember 2012-09-30 0000728387 isr:OverAllotmentWarrantsMember 2012-06-30 0000728387 isr:CommonStockPurchaserWarrantsMember 2012-06-30 0000728387 2012-06-30 Quantity of warrants either issued or outstanding as of the date of valuation.

EX-101.SCH 6 isr-20131231.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Disclosure - Basis of Presentation link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40101 - Disclosure - Basis of Presentation (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 106 - Disclosure - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40601 - Disclosure - Commitments and Contingencies (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 002 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 003 - Statement - Consolidated Balance Sheets (Parenthetical) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 005 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 004 - Statement - Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 001 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 107 - Disclosure - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40701 - Disclosure - Fair Value Measurements (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 307 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 104 - Disclosure - Inventory link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40401 - Disclosure - Inventory (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 304 - Disclosure - Inventory (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 103 - Disclosure - Loss per Share link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40301 - Disclosure - Loss per Share (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 303 - Disclosure - Loss per Share (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 102 - Disclosure - New Accounting Pronouncements link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 108 - Disclosure - Preferred Dividends link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40801 - Disclosure - Preferred Dividends (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 110 - Disclosure - Related Party Transaction link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41001 - Disclosure - Related Party Transaction (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 105 - Disclosure - Share-Based Compensation link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40501 - Disclosure - Share-Based Compensation (Schedule of Share-Based Compensation Expense) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40502 - Disclosure - Share-Based Compensation (Schedule of Stock Option Activity) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 305 - Disclosure - Share-Based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 109 - Disclosure - Shareholders' Equity link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 111 - Disclosure - Subsequent Event link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40906 - Disclosure - Shareholders' Equity (Additional Information about Warrants) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40901 - Disclosure - Shareholders' Equity (Common and Preferred Stock Transactions) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41101 - Disclosure - Subsequent Event (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40903 - Disclosure - Shareholders' Equity (Schedule of Inputs for Fair Value Model) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40902 - Disclosure - Shareholders' Equity (Schedule of Initial Warrant Liability) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 309 - Disclosure - Shareholders' Equity (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40905 - Disclosure - Shareholders' Equity (Warrants) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.CAL 7 isr-20131231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 isr-20131231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 isr-20131231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Basis of Presentation [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Basis of Presentation Effective Income Tax Rate, Continuing Operations Anticipated effective income tax rate fiscal year 2014 Commitments and Contingencies [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Major Class Name [Domain] Patent Rights Knowhow And License Agreements [Member] Patent Rights, Knowhow and License Agreements. Patent Rights Know-how and License Agreements [Member] Percentage Of Royalty Rate Payable On Net Sales Percentage of Royalty Rate Payable on Net Sales Percentage of royalty payment on net sales Schedule of Finite-Lived Intangible Assets [Table] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Accounts receivable, net of allowance for doubtful accounts of $32,515 and $52,598, respectively Accounts Receivable, Net, Current Accrued vacation Accrued Vacation, Current Additional paid-in capital Additional Paid in Capital Asset Retirement Obligations, Noncurrent Asset retirement obligation Assets Total assets Assets [Abstract] ASSETS Assets, Current Total current assets Assets, Current [Abstract] Current assets: Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Class of Stock [Domain] Commitments and contingencies (Note 6) Commitments and Contingencies Common stock, $.001 par value; 192,998,329 & 193,000,000 shares authorized; 38,419,502 and 34,618,517 shares issued and outstanding Common Stock, Value, Issued Warrant derivative liability Derivative Liabilities, Noncurrent Accrued payroll and related taxes Employee-related Liabilities, Current Inventory Inventory, Net Inventory, non-current Inventory, Noncurrent Liabilities Total liabilities Liabilities and Equity Total liabilities and shareholders' equity Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities, Current Total current liabilities Liabilities, Current [Abstract] Current liabilities: Other Accrued Liabilities, Current Accrued protocol expense Other Assets, Noncurrent Other assets, net of accumulated amortization Other Liabilities, Current Accrued radioactive waste disposal Other Receivables, Gross, Current Other receivables Preferred Stock, Value, Issued Preferred stock, $.001 par value; 7,001,671 shares authorized: Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Property, Plant and Equipment, Net Fixed assets, net of accumulated depreciation and amortization Restricted Cash and Cash Equivalents, Noncurrent Restricted cash Retained Earnings (Accumulated Deficit) Accumulated deficit Series A Preferred Stock [Member] Series B Preferred Stock [Member] Series C Preferred Stock [Member] Series D Preferred Stock [Member] Class of Stock [Axis] Statement [Line Items] Consolidated Balance Sheets [Abstract] Statement [Table] Stockholders' Equity Attributable to Parent Total shareholders' equity Stockholders' Equity Attributable to Parent [Abstract] Shareholders' equity: Treasury Stock, Value Treasury stock, at cost 13,200 shares Accounts receivable, allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Common Stock, Par or Stated Value Per Share Common stock, par value per share Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common stock, shares outstanding Common Stock, Shares, Outstanding Preferred Stock, Par or Stated Value Per Share Preferred stock, par or stated value per share Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Treasury Stock, Shares Treasury stock, shares Amortization of deferred financing costs and other assets Amortization Adjustments to reconcile net loss to net cash used by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Asset Retirement Obligation, Accretion Expense Accretion of asset retirement obligation Cash and cash equivalents, beginning of period CASH AND CASH EQUIVALENTS, END OF PERIOD Net increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Depreciation and amortization of fixed assets Depreciation, Depletion and Amortization, Nonproduction Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Accounts Receivable Accounts receivable, gross Accrued payroll and related taxes Increase (Decrease) in Employee Related Liabilities Increase (Decrease) in Inventories Inventory Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accrued protocol expense Increase (Decrease) in Other Accrued Liabilities Accrued radioactive waste disposal Increase (Decrease) in Other Current Liabilities Accrued vacation Increase (Decrease) in Other Employee Related Liabilities Increase (Decrease) in Other Receivables Other receivables Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Change in restricted cash Increase (Decrease) in Restricted Cash Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash used by investing activities Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used by operating activities Net Income (Loss) Attributable to Parent Net loss Noncash Investing and Financing Items [Abstract] Non-cash investing and financing activities: Payments of Ordinary Dividends, Preferred Stock and Preference Stock Preferred dividends paid Payments to Acquire Intangible Assets Additions to licenses and other assets Payments to Acquire Property, Plant, and Equipment Purchases of fixed assets Proceeds from Issuance of Common Stock Proceeds from sales of common stock, pursuant to registered direct offering, net Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from Issuance of Private Placement Proceeds from sales of common stock, pursuant to underwritten offering, net Proceeds from Stock Options Exercised Proceeds from sales of common stock, pursuant to exercise of options Proceeds from Warrant Exercises Proceeds from sales of common stock, pursuant to exercise of warrants, net Provision For Reduction Of Doubtful Accounts Provision for (Reduction of) Doubtful Accounts. Allowance for doubtful accounts Repayments of Notes Payable Principal payments on notes payable Share-based Compensation Share-based compensation Consolidated Statements of Cash Flows [Abstract] Supplemental Cash Flow Information [Abstract] EX-101.PRE 10 isr-20131231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`:,QE5V@$``#$6```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%UKPC`4AN\'^P\EM\/& MI)MSP^K%/BXW8>X'9,W1%MLD)-'IOU]:/QC2.63"SHU%FYSW,90'^@Y&JZJ, MEF!=H55*6-PE$:A,RT+-4O(^>>[T2>2\4%*46D%*UN#(:'AY,9BL#;@H[%8N M);GWYIY2E^50"1=K`RK[?9HII4'Y3N^GD&&@T>8 MBD7IHZ=5^'E#8J%T)'K8+*RS4B*,*8M,^$!*ETH>I'2V"7'8V:QQ>6'<5<`@ MM#6AOO-SP';?:S@:6TB(QL+Z%U$%#+HJZ:>V\P^MY_'Q(2V4>CHM,I`Z6U3A M!&)G+`CI<@!?E7%SC2M1J!WWD?QFL:/-A9T9I/Y_S>`3.3@2C@0)QS42CALD M'#TD'+=(./I(..Z0<+`N%A`L1F58E,JP.)5AD2K#8E6&1:L,BU<9%K$R+&;E M6,S*L9B58S$KQV)6CL6L'(M9.1:S*TG?'A$%@?0'[%K.M#=PGAGKT],"#.A+J`E:";,FF3>$[ M_`(``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\ M(V(T'4\4"_'L)MI< M3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?```` M__\#`%!+`P04``8`"````"$`_GO?E-(!```<%0``&@`(`7AL+U]R96QS+W=O M_%[)K?BL"EJL2UI0]@)88@((EL]X>W MKX40%*F=7J*]1+*C.*/)>KYX9XNOPS[[<#YLFSI7U.NKS-5%4V[K3:[>5L\/ M$Y6%:.O2[IO:Y>KH@EK,[^]F+VYO8WHH5-LV9&F5.N2JBK%]U#H4E3O8T&M: M5Z<[Z\8?;$Q#O]&M+79VXS3W^R/M?ZZAYC=K9LLR5WY9DE'9ZMBF5_^_>+-> M;POWU!3O!U?'7]ZA/QN_"Y5S,2UJ_<;%7%VF@C[=(=-+FI7^0T[R0U;.!,GA MD;`<'D$Y)"V'D!PS$)9C!DC.6%C-&(DA%E9##.5(FT/0'1X*N\-#Y(Z1#D$# M0U"Z='#E2$<@X0A,!!4%!/=1Y?!46LX4R9'F`\2#=.'`NB%Q:Z`W+(U.AN@T MTI%C8.:83FD5*NM=^1I]^ND.:;N>?TQOIM&FDF851!5)JR$HAZ7)R9B"'XJD MK2'H#4O#DB$LN5-87MHUUYRY3)T[.`R/=D8ZA/EWA MUI:F$H92TB_9\+L`6]_T-.??````__\#`%!+`P04``8`"````"$`!0F[RG(# M``##"@``#P```'AL+W=O3KE_.-TL]/2CT' M("#-.%Q;6YY%DL:G*JH))VXAH)JB%],V:ER:S=T55Y57,#3TW20AM&D+7*F@YPM:27L`LK;J8-?R3!) MCMT_G14/G&W,>Y!;!F^/7.9JX_X*UF[;50H);.I'CSRW:W@^&`S:>S\87ZWM M[B;(1TB_=A#>4_\&LBYOYPB!3I$;:;G=DCO9N,\5M-"Y?@>5Q6&@SSA4["(7%%!9<;(W(4:))$@B>0_),B,(I44J=1>'TQD;B$?UVY# MU)+\+AE2&2*5X8>Y[*M<4UP1^-Z:,NJJ7%'#ZS?/-#.01-5^XIBH\'70&(*KAMNN58!*1SMF./;PJUU8*Y'#%"$W+Q7L)IPZ1C?VJ/OCQA&\=T8U;,*%IN!AYN83EL#< MQAYR\^K)L)<*>D=N7`=Q)*8M]G#;!X4LZ)/8MQUC%GN%OH:(PQAXD'8,7/*+.4"8Y1@CR>'=S9Y0 M#%'23Z"_#\D\6[.\0CPDF"18=%(XU)9&![90/:O$H_4GOU->ES&L"7]T.[O%ADWC0]L'6 M."P8P:=OBH9^'*FU;='N^W/R M#P``__\#`%!+`P04``8`"````"$`._W[NR0&``"S&```&````'AL+W=O\WI>7X\[^Y^]/J\"VVBZ[[+-S?2EV]K>BM3\\__S3TUO=?&Y/1=%9 MH'!I=_:IZZ[;S:;-3T65M>OZ6ES@SJ%NJJR#C\UQTUZ;(MOW#U7G#7<<;U-E MY<76"MMFB49].)1YD=3Y:U5<.BW2%.>L@_FWI_+:WM2J?(EUXJ9OLY0R^OS(WRV_:_8>9?%7F3=W6AVX-G_H%^K.@BW!$?* MV';_+2G:'%849-9<*J6\/L,$X*=5E2HU8$6RK_WOMW+?G7:V\-;2=P0#W'HI MVNY3J21M*W]MN[KZ3T-LD-(B?!"!)P81QM<\D$QZCU4V>D:]P23KLN>GIGZS M(&M@S/::J1QD6U"^.=/S&+W^R"IX5"(?EB-4],#1:`L6R[3U_4#=9J]@-?O;N)&^`-JC M'8['C>>$+S&2S!$BDLX)0P39$=B.BI*`++YO2ST$G.'"]_`<(XVX!D)&?#&HY!\GUB3R-!GY#,":3K!)B(32+TI2N)1&("G`DI M.$GL%!&PI;T@'`=![F![+7>G8.*.S#W2B*?=,18*1C<4)@38)Y-/3()SUY." M+$"*">;XKO-]>]Y[["F8V)M6K=_\D4:TO940H4.2-T8`DX''"9%@@C%.5RC% MA!\Z4?6&+P#EH>MIXDY M4@^B@='N)!.A1R8?(\+U0BG)QDT0P9@G'6>:?Y\>*4&8Z[)I#;!%]89?G)E, M]P/F2R$@!J*!&7+388[KD>R-$1)"V>0SCWH@+<*9YWO^9&#PB!#'%9Q-RX`] MJD9@N4?=-B"/I'9$3#-Z>BNPZ(I9FE(F#%U)=!+,<.X'04"*;$H9SKFQH-BH MZ@26&]5]`_P<:R0=/&+W>HL^#O%C)'F,I'<1;%(U!,M-ZO8!19,4E(AIQNW? M]"ZMM3&ZS?A4!GO_";H="!+B%-WF1A9C4ZH-,$PMZT#5=R1:3LGTHH$9MB,4 M>EHL8D2LY+R<)(@(V$PB10!T,,88V*;J!PR;]]^#3'G''>)1#(RZGO5*N`D/5)\?]J>V)EJ!98[TXV#Z2R?5Q'3S!@X$9+4 MBA&QDFY@9->0FZ:&"AS)CA1)^"[W?F1/=0/+[>G>`=DC[X"(F?W%*N1>2&!"?!#&>A'_@SDV@H:%+]T%A+'$;5&A@^%^Y#W5`@O^1U%3'-F!TI MS<1X`9,,S/#J\;DGYG[O#H7\\G=U.#V-.YR0=C@#,\R/>Y)$(WX$)!B0\(UO M_$+49W5Z!\#F2&^S+)A\WN/0#C,:&/W-%Y(W]&8-.$8@>;TP(!LXP0P''4DW M04H8)H5@TU["?B$!S>2]7UVYHDDPR02C@0G[-^/*63LDJ^,90-(AF0$D'=(9 M,$4;FR.]S<)@SGN<!H]E9)$F=C`9&;TL1 MN"R4\V!JG8%Q/>C<'9(1"=;QF1"!<:@V[$^LPV$XAZ:L/@O61Z55T1R+N#B? M6RNO7]4YKX"$&Z^.9]`?N3I")-GKF[[<]94_GUB2['8IC?GO;6W__19XVUJ2JT]LQO12W;&]]SRKKT\NOOSQ_ M%.67ZIQE]004;M7>.M?U?3>;58=S=DVK:7'/;O#-J2BO:0T?R[=9=2^S]-B0 MKI>9,Y^O9].T2A.I_R0!<7A_9K=:B929I>TAO%7Y_Q>H=KU,$;N MFI9?WN]/A^)Z!XG7_)+7WQM1:W(][)*W6U&FKQ>8]S=[F1Y0N_E@R%_S0UE4 MQ:F>@MR,#=2<\W:VG8'2R_,QAQG0L$_*[+2W/MN[Q-E8LY?G)D#_Y-E')?U_ M4IV+CZC,C[_EMPRB#>M$5^"U*+Y0:'*D)B#/##9I5N"/] MM5A/5^Y\80-\\II5-ZGKCW?+ESPWL-;-B:B_G:SKJ'AY\VTP7GIP'"CWX-'Z'(B/']H8K`OFP'"\\<<;CD1GF,-&D5I'7Z\EP6'Q/8J[#2U3VE M.]_>@1;F$YNJR+"N!(/,HB*?J@LE#[E2P*[Z^+);V\^PK9/*!8SP3XRY5 MB(\0FK=4-]`-H6X@:'AXUOQ&B$#16#0 M'2T.B$!*@(8'Q5VIG!`AR"%H>'`T-Q$BD!*CX4'1W20(`8X2*]C16Q!N,7]G,5?7W&.8OA@A`DP_1M.$3@5@C0T+D50D0@A:"ADQ(A`BDQ&CHI"2+T#6?# M[I*#U9]*#5HO2WH+P$%]81(0G$$@+)U3"`4$2418.DF1@"`I%I9.4B(@1K1H MSREMO*;O=NF9;:!$V:Q9[>\+.(CMPC4M.5K%]SF"'KM$S5\LM:H?#.J$HW3( MH$XT2B<>U$F&=)3M;=-F]J<6@77!ZB(8V#@6485@I' M*1&.ZAM3-$HI'J&4#"FIBT&[YI]:#-9NJXNAY;MG,U#?CF"(H:48T@FYIWX= M,CB>:)1./*B3#.FHBP"9(2_"0!&G:+V(&Y%G(#GEM#+CVPC!TAH(RZ,Z::10 M0)!$A*63%`D(DF)AZ20E`F(4<=J@2RD[$"V*5AL#\T1'?\L#$,M3VVEI+SE" MZJ!4SGICME`&ARB%C#IB,!_56(61J)O1[WEY*J/&!/53TN''1F<6.6TK$LB<]2`T7Y= M"MA`9K'N7@Z4V9C;#,0F#;_:ZY/V.>`QZ4"EV&V))9TKFM@2E6.ZB0PWL4II M<9/('#5.M',?'R?6Y\MQ6BS7ZBO9L_$PT%D0?`'!*A((2R.%)':+1Y.!QX`'2"K5O(P3G$`A+)RD4$"01 M8>DD10*"I%A8.DF)@.C1@6O2$.%7H.8MMQO5AMM1\:?`[H[R."(9EP ME`P9DHE&R<1#,LF0C+*YG9\](S5$?0'TS.4@N2\QVG..&5H#=B3K4PI'*9$1 M8XI&*<4CE)(A)74QH&K*M6/\;J!$?3'T)M%AH)[=P`!#*S$@$W(__3)D:#31 M*)EX2"89DE$7@)X\1A=OAYU3U.)M1)V!Y,35BS?7D9H"8>DLJ:&`8!TFPM)) MB@0$2;&P=)(2`3&*-SU2C(\61>LYJC6%GL-`+$=M\W='GP/D6"D4LS<-#0I1 MO;3T3P8E5BB.V:4E,D7-*>T`,ZXOIS]2:=$R^G*.8<&"OMQL-SE"CI9\]FGY MG=Q@$-6+&=_(H,0JI>40(U/48&F'F/Z>W#$/+V9/SD'LKPEM&64<712&0]MX MM7T-.>`15J)03">1P8@51HN31*:H,?JA`&T+Z#C)^?/4XB)X1I0;<5=?;?Z`PAH%I M"DT3,4V1:8I-$[W>1`JS0WUJ=L_>P;40TT[@*E:;W7-V?IM.X.S@ M$D6+CK.#FQ*F/79@H-0^$P."FU;W]"W[/2W?\ELUN60GF/Y\2MN-DMW58A_J MXM[\OSEQ_&@?,^KNBA/*Y5H4U7)3YMR6YS>5NH_ M?_M/"U6IF^RTS0[E*5^I/_-:_?+R^V_/'V7UK=[G>:.`PJE>J?NF.2\GDWJS MSX]9K97G_`1'=F5US!KX6+U-ZG.59]OVI.-AHD^G\\DQ*TXJ4UA6CVB4NUVQ MR=UR\W[,3PT3J?)#UD#_ZWUQKGNUX^81N6-6?7L_/VW*XQDD7HM#T?QL157E MN%E&;Z>RREX/<-T_R"S;]-KMAX'\L=A495WN&@WD)JRCPVNV)_8$E%Z>MP5< M`0V[4N6[E?J5+%-BJY.7YS9`_Q;Y1WWSOU+ORX^@*K9I<"U++]1 M--K2)CAY,CC;;QWXLU*V^2Y[/S1_E1]A7KSM&[#;A"NB%[;<_G3S>@,1!1E- M-ZG2ICQ`!^!5.18T-2`BV8_V_:/8-ON5:LPUTYH:!'#E-:\;OZ"2JK)YKYOR M^!^#2"?%1/1.!-X[$6)J,]VT%F-4C$YE?E71-7UA$G,^HB]6IP+O?5^@6P]> M"(R*-AKPWD=#U\AL.J8#=J]D]-G8KI#>&/K/ MM3,/VCMAJ=)FGILUV?(=LWW2,PQAXO3"Z/>.9]5#'$A"W1VC^T^_V^H:K M+N%5_9[H3PE8`TM\JA'VQ%5CT+>H9WJ56&Q(Q(;TIF$"`;]$'0+-1?W^".^# M2VD:W/Z+G;[AVEM#G_/7O!XR.D^X0$2+/.&B"#B#PE1)!@B8FJ$#(%H75)C M<$'1`TS\`)/<88PI'YKT#G,38,Y*F.E&6$EISDJQ82TVN&*#)S;X8D,@-H2L M@8^OQ5]S=(]9\$Q\C[%Y)GF`28?,_#IFN?#.1H67TG#7N\TCXRK<3A<.8^#U MDFM"UJ]1PD4)#R5\E`A0(D2)""5BE$A0(I41G)UPUQPQ6BB]4F$P7JPR#&$" M0EK.\Y+NG0P8*TCOYG1LT1/#?[['<;(/$4)%R4\E/!1(D")L"?H MFFBJ+8AIW_X)WD0]_6DVQRB1H$0J(SB+84'W/RRF9XD6"ZLXAS$RBU'"10D/ M)7R4"%`B1(F($=:L'97$U$U-%W(^1D42E$AE!."CAHT2`$B%*1"@1,$N#9]JIL'FV7:RA1?!_`352QFQ8`ET.V-S MOL+OU!&^4IKW53>%GQ$.8V2^]D0WP0G+0;<__.F,YO7$?0&_/_RI0-`35(!H MAK!H#6\/3S5+6$!$\L-Q?_C3KT]0(I41G'^T5##"P!;G'30,T<$.DEF((RZ. M>#CBXTB`(^$=Q##$GS./0/$=2)C8$AQ)I0CO+RT(W$Z\CZV9"*LC\`MA(#CBXTB`(R&.1#@2XTB"(VF']+?PQ=S6R#55>)-I]>#69/G= ME5;=A&G8,(19U.D@B7-K''%QQ,,1'T<"'`EQ),*1&$<2'$D[Q#+:VZNMV79_ MHV[?#>_I>M/@K::%C!%6L[H'-XYGUU]7K#Y!&"2U>HC,A(QQ[\B(C-CO@X$N!(B",1CL0XDN!(*D5X;VF-8\3(9261 MVY&K$[&R2)_500(P;Y\(/.VRA,78ND.DWC(5">+A*CZ.!#@2XDB$(S&.)#B2 M2A'>6UK?&.$M*X?PWHKU"L*@B[6UCA&>,M*(KRWPJ!T"(,Z;V<+^*W.%R37'2&U5E9\Z1Y4HHB/?U&` M(R&.1#@2XTB"(ZD4X:VE-8X1UK*2"&^ML'YQ"(,Z:^?3F;`R67>`U%FF(4$\ M7,7'D0!'0AR)<"3&D01'4BG".TL+(".<9?42SEE=&)(.;,2A-UNV=C5TR];M MZR*]'6_K#I$8Y^*(AR,^C@0X$N)(A",QCB0X0KC>#QWSEFUC8IM)CGGU MEJ_SPZ%6-N4[W:($-9&7YTOS9?_45X/N8A#:UV0)NSJ&[1Y9PM:-87M(]V'= M:7?TI7-77U_"8_6ACJLOX>GZL-W3E_"0?=CNZTMXUCYL#_0E/'*']LGEPF!; MUCE[R__(JK?B5"N'?`(CK.TJMK&+?6C*<[L'Y[5L8$-6^^\>-N#EL"<% MJL:JLBO+IO]`O^"RI>_E%P```/__`P!02P,$%``&``@````A`+N'!,70`@`` M1`@``!D```!X;"]W;W)K&ULE)5=;]L@%(;O)^T_ M(.YK_)%OQ:G:5-TJ;=(T[>.:8&RC&F,!:=I_OX-)O-A9TNPF,?#ZY3GGX,/R M]E56Z(5K(U2=XB@(,>(U4YFHBQ3__/%X,\/(6%IGM%(U3_$;-_AV]?'#>"\0?%MI+7UIMH7E$+_*84C3FX27:-G:3Z>=O<,"4;L-B(2MBW MUA0CR19/1:TTW500]VLTHNS@W0Y.[*5@6AF5VP#LB`<]C7E.Y@2<5LM,0`0N M[4CS/,5WT6(]PV2U;//S2_"=.7I&IE2[3UID7T3-(=E0)E>`C5+/3OJ4N2EX MF9R\_=@6X)M&&<_IMK+?U>XS%T5IH=IC",C%M'KAAD%"P">*Q)$=L:J^1O+XKV5MXDWILD M0+]?CX-X-H[&$]CT'1?BB=H`'ZBEJZ56.P2'!O8T#75',%J`\R$RS]'%>BY4 MB-&9W#F7%$\Q@B@,E.=EE<3QDKQ`3ME>'=N`;'VJF(X[M!X)9.AZ$B>&2A]MG,1)Y^OAO&9TI/F[ MC8G3C$$WB4EBB8#-J^9M>6,PDDR3-OY]1X7G,WKN9RXSS6> M#["\!#;OT(LWD;#G/ MK_>XW)5VU#`N?XQ.W.=*XM&@GEYS_IB=7_=&PO=V]R:W-H965T"7@HN:*+@56T^V M@I+<#*HK+_#]J5<3UB"K,!?7:/"B8!F]Y]FNIHVR(H)61(%_6;)6'M7J[!JY MFHCG77N3\;H%B0VKF'HSHLBIL_GCMN&";"J8]RL.27;4-C<7\C7+!)>\4"[( M>=;HY9P3+_%`:;G(&L_%L('*2L2'$3@?!#!@1O$$8ZF'U"9'%3@?%+YGP7/3L>D79/OU^QH3L,I@N/97."?=,T$5I8).\SYR898CQ$];Q#: M]=XT#)W3>2Y.!D]>66;,VQC1\P8BUWO3<#^W8#:(S2*QJ7@8XC":#6O:)8(X M29*.1L\:]-CUUC3-#SLM6%!+3/F;8SH>=/[9&X%=[5JRI4]$;%DCG8H64`K?G4%+"+L3 MV!O%6[.J;;B"%=QDOP/(O````__\#`%!+`P04 M``8`"````"$`@+GG##L"```N!0``&0```'AL+W=O5^@Z6]X.YA"2#`J.)HK0CM5)5];)VC`$K&"/;"9FW M[S%.TC1IU;0;P/"?S_^YX,730;9HS[41JLMQ%(08\8ZI4G1UCK]^63_,,3*6 M=B5M5<=S_,H-?BK>OED,2F]-P[E%0.A,CAMK^XP0PQHNJ0E4SSOX4BDMJ86E MKHGI-:?E&"1;$H?AE$@J.NP)F;Z'H:I*,+Y2;"=Y9SU$\Y9:\&\:T9L33;)[ M<)+J[:Y_8$KV@-B(5MC7$8J19-E+W2E--RWD?8@FE)W8X^(&+P73RJC*!H`C MWNAMSH_DD0"I6)0",G!E1YI7.7Z.LN4$DV(QUN>;X(.Y>$:F4<,[+R[JQD*W4TC(Y965KRMN M&!04,$&<.A)3+1B`*Y+"3084A![&^R!*V^0XF0;I+$PBD*,--W8M'!(CMC-6 MR>]>%!U1'A(?(7`_0J(XB.=IE$[_3B'>T9C@BEI:++0:$`P-[&EZZD8PRH#L M,IO\,3-(R<4\NZ`Q%-0&NK$ODBA=D#V4D!TURUM-?%80V/SL`':]=I!`AWY? MVY,#%Y1CN%XXF)[YH\NEUTPN-#\]_N(@^1\'+@CZ>$%/HMF5`Z^YPP%(_KT& M+NBZ!O,K!UXS2\8FA4$8G;_["OB1]Q/1TYI_I+H6G4$MKZ"R83"#6=!^X/W" MJG[L_$99&-3QL8%SB<-8A`&(*Z7L:>%^J?-)5_P```#__P,`4$L#!!0`!@`( M````(0`31G`9\@4``(\<```9````>&PO=V]R:W-H965TM$VY/%KO^?8^("?/GPK3LY74=5Y>=ZX;.:[CCAGY2X_'S;N/W]_ M?%BZ3MVDYUUZ*L]BXWX7M?OA^==?GM[+ZDM]%*)Q0.%<;]QCTUS6GE=G1U&D M]:R\B#-\LR^K(FW@8W7PZDLETEW;J#AY@>\OO"+-SRXJK*LI&N5^GV>"E]E; M(BKI.D:T_'P/WYJ`_1O+M[KWO].?2S??ZORW>?\+"#:D">9@=>R_"+13SMY"1I[ M@]8?VPS\63D[L4_?3LU?Y?OO(C\<&TCW'!Q)8^O==R[J#"(*,K-@+I6R\@0# M@-].DZ\BKKYF$M)U\G>ZJ8L_D.(*2D4 M"91("*-7WP>S8#EG\\4=*H]*!?XJE2"_]8/(Q.&VR> M-NGS4U6^.S"#P7]]2>5Z8&M0OD898]+%_4=AAWA+D1>ILG$CUX&(UC!7OCX' MJ_#)^PKYS103CS&/E-E>&9E.*>*CB!&QN332G`DE$]_"7NZ=@]*3!K$)]SN^ODTYU'"=#V&OA;A M&!F3/RO!K41B(H@_64GUM@:S/PG3_`W7(S(F?U:"([%JUR.;1=H424P"Q-R* MFINV&&4C:G*X&)$QF;02'(FKR:4^0TT"Q"2#VTL_A=-8P5"5^M-N4U:+!\1(1A&GU:$VU42(T)GL:PHIKO$^J,_>X<[*3,5*6KV M6A&N5):XF0;SY6"G,?9#3F8M MBQ2+D[[)T-M5*)7,^`RQM:#[U!U`%8==S'WZZ,"N'J*+& M)@D*<**P&`*)`L;#2/W!6*?/UT#2>@[U1:D@+%-]>(NX(C^W0"NWJ-GAFAQ7 M6HG$B%"[6HUD2>>P-@J9EHPX0`CWA0!>=FK`E@"+E;Z^N?K>:!#[&$>H M06#NR*>D:3Z#N9:@.$"H2Y`MGQH^R"=^#[^[QPBM+$E4C^,(M7M7323?0FMV M0Z8_P2BHWSF\!:J>47,BSI5Z/XX#]Z:JB[J7]5CW_MJE3P,DHZR M78LH&C!/'@I1'<16G$ZUDY5O\@Q'YJN[VITOO03RA;QV M/69K."887N=P'M5>][H&FO+0' M(:]E`P=![;]'./@3<``!-WO7V9=E<_T@CQFZH\3G_P$``/__`P!02P,$%``& M``@````A`*[MT7#[!```_A0``!D```!X;"]W;W)K&ULE%A-CZ,X$+VOM/\!<9\0`P$2)1EU@-X=:59:K?;C3(B3H`XX`KK3_>^W M"@.Q38^=N70:ZOE1KZI<%%Y_?2\OUANMFX)5&YO,YK9%JYP=BNJTL?_Y^_E+ M9%M-FU6'[,(JNK$_:&-_W?[ZR_K&ZI?F3&EK`4/5;.QSVUY7CM/D9UIFS8Q= M:066(ZO+K(7+^N0TUYIFAVY1>7'<^3QPRJRH;,ZPJA_A8,=CD=.$Y:\EK5I. M4M-+UH+_S;FX-@-;F3]"5V;UR^OU2\[**U#LBTO1?G2DME7FJV^GBM79_@*Z MWXF?Y0-W=S&A+XN\9@T[MC.@<[BC4\U+9^D`TW9]*$`!AMVJZ7%C/Y%52I:V MLUUW`?JWH+=&^-]JSNSV6UT\9>$/KM@+=@L3-9_=QEX,_: M.M!C]GII_V*WWVEQ.K>0[@4H0F&KPT="FQPB"C0S=X%,.;N``_#7*@LL#8A( M]M[]WHI#>][87C!;A'./`-S:TZ9]+I#2MO+7IF7E?QQ$>BI.XO8D'GC?V]V9 M&RW((O@)%K]G@=^!Y>==`:<[/?`[D#SNBL.#T\4ZR=ILNZ[9S8("!OG--2/"'+Q@YM"Y8W4"IO6S=RU\X;I#?O,;LI)O1E M2#Q`,)G(FPPW[KQ$7I(."*PDD#3J@L2)NCXOFL%]!*/[PW-W_`9PW_7(SXVG MB'`A0Y(I1`E).D4())($B2*>H(O)D)W<<`X4Y*E5DQ$9$ M8D2D.H2D$QP1=>KU(7AC0Q!'W\E<\7[',5%7D\3S/24%L6AWH\@-Y/@DHGU! MPD@IV52RAV&T'-=+NB!7HJ['\H>+9'VN^OP=QP2=/M\-5/]C;@.;L. METIV$OK>'2!+@R"*TAXL6UPE;TUWJ>R<'>$@399B,R0Q0U(M1%:+XX.0R,&$9)J'R2KQ1%"4&LH6SYP&,IVF$KPJRH*)]V6FWE5 MDX6KS/<)D>SA0JGJ5+)[1-@5LC"<'`1A#Q8MGS=$@>Y2F4=#F*S9#$ M#$FU$%DMSA&*V@=Z+9\^H(WH>JUN1.G5&B$),4)2+416B].$H-90M'SV$'/Z M2:_E(/[9Y2]")>R+9/9_X2J?#@Z<[`0DB_SYD<&W\6(D? M=92T/M&87BZ-E;-7/#+RX'MIO#L>9SVY>`*@W-^1%9Q+3.\G>/R%]YUQ`9P^ M7;,3_2.K3T756!=ZA$?-9R%TF)J?7_&+EEV[@Y<]:^',%$X\YC,` M'QEKAPM\P'ARN?T?``#__P,`4$L#!!0`!@`(````(0`:<%OJXP(``"@(```9 M````>&PO=V]R:W-H965T\8=J1'6_A2RE5PPPLU<;5G>*LZ#-JU4;%V#[Q<_8OF!NU^+WC.H>,`HT3Q)8IES4$`%?2 M"-L:D!'VTM]WHC!51L/$B5,O]`%.UER;>V$I*X!TS;+54@:T!3=\SVH+\`YH,SC&/P^I%5\&A);BQ+ M1E-*P(6&^CROPFBV=)\AI_D>VL<(!,5*&;INN;,%OE.-CR5`9,:@<)]$L#8]E'RDGERA;\!OE M$T>HC!A43A,O3M-C;"-EZ,KIGBUX7.DW[P/\$`OL!NCQX+AV?">]!!>7:L M!%88!S;.LX:K#?_"ZUJ37&[M,/8A3\/;X:"X"?I1/WR`.=VQ#7]D:B-:36I> MPE9P"9VM<-+CPLBNGY9K:6!"]X\5G,@<9H[G`+B4TAP6]BP9SOC5/P```/__ M`P!02P,$%``&``@````A`&$SH!`(!```DPX``!D```!X;"]W;W)K&ULG%==CYLX%'U?:?\#XKV`^0Q1DFH2\JE66JW:[C,!)T$# M&&$RF?GWO<;`8"<=ALU##+['Q_:YQS:>?7W-4N4%ES0A^5Q%FJ$J.(](G.3G MN?KSQ^;+1%5H%>9QF)(R&U;)O&W),<@-J2))>!(R#.#[F-6!8WUN]:;.@'_ ME$J,3^$UK?XEMQU.SI<*LNW`A-B\IO%;@&D$@@*-9CJ,*2(I#`#^E2QAS@!! MPM>ZO"5Q=9FKEJLYGF$A@"M'3*M-PBA5);K2BF3_<1!JJ#B)V9!`V9`@4S,G M#G+<$2Q6PP)EQ_+I(=A-8QAT.P]'FSB.[4Z\ST_$;5B@;%G&J^$U)%"^DR#; M&*,%K,XZ+5"V'/]C.G[#`F7+8FL>,GQKA"8(/,DMPLPYUB,Z]UMMWR"LPL6L M)#<%M@1P%"U"ML&@*>NB-2ZW66?E/SD9+,Q8GAC-7`6IP:045M_+PG+,F?X" M2R9J,,M[C(18/4`X(DG`(?#?=221K`<1FT'$=A"Q&T3L!Q&'CQ`ZY*=+$BSH MNR19D*S'NTN;$]:*Y83M-BQ)2[EB)5<$O`+&U:EK.9:8@?4CC"UB-H\P4B:W MCS"NR+-[A/%$S/X19B)B#H\P?H<1M(9M3]#Z8XT9&O;JOF"V9,@EQ\#.V(DJ M2;$:1`2#B/4@8C.(V`XB=H.(_2#B\!%"2`5(-B(5##U7(=.=S*8C^7+),6Z] M07FNX7@>ZEQ0KY%5'X%\=@)+_@_Z"-VB5QI[FLQ;B))O(T4MR4';,6X9;[O$[5#=F+<=27^O1CWD,1_ M$.,^>A^_(#Y\^XP0GZ%E\:7-=,DQ=BV:WZ8:3)K@S$,)(Z')44V M_9BA>5)XVP\CS9&&O1/#AFWZ_9^X^O9CP'`?8**U@O06"4\$_]CG7TL9+L]X MA=.4*A&YL@]Y"W3L:KL[QI/)CENI?HFFUZ_0%(Y@J->[!G`G*,(S_AZ6 MYR2G2HI/T!5H!J8I^:V"OU2DJ+_=CJ2"VT#]>('+'X9CWM``?"*D:E]8!]UU M7&PO=V]R M:W-H965TTT[;_?9YRPA'1==I-@_/+Z^0Y\+&Y?9(V>N39"-1F.@A`C MWC"5BZ;,\(_O#S=3C(RE34YKU?`,OW*#;YZ7 M:$39T;M;7-A+P;0RJK`!V!$/>AGSC,P(."T7N8`(7-J1YD6&[Z+Y.L5DN>CR M\U/PO3FY1J92^T]:Y%]$PR'94"97@(U26R=]S-TM>)A"K1CDOZ*ZV MW]3^,Q=E9:':8PC(Q37/7^^Y89!0L`GBL7-BJ@8`^$52N,Z`A-"7[G\O5%TL/(F\<$D`?K#?AS$TW$T3O_M0CQ1 M%^`]M72YT&J/H&G@3--2UX+1')R/D7F./M:_A0HQ.I,[YY+A"480A8'R/"^3 M-%R09\@I.VA6EYKH7+$^*EPI`*]GA,A/&=_.^A'%B1V*JX)C6_D;X-VSQ8-S M+Q63<2\Y(X$,74_BQ!D&\_[@)!V$O/*:T8GFS\D=_OH]Q1D;F%S/YL30A2?G M)ND@+2NO>8_M/<49&W3Y]6Q./,Q;TM?#%]5KIEVKS2;QH-?6I]O3V4DKGE&E M_T/EQ$.JT8#*:SQ5&H9#*K_]=D(]F)]`_@657)=\S>O:(*9V;KK$$&Y_MQ]\ M=['K]<']%0S$;GR0?@,&4DM+_D1U*1J#:EZ`91A,(%?:CS2_L*KMQL)&61A% MW64%7QX.[U(8@+A0RAX7[DWMOV7+WP```/__`P!02P,$%``&``@````A`*S3 MK<6S!@``QQX``!@```!X;"]W;W)KKBF)6L];N#&5*O(FL MZ./HWYG9^9?B_?F_7+H3KV M&*2M]F4/^KM=?>K>HAW6MX0[E.W7E].'=7,X08BG>E_W/X:@P>*POOOM^=BT MY=,>UOU=Z'+]%GMX,PI_J-=MTS7;?@GA5BATO.9LE:T@TN/]IH85F+0OVFK[ M$'P2=X76P>KQ?DC0OW7UVGE_+[I=\_I+6V]^KX\59!OJ9"KPU#1?#?K;QOP7 M7+P:7?UEJ,"?[6)3;BAW!"LR"[O;_/A<=6O(*(19RLA$ M6C=[$`#_+@ZU:0W(2/E]>'VM-_WN(5#Q,DI")0!?/%5=_Z4V(8/%^J7KF\-_ M"`D;"H-(&P1>;1`AES*-1!3/B*)L%'@]1[DF887+&;+SN>S+Q_NV>5U`RX'@ M[E2:!A9W$/!R.B`/AOUDX.$26&D'-?SV*/7]ZAND?6V1_`)"B>("$9V1%<@Z M:X,TW:[-P%"48.&TQ>>P@_P<$>TA[HL'HI@BB#3XGMNE&?@A@-A.6L*D(9(. M.=5:Z"B1E"A\0J99EDD7@TB#]?G23*/K=QO]K;+F(B8QI0)R1.)!8B82*;E" M`DB5I.$Y`A$(8GR!TRUG8"8L.X?%LB*"PK2,E5(4*`@01E$BS@`1%L\19F`J M3+GUHC!$4)B`<<_V2D$^%U'H$DID)526*:B"^3>=-W,1D^=6C?(0L?*B6,5\ M-_B`#&7Z7D&-1]X\0PS,A+EUHS!$4%B421U%;"<7/J&U5G'LO*@A!QJF7JEDDD"JCE[>D;:":.]55N&:LN%2)EI2]& MA';RJ;AY_H"SW9]TBC55+I!!<9"V)&*#II@BJ#@SKKW&NZVZ`H<\$F.,AS`';J4I&L6L3*G*6<8BQ&;QU" M)EJXQJ#BF'5LXK99+-$RB$RF(;>,;QG>@<3JQ#CO,%0H,XTK1<8Q M[WM:Y#)@BXR,_^6L1PMS`P]N<1FA\IA=W)C'L6U$?#9+9/1PCQ:S3POR:?3. MV)/,,(RX^.K=QG`5G3`1&VZY9;#1%!R(69(+"NA8N#:A^9ME&W)L&Q&?S)9! M:1]2E8VD^:Y!`2IMEFG(L6E$H[GLFT8<)CK)^)&ZL'%0?I1H^$W*.\P0@>;& MT3\R3V^-@69E97V?6\;F+H+[G$P*5ON"03+,A%)NJ53B+/M08_OPCKJX>RV# M$F.=IJEPWXW3A2`1W$]*;]!3>6::S[[I4.@!_A2,^+"V#,J\?*XGR.2Y7LWR MDH%FA7:[SV81C>+R@+-9G$)H%B&,G\4K?6AH^N/>:$0K9";E32%4'G.0VT:T M0@L@169#.+>,+W-D==,,%+WB(\P%;YC

6^8*CC,J,##JQY[5VG[SS*14WRTO4V$N\W\1L M:9&9S-T40N3I64XRT%=VL&6FY$TB5!YSD=M*JR^X"2^M97R9HQT\S5"AS$^F MMX@>^P@_Y^66\07R+3*)4'FS?$2C`4SN8,M,RL,PEQ$J#QC?1VXLL[F*V=VH MS,C@(QE^GH$GE?RP[_4`*L1'D?BP[50^5W^4[7-][!;[:@MGZG"9@%NT^"`2 MW_3-:7BX]M3T\`!Q^','#XPK>/(6+@'>-DW_]L8\ZCP_@G[\'P``__\#`%!+ M`P04``8`"````"$`D_*<:9,$```'%0``&````'AL+W=O3!-IG#X>S,SAQ[MU_>\HOQ2LLJ8\7.)`O;-&B1L#0K3COS MQS]/#VO3J.JX2.,+*^C.?*>5^67_ZR_;&RN?JS.EM0$,1;4SSW5]W5A6E9QI M'E<+=J4%1(ZLS.,:+LN355U+&J?BIOQB.;;M6WF<%:9DV)13.-CQF"7TD24O M.2UJ25+22UR#_NJ<7:L/MCR90I?'Y?/+]2%A^14H#MDEJ]\%J6GDR>;;J6!E M?+C`NM_(,DX^N,5%AS[/DI)5[%@O@,Z20KMK#JS``J;]-LU@!3SM1DF/._,K MV41.8%K[K4C0SXS>JM9GHSJSV^]EEG[/"@K9ACKQ"AP8>^;0;RG_%]QL=>Y^ M$A7XJS12>HQ?+O7?[/8'S4[G&LKMP8KXPC;I^R.M$L@HT"PJ9OF_$D04E21Q%`F\ M*Q+B+)RU1SQ_!HNK6."]8?D_"99K_PF<2N@*ZCEZ]YWMM8KI#]1D+`+T1!1#\)K2"R0UVB$=,W7 MR&_:F?!ZU^@V]&(9H82LQ0)L&[B2!ZD;;X\?I,F;]G02WD2 M$@AYY+<'37TT&$;BEEC<>%TY6!.EY224$%^(6MDV\5<$RXXD`EZ;Q-\YD#3H MFW;>QJ5QL";-QP\.)60P7X-A),J?(XJ#-5$K392$R'R1P`F"M>L$&!-AC&N+ MOP:#Y*WFR.-@3=Y]"\L])B%2GKM>DL"S]3Y%D*5/8%S=%XG$<:]LS9+Q@G*P M)D[+2R@AH^(09%1<,$<W>-"JHB2IA^"Y6FF,/%+4H\[=)I` M8H:;8#".!^Y[@>UK^B-%(CL4 M`["T6;9`>GRATPSMP8^?K/;=,`!)IYS! MF>`,"C/8%,-Q+)`/ZGK&.!KON(XS.!(S(*D_B"7-<@;^(UJ3Y&L_3T*%@69^_7?MP<[YYM&:*,DHGT31+XV_7GN)B M[<^O__,_OBF*TF!N6GR[]E"6\S^]>E6,'^)95&QE\SC%-W=9/HM*_#._?U7, M\SB:%`]Q7,ZFKW:VMP]>S:(D73/C;)&6V'=_^V#-+-+D;XOX1#_:/1RNO?ZF M2%Y_4[X^S<:+69R6!G"8L[1,RB=SD>H&@/N;5^7K;UYQJ`X_,#]D:?E08.@D MGH3?GL;C+;,[')B=[>%N^.5Y?+MEM@_DR[WPRV?`,+^,;HLRC\;E_X8S7X0? M5$O=/,WC\,L7P^W-'\,/1T#`1)!P/HWNPV]?W$73HK50MG%19.^CIP%0/]X*`;!+G(!*>33%D$G\R?PU?@K' MO=C&_QWN'.T>'89?G2SR'-/->5*,L<3_Q%'>"_&+SPG6[QUKW`CSOAFA8)Y\DTSLT)$'V?Y6T,7,^B*0>\C^=97D+0 MS$DVFT=I:Z3#:3:;9:FY+K/Q;P-S_1#E<6$N%Z6()::'4)QD:9%-DPGVGY@W MT31*QS&F0?8*L_'A^M2LOPRG_&610B:VNV7"T24J"BSQIW#N250\B&".^4?\ MMT7R,9J"CBV,C\8B[87)XW&,0;?3>N#39G0%&LDHL@+8IM[)9-;8,JDB(\3%35:"/.4\^@2XZOS[_&!IN,162 M3>(Y8$NB$JI-=HYFY)/?Y8-PQ_)PO<"9O8@@TYLF0>9Y!,K*I MHU;?N#R:)!F4,WC%/$9%&9M)4LRS(IKVS0!`>38%%X+Z>:S$*:-/<8M?'"@? MHW$GD9ILL>1,/T>YJ-\)]/5'+`50W>@6>X\HCH"K3/)8[$)V.TWNE^SO5@(1 MPA-#`(??__'W\.E1#\]9%,B_AKE;:GB\,SB&LMC=.3;_%#?:& MQX/][1TA_>[>X&!X!-USZ`8G14'F%*W0KX=OX/,4B_S)`1:5<'?@-0UW!_"` M[%HA^D:3"<0D2Z%&J((VDQ1R/4^@5EHC&RKC+ADG93A$^4X0&%"D>Z3'(7*X M569>@U7!(R-3TU0LE?GEAWAV&^/.Y$TX^=\+IRA.66LPKV%MXDY`S M>"4O^RQHI<5JLS)XSJJ%1*@Q:%F9\@!S"$-/_2Z28>8P74*79V>W!">6@V*'9ZK*E,\)56PA="D/?Z"5@-!CGFF12'0IWY1*$ M$F7N\FRR&)<&QJ_+&$!)X00PK/V#OLNSHC!3_%>( M='MPN+7.?6HI;#@M<.['ZC9.8CAOV5Q,F)L1KGE-.$4ES:+\-XBBMWHX]KLX M!>;5:D>369)*3".VM&]YU9.(6TFQ)4O71^LZ^#LX6/4:":+H66PV[)XO6TBX M2,L8[FMI=&1XC).'"`887YJ[*+%FD51Y_`P7X3Q)X5/S1#15B=O0@A3NV`G_ MJ_H$XJRV)L$'Z4)&($QF$D,T)G"Y/B83!++.J3AN.16MB6Y&W\XFFL^GT,UT M'`:H+,Z#C[EWQ+A MR:EOGTS-ZN)4]SCWR^.Z\.RGRT(?F,2Q$^=CWE5B0/_+C^:Z MHQ:Z\]`Q<"FQB@P!3E9PLZ_)$B6Z%J[TW+`V MK5Q$[/L9]U3&+72XD5UQ59\F?+<*E<.=0J:[>/?3V?5S3'>U@`$`JHIGR6H] MXH+2#4$/(_)N&BJ.B6+JV"412!)N8AZZ!`W,+3*W=S/3!G^/3RW,"67%R>AO-HT$2( MP=\%(J5.E=2`H,,F+$FR8I#JI:;$()T]"(YNWR&'_'S*EMI^J M1AQ&[P>*_Q$.P?1I,WM,08UB<5LDDR22\'5#)S#:0JCG$K(OM\P(^9\BN4\3 M!-B4-7&B+%QU>I(;,'%>D*J`U#S`50#2(8SQ-($/*@&M5X?03*$``1U.!#T`-+$LPC^YD,M$RE)0 M(!5]6OG["]TYF\-?5L,WBU+X.L3M0-9JD&.11@LD*K"I("29K4(@("E%)DD4 M.:%;?2J.I7AB-J[V5@:R*_Q[R]@I2TY3`Z0@2\O/`.%,)'X<%T6$5`SP8M$@ M;O44U0RB'\NB5@6QD-F24L8TPECC'ZE"RIZ[MI@GNWD`]J&G/Q]O MQ4.VF$)[Q#A81(3SU+\N4F$U\YB4#R9;Y,8MO(*D@!`NGWF79:42)2H,$XI@ M'RQH&?%$!?`%?:9T(#O$GA^XE%07Y(Q8N/*!)$261;_V^),(`[0%HLIY`.HMQX3A31['K6U M9`(89%0`BV]+R5'YPL6R,'],^8O"$-A0IB'KBBLM;'7V"3X2PT`08H;,"94& MF3"14[0B\R8B<&<7B<"YR$\SRI;/+@ M)J?9)C%JKVC@0FT^6*F'H4>*()+!,](6$'#[=Q?,JN?`K1#LYM(YD)HN+%PN8C`3,"@H7L,C]!>70J`( M"8"M@1)R"4Q)521LAB^IBB'C@@F@2^4=_`7--TGH%0)9JJ'!@JHU MQ-A7V&O1[%W\:+B\95$XOBG^'FN*[IN@9V#IX"6.RCE]=%]_T;]\;(J&OZ\A M/]KZ`?Q!(NM*T0'@Z&32E#0>!?R9>.RB&P*RDDM':"+2*A:P"A8+V!`M3;_B80-?R8U&; M447A:EW$,K!L/6K7&62I`G>8!SIEXC+?2<9D,8>]BB;JK;>8Y:W+`%TSB`^Y MH_GM$G;0[`ZL!WUM+Z4$M`"6Z=B6>$$-B0$I.JFZ^Y(L9.[H)=),43)=DL\B M,*EVPXD)AAX4CS0?XXH`$''2#[*@F])8D)EV*L(7L0G$[09^`CTE8"2@KK[3I'Z-"P4!DN*'F<3X? MYV#ZCX@.$J8UX2C7B4W!/039NC+.-_3/"1VM_A28I,8G&8T,AFW4DVT)0>U] M##QGBF*#_Q2;%B1HDQ`HS0%!T3<-7H0M./(CXI MTR"3CT1IJA.!:CC_+<2[;T.XWD>/E15H9536P]$_9_EOY`ED6!C@A5_#L";H M.9R8^RR;M+Y5K#';U]DD)'9@$_H<\RE#?-J/1:I+F1571V MB-'K:MWPF_8VX0C%MVC-CJ.%HT?BJ;3`AHJ6%JM%ZJ$`&K8BCX^MH1\+*HJ5UR0Y62[N$#2;8K"&"Y?6"MVS\PA#%TPEFSC" M*:VTZUK61V."66+\683#+>#\QOF,7@6P8;.M"`;'`A)<6F`&*@)A%0J=Q+$4 M,[6(:QL:["86`X'=9XZ!T_P@1@!5/^8C8 MLE"<(I6@L;?&M^@/PUBW$B?#HG%O1YN*O.*:U!PG33TTDE@VCU@JW)QB7R-& M49F&RT@(",-+M9Q_)(8L6[DT!BE'M0-4$O@W)?.QZUU-;2@C9P!QE* M4NHAB>\,I&XLD9.YO$,!!':!QSAY0$<*$EE4SM=,!4K4N:_=XYKT:IL#J*WU M[:W]H[K-PII2JASNR'PE=;E:CZ95:,2"M4T094BXF:94AF@VRW!='^/(3FIZ MHA/RA>P?F3?3".'M]1C5(H3)LVP23\F@ZSO[`UQ4,4#(-/F=H':`[/G+!@[URLSN,]0__C>D MOH/\.>H?#(ZW#[Z4^/[!__7$/SQL$Q^N0:/%FX83/*PMWJ&Y63IX261S!?X# M&Y*C_YIFCYO?9X_F??:$9/V3>0O]@72_&<'T2PXVW/2&:D>S/V(/\$]MX*($ MB4)!]J>@6-@N$)J,!5:$7I+JX-IOW/,A>UR#]R=-A>K\X>*:?1+(''?I,O"M1* MHVJ<&#$]@BHG<2H5%.@3=XK((41=1%AN;H:N'6F)Y-E-;G$(EQ)'@N!Q!/L$ MSN'ZX(:+N98&2?%@``&]7Z3Z,=3ZA=46R#O=N8U1;?$[/+?,FW@<$9]<7('+ M-%OA?!CKN.<"=E*@& MX-$!`EHSB0T&R!JX#NFS4B%CO9-85M#<69=MJ&CNP/V^*X44NGPD`J!V!,E]#H3Q",^1,5;+: M74Y%$XF;A^(Z+K!.U()1!#KE&RGD.ZR$0D)U3\-;QU9*F(U&K40R!9H8P;E& M<&RF/"RNK7%Y.08(#8^%Q71032"`\-0+JMIP(UFPGD`&P)+NP%%^FR#^$:$$ MKS-QWUE$/VYE=)=!>L9MD3CW^`DFL%"%1;:'K!+81X]!#RD59G@ MD[KTV%.Q%.[1A*T6[8`4AL8XEN_4,)1$;A5]]74+\EU.'7H^[+G#+6 M#,/1;Y?GRT[X6[XXA2U@1BJ5B`5S?L@0G>=MI M+\@1&J=8I*#WK#WISJY6B?]Z^VL-[&"*4;"TH2MS=!TW%KU:FQ#>WNNDV^(V MHM;.I7FA@M?=1Z\,MA3XR=7KP^W!`;Q]I.QL3"_;Z!NYX MJ-%LAQQ5%8%6QK2:'3+C-:MVZI/A>N*9I$U7&;.$[^@L`\=4R_.*IS6@\GL" MPUW`KJ/%/5Q&L]-@5N=EPI3#<:&%@S:!^UN;??R[B,&(2$O@$N/QT;X+C_&` M0@G#(ZK'UFQH%8%3>XV2?X[]LA.!CESQB6H+_LR8;=E,6`\/W$V'<)IV(]B# ML].G6'NIVI1W-K<]/*P$DN5DM)YZ1<]0^OI!'0[V=_:W=G:70UNO9P$F=S/. M1@<;<:+W7S7][3JIQ;RH$?8/JQR'?E0@CT87-$+/%K+=R.AB`;A`%1JK;`93 M`+O[EJEC[VJB0/-%*PZ9=%+HZM(ZO%0J*9NFLUE")B`.=^K@&[3".)@Z:3-0 MRKG\_B,8[VD3@1(Z;EA"L@E^29)3F;H$((C,)#;)0J>7_;2_2J,2'1E>'*-+ MF"!974N5^!>($*=PG/F33%5/GM;YHR% M"5F3S$R`5N(>;`B)@.OG5=2'2.L=;^%)`5E.?(BF<)"VZE"1SMS+YO;LSJI' M!O[1Z^Y4EM!MX[>+0UP\*WTOMW`!\^PA@0-'3X=]1`Y"R.QJAZ)JJ($G@ M>;M]`G0`FA$Z@#3LK"+JB@40J3NRKU"=4G>B,KN/L1S*76PO10L:,D_P6^C5 M2L,!6JC!':`9CI::XZWCXZ\<.;1`MQ)4V`$LHADY,H%G,:SG6^M3[;90GUJ8 M-Z1FO6.#B#BAM@XC+$P1%>-A!9APFBW=%-VJL>WDI1<,?X#8T>XEG717Z=-G%`/#$C&RLAP9_SG,B/^X MX:G(6D\0"96FL!@:4T_QQH&F]&RQWX@G"5<5^XK%:FTR">%M[ MS,^[":6LB\RX:E/O6Q5UJS$L9,K1X'M?/_!NA:\C:DD#-:$J)#1?IBWJQK6: M0-KYY[7(+-46SQ&@-D),K=!"IJ[OD-C,6;:E-'_D4Q=T#*#X-6F@C9"JZ-2S M1(Q+]O7:Y)OD0E16D:LRFW5[#G6V=E_2`"-;-H%9@D.'O^I6W^H\2\C;DML/ M#P^QC-]I\CC7` M%27>0FG,QL?\(=9-O(D&9J%*\>H/GOS11DS@ES=PT+@`N'R%+!"W M!6L)'LP&F!,MX`N>UN-?Y:67DD40<16]2V41#E+C)WKI-Z22U".I0K"ZC0H7 M3OC($1`$B86SA[0VI!?^GHI*G63T]9\]N)Z;*,GP<@>?NH+W!(#%#O=1"$*) MU1]P[>,6EXG03#G3%!>Y!?X7=0&XB9:\9P7?K',W[E_+6,-2BH)4`RLK*CF1 MNJG'K\*5-GV\_W(CIK\+M6^D4.Y5J9*M=`FE3T1G2[4^)-Y)45[A=X.HR\ M29D7#YT1_^CZQ!S!55X[A8^B3Q-!8T!4OH\GN%IXO];(P#,MANFV6[=R?ZLH MQ?I\UJ:X="_J[$S:#)LQ&#*YP+.$PM5IP,AX`*SY@H_(OFI.":DH6\#=;4)5OMA2==BUA40<#=LU<6:QX-G..C#6\K=CU2704`(I@E6%3>I`U$+,C9S M7S0DE952[0;T33V8HQ(S33<-`VSD?&GS1UXH1X^!'A$?\3]7^"]J\A'>%TO9 M://M6K&`]=/<\]HKO+OYNWX\W.:_\!B;.JDS/!@ZY"?Y.72)#KG!';\"M4L6 MAE'*X+=W6C^5A67X*]FR?&WST-C>>]T3SSQT*'Z;.%_IIO/&$"6E#GK][/#I M4AR3D-+5+JCJD)+:P1>.^C>C>Y7\11V-ZC6@>_D:^.A"AS;L>MH)!W9BZ;&O MIT);YKC:NLIO4\VR:^D/Q9DX-55KL@IR*^>]*RI^A8ZINLFY6R5L'$GB+3S! MQN%>%Q8W#HXZ/^[DP`V8_U"/@/M]27`"^:\1.3[I^Z<"E[H@N0CL"W2JQFNO MC5,+Y/E*Z\1(#4$+65O.H*%^KXNFQBEU&\1"O'$'DTD+Q5Q3JIWLA5B]H4VM M;AMHI5$[8=']+N7O&J#N_6_]IP_(*79 M(W/]!'^7W><7>&@9+37R7`6*=*>/DJ5X$]V.Y=%,;P=$:;`ZVI5)WNQIWT0T MB$O'N"**AEH.8S^-9$>;2SW&MRP[Q?D=%`%ZA@D4C/H4Z7WF%.R#6_(WUHM< M,S<[A1)&\S(!SCUG2=Z`F<`X_9C@"B[3$.IGCOB"!%&$'%2)+D,"U%&IE60F M[S`01K8G6;V2I?<90T'J*$A)-P[1>).CL4DQ1M\>"\#/3V;(M^`*MUS>Q;*Z MK>1^[-4Y-MH`^#LD9B5;+NA`;[:"+M%4%2EXRN$S^G9U]QZJ2\Z"!Q8*Q7S& MK3KX9U"'?5KKQX/#G6W![OK1X/@`KSQ#L=<-PV8$0M7=+.MB@J`7$??/24P; M5N!VJ#;+:!H21#A![1*W5G,CX@?&*!Z2N=_H5&1W)10IN[25VY\UT2W7Y+I. M$9WQHE8HT.'W2^3X(C5_B?"(!;KEX`3L=25&M'A9:*D!)ZS2'>`$E\J`3FY< M\Y,'(YY.MKU43"-UHUD;OVX@1OH5D[Z&RNL<*,]H//$SC&[*FGDUK1VRG^CRT:3.?[S.T MB/^V<2?;;-RP*EBT4CF(HU%O1%8/%!M!SU:W1>OKK&AD]V\.4RTORHJ1F_N$ M+%9?@UP%`"Z-3DC>Y`,XU=QPT6LBJ^-VX4J'[)T,(\H6V]9F'H*TD^52+U,P M.0W9U/6TMY3PNZN.YHJ7R,+5SKM;R5:"W'OJH'[N[FW=7.1>0(`8,=Q'T=7; M#8KH?=7XA905-#1-AC?BI+X-#M2S=^N9+B@YN2W2N6Z0E0YRU@ MP174O2#-_/*6=]PNZ*BTGGAN[%%GSZ$D?2D<-Z40[GCP:`)*UIVQOL5%[PO3 M9^[V3X/9^]ZCKF2TQEG?(\^]@K?A$[=WE!5/O"'MB-.W47T">U50UVR+Z(`/ ME&5\WPC\!U:"@+B+P2`5?_/C1)Z\7$:M#__L75I*H5YE"CGX#UR:;X_H,ZS5 MM5PZ8$A.RMF[,S$OCK6'I3"XYCN)GEK*3#G$WA)C"KN^TQJ>!;_*HA=XPR^( M8>(>.D'>2[Z67OP^=GN/H+IZ^_B4K9'V[6/+'44O6^NZ1#9:8NPCR,].^LY[ M#7GDO88,=GEV;B\C-]E=:MO6HCCMM`*/;YL?$!ST_4H/[I7AAWCLG;(0X_JE MO;@3?EE=(74WF\,!RV]>MO-&2^?[=S&?GUH%_B.XDPP"S[3=B?U@'9%^:WAU MH19BC)(O04'-BYHU:JHY7-_ MV3(AU'R@HXPWWZ(M8`*'#4]&W4(:A>=RFGNC25RK-* M1=?S]I[OY5^%\)%4#QDTKDL,/`?4Z?>!Z?Y))=M)WZO-]?N=WN^OJC"S;OQ^ MUF^HAU[9UO1EAK\>/;'=\"&!Q`*T_&/K[M(2U5"J4'FY-SQD]2R\:(#>JMJ? MP\WM-NR/K5SD%="UVGB[N$+M:!E"@(K9%G^N1G=?JI?(6ZEE#3^`4H>B_ MNEKN,[H><5PMMVL^?EY-?AJUH[1)\)F&$_`3`\TNX%'X#S'^R&%3'L=UTL4CT M=4I(T,I9006;''FG!3Q%W&7,N[5B'US;AZSSY\C?1)]:K)OIW.V<'[V)-Z4 M^MQ)+-E^]AS$7FG_K+Z2DF_41JXOOOI54@=$GU?0/Z-%\EX`EIGT'UC0L>4" M%BG:`6^5DV_F\[L'!]GW^NPAM,BL5S^JNA=^Z:6.)8G?B_3VP"5&M;8HE<&4 M)'W[%U_KD6W;`P,K_:A=EN<5?N/V]?\)````__\#`%!+`P04``8`"````"$` MUMB,+EX,``#]6QE"UQ8) M4)\DBK(DQW)PTIGM`==KD'/1`DU1T!)E,\>'2E%W=H+^[YU9OF9%D5R**ZV+ M)$+.$J6=^>:;QSZX)*^_??(][;,3;=TPF.F#UWU=7/5ZV^6CX]O; MU^'&">";=1CY=@P?HX?>=A,Y]FJ+C7RO9_3[ESW?=@,]D7#E+T6$^';T:;>Y M6(;^QH[=>]=SXV6T-^V!I)OK8.=;?KS5EN$NB&>ZD1_2DF_>K6;ZI:XE)B_"%8#X MPW]V8?S-[Y(_K_[XZE7_WU]_\\_OG=6_?OBJ_-T/7^N]3`V1"3ZHE_FZ7RL6 MODXD]U(+;J[784`,&0%-R-;5IR#\$ECX'00#F(<_N[G>_J1]MCTX,D!XR]`+ M(RT&+X-][$A@^T[RBX7MN?>1BS];V[[K/2>'#3S``B/]G>^"F_!@+]%P7CWW MB":S:8(P.)N&>(3:Y(-)-AZLM\G^\8!-G*Y1LZXN_'&ZF!7U=DG358Z+$H== M=.6^(GJBA_N9;EE00P;]/M)*'78B9=-%'_2=3=GEZ&R6#:VA-99J&1>+9;^A MPJ$ED\H&A=:;\=NST2E?695U:1D^5P9@PLEET874K6*/DN]HC;>N;ZSU3XX7[3O0]\.D%C:J;%?^H^^6+KT*?]AY3 M?S&/N8>CG!4"D=NKF'X'SM18,$'+7U_][R!,6D`,Q7DII?\KN'7#Y'] M/##8R$RLP3;TW!6B>%BPD7`:2XO+6VMQR_029*(H*H1:UF)\`J&W\^E"/M+% M="I;J&'!2[+0-R-\219JP7\+:9RFB<0J4T]"-.7RM-C%F6O_]7@ZG4X&EY/) M!&K@P#09R?=I1+O!RGER<#(KC:8R@A$@F`XGTTL#@/3-"5-U5@1#`#`>C2:C MP=0PX7]6R4Z/0#:G,'E7[%6"0)%7"0)%7F63)XFY"NM(BKU*$"CR*D&@R*MC M6=U$6O_&RKU*$"CR*D&@R*MLR4]BKL+ZK.)<)0@4>94@4.15:8//-%>GRKU* M$"CR*D%P;J]FTZI%-K`NC\RDC8]373B(M]AB4QM=;-8(\]3[,%K!U#P[.S0P M88Z8'+NY]IQU##/2R'UXQ+]QN(%_[\,XAM-.-]+YT@>7Y`)(]OKF?'P<#%"4-,SQ[13"M3W@J)CD9(USN>'-+>O9,D:5'V`S" M+F!KURT>HT2X39T?TRX;1@!+Q_,^8I_\CW4^#("5M9OKIS79S0%;;'"[`VX6 MP;>P?)V^3;K\Y`.87]7(J&RDV9N-]_QAY]\[D<7VW3`5["@NDQ>?YFRL4GQF M)QA\AZT-ZHF8[Z(P=I8QVQ?$3BY4X1E6X!FD@D3P=-%O5N@'GH3YZ*(?UIX. M.A%X4:H?@DM8O\QXP!U0:5"#"VA0U^&1B0!6&#($X`05"'#'5LH!A*<*!#!S MRQ!`@!8(`$Y-5'3)@P&I9A`#A4K0?RJ54&,R*SF5)[2RJOR"_AHK+:[\=J*9 MU%L(]()F^%`#H)/*JA*KJL00MT.F%13`AQH*+.AUY71Y@ZJ:KXP04G0!0\$( ME($Z1N1%):FYH+,`4,_(7.(XA`0%EB+5$`".$@C$$0-%_>^`8E#4`]-H4-0% M4PA<'WS&G*">X'I(11@`CY*L*,8)`Z['.",-!(*J"DFBP5!5(BD&536R<(6A MJD02"*HJ)/6$JA)),:BJD<05JDHD@0",**F0U!.J2B3%H*I&%JX8JBJ1!(*J M"DD\,3QQB>S19=-D$96LG\)5*=5+H>"@;/J_[ZNG=>-"ZJ!JT@2RLN;)["F9 M.8(OV%R*3*7Q&CD;-V?CVJGV&$;N3S#)Q&OEEG#`B72\MC)VE_3(E\C>W#E/ M,!5-3CT]K3L9V("IT`^+Z[K61KET?CI@$?!T`Q&-EK-)?>/"_%YD\(O;C1'2 M"`(7=U1C0*Y3#-)#0%**8.:JI@DZ2>48J*L03[KF#(>Y,<3A:E9SC@DG2>V$ M-61?A]0?P$C@Q6"1S4MC0>CDX0:GT&3\<;>-W?5SNQX"P0F%7&67V<;^[MJZ M1.&OGF>GJ[..038=!V.QB[]D5PT*$+>\T*%=^Z'5*='EJ?Q2ZS5;:F@8Y+S@GAI2=*9L0&4 MQSJ_'157/+.,&(59!,R]`@V1?KE(U)'E&,AT&6.VZ,^JD")6E$5R/P,K54D MGQ1O5??$AW8);WO6A1 MUK+@,IQ4%EZ04^`R8=-M6US0))7%$(QQOBG"42"F\QD?Y4##*$RF% MO_CX-@7C.Y%2>`KD$8M,^$+*>/!,7]*0QSCG@)!GP4`?1G>)`=/"-/`UX2AO@8QNMFVHC)4(4C,![R96BZ#+Q')@U>R.[^EX\\/<.^TC$2HSW&!_UR&ZYE\\'@*B5L[9W7GR7?SG3B_=_ M83>4A6!*?_6=^SF,F8B97KQ_CW?JA2R&LPE0;MYOX>ZO\%?;1>Y,__EV/IZ^ MO;6,BTE_/KDPA\[H8CJ:O[T8F8OYV[?6M&_T%_\%RO"YF%?P8,4.SYUDS\>$ MZT,'YM76@Z=31JFQ*?B/Q;&93CXD\-GM.0$VG!')C.AM\^=VWOP/``#__P,` M4$L#!!0`!@`(````(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q M+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE] M&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_ MW^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$CO MVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T M0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I M@O%TS?`4P2AG6NO76U=VJ^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$N MCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+ MKS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX M.(N#UO5D"53,+2L?VW9`X8NXS'"LY1ZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-Z MAQRZ2$@(S$J$'Q+FF/$ZGBD".S1P1%H$B)Z9B1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@ MK,S6KZ1$0;?785;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D) MQW[-&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)Q MTO8F<%2&QR@!KTO=3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2 M(=4.EJ$-#3.5A@"+-2[\JIB4OR!5BF'\/U-% M[R=P!;$^UA[PX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@ MA_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/ MR"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR M@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NM MK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1 M?F#R`Y+<&ULE)9=CZ(P%(;O-]G_ M0+@?H'RI1)V,(KN3[":;S7Y<5ZC:#%#2UG'FW^\I15;0"',#&^MT7%"<[J045NNXX3 MV@6FI:D5(CY&@^UV-"4Q2X\%*:46X23'$O(7!UJ)LUJ1CI$K,'\Y5@\I*RJ0 MV-*EXSC;0YUOR$?IV?M^N%*OJ`I9X+MI`5RMD[TNN:9/;-! M:3G/*%2@;#SFM__E!R$A>_#7%@IR^<9M]H2R."7,N=!B@(/Z#B-2IP;U5&I^`W@R'I9K`[L9#O?"2!L-&`>Z/A MN6.]L+6O]33%6.+EG+.3`:T/SHD*JP\)12!\>UY@0A3[I."%.3$-L%Q`+[TN MO3"8VZ_0`&G#K*X9MTNL;Q`]D5@C<+UX4=B5V8Q@DON,#1ZT1D!SC#="PF-`>;75>V&N>E6;@_2W3=V"0B`>)S2"1:"*LEQ`43IQV MHCKEPWIT6;[:.SS8@>ZO46I0SX8+?=T(FKEGPR`1#Q(;3>@B8;]"_O1_G74> MR3V-CA.PY%XZ<=\!!7<=N.H#C32I37TT"YS^*MU!_!#!=MG[EN-+Q$>![\RF M/96-1NXX#8UM0GN@#Q=ZURH(WY,UR7-AI.RH#@X>-%$;;<\T3YY:FWOQ M%8I6M^)K%,'JIHXQ[0`X@U1X3[YCOJ>E,'*R@U,R?.#>D%[?%W^`P``__\#`%!+`P04``8`"````"$` M5BS'EGL#``"["P``&````'AL+W=OKTUBP&H29VU3VK??F3B$Q)1N>@,Y M_/[G\]CCS.+F.<^\)ZZTD$5$Z"`@'B\2F8IB&Y%?/^^OIL33AA4IRV3!(_+" M-;E9?ORP.$CUJ'><&P\<"AV1G3'EW/=ULN,YTP-9\@+>;*3*F8%;M?5UJ3A+ MJT%YYH=!,/%S)@IB'>:JCX?<;$3"[V2RSWEAK(GB&3/`KW>BU$>W/.ECES/U MN"^O$IF78+$6F3`OE2GQ\F3^L"VD8NL,YOU,1RPY>E$IK!SQ<$764C[BT`=X%$`070DPB/Y[#',;8A2_"=.^/H:\ MKY;MF_)2OF'[S'R7A\]<;'<&(HTA#9B->?IRQW4"RP"Q!N$871.9@07\>KG` M_01I9,^63J1F%Y'A9#"^#H84Y-Z::W,OT))XR5X;F?^Q(EI;69.P-H'_@WT? MOM]D6)O`?VU"PT$X'=/QY/\HOIU6E;$[9MARH>3!@_T*X+IDN/OI')Q?3POD M`[6W*([(-2Q<1#2LS=,R6/A/D/VD5JRL`GX;!>TJXJ,"%Q`8&A#(37\0%",( MKA>2K>R#=MS0B7NN&#:*#@ADH0V"&V8(>_7MS.`@T+7F/6K<+:%5C%J*<5<1 MOZ7H$())F_!M,A1'!&;?K,BD&W=E%6VRZZXB/E>2<54$(SH9NF#V?1O]`AA44_^4H=@!<^IK M927MP-0MA7/)!3;\%CWY[-'>YLO=*N"6DV'SRV+5S27^/"H;O'U^T9` M;^3NPM"MD%K3YCPQ5!L56RRTF=1'SW@4S*:GJ=A]:%LC^Z'/N=KRF&>9]A*Y MQU:'PM#F:=.[U4U5\P*ZH))M^5>FMJ+07L8W,#087,.1JVP?96^,+*LV8BT- M]#_5Y0Z:9`Z?Y6``XHV4YGB#'_VF[5[^`P``__\#`%!+`P04``8`"````"$` MUS\C/)L"``#\!@``&0```'AL+W=OY+$2[S?"OG_=7,XRT86W!:MGR#+]R MC:]7GS\M]U(]Z8IS@X"AU1FNC.D6A.B\X@W3@>QX"S.E5`TS,%1;HCO%6>&* MFIJ$DTE"&B9:[!D6ZA(.698BYWDWMB:_A*YAZFG7 M7>6RZ8!B(VIA7ATI1DV^>-BV4K%-#;Y?:,3R-VXW.*-O1*ZDEJ4)@(YXH>>> MYV1.@&FU+`0XL+$CQD:[D_HL2Q3?1<@@;VF0; ML)'RR4(?"OL7%).SZGO7@.\*%;QDN]K\D/NO7&PK`]V.P9#UM2A>[[C.(5"@ M"<+8,N6R!@'PBQIA=P8$PE[<-;/[X27J@\,7A MH1B>AV(:!N$LIG'R`9;I@06>/CI.=U!FX])CK!'%=VB/6_$`-ML-#EVBP8=LK)NC2:C[1YS,S%2I-9 M.ATENQX"TB0]`@;*P-[ERBQXI"P^\OK4/";Q#:=A&HYB79\"Z#R>AM/>VT`9 MG)3+E5GP6%G8\WIE'N.51=$L'0L;S(=QFO;U`UW)1W19\%C7T:_7Y3&^EU&8 M3*:/:L>V_)&IK6@UJGGI+J<4K"E_?4T".S"RP%V7^W5G\!``#__P,`4$L#!!0`!@`(```` M(0##HKPTZ1P``**=```9````>&PO=V]R:W-H965T1^T<`21(DDT!FLM[]_9]/WR[^W+Z\/CY_?W\YN;JYO-A^?WC^]/C] MR_O+__E'_+?;RXO7M_OOG^Z_/7_?OK_\U_;U\N\?_ON_WOWU_/+[Z]?M]NV" M+'Q_?7_Y]>WMQ_KZ^O7AZ_;I_O7J^OIV/;VY65X_W3]^O]06UB^GV'C^_/GQ81L^/_SQM/W^IHV\;+_=OU']7[\^ M_GAE:T\/IYA[NG_Y_8\??WMX?OI!)GY[_/;X]J_!Z.7%T\,Z^_+]^>7^MV_4 M[G].YO#!]J7BT_;S_=_?'OKG_]*MX]?OKZ1NQ?4(M6P]:=_A=O7 M!^I1,G,U72A+#\_?J`+T_Q=/CVIH4(_<__/]Y90N_/CI[>O[R]GR:K&ZF4U( M_.*W[>M;_*A,7EX\_/'Z]OST?UIH8DQI(S-CA/X:([=7J\G-W6Q%-@[HS8T> M_>6+'Y0G:T-EZ:^1G\RDL@G:4YH[`S75/]@W9/<,.%!,)%1,#FIF1/V MO/J'N>;JQ.JR\]5HY>J>=E'VYD3<214_X(T)NU']X\QJLB+!R&Q09N)*!"RA%@1E-O1!Y(/8!XD/4A]D/LA] M4/B@]$'E@]H'C0]:'W0^Z"UP3>[9^8B&T:_PD3*C?,2]NV%@.Q#Q(?I#[(?)#[H/!!Z8/*![4/&A^T/NA\T%O`<0@M*[_"(6TGLO,:D`A(#"0!D@+)@.1`"B`E MD`I(#:0!T@+I@/0V<;Q&7>AX;7P'R;NNP(CM-PM MC:$A]@UMLO#4(B-T.]SO9K0[74Q7KN5X9X&6#XSQ/69/_1V:B>TC(:1TS*]"[Q2@=+;U\>'WS?/U(6T/1F9?3,:_7H/ MJ(RX#=;$<^6MUV`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`V>,=AT]D&]Y)FW4ID)WO+U6>5%'(%*L&"**$,6($D0IH@Q1CJA`5"*J M$-6(&D0MH@Y1[R#7/2IX.<,].M9QW&.0/54`A1-`$:(848(H190ARA$5B$I$ M%:(:48.H1=0AZAWD^&)Z7FPXB+O+ED'3V6[V!(A"@V:T>EF;=>^>%HD43Z@8 M48(H190AR@VRJEH@*D7Q0%4KD>*JUH@:1"VB#E%OD*ZJZ['Q"/C,_,5T%_]R M]3<&6;T3(`H-6JA4B-J8X)Y')-ATC"A!E"+*$.4&6=4L$)6BN&?_5(D$5[-& MU"!J$76(>H/&'.A'OM:F%9Y$GIZ1FF*$;)#550&BT*`%K9;6U/0R5Y%(<7?% M:"M!E(JB;=[;*&9SM%4@*D71-N_5OA(I-E^CK091*XJV>:_VG4BQ^=ZQ MY4Y@%?*>?OLC[_D[18/\2[7G]?;3,8N(5L)( M;*>,[!4>]OD92^G+45B#>VP6DE8 MRC1E>0M-Z5EDN)P[",Z+Z:<8TQODY63]@,Q(V3E91E9.EI'.R8X/`EV#F6@E MK"61;,I(I#)&-(QE>9EY3V]REJ+;DDCYD5W!4G+%DI%/TSFGJV8;9S]F6F"\8B?D2S5Y$'L$'$[#3'7JQ(Y\#')G_7!N( M%`_L$%&$*$:4($H198AR1`6B$E&%J$;4(&H1=8AZ![GN40F<,Z:*R??(&KY1 MZZ0[+P)$(:((48PH090BRA#EB`I$):(*48VH0=0BZA#U#G)\0?>2U1M0@ M:A%UB'J#=%5=CZD4CSU[?FJ[21L&__YCD-4[`:+0H`.)(I'@GHD1)8A21!FB MW""KF@6B4A3W)8I$@JM9(VH0M8@Z1+U!8P[\_TD4S3!19)#550&BT*`CB2*1 MXNZ*T5:"*!5%>SIYJ99,I-A\CK8*1*4HVN;]1)%(L?D:;36(6E&TS7NU[T2* MS?>.+7<"GY1J!2.Y6LE(I"I&>QM2LX0H-8S$=,OH8$,Z MEC(-P7Q7SQ+#U=P!<%Z2:(9)(H/4;7W7V5-X:F^DZ%;"HS)D).%2Q,@$66,# M`'-$K"2F4T9B.F/DYHB\7%;.4G9P!D__"Y:2*Y:,Y(H5H[V-J5E"E!I&8KIE M)%(=(VT:7R+H66#0<1VN$CG_^2U;IX/LM,%,(V\A\+(Z`4O)(`\-LC-$!AW) M$+$MF4,)(S&?HOGL)/,YVQ+S!2,Q7Z+YZB3S-=L2\PTC,=^B^>XD\SW;&IGR M*F]@CX##&2+UOHR7'3#(G?*0(3)2SI2W4Q;Z5626VCM+8I:0\9\PDEF2,K)G M[LB:;RJ@KS:VY$,-"[8L%RL9294J1GO;4;.$*#6,Q'3+Z&`[.I;25YNJ3)?[ M]G;/$B,K@$KDV/Y7F_;IXHKF[Y&18#)`,CPW*H:BP;&DR$T6_YGW3E7`4M+R MD-%T=S^(&$GP%C,2J821V$H9T:9S5XD1UYNJJK?0Z7/*,=\;";E:P:;E:B4C MD:H82]8RM1\CFG-GD6&R[GKO9]_^KD0#=-2,XT\U_OO M+[&4-#ID)%T3,9(.C!F)5,)(;*6,YKMAE#&249HS$EL%([%5,A*IBI'4JV8D M4@TCL=4RDGIUC*1>/:/!ENLU/RWE>^T?SS\H]7%TQF*ZBFZS?KH*48@H0A0C M2A"EB#)$.:("48FH0E0C:A"UB#I$O8,<'\W/2U<-XFZZBI&594<4(HH0Q8@2 M1"FB#%&.J$!4(JH0U8@:1"VB#E'O(-<7-!6<>]KA.]E[QTTQ'W(/IH[E!TO$! MHA!1A"A&E"!*$66(@>YOC@OY3/'E(]!=BH/46B0 MVIGL=F53^'I!I#@O$*.M!%$JB@?,9R+%YG/'EMLS?B[$O^F>]-GF'%,D!CD= MIJ4L%!JI`]ELD>#6Q&@Z092*XIX,="82;#IW[+@=Y><0CDQG3!;,QY(%D#1B M*=DRA8SL405[_H=Y/I"18MG^$*)>UL.@YPMAW_D03#?2?',#!%%B&)$":(4488H1U0@*A%5 MB&I$#:(648>H=Y#K'A6>GN$>'ZH`"N>`(D0QH@11BBA#E",J$)6( M*D0UH@91BZA#U#O(]84?S1Y9MC!JG6MDW2X#1*%!Q[8 M05;O!(A"@PYLA42">R9&E"!*$66(1`)5)LOD9;#:)6%&WS7NT[D6+SO6/+G<#G1=P+C+@-\I[G M>7OH@*5D=QPRDO4U8F2>AX]]`<(BHI4P$MLI(]H3[3;VL/W/6$I?[DXES-VG M(SE+R-4*1G*UDI%(58SVMZ1F$=%J&(GMEM'!EG0LI2\WO5U"4WH6&2[GCH'S M(GU:;?T=JD'N@SX(TXR4_:"/D:3$(T;F`=GH&-`UH->5>(0GK"5/R%)&(I4Q M(OW=L)C._5"+I6@-$RGX`(2EY(HE([EBQ6A_:VH6$:V&D=AN&8E4Q\AMC?I?:UQA\(O26TL,+5AD+=*>'4-6$K&?V@0I=?9UY%!1Y[ZLRV97@DC,9^B M^>PD\SG;$O,%(S%?HOGJ)/,UVQ+S#2,QWZ+Y[B3S/=L:60S.R]DH)WCAJD'N M8@!/_8V4LQAH6]:TCEAJ__2)640F1L)(ID_*R)X%(S<$4P/SN!P?H.9BAX=C MP4BN5C*2.E6,]K>D9A'1:AB)[9;1P99T+&5:,O9="(L,EW-7@?/21W0T#8P! MR!4%+"5AGR&,]0JD848(H190ARA$5B$I$%:(:48.H1=0A MZAWDND>E=(0D01HAA1@BA%E"'*$16(2D05HAI1 M@ZA%U"'J'>3ZXKSTD8HQ_:F"Z2,C986MH4%'TD^%S%6(L55K1$UB%I$':+>H)'L@WHIR)D]5O;A],^0!RMN^L@@JW<" M1*%!M$/6>1D\0$0DN&=B1`FB%%&&*#?(JF:!J!3%?>DCD>!JUH@:1"VB#E%O MT)@#:1>RSX'_0?IHJF4R92;#Y'6P6B4A1M\U[M*Y%B\S7::A"UHFB;]VK?B12;[QU;SI*[/"]] M-(A[?M49)2\P]/(P@5&DKYVY4B$CB9`B1B;I,O)9`$N(4L)(3*>,:/^S&T48 M++"4OMID)%A@";E:P4BN5C(2J8K1WH;4+"%*#2,QW3(ZV)".I3AYA+DCEABN MY@X`E8HY??^SU)D;^_&906ZX"+DC(V6'BXPD7(H8F2!K;`#H"E@Q9L)*$F.E MC,1TQLA-MGBG'>0L90=G]E/ZX5WV@J7DBB4CN6+%:&]C:I80I8:1F&X9B53' MR&V,%Q+T++6O,>Y`^"69HR5FC@SR%@@_<\12,OA#@^S,D4$J\I6)#2>*L"V9 M6PDC,9^B^>PD\SG;$O,%(S%?HOGJ)/,UVQ+S#2,QWZ+Y[B3S/=L:60I4\N2, MI4#G6IRE0"-W*8#,T5)+.4N!03+$(Y;:.WMBEA"EA)',GI21/0E&[@6F`OIJ M(]\,B!F^@16,Y&(E(ZE2Q6AO.VJ6$*6&D9AN&1UL1\=2^FICWXNPQ'`U=P7P MLT9J,S]=JE^:._+!R!(32`9YL][_8,1(T?Z$>S5D)._=1XSD[?R8D4@EC,16 MRHBV*+)<^#]'DK'4_@]&6$*N5C"2JY6,1*IB)#6O&8E4PTALM8P.UKQCJ0,? MC+#(<#G7W2H[9$_WGXO=3(Y)EJ;-4B//]?X'(T;*<;U6I,T*CX:(I:0#8T8B ME3"2#DP9R8<9&2.I:LY(;!6,Q%;)2*0J1E*OFI%(-8S$5LM(ZM4QDGKUC`9; MKM?\?)7OM=,^&%EB'HN1E<="%"**$,6($D0IH@Q1CJA`5"*J$-6(&D0MH@Y1 M[R#71WX>:_`1_1#GT744,UI+C5;V0C"=>Y\S!R+%,R=$%"&*$26(4D09HAQ1 M@:A$5"&J$36(6D0=HMY!CJ-6X^DK_O7)DW_%<;`SA,5RGYFN/"=M6(J&P>YN MY,D$(K-S)*((48PH090BRA#EB`I$):(*48VH0=0BZA#U#G(=2;LBYUYV^,7# ME1)WTQB,:%W<.6ZMQQ#U*W'./0=++@5H2E92@$%&$*$:4($H198AR1`6B$E&% MJ$;4(&H1=8AZ![F^4`F4,WRA\RUVE+?2R$K;!@;1[\[(O#"*$L9&+"4H9B2* M":+4(/>!S=S+JV8BQ97('5MN-_R2=,<*TQT&.;UCI*21H9%2'P9;RXT7'D4B MQ2V*^8IB*T&4BJ)MWLL49R+%YG/'EMMA*D(^8]PH<6\.:^3&!7XT%JC?SB-% M.U/,2,9-Q,CD;N_4;YQ[N;R8940M821;[901Q1X[3V!^P$C1AT;J$<[D:N8- MOES,4%^Z'3<65D\69QZRO\(0VR`WV[+P7H8+C)2=;6$D,4C$2$>2B^7\=N4W M,689B6821I*G2!F)\+UV[]H/&P>P9Q]T9H$/VL`W=\@"A$%"&* M$26(4D09HAQ1@:A$5"&J$36(6D0=HMY!KB^@$9]2' M1\8S!F>W&M'9V'RY@)%Y``Y/I$,6$)V(D=P/8X,HU3:\.3.EGPAR/_!(4"EE M1'?)7>?BCLY([79T$W]')V:H56Z/.2'4\1[#$.I6(^LI=L#(/+G!L_Y"EK!V M'HQD_Q4;1$DOW673B;>I25`I922F,T9ZD^'9R+D4=VRW3F!UO',P@AHL4`0@ M0R-@I,?!Z/8T9!E1BQC9(TI?;S>BX.N1!)521F(Z,\@,GY$]K:/C#A\GDCK> M0QA)W6KD#!^#]/"93&]6M_ZO=H2H%C&R!Y"VM!M`,__SN@254D;V`#(UT@-H M[$A0 M*65D#R%M9[<"WE%N.Q-5WK6.,T,CI6S!D;M!MQ=_[';`DJI099U\-K,;/;&5R_?MUNW\+[M_L/[YZV+U^VP?;;M]>+A^<_OM,> M9$*)48M?O&P_O[_\N+I9?R139&.GH4OH2=%:/>P8*YE0R3`K0&=*)4-$`26W M5#)DR:'DCDI&:W!+-:!M-];@XV2R_DB3&4LV5-)/1NLVH;K1[\./Z7I4/9V MK7*SJ$.)U[5*JV+)YG:R5O$"EM">?JUV[%CRD;IZO->HF2/R&^KF47GJY+$^ M_CA??YR,.7DS7_=CC:`W5=;JI0:L*KVPLE;O-F`)O:2R5J\X8$E/)>I-!RP) M5S/JX+$JTZ,`ZN"QDLV2'$DK)%K;+,F1HT.67OU9J]="4">G$O5V");0FS]K M]9((EM`+0&OUK@B6T'M`:_7*");0ZT!K]>8(E@14$HR6T"M2ZW"TA-Z46JM7 M9M`:O3"U5F_.8`F]-[56+]!@";T^M5;OT6`)?7A!_38V+K.6`F=0+&.Z+P$K#4='K%61T-@"9W[L%:G M.F`)'=FP5@,Z"S(VW0""9;0P2C4 MTK&2S9Q:2F=JHCI7068;4HV.K"QU#2/TV5K*9T>JB-UG>;6(SIYLH;?VP!ILY MW2KU$P30H36<'B2@3D:U5F<>8TE.)>KH8RRA8ZW7Z@1D+*'3K=?J(&0LH4.N MU^H\9"RALZ[7ZEAD+*&#O]?!:`F=_[U6!T&C#AT#OE;G06,)G0:^5L="8PD= M"KY6IT-C"9T-OE:'1&,)_0H4]=N8%^A'EVB$C)70#PZ1SMBLI]_X(9VQ$OI) M&VK/F.?HUVC(VE@)_9`,]?58"?T&#%UGK(1^-7N=T2]"8TOIAZK7ZN>CL81^ MEWFM?G492^@GEWYB;;M%!MN[S]M7Y0`"7]^?G[C_Z!N MN?[K^>7W8=__X=\"````__\#`%!+`P04``8`"````"$`25.0CY<#``"-"P`` M&0```'AL+W=O?:""=8"1K:SV?W[CKEX;:!15NI+"(?Q\9DSX\OF_J4L MK&?,.*'5UO8=S[9PE="45*>M_>OGP]W*MKA`58H*6N&M_8JY?;_[^&%SH>R) MYQ@+"Q@JOK5S(>K(=7F2XQ)QA]:X@B\99242\,I.+J\91FDSJ"S
^U'L^[:[VS0&_2;XPK7_%L_IY1,CZ5=287`;ZB0K\$CIDPS] MDDH(!KNCT0]-!;XS*\49.A?B![U\QN24"RCW`C*2B47I:XQY`HX"C1,L)%-" M"Q``OU9)9&N`(^BE>5Y(*O*M/0N=Q=*;^1!N/6(N'HBDM*WDS`4M_[1!34:* M).A(X-F1^*$3K!;^(I0L5T;.NI'P[*>_;>"\&PC/?J"F>SRCV^;=V!@C@78; M1B\6]"9DQFLD.]V/@*SWKV50CO[+4'!2DNPER]9>VA9XQ:$+GG?^:K9QGZ%R M21=SF(@Q(XY]A"R3I(TUP`6]2C08_1]$2Q8INI_NT`-O600#A7U$/R36`$,A M%'2H<`;-/=V6O8MR$#2@X>+<5'!H8V2+*ZL79LA1A2B5.F+(A(H/94KJ=U9? MLD#_A)JF0X>L5>V/+1)X3?.&IJ-Q M]Q':49FN)V@H`Q=N5R:#364=LGI3-D)B'3'FA@5X^]PRV)R[1>9K(\UA=ZF@ MWLQ81PPY\I#5]I;K19+!IIP.T:P8(;&.&'-#$OKMM[0'N`E9B=\!$7!;<2>I9GO!_`ZE5P M>P$Y^![<0)I+Q.B+NIL,OL"E91_(!3C`#W+`%!Y$#:![^?1'I*; M&#"/XOD4'D:PZ"?BEQ&LO@E\%<'*F,#74=SL>:[*#"Y#-3KA;XB=2,6M`F=@ MI->L$]9>I]H706LP&*Y$5,`UJ/F;P[47PS'M.=`G&:6B?X&)7761WOT%``#_ M_P,`4$L#!!0`!@`(````(0".NA"=R@\``'-2```9````>&PO=V]R:W-H965T M7YXK?-_K#= MO7Z^]*XFEQ>;UX?=X_;U^^?+?_\K^L?R\N)P7+\^KI]WKYO/EW]L#I?__/+? M__7IYV[_Z^%ILSE>D,+KX?/ET_'X=G=]?7AXVKRL#U>[M\TKE7S;[5_61_KG M_OOUX6V_63_VE5Z>K_W)Y.;Z9;U]O=0*=_N/:.R^?=L^;(+=PX^7S>M1B^PW MS^LC]?_PM'T[L-K+PT?D7M;[7W^\_>-A]_)&$E^WS]OC'[WHY<7+PUWZ_76W M7W]]IL_]NS=;/[!V_P^0?]D^['>'W;?C%^WC\7V=4.C33XI![[N M=K^JT/11(:I\#;6CWH%F?_&X^;;^\7SL=C^3S?;[TY'LGM,G4A_L[O&/8'-X MH!$EF2M_KI0>=L_4`?KOQGIK MJM%?4\VC+KS308\N`>T(#3E_N(]UT6,;U/^LC^LOG_:[GQ>T MFI$OA[>U6AN].Z7&4TZ;>IJ$_]<*1DE$<\NO<,Q#3?,80CN$K@@M`%D0MB%R0N2%V0N2!W M0>&"T@65"VH7-"YH7=`-@&4(+2Q_AR%*AFY1UJ29VP[^`-H;W-P.0;>YE= MG8+XP@F`A$`B(#&0!$@*)`.2`RF`E$`J(#60!D@+I!L2RPL:Q#.\4-&V%X8L M3WN0%9``2`@D`A(#28"D0#(@.9`"2`FD`E(#:8"T0+HAL0:>GKC.&'@5;0^\ M)OY4!M[$"`DTF9+Y@XFRL"=*>`KBB1(!B8$D0%(@F2;T],;*.9#B5&O8Q:7= MQ?(4Q$(5D!I(`Z0%TFFBNVC9HYYSS_"G#[<-,FCH$$?)B`0&.1[=V@,02A2/ M0(0H1I0@2A%E!@V=0E1(Q:%73E=+B>*N5HAJ1`VB%E%GT)ACZF$+'WRO5.+D M^+1]^/5^1[.`@D8V'%/:3)C'7OW(1KM![OZ]IY%EI(D:&JG1=-GO2_R)-W4] M/`6P(TH,$F7GF2Z5`%;.4"9'5$A%]7R/?2XE@)4KE*D1-5+1*#M] M;B6`E3M+QIZ,ZK%M:.V(A93).WFHG_(L#S52Z;[34KAPEIF5RDO1*NN+]P$C M>PF=N-::BMK[V>S6F121R/"GC1E)8PFC=QM+.4HWYDV\&RC=UDJ.TJTM;WW/_NP5!TAC-2-IK&'T;F,M1_$YJ&O?UT3SA=(TOGXZY,T+1/>YN4EJXWU3EGE>4*.K2H.D#HU M(U%N&$E4RT@K>XO9U)'N.**O9-NJGB//L-4\=@YMU3%W MKI>*`Z1.S4B4&T82U3+2RE//'=..`_HZMJGJ,7UHJLY1GWNKU@_[UC*OD6]- M863-G^:HX0J1K1B+=,!+IEI&6]FZ6,^>NTW'$ MR!Q6F8#_O]TFGR!7Y3U9WZ_8Y,1IQ?9NG+OSBJ.D8F#0='B=>'.G8FBB9CK5 MY$UG4\>IB*5E6L2,I+7D0ZVE=FO^XMEHZ? M%4M+:S4C::WY4&NMT]IBL726SHZE1Q8+VC-85\^?;/Y4N/,D9M`@2>$!"A"% MB")$,:($48HH0Y0C*A"5B"I$-:(&48NHLY"]<*MTQG`F_XD7)OLAU\N].I%4 M]M"?P91UEJF51/%^.4`4(HH0Q8@21"FB#%&.J$!4(JH0U8@:1"VBSD*V/2J= M<88]*MR9*@8-IPJ@P`,4(HH0Q8@21"FB#%&.J$!4(JH0U8@:1"VBSD*6%W1` M87NA]CC^_(KN56>>Q/=*MDV,[%GDW)U6$G6:18A"1!&B&%&"*$64(D+R6JO?$"!071B MP5,E1!1AQ1A1@A531!E6S!$54G&XLW2>:DJ)XMY7J%4C:K!BBZBS*MKVJ'3! M&?;H[()ECT9T!7#75RJI13NX`0H,LNS140,48<4842):[PQI*E'($JDX'&4GMY!*%,MGJ)4C*J3B4-[),I82Q?(5:M6(&JS8 M(NJLBK:)YV4/?,P>Y16BP"#'1.?X(I0H'H8(M6)$B50X8SE5(4[SU`: M6;X""GR-;%_=7'`H4=SUR*"!?(PHD8K#D7%VIZE$L7R&6CFB0BH.Y>&>>/J, M+%^A5HVH&9=W%O!6HEB^L[1L7U5JX0Q?329BN.$W2)+7*W4>H-R7=3A@))O, M$%'$2"K&B!)&HI4BRAB)5HZH8"1:):**D6C5B!I&HM4BZACU6I87=$)B>_&7 MCFEZ%7OJ&:1NO9($7#BWI!5'B;>!03,YO@@9Z<-%?[J83-SI&;&2;%EC1B*> ML!(]STNOW$.!E*/4*R/TG8@K]Q`P8V5I+&>HG65$ MN68DR@W+O/LQ6HXR9[+^?.D>`'2LW3=G7QANAL2],/ZU>R/'1U^U(=/Y/0TZ M,7<798/4-2D>+)R!6)DHZB"O*`$C&<^0D4R2B)%$Q8Q$*V$D42DCTH8]5&V;6XRQ;7M0V](33''8M!LIL]* MO9NILS-9F0C+,:TSTU_[ZU^;8!U]ON[["SH#2D5:FN>Q.9=TR><55:A1N6.7=3]%RE!XU MSYLM)\[6JF/MD6O"S>"XU\0'IS)F=J8:.8N\LR-><90L8`$C6>9"@^C%"QZN M"*-B1A*5,!*M%+4RC,H9B5;!2+1*U*HPJF8D6@TCT6I1J[.B[*GL)GM89;IW=:^*#4UG)./LU@V0CN9H""A"%B")$,:($48HH M0Y0C*A"5B"I$-:(&48NHLY#MT7DY)5KPP`N#Z)EML$-R+O<55Q3'`D0AH@A1 MC"A!E"+*$.6("D0EH@I1C:A!U"+J+&3;CT>O##(FBI+9T.Y MXHI#>TX5^<848E2$*$:4($H198AR1`6B$E&%J$;4(&H1=1:R[5$YE3/L,2D8 MN27>J[?OU.R1@5\A"A"%B")$,:($48HH0Y0C*A"5B"I$-:(&48NHLY#E!;VA M:'NA[OQ_Z5V37LF^^3.R9Y'SA+&2*)XR`:(0480H1I0@2A%EB')$!:(2486H M1M0@:A%U%K*=4RF0C\\B2GRYBQRCP2Q"%"`*$46(8D0)HA11ABA'5"`J$56( M:D0-HA919R';"_5,/O3BK\\B_70_/+RE'UDRB]U@V^:^,K^2*)E%IXJ,0HR* M$,6($D0IH@Q1CJA`5"*J$-6(&D0M(O4[57*_T,[IWYW2/W_SLME_WZPVS\^' MBX?=#_6;4G.5$3EA_8-7]S/UBU?]\QV4^/Q;6&[)='ZG]O1D`)3<4$E_3X.2 M!97T#VE0LJ22?KI"R2V5W(ZU,YM0W_J4DUO'(S5]"X424J/W$T=Z[9,:O?\V M5D*C0V]CC970Z-"+0&,E4RKI$Y!.#^C'Q7X9K4&-C+=!0F,M4`.C^K.[7^BB M&.G2C$9KC)-;HV:15Z-6T=B.&N51!7I+&ENF\\([=1J()734=Z<.\K"$3NGN MRM$2.F"[4\=G6(?.KZB=,7/I-(K:&2NALR5J9ZR$3HJHG;$2>CF!VAD;,WJO M@-H9*Z%7`JB=L1(ZS:=VQDKH_)S:&1M1.OJF=L9*Z-2:VADKH0-G:F>LA-Y> MHG;&K@UZ%XG:&2NA-XNHG;$2>BF(VADKH==PJ)VQ)8->JJ%VQDKH?1AJ9ZR$ M7F6A=L9*`C)[S+>"#!WC]'WS._4-<+RBZ.O==^H+UU@2>-Y=2%_.Q1+Z:C*I MC9705XOOU+>'L0Y]-9C:Z4NN3^L%_>3?V_K[IESOOV]?#Q?/FV^T?$_Z[X/M M]8\&ZG\ION]V1_T%-7Y]^+O++_P(` M`/__`P!02P,$%``&``@````A`,IPYE*R!0``XQ4``!@```!X;"]W;W)K]`>#\B(%Z(>K(5N64FF4SF\LS& MJF2+&&!?SK>?5=I2VN7LZ,E^V6Q_KOYI_UUMEUU^_RC/QANIFZ*ZK$Q[-#8- MU6_-"="6@,4+LW* M/+7MU;>L)C^1,FM&U95BW/1 M_NA$3:/,_>1XJ>KL^0SC_K`G62ZTNP](OBSRNFJJ0SL".8MU%(]Y82TL4%HO M]P6,@-INU.2P,I]L/[4]TUHO.X/^*U07^]^*"P&W89[H##Q7 MU0L-3?8406,+M0Z[&?BC-O;DD+V>VS^K]Y@4QU,+T^W!B.C`_/V/@#0Y.`HR M(Z?K1EZ=H0/PUR@+FAK@2/;1/=^+?7N"_Q:F\4R:-BRHE&GDKTU;E?_R+VEG M^L8.;PQ/T=@=S>SQPIU!%^X4<;D(/+D(R-W9=L+;PI.WG8^\R73^@!-@?"<"ST<[8K%I[;(DR-IL MO:RK=P.6'DQ@<\WH0K9]&[)+Y`>;U3YC_B]A8+*IRA.569DSTX"<:"#+W];. M8FF]06+F/&2#0VPU8BLB:`I1U4`'.QV$.HAT$.L@T4$Z`!:XTEL#:?85UE`9 M:HT8U4:`@5>:$2)"-`ETL--!J(-(![$.$AVD`Z`8`2OO*XR@,BL3_O8Y8D^F MZL@W+(9N4'V0IX9L^Y#>'41VB(2(1(C$B"2(I$.BF`1;S%>81&5@+4X'!J"5 MQ&,^,ZD/Z4U"9(=(B$B$2(Q(@D@Z)(I)T&7%I-NGD-A4:'3GA1C$AI-%OYBV MC#CC;L^9J*D2\"]A@??9-#!3Z1D8_D#/:+3:,T[FLF>(!(CL$`D1B1")$4D0 M28=$&2CLT0\,E$:K`^4$#K+>4WLR4XW?]D%BY@)$=HB$B$2(Q(@DB*1#HHR= M%K7#P^[S]*/1ZM@YD7OY%I$`D1TB(2(1(C$B"2+ID"@#A0KA@8'2:'6@C#BN MS&9$`D9<,%LF@JL=^KL^2"1"B(0B1.*^U4!Z,E=S+.F#A'0Z%%+LH(6-X@>K MXU`5U:=.>&4.C<(HX,B=L\)H;+OJ4'8R M0(PEQ#(11K%LV)5<2#F1`4(Y5614FV@E=/_ZL%GA!&>5T-YP1`MCF103+2FV M(DHV#`12LLD;ZSZQ-SK,2!N*9U>K(4,I)#H5"21?%POTZ>L2$25>-YO.M->E M(J3;$E0S:37U@)FL^%+,9,B!M)9F>EH/MC:+"I"NE:J3;2@&MKTHZ:45L1)1L&'+FRR-AQ-.%5QF0^0^;QM\FC(<+2,99.-&G'FVEG:2IT M;J08K;.&WMW8OF#\_?[%RS(YUHW-$*286"U;CI1\8E&NG/.=B)(G1"B0C(H$ M&N8/TDI$E-1*!;J1+[2F&X[YY_*%58;*:F-(RQ;J0^E)B2/SF<^E&$W^-R'J@7S8.%#K8!YO/#A MH,<X++5`*W(^,13."AJEKQ@;Z@OYY=_P<``/__`P!02P,$%``&``@````A M`.'<9@%7!@``\Q@``!@```!X;"]W;W)K(C,]ETU;U;6O:$\LTREM1'ZK;:6O^\W?T:64:;9?? M#OFEOI5;\VO9FK_M?OUE\U8W+^VY+#L#%&[MUCQWW=V;3MOB7%[S=E+?RQM\ M]-F1_ZI.MEZEC68GK-JYM)%;SF$8WZ>*R*,JB+UVMYZZA( M4U[R#L;?GJM[R]6NQ2-RU[QY>;U_*NKK'22>JTO5?>U%3>-:>.GI5C?Y\P7F M_<6>Y077[M\@^6M5-'5;'[L)R$WI0/&Z[>XJ0Z_5[<2W(9U(BOP7-NG^JM^2LCJ=.UCN.3^=)R;2+R3J++$N&5)*+S4.*:)<(K2[37DYDS7ZZ^9X\-U4`7AY0%6YUWOW1*5[0-G^#&^( M#/&&S\KG0)CE:$;P")X2Z"#40:2#6`>)#E(=9!)0C(#+\&<8062V)OR5BF2A MSMRG,62C&H*T.MH/(8,[B(2(1(C$B"2(I(AD,E%,@BWG9YA$9.!BA%UE,`!? M2BSH/9>&D,$E1$)$(D1B1!)$4D0RF2@NP9`5E\9O1WQ;(=&]&7P2/B/KX6K: M4^)8_:[CJN44L`_A"A]U4QD:6/Z!H9%H=6B,B`M]CTB`2(A(A$B,2()(BD@F M$V6BL$TK$R5[OKLB;0"[)S^\[1,EU01&X&8H&;Y45V4_!/%E#1`)$8D0B1%) M$$D1R62B^$):7_E>^'YMDFAU[HST35U__]HC$B`2(A(A$B.2()(BDLE$F2AT M'!^8*(E6)\H(Z$N+O-(6>0@:%AF1$)$(D1B1!)$4D4PFRMQ)D_.!R??AZNPY MDM89HP"C$*,(HQBC!*,4HTQ!ZIQ)A_-X9=NT(8)[$%\ZGR'''=`>HX`A%ZXP MJ3#6:F&$(HK+1QC%&"48I1AE#-&AJC:0_D:V@3:[$_),T9VKXL6O8=@P^9$+ MWX7;"VMU:9>DN$.1X@Y"@4V1N^KO5(YE:S>K4`0(8Y!,S**D+TM$(NF\05GK M)U,1P)4S14:UB;0XLDTC=L"]8O"#=41RM5!$;BBB#F:66@=[FT6)Q(`C<0\- M.:*NS=?60NL'(QXADF*.A'3"D8A*.?JF=,8C^B35)-+A?,`DUA")`?DV10[L M5)))MFX2C7+[AWWV4,00?=8FSTDATW(=V@39CCU;:79'/$:DQ1P)\80C$95R M!,LE#50KL8Q']8FJ5:0)^X!5)%S;<2G2ZDF[?/;DH0$2'>%QP)%8])`CNNC+ MA35?+C73(QXCTF*.A'C"D8A*.:+B]IJ<=6C#S'C,2$V1CDTVZL?V)];WB9'Z MY&F".*.6VDPO-1JEE!I#LV';#YF62S8`V&O(PHHI@CN=20>,JC MN+CM(/&,QXP4&NGL9/^^LW&Q1E`VBB(H-+Y/[FV&1%3`D5CXD"%71$4X*N9( M1"4<":T4:V5*E'IQD29/GO./U0QK%<7`?#B;'*D9;>_=LRBE9FBB*]<,0W19 M;=>>+]R5UB]&7$HN&I8G%PU23WDB59^YSLI>:IL?.6DELW&EHJ$GI_0P[%HV MIW)?7BZM4=2OY%04MK/=9L#TR-9?>O#P`)6A\Y4'O?8(7WO0AXYPVX*SWWY2 MFA)T4![I:7`.=`\>:1#P)W#WAYRQ3^"(^6F,^^3H>43)=SPX`L+?X+L>''M@ M_C3SGL!8_($_\^`$8(0O/'@J!3X=Y@U'SO?\5/Z1-Z?JUAJ7\@CF6WU+UM!# M:_JFJ^]]:_9<=W#:W/][AA\72KC[61/8^(]UW?$WY`N&GRMV_P,``/__`P!0 M2P,$%``&``@````A`._(8$$8`P``YP@``!@```!X;"]W;W)K)GTI:*4,B:$$4Z)#S5=S$O:Z`XLH*IEX84HS(.OF05%^180-W/[HS$'7=SI:#_TCF M_/Q)L.0KJRB8#6W2#3AR_JBA7Q(=@F3[(ONA:BWB7#M5G]=_$;>K,V#:Y=W M=X*,FV6F6$"\Q`JL![J^=CR*&']"J' MD9%,Z/A4IJ9^9_TPSOI.U1^Q#&L3=]6.!(&;CP=F4:/%9F(I[WJNPB$@TCH[7A!1RN MK5_FU5IO>^_MJ"8:ZVHC<&@.+)A-)J\'=4;#QM\0K70Y1JK9R,T>5%*1T0,M M"HEB?M*;]`K\[Z/]^;%K[)C$]W"N-+OP-.X%\%K">M.X'T3^E?AN%NR:36"* MGP71[`I^OPB@`U?XE^TY9_=$<,[4)*/?B,A8)5%!4RC1L9;0$&%.*G.C>`UN MPVG#%9PPS=\"4<]7=:"/[3Y3M7P```/__`P!02P,$%``&``@` M```A`#X.'9?D`P``&0T``!@```!X;"]W;W)K'Q_;EYO5_6M5.B^DY935:S?T`M+ MK"ZRDM5D[;X1[MYO_OQC=6;M,S\2(AQ@J/G:/0K1)+[/\R.I,NZQAM0PLF=M ME0EX;`\^;UJ2%3*I*OTH"&9^E=':50Q)^Q$.MM_3G*0L/U6D%HJD)64F0#\_ MTH9KMBK_"%V5M<^GYBYG50,43[2DXDV2NDZ5)U\/-6NSIQ+6_1I.LUQSRXNOUE)@[Y3'"DN(M)3P'1X'&BV)DRED)`N#3J2@>#7`D>Y7?9UJ(X]J-EEZT MB,-X!O'.$^'BD2*GZ^0G+ECU0T6%'9=BB3H6^-8LL1=.`\EQ(V_2Y<%WEQ=[ MTRB>+T*<_$;BM$N$[RYQ,O/B>3!Y)]%7RY8NIIG(-JN6G1TXFK`NWF1XT,,$ MR+1]:NK>T/?\!".1Y`%9UN[<=<`I#H?@91-&LY7_`AN7=S';D1@[8J0 M-C4`'_3VHL'F3Q"-+"A:3[?5P&45T95"':%34@.P%,*&?H)"9%F[\&G8.K/NR2C;4$:,GP:0JD%V0*P)!O;]+M6A:JT0XG0B]YJR#)K$ER9 M=8G2B:D%V6JQ/!MJ;Q^J4!5S2U,'F78-H%0GRBA;`!9:0\#O7T#HH:X/EX9L MP\)KP[K$RQ*P'Y-Q(67(G9R?LG<(I5,$>5HW=-@R@LY/- MV6`$>SY92@#D8GN$Z]&H(%\&,^`A#$FF&(T'B:0?>@U_S1Y4`WJ MUZ//48I"V/>0_\NT-U[L9H=;$D7)VWWY[/JZ*ISQ#B ML3I6_<\AJ.O4Q=V7IU/3YH]'6/KC?5;`"*;O3EONM^Y'=97[L;A[N!X'^KU^?BJ[`A2%,&L>R$A%I*UD:H$C^8_CWI=KUAZWKA^L@\GP&<.>Q M[/K/E0SI.L5SUS?U?PAB*A0&X2J(#^S5[WS-XX`%X>TH&V0T+/!3WNZ+&R7WGB"B8(!83 M$,AD(L7RH9BN,Y(7`.2($&%`-($!D5U#6!0AB$GQ.C4)WKJP_DF; MA"0E14@\Y'3%61+%$$1`Q0&1:B&:` M`EY#6!Q#F^-U`278%I!Y5$'$A$I!SXM]FWQF`9@OHF@"6,R@O=ZNGKR(,B0- MD"(&&?HBX3X!9!8@CEFDUV@QE'Y'ALGM_I`7489$HA0QR)`%OG%_S*[UN_"X MN*Q@\AY^\B*;7TPZ($6(2G$,Y4GJ,[,`D3`!EH`,ILG;%1RNLBDR3TN`,T:! M5)9#GX>31JBA#?`Y>R7)3,YI(\O7.V1`4VZD.5,%0FX!B^(9-_0&!8BB6$]0 M6S\YRPUNRR8,0P[1Q3<`J%CS0ZMH9!8G7,*I+BQR(\]CRB;$4S`>)+H)=@,B4LL MFRD`0G0YD`?&$8MDV.&,>-WIT; M!F.S%D&0P$>.V6Z>6S_'KQ@:)V9Q@]<%DS"L4B75](`5"SW*/!MN.IKQ"IZ% MC.=16S7B$PM;`T>]W1JD[E..(+.P""2["K%YOLDT^-PT&-/#0:EHFL(*-JKS M!%]!6.SDPYG9N,M4'*XBHY#1[:@"88,P`:\-:`]E"F(*_5H'^\1&%A*=VPEC MQ/[3(?18<@P&=A"389DIR"*BQ%0D40$#Y7KW^!?,A0Z\5(%>83'41J8PJ+K/ M$WA?HQ-CIUX:@#&S%RJ*MF'-;F,KAP7JS[W%R*LBBAA5'C'7'6:SA-6^@Z6\ MBA0HUQL4Q1)!U^5$C&+)?,/P;9K$8!:*><%H./&1U$?0F-$P#L-9>=J01,`; MN,F-;)[$:Q;RO.`YG'J.CR`E5T*]6ILG\9Z%/"]XD/$F M2*7=]"`>)\!!=XCB:4'"B$?&]L3F^2X7@I.*>7D2L5(%PA>OL/T10:3%4CPQ MS@B!'8:GLX(\\40#7_C79?M49N7QV#E%\RQ/*SAL$*9OIY.4CUR^/"??IW#" M,AQ';*8?X(#CG#^57_/VJ3IUSK'<0TAO'4$UMGA$@A_ZYCP<,SPV/1QM#/\] MP%%6"2_GO36`]TW3CQ_DJ__I<.SA?P```/__`P!02P,$%``&``@````A`"], M@0#+`P``F@T``!D```!X;"]W;W)K&ULG%=1;Z,X M$'X_Z?X#XGT#)@&2*$G5I.IMI5MI=;K=>R;@)*B`$7::]M_O#$,(AM9E[R4) MYO/G;[ZQQY/5W6N>62^\DJDHUC:;N+;%BU@D:7%E&>.Y[J!DT=I81/#LAK#(0Z'-.8/(C[GO%!$4O$L4J!?GM)27MGR M>`Q='E7/Y_)++/(2*/9IEJJWFM2V\GCY="Q$%>TSB/N5S:+XRET_#.CS-*Z$ M%`^5E?!#=,[4/^+RE:?'DX)T M^Q`1!K9,WAZXC,%1H)EX/C+%(@,!\&GE*6X-<"1ZK;\O::).:WL:3/S0G3*` M6WLNU6.*E+85GZ42^7\$8@T5D7@-R134-^^]B3?WF1]\SN*0HCK`ATA%FU4E M+A;L&EA3EA'N0;8$YFMDI*.-]:-0(48DN4>6M1W:%D0A(3\O&R\,5LX+>!HW MF.T0PW3$[HK`5("\5B-$WM7XONM7*0A&*9@%U+:E`>"^:>NM.T2$?@O1E(!# M727HUNS#?7!5A),@XUT!8=CRDTC"S#J8FX(:L3,A-(U`\OL:<=+:!B-N)H7S MGD;"!'5ZV12VW73>@^RZD-G4F[/0;4DTD6!:5Z0YI0C6Q?F+EI;\(P@LW^KO M^V=":-("7=JX'..DSW),&)-&$T+3"">M:]\XC3A)M]$;Y)@PE&-_X09]%S]^ MK^G#BZ]3596[,=)(; M4'?U_B8T0G1]6-H[^D8:21>"N6(S`AEUFB"Z3JSNOZ^3[@18I:UZ[R2<0)3P M,'#],.R=KAWK0M@"&Y-I6U]UG1!N5Z?Y8#-$]S9D?[=M&Y#11^)Y'Z+KZ]TK M(_--=P.XT/&Q?T-COP?!O"^B.3@FB*[S?UTRT.(._!Q4\`9$^?:"T'5#KTUF MHY-X&@@4@2Z$=%(K3)UBSJLCW_$LDU8LSMCF>M`#M*-M"W[O8=/5&]]B:X[C M3OL".N,R.O)O475,"VEE_`"4[B0$]RKJK>E!B;+N3_="04]<_SS!?R`.39T[ M`?!!"'5]P`7:?U6;7P```/__`P!02P,$%``&``@````A`.(A@KB0!@``_1D` M`!D```!X;"]W;W)K&ULK)G;CN(X$(;O5]IW0+D? M0A)"DP@8-82<5UJM]G"=#@&B!H*2=/?,VT\YMN/8Q;"---)H@"]59?MWV2F[ M%U^_G4^C]Z)NRNJRU(SQ1!L5E[S:E9?#4OOG;__+7!LU;7;99:?J4BRU[T6C M?5W]_MOBHZI?FV-1M".(<&F6VK%MKZZN-_FQ.&?-N+H6%WBRK^ISUL+/^J`W MU[K(=IW3^:2;D\E,/V?E1:,1W/HS,:K]OLP+K\K?SL6EI4'JXI2UT/_F6%X; M'NVN_N! MPI_+O*Z::M^.(9Q..XK'[.B.#I%6BUT)(R"RC^IBO]2>#3[2\E*`VC!/9`9>JNJ5F$8[@L!91]Y^-P-_UJ-=L<_>3NU? MU4=8E(=C"]-MPXC(P-S==Z]H2.H\4< MX9,Y3L?FW#;L&6G]CN.4.<+G8RU"V&Z\\,D_A\L(L&I`^=39@O[ONY3AI\#LD7YFK.[TZ& M3E.IRTPO:[/5HJX^1K#\K8SY?Z.^P&G)FL[YA(UMLN`5)?1+64\%6!;X*`A6$*HA4$*L@44$Z M`#H(UZL'@OT*]4@8HAX?]YH#(:>I2,4MN(NG@JT*?!4$*@A5$*D@5D&B@G0` M)*E@V_@54I$PL.])B>;(VJRI#=E9^VRT99--;]+KA\@6$1^1`)$0D0B1&)$$ MD71()"%A&_T50I(PL.AAI^Q%PDN6&=U3LC?IE41DBXB/2(!(B$B$2(Q(@D@Z M))*2,"Q)R=OO8;[%$>M.,#[0-2-.OVXWE)B3;@=\DG/.8P]A+[FIN-0UF)8' MND:LY:XQ,A==0\1#9(N(CTB`2(A(A$B,2()(.B22&/!:D<0@[RC3'H.>#[ZE M2"!9)T;@=2_FQ)G($[?IC?C,>XAL$?$1"1`)$8D0B1%)$$F'1)*.'!V&K_?[ M*4ZL97T8&>01(AXB6T1\1`)$0D0B1&)$$D32(9'$@"+M`3&(M2P&(U.QJ!BQ M>N)18L&$#!+*D!-JVQOQA/(I,46@`)&P][H3.NJ->.@8!4H027LR#"U*#DE% M4KA*,M*2<4PJZ_98YJ_K"H8.N]R-7+-@8V0%(XDBR]L%7FHV/!EH9\G:;9B5 M(:3RN".)_KZ:&C-+J0BVPH++XC,TE!RC4#C2T%-;J20B8<%#QSA.@E'*$;R> M!L.=]L.512<5Z.<7LD$+5GJ8[01?,T3.:H/FE-%LN%5W"F8U.(UEB[3?,JL! M\K%C@%&('2.,8NR88)1RQ^YX*XM%:M`'Q*(EJR0612:LBUXL4WF?;\AQ"5+8 MZ@[]3"N&0++>S["5]\F6.YHT7Z?&U'X2BZV+Y',;>G@GAZ&`(]%>R-'=]B)N M1=LSYX[CJ(.)N8UH+^%(M)2L->$5<"\1.^1(6$45P:*YM4$19#G?NC8,23E-K2R1&5MN)?9@ MGR-A%7`D\B?D2%A%'(E8,4?"*N%(Q$H9@ER$WLOKGU3:#RA#S)57$452XAD. MV@"8E9#4(X=.DK%BGK<,6<+*QU8!1$JY$C$BG"L&%LE'(E8*4.064@L4G8_ M(!:KTD7L-3E#DC$/-TO#46Y_-LQ*RBSJ")DUV$WP;LFLV.YE32;*?NKST")? M`HY$OH0XOJ9^[E%?XFEQ>D]E5N>G"G%JA9S*/M<4MCA M)U"UN:0NPT\\PP"?6S)!:0(^W1.]5Q`NWZ_9H?@CJP_EI1F=BCU,RJ2K=&MZ M?4]_M-6UJWA?JA:NW;NO1_@S2P%O[0DYINZKJN4_H%-Z_X>;U0\```#__P,` M4$L#!!0`!@`(````(0"5(%U8Y"````:[```9````>&PO=V]R:W-H965T>?M-$$@F@)]UZNF9BU'[PX\DB`1`9/)0[__^SZ=O%W_L7EX?G[]_ MN)R]N[Z\V'U_>/[T^/W+A\O_^4?\M]O+B]>W^^^?[K\]?]]]N/S7[O7R[Q__ M^[_>_WQ^^>WUZV[W=D$6OK]^N/SZ]O9C?77U^O!U]W3_^N[YQ^X[E7Q^?GFZ M?Z-_OGRY>OWQLKO_-%1Z^G857%^OKI[N'[]?:@OKEU-L/'_^_/BP"Y\??G_: M?7_31EYVW^[?J/VO7Q]_O+*UIX=3S#W=O_SV^X^_/3P__2`3OSY^>WS[UV#T M\N+I89U]^?[\_@'F']Z?'AY?GW^_/:.S%WIAN(YWUW= M79&EC^\_/=(9J&Z_>-E]_G#YRVS=SZYO+J\^OA]ZZ'\?=S]?K?^^>/WZ_#-Y M>?Q4/G[?47>3HY0+?GU^_DU)LT\*4>4KJ!T/+FA?+C[M/M___NVM?_Z9[AZ_ M?'TC?R_IE-29K3_]*]R]/E"7DIEWP5)9>GC^1@V@_[]X>E1C@[KD_I_#WY^/ MG]Z^?K@,[BXO?MV]OL6/RM3EQK]XM;Z[G M,SK6J4;FQ@C]G3!RX.@+4Y'^FHK+=[?+Y6)U>T-'/U"12H=SIK^F8K`XK>;* MU*2_Y[7UQE2DOWS(V],.23-U:"S]/>\LR8U#1?K+APS$.0>Z9T:#4($-1JU MWT_LG]DXG&1(!">>Z(P'@OH/;O'UNYO9]=W\B$-G/!34R.>JIQZ6?3H3IYXX MCF;L5?4??-@36\QNG8E?#_?QE9ZXPSH0WK_=?WS_\OSS@E97ZO+7'_=JK9ZM ME35>`;2'QS5AWY)`:X&R\HLR\^&23H1F_2LM9']\#*[G[Z_^H+7GP6@VJ)FY MBBTKU$*CS(8^B'P0^R#Q0>J#S`>Y#PH?E#ZH?%#[H/%!ZX/.![T%KL@]HX]H M-OP5/E)FE(^X=S<,+*=Y#F$%5PE]$/D@]D'B@]0'F0]R'Q0^*'U0^:#V0>.# MU@>=#WH+.`ZA)>:O<(@R\^&2_M^:-`O7`QNM42O3*%JZDNTH&;T$)`(2`TF` MI$`R(#F0`D@)I`)2`VF`M$`Z(+U-'*?1*O]7.$V9H<62EOO1(;C4&=$AKXV2 MT6M`(B`QD`1("B0#D@,I@)1`*B`UD`9("Z0#TMO$\1IUH>.UZ9TI7X:4>G`. M=^I&D^!ZN";=>3/'%-*Z.^E+IR'D\#,:HM1N0S2Y&?;CP\5M"R0$$@&)@21` M4B`9D!Q(`:0$4@&I@31`6B`=D-XF3L?3IN*,CE=JM^,UN7&=[*^AHX@'3@@D M`A(#28"D0#(@.9`"2`FD`E(#:8"T0#H@O4T<7]`&\0Q?*+7K"T-NQSW(%D@( M)`(2`TF`I$`R(#F0`D@)I`)2`VF`M$`Z(+U-G(ZG,,SI>+5-7]*0/G.;KLRX M'C&$#FPM@2MOG1Q%X^P`$@&)@21`4B`9D!Q(`:0$4@&I@31`6B`=D-XFCI-4 MZ.MXZ?#%:I"[WF!D31!$(:((48PH090BRA#EB`I$):(*48VH0=0BZA#U#G)] MH8(I.[`]X@LE]WRAT8+<;4V-&V]JJ)P%5235.#<018AB1`FB%%&&*$=4("H1 M58AJ1`VB%E&'J'>0ZQX56IWA'AV)T:Z;>WDS,TCBV2VB$%&$*$:4($H198AR M1`6B$E&%J$;4(&H1=8AZ![F^4"&3[0MU<0F6[VAW?.;E1>7>_%EDD'N!N?5G MT:AB_X9L2Y;""%&,*$&4(LH0Y8@*1"6B"E&-J$'4(NH0]0YR/:?")MMS1Q8Y M$V79L\@@Z>6M2H3Z0H6>9_A"1ZIDCZ\;&W4WA2:!NH4HV[;9M7_!,2JI&')% M*ADKSI9>Q8A5MT-":4YW*Y>!MR>,63-L3=S34P'>&:>GY-ZN5"-UFW5L93"# M&RE:-9=L4ZAN[I"MN;X'J^ZN1(SHXFO9"MRNBEE%&UU+)3=WW!-4P=$9)VAB M*7'#9J:1YS\O+;YEE50,&YZT&# M/`_Z(;=1V1YD9'F0D>M!?SRRZB0/!BJ@L3VH[PB^4S=1W[X^/ORV>::^)-'$ M*CFG2:'O!PY6O/-6AF%B^CM!4S&P'&O07$*LR*"E.\F]ZV',MNP9'7OT`/?H!KD9[,!?\D7%E\(0480H1I0@2A%EB')$!:(2486H1M0@:A%U MB'H'N>Y1&^0SIHJ2>^N:0?94`12JZYFJ**H(48PH090BRA#EB`I$):(*48VH M0=0BZA#U#G)]H3;(MB_^=`A%EP]PT[C[MJ[R@;>F;KFBN"E$%"&*$26(4D09 MHAQ1@:A$5"&J$36(6D0=HMY!KN?4=MKVW)$+CMY]V]OVP"#I^"VB$%&$*$:4 M($H198AR1`6B$E&%J$;4(&H1=8AZ![F^4!O],WRAXP+'%P;1']DV![)OTK>O M@U$E%QQ`$:IB1`FB%%&&*$=4("H158AJ1`VB%E&'J'>0ZY[S(B2UF_0O.`;9 M4P50R!5%%2&*$26(4D09HAQ1@:A$5"&J$36(6D0=HMY!CB]H$W[.5!GD[L7? MH*5LG;>LLF)O5CF!2.#%M)&H>$+%:"M!E$I%>[YZYC-1L?G7VS%\2!5)$ MXP]>@YP.,RJ[PS1:ZBS+8K::>[%=Q'9D>,=\-+&3($JEHGI*=3$+;J"CQH-+ M1]E-=#OJO+!QCF&C06I;9*VV7I)BRRH9:"$C>U1APLJHW!Q(X*4;XBE;=J@\ M+/D)JZ01*:.#CV%QS@K,F<'L'(-91N[>PLM8;47%4S!$ M%"&*$26(4D09HAQ1@:A$5"&J$36(6D0=HMY!KGM4D'GZUF]N8E*9SAM&,B^V MB$)$$:(848(H190ARA$5B$I$%:(:48.H1=0AZAWD^L(/9@^'1&I]]O9Y!E%J MB2?!%E%HT-Q>@`/<6VCSI&);L51DE"!*$66(_9/E2BX336B!E&+J$/4&S3E0!5^VLN? MY4!XDN7T>QES$]7:RZ1&5E=MCB8O,UVFH0M5+1-N^UOA,5F^\=6^X$5E&P[?\C M2ZX)FFV_:N3NQ>?>7G5+=Z+4%*=T&#SS,U;IPU%8,[''-NV6PQ5<2PY7,A)5Q6C_J=0LD5H-(['=,CIX M*AVKS*FL;N%4>I8,AW,&P>*\F'Z0N^&"02IM,/9W$/@!F5%1"#T.`D;6#5I& M^C[>Y"!@B=1*&(GME)&H,D84W4@[Y]Y]H9Q5%,&*RKH).D1V!:ODB"4C.6+% M:/_9U"R16@TCL=TR$E7'2-M6L\6;=CTKADJNSU5X;D]\:^$_?9U?F"!?QNO& M(&\]\&\:L$HJA@;1,.71$1GDW+.>+3Q;,=N2>90P$O,IFL].,I^S+3%?,!+S M)9JO3C)?LRTQWS`2\RV:[TXRW[.MB5E_7AIF@6D8@]Q9/_=6[*U1.;->VZ*\ MDKC:H/WS)&9#4BMA)/,D961/7ESZ6:4/1]_0\*=.S@HY6L%(CE8R$E7%:/^9 MU"R16@TCL=TR.G@F':O,F\@USWG)8H6F"AB9$\5HQ(4HBI" M%"-*$*6(,D0YH@)1B:A"5"-J$+6(.D2]@UQ?G)4#&B!%&**$.4&V0UM4!42L4#3:U$Q4VM$36(6D0=HMX@W5378RH/ M\^]O-Y45+_+0R.J=[0)0:-"!1)$HN&=B1`FB%%&&*#?(:F:!J)2*^Q)%HN!F MUH@:1"VB#E%OT)0#_S.)H@4FB@RRNFJ+*#3H2*)(5-Q=,=I*$*52T9Y.7JHE M$Q6;S]%6@:B4BK9Y/U$D*C9?HZT&42L5;?->ZSM1L?G>L>5.8)4(L2?PX421 M>@74GZDFE4*7/%E,(5%D*MJ)(D82(46,3'9EOKSS^BYFA51*&,GN-65$*\;8 MIHE@P;3<)%?F$\&"4F6D:@Z1MHT/D30 MLV"HXSI0F#0D0P1JV20AP;9&2*#CF2(V);,H821F$_1 M?':2^9QMB?F"D9@OT7QUDOF:;8GYAI&8;]%\=Y+YGFU-3/GS,D1+S!`9Y$YY MR!`9E3/E,4/$JKVS)&:%C/^$D':OTT0*5Z7)?5NM9,1S-70'\[)!:`?1;[H>O_K3/ MADFOT8JN(N.5-IA[SU1M3<65G'G(*)!<(2/KIBXC426,Q%;*B`;7V(@)UYNF MJK=]Z*.,4[XW"CE:P:;E:"4C456,I.4U(U$UC,16R^A@RSM6F98O,*W9LV0X MG.MM/__TY]9[3$LM-?)<[S^_Q"HYZ9"1=$W$2#HP9B2JA)'82ADMQF&4,9)% M-&T6#+]9J?EO*]]H_G'[0- MFWSWD*[`_#Z;NH#ZEVG(36U99:6K$$6(8D0)HA11ABA'5"`J$56(:D0-HA91 MAZAWD.NC\])5]*`O^,(@Z?@MJP2%B")$,:($48HH0Y0C*A"5B"I$-:(&48NH M0]0[R/6%2@[9N]HC5S*=2[)?]5@:Y&;9O?AS*RH.KD-$$:(848(H190ARA$5 MB$I$%:(:48.H1=0AZAWDNL=/,QUQ#Z:/Z`'X8?;(O-@B"A%%B&)$":(4488H M1U0@*A%5B&I$#:(648>H=Y#K"Y74.&.JZ!R(,U5,6D2NBEN5L*,+C97="PUR ML^SP]H*H>$+%:"M!E$I%V?0%OOE,5&P^=VPY/:.V,D[/^!?=DU[X'ZRX*1*# MK-[9(@H-HJW1<%G$Z.=!%$J%?=DH#-1L.G-VE(K^3Q]"M._WKWP& MNL@7)GH15THB4T<%&9-.-\)]* MFK)E-\+M>!4_G]'Q.MRVY^[*(&L=110BBA#%B!)$*:(,48ZH0%0BJA#5B!I$ M+:(.4>\@UQ]A[<<*PQP&=E3Q:@$A:B*$,6($D0IH@Q1CJA` M5"*J$-6(&D0MH@Y1[R#7%WXT>\07&+6N-'*NH(!"HSJRY1`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`I$ M):(*48VH0=0BZA#U#G)]H3(]9TP5G1BR]['JD\WN[:DMHM"@(^DC4?&$BA$E MB%)$&:+<("N<+A"54E&V2G#WJQ(5-[5&U"!J$76(>H,FL@\W?TGZ:+#B77\P M?6145H>%!AU('XF">R9&E"!*$66(2^9YMX5)P2^/DC*5@D'NN5A;HZ3":HV-B+X#W14Q%.W/$ M2(9XQ&CO[(E9(9421C)[4D;V),#$$:OTT2;>&6"!'*Q@)`L>K`"R,L&0[GNMM/3/VI6P6W MF*\RR'.]_\*(43FNU[;H42SNYHA5TH$Q(U$EC*0#4T;R8D;&2$9ISDAL%8S$ M5LE(5!4C:5?-2%0-(['5,I)V=8RD73VCP9;K-3]?Y7OMM!=&;C&/QP8.'?F145SYP0480H1I0@2A%EB')$!:(2486H1M0@:A%UB'H' MN8[RTU='W*.34HY[-*);,=SQVUM`(:((48PH090BRA#EB`I$):(*48VH0=0B MZA#U#G)]X6>BCO@",TRW&JG;8M94@2W'J&*/A5*1480H1I0@2A%EB')$!:(2 M486H1M0@:A%UB'H'N>XY+U%TBXDB1O;UQ:@$A:B*$,6($D0IH@Q1CJA`5"*J M$-6(&D0MH@Y1[R#7%RH'"Q"%"-* M$*6(,D0YH@)1B:A"5"-J$+6(.D2]@QSWW/F9E,,KV2!WXVA&TLM;1"&B"%&, M*$&4(LH0Y8@*1"6B"E&-J$'4(NH0]0YR?:$R$J=/E3LE]WRAD7W?@E6R^0\9 M2=(F0A0SDHH)HM0@]_;DPKN+D(F*)V?NV'*[086X=C?X4<-);[S=Z4#97D@, MP7,K*'DK%E[E3<+>E'N+W,=8S5$D9B/&5$FZ#1 M$Y@1,2IZK4YE1&;OYM[@R\4,]:7;<[&2W7G7&>P[';> M9."X//.7J.\PBC3(&XQ>P[:LDO$2&D2?H>9)$S'2*<:;U?7RYL9S0\R69`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`1WUSFCO\#;#R/9& M[98A.J#NL*O7K[O=6WC_=O_Q_=/NY8_\XF7W M^W(ITKH.)0IFBJAX^@]I]_J@(ZCYR.44.^0XZ:LD7_T9;ZU@(ZCD]I^"569[&GJ@,E^5L-SZNSI MY"?'YHS&YFQR;,YF5#),8Z]-E%]?1Y3+QCY.J40EOK%DW5A$=EE#4176F M2GZ9K7^9M*4:-F%I0VZG1N;5ZR@IKT!-T M:_6P%9;04W-K]&>FNJ9'-+C::'A-#:YI9& M)#V5,E5"PXN>D9@JH0%&M^>Q)*-6JV?;L"2G$O6(&Y;0XXMK]:0;EM!3C&OU MP!N6T,.,:_7<&Y;0,XUK]?@;EFRI9#M90L]YKL/)$GK<^T-K,96HQ_^P MA![^7*NG`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`MI54TDV6;.9J MLS.Y4LQII9A/C9W-G/8'\V$5NQH;]_KQ_8_[+[OJ_N7+X_?7BV^[SQ024::- MXO:7QR_J3H#^QYOYP8!?G]_>GI\H:KJ\^+J[_[1[40(2?WY^?N-_T(E<_7Q^ M^6T(NS[^OP````#__P,`4$L#!!0`!@`(````(0"ZUZ8B,@8```88```9```` M>&PO=V]R:W-H965T_E,(RII$0-T]\R_WU/4#>JXIDTFF8SZ]#EO46\=BD.M?OM>7D8? M>=T4U76MZ>.I-LJO674HKJ>U]O=?WK>%-FK:]'I(+]4U7VL_\D;[;?/K+ZO/ MJGYKSGG>CD#AVJRU<]O>G,FDRK\DK9P_F M]=O[[5M6E3>0>"TN1?NC$]5&9>:$IVM5IZ\7F/=WW4HSKMW]0/)ED=554QW; M,A.HEO:9+/J#/JGR#^;WO=1]T*_%&/#ODQ?;^T?U:?05ZFK-+<.>+[JK?I`(LMUTX9,EZLN'(\U8PEPD?.T*X?[J!H+/YZX0 M+J=+A,^O7:$.-4.7$!:)I7SM&G6^;N0+RS3A*_9O0JNF*T(W;=/-JJX^1W!G MPY#-+27[A.X0%5Y^5$(4Y/_5(Q0B47DA,FL-/(92:^`F^M@8\^EJ\@&%G[&8 M+8[1AQ$['D&JG,BZ*MBKP%.!KX)`!:$*(A7$*DAZ8`+&"??`L)_A'I$A[O%Y M;SGHV:E8Q2-XBJN"O0H\%?@J"%00JB!20:R"I`<&5L$.\3.L(C*PQ?4*35\L MA]YL:0S91$4UVL.0G0@1_B&R1\1#Q$(CXB`2(A(A$B,2))GPR^L/(0FQY.T1<1/:(>(CXB`2(A(A$B,2()'TR,`,>>T^80:*' M9C#2-9G=]M6,'-X$-\I-1,Z#MJ'$)&AN938T&/U MC#/%)5"_69JTR65I1/EC8^DS4WG([$4`-\2CI.\U(H'(HK*6K3R80A'`92,D M$B.2,`([76^2EICDP&?H2P<^W_$3FG=N*(D>&DH)Z>][8RG3V+&@F2Q@2FQ9 MY'M$/)3E(Q*@K!"1"&7%B"0LJWL/&OA#VO$G#.K"APXQ9,`0PB)C+E:#EAP+ M,KNWPPZY'$&1BSS=5IX:>QYET-*T=,N>RUNJ4_)X#'W+(ZVTSY$<+^#HX7@A MCZ+C&8OEPI`-+:*VD6^+VW)VR(X#E7.T8ZA04W3*%-6 MQIY'R=W6XTA&^1S)^@DXDE$A1U(KXDA&Q1Q)K80AJ$6X^F'AD<[["6=8H]YW MAJ)!X>E+M`&P*)GHZ@S)==XS9,HH#T?Y',FH@".I%6*M"$?%'$FMA"&H+&06 M::Z?,(OUXE)["V=KK(SZ5;L8WET[%C6H+)H(E=5+Q+LEBV*[ESF=*ONIQZ5E MO?@BW, MW:4#C0GFP=*!1@/X1#@$I["W])3_GM:GXMJ,+OD13)]V#6M-SW'IC[:ZP6+` M66S5POEK]_4,Y^TY/)6GY&7S6%4M_T$&$"?XF_\```#__P,`4$L#!!0`!@`( M````(0!BB<[:GPP``#<[```9````>&PO=V]R:W-H965T6F[UP-^[W=R_9XOW]YO.G_ MZP_OMWF_=[YL7NXWS\>7W4W_S]VY__OM/__QZJ#PN7/VO1?N^P782/+\?3YLLSM/NG,]YL4;O^CY`_[+>GX_GX<+D" MN8%^4-GFZ\'U`)1N/]WOH06JVWNGW<--_[.SJ-QY?W#[J>Z@?^]W/\ZMWWOG MI^,/_[2_3_8O.^AMB).*P)?C\:LR#>\5`N>!\/;J"!2GWOWN8?/M^5(=?P2[ M_>/3!<(]@1:IABWN_USMSEOH49"Y`?WN'O1H:T".;G_7/'_O[ MR]--?S2]FLR&(P?,>U]VYXNW5Y+]WO;;^7(\_$<;.49*B[A&!'X:$??Z:N8, MKT>S]XN,C0C\-"+.U7PR&4_G'Q"!ZNKFP$\C,ONX",R-6@1^8G/>;/ZUL8>? MQGY*K7^CVQSL-_4+UG3ESB?.9*IZ_RW7D:G3@5^:EK[/=8JN\(MQ_1L][U*O-97/[Z73\T8.5`L;9^76CUAUGX4#_XW#67=$,\/\U MOF%@*Y7/2N:F#P\&0_<,D_+[K3N=?1I\AXFT-39WTL:Q+99HH6:-DEUQL.;` MX\#G(.`@Y"#B(.8@X2#E(.,@YZ#@H.2@:H$!A*>)$0S67Q$C):-BA+U[AZ`5 M-!80M$"7%0=K#CP.?`X"#D(.(@YB#A(.4@XR#G(."@Y*#JH6L`("2\"O"(B2 M@>6_-6F(+T@@ M2"A()$@L2")(*D@F2"Y((4@I2-4F5M2@"ZVH=1^SE("M!UH)X@OB"!(*$@D2"Q((D@J2"9(+D@A2"E()4;6)U M/)RK/M#QRMKN>$W<4;/U+XT-D94F(_C1FBCL"+=NC'"B>(+X@@2"A()$FL#A M&I5C09+&J_V(;.E-&R,4R@3)!2D$*06I--&/:(4'%I8T.] ML=*$A>?:7L?6C1&VW1/$%R00)!0DTJ0='D&2QJL='O:(:6.$CY@)D@M2"%(* M4FG2$1ZX)5KAT5><*W7)O3SMMU_OCC#BX>S=L;6,X"JC+SA*Q(Z:)NVH&9M6 MU#09S?6-:.B,6,":W<]:-N6H6K4UK&GF0*[&"F1'P.`6CQ&KS>V0&:2N^LTB-V,+ MR!*-ILU2M$($*T#CYTR&=K>OT4I'>SR^9F/?0P.Z@OF(J+(`T9N5A6BE*W.& MSG1L/TZ$%E1;C(AJ2Q"]65N*5KJV^;7+;NX9&E!E.2*JK$#T9F4E6N&L&;DL M1!5:U+798T3=H=OYC+\8(_K*#:=Y''YWCD8N#,,FUG/6W*4Q&M6I0I.JT'XC MG:A3V8LU6KGU]!^-YVRB>FA`/CXB4@X0D56(2"O/9P[;J",T()\8$2DGB,@J M1:25I]=3=MO,T(!\^WX\E,3&'C0P/=1Q^: M#@$B4@X1:>7YV&7*$1J0&%B2=(R+I`A%)EXBT MM#.=C]FN4Z%%QQQ6=_S_/]PF4T"C\L[1R)K:SI3MSDNT(L>50:/V4M^QK6OY M\;`>`LYH/&*1\E":IH6/B&H+WE5;:*Q,;>Y\[K)D18325%N,B&I+WE5;:M^)H3.5*SOC16%1Z`U::&5 M)Y$O42!1*%$D42Q1(E$J4291+E$A42E192$[/'`V_TAXE#F[9!G42O.I5Y M*AJUDQ1JVD`L6FAE$"27,#QKB3SIZ$L42,=0HD@ZQA(EY-B>Z&R'2LD*GSZ3 M6KE$A70L):HL1SL\*E/Q@?"8Q$8[/!JU8K%T!%H99(5'6[60)QU]B0+2>J-+ M0[+"+HVD5BQ10HYM>;9SIF2%\IG4RB4JI&,I464Y6A%S/Y9!JLWMQ5*1Z#K"":K$\K=VNL6!!9*FI-5M@-GI3W)0K(L=W+ M["`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`1>9BQ4/KZK9`HE=9.$SPQ*ZO:S$OB\ZK/;J04.7=R% MS[&Z^&A1U5LKI*X*X`]725P,D?ZNDJ@603U%/O M7:PK(4\$]7250(H'ZNDJ@>P,U--5LG(=J*KI M*H%L]$*EGV6/0FYYH9+)L@0RQ0N5!Y8ED.1=J*RN+(&T*M1SW5$"25*HIZL$ M\IM03U<)I":AGJZ2U6P!?^XJZT]FB[*+KZ"17<^;0$.Z^`J:T55O`(WHX@DT MH8L7T(":#YIA!)\MOFX>=^GF]+A_.?>>=P^P^`SK.\%)?_BH_W,Q=X,OQPM\ ML%A?$Y[@`]4=_`W4\`H."P_'XP7_`QTQ:#YYO?TO````__\#`%!+`P04``8` M"````"$`(@\&R.@"``!$"```&0```'AL+W=O6^ MKA4C:;-(E'X4!'-?$%[AEB%6UW#(+..4W4MZ$*PR+8EB)3&@7Q>\UCV;H-?0 M":*>#_4-E:(&BCTON7EK2#$2-'[,*ZG(OH2\7\,IH3UW\W)&+SA54LO,>$#G MMT+/<[[U;WU@6J]2#AE8VY%B68(W8;Q;8'^]:OSYS=E1#YZ1+N3QB^+I-UXQ M,!O*9`NPE_+90A]3&X+%_MGJAZ8`WQ5*648.I?DACU\9SPL#U9Y!0C:O.'V[ M9YJ"H4#C13/+1&4)`N"*!+>=`8:0U^9^Y*DI$APMO=DBF(0`1WNFS0.WE!C1 M@S92_&E!84?5DD0="=P[DIFW"(/;R0(XWEDWZ=;!O5LWF?_[^?E"OQ7?>'%/ M#%FOE#PBZ"^0IVMBNS6,@:PWH65PMOS/%;##DFPL2X(7&$'"&BKYLH9>7ODO M8#_M,-MS3'B*V/4(6S60YS2".1^@T;)8C;:25O2V#PQ$CP3UB+$@,.H#!%F6 M!,-U8-K(DFV+L6WI0+.12`<9JYQ^B$K+`LTQ'R@XKVT'>D^F@XQEPJ*AF9>W M7]]H%MRH<55L(U'0=-URY$WW$1K+V3<4?])ED.'U.BSX5$<76;K^V@TC)W^" M?3+\4[/GILV4Z;;\U?O.,IW*Z")P1@TRCD:V.)"K13LEV\D@F,K9CI6E1E0> M[`1<@KDNZH;S)K*YCN);&-K-B!O'HWAW$3^)=Y,+/)MIO&GVZIAG&N^F%_#; M>0R&7]"SZ`X1WQ'!$*])SIZ(RGFE4&ULK)A=;ZLX$(;O M5]K_@+@_(4#(!TIRU(3PI5UIM=J/:TJ[)1J^U-:9Z, M7S.O!\;Q\OM[>3;>2%47]+(R[='8-,@EI_OBR M,G^0VOR^_O67Y8U6+_6)D,8`A4N],D]-<_4MJ\Y/I,SJ$;V2"WQSH%69-?"Q M.EKUM2+9OAU4GBUG/)Y:959<3*[@5Q_1H(=#D9.`YJ\EN319+G4;C\@ M^;+(*UK30S,".8O?*,YY82TL4%HO]P5DP&PW*G)8F4^VG]JN::V7K4'_%.16 M#_XWZA.]156Q_ZVX$'`;UHFMP#.E+RPTV3,$@RTT.FQ7X(_*V)-#]GIN_J2W MF!3'4P/+[4%&+#%__R,@=0Z.@LS(\9A23L]P`_#7*`M6&N!(]MY>;\6^.:U, MUQLY<\_VIA!O/).Z"0NF:1KY:]W0\E\>90LMKN((%;@*%=L=S>SQPIU]7&0B M1.`J1)S!G3R8':9H;.Q:[,,'HR#9Z`=!U=YUZ.YYTVF\T_<]4*( MP%6(3/O)']MG\;5HES;(FFR]K.C-@.<%S*ZO&7OZ;-^&DI"+RG/IEOF_5AF6 MEZD\,9F5.3,-6+\:2O-M[4R]I?4&Y92+F`V.L=6(K8Q@M<-D`QWL=!#J(-)! MK(-$!^D`6&!+YPV4V%=XPV28-S*KC00#LS0C9(0<$NA@IX-0!Y$.8ATD.D@' M0#'"_1HCF`P\](,BL2=3-?,-CV&OE:Z2M#K:=B&=.XCL$`D1B1")$4D028=$ M,0G>)5]1+4P&'L;IP`!GJKLD@AZYU(5T+B&R0R1$)$(D1B1!)!T2Q26X9<6E M^\U#OE98=&N&3&(C"+Q'N_JP)S.UB+9=D!P6(+)#)$0D0B1&)$$D'1(E=UC3 M3^3.HM7G?)%M$`D1VB(2(1(C$B"2(I$.B)`I]X!.)LF@U44Z<=B_3-H(M M(@$G+ESZ0G`7:B'LNB!9""$2BA")NU$#ZO\ MS:G(7S844H`F=.=9<*&7\@[+1%27.!FZA$C`B3OG+7ELNVH6N^Y[F46(-")$ MXFY4V^B1:M)]+U73H8;B#>QE%&_N>`!;*VD"BU9-X(3MOOHRF&AEL!5!TZX% M!X+`DO7#O+%FC@CBYMFP57.U#4O8RV%YSI:/:?_[*;3Y7A':LUSQC4!J M"7J.6DM;&=4/#`1R%YW63J#)N'5O,IG/D'G\!IR^"418.L;2B2;M>#.M:Z92 MIY56O6,;PZ%WCY]2F^\C%9,X@A*3OFU%E%)//$JI)X'Z7A#*@7UE1!(-ZP=I M)3*JUTHENE,O;*,WS)G_,OKD6QM^C^MO+(&T>M$*>2NCAO7"M:!>AH^I_M(2 M`V4).5/7U;1#J3VL(:[M]-/%(NKQ=(DVW=CST)M+F8[7%3]CX#]$2U(=R9:< MS[61TU=V?@"+LEYVF!]N;#P?-E90/#J?^K`/P3R8^=#],8]G/K1NS(.Y#\T0 M\WCN0SO#'`Y;GIP[?,,.8>YQQX>?5UAGX_KPDP+SIXG_!,;A+S83'W;7P*W. M"3ADN69'\GM6'8M+;9S)`4P MCZ"#'BAMY`&PO=V]R:W-H965TG-V^&P\WM M2U6B9R85%W6,?)6YJQK)2-HNJDHW\+S0K0BO M<<<0R?=PB"SCE-T)>JQ8K3L2R4JB0;\J>*,&MHJ^AZXB\NG8W%!1-4!QX"77 MKRTI1A6-'O):2'(H(>\7?T[HP-V^7-!7G$JA1*8=H',[H9K+YO"_!=HI1EY%CJ'^+TE?&\T%#M!21D\HK2USNF*!@*-$ZP,$Q4E"`` MKJCBIC/`$/+2WD\\U46,@]!9^MYZM@26`U/ZGAM*C.A1:5']Z4!^3]61!#T) MW'N2M1.L%OXBA'^^M7#6+X1[OW`6.HNE-_.O+W0[]:T9=T23[4:*$X(&`WVJ M(:9=_0C(!AAMW&?PG_:8_27&/T19C>#.!V@T+$:C*:41O1\"(]$300-B*@B,^@!!AB7&U[4%OR;20J4Q8-#;S^OX;&LV`6S6VBETD M\-JN\R?^)?U7Z"SKWUC]69M!BN\78L#G0OK(RC98,HZ<_0DVROA/[:;SH-G^ M<]<9FG,-?02.J%&ZP:1A+,A6HAN2W5RHF,Q9PLI2(2J.9@"NP%H;M;-Y%YA$ M)_$]S.QVPDWC091/=NU.G?+,HV1^!;\/(W#[BIYE?X:XE@AF M>$-R]DADSFN%2I9!BIYCAK;L3H'N18L&O(5)+C1,[_:Q@,.:P>3P'`!G0NCA MQ1AIC__M7P```/__`P!02P,$%``&``@````A`(G!8;OQ`@``10@``!D```!X M;"]W;W)K&ULK%;);MLP$+T7Z#\0O$>;+V M@K0%6J`HNIQIB;*(2*)`TG'R]YW1!BUID`*Y6-+H\>G-F^'0V]NG(B>/7&DA MRQUU+8<27L8R$>5Y1W_]O+]94Z(-*Q.6RY+OZ#/7]';_\,&T)2M>PIM4JH(9>%1G6U>*LZ1>5.2VYS@KNV"BI`U#J-[" M(=-4Q/Q.QI>"EZ8A43QG!O3K3%2Z8ROBM]`53#U3^Z2Q1UW_3"C+T2LI):IL8#.;H3.<][8&QN8]MM$0`9H.U$\ MW=&#&T8!M??;VI_?@E_UX)[H3%X_*9%\%24'LZ%,6("3E`\(_9)@"!;;L]7W M=0&^*Y+PE%UR\T->/W-QS@Q4VX>$,*\P>;[C.@9#@<;R?&2*90X"X)<4`CL# M#&%/]?4J$I/MZ&)A>6O?]5>`)R>NS;U`3DKBBS:R^-.@W):K8?%:%KBV++X5 MN,YF$0#'*^L6[3JX=E]?67[@+%S\^'RAW:BOS;ACANVW2EX)-!C(TQ7#=G5# M(.M<:!AZ7_YE"_B!)`=DV=&`$DA80RD?]YX?;.U'\#]N,<".H04T%@U#L(0A;HFI%IZ[&"8X/!ONR=]<>0 MJ(=,52[?126R0'.L!@KFM6U!K\GL(5.9L&AHYLO[KVLT!-=J^BHV$<^IN\YU M)N:T;Z&S>O^&ZD=M!BF^70B"QT+:R+IOL&@8&7T)-LKP2[CI/&]C@=C_W'=( M-%;11N"0&B2\F;C2@_I:-&.RF0P%5V<>\3S7))87'(%K,+>/]M/YX&&JD_@1 MIG8]XJ9Q+XQ>Q"]"Z.`YSV$9'NJ].N59AM'R!?QQ%8+?&PO M=V]R:W-H965T?%?GVP#ZQ_^5)=C,^T M:BWJ0WD];>ZZFV]9;7&F5=[.ZAN]PB_'NJGR#KXV)ZN]-30_]$G5Q7)L MV[.JO+R:7,%O/J)1'X]E0<.Z>*OHM>,B#;WD'8R_/9>W5JI5Q4?DJKQY?;M] M*NKJ!A(OY:7LOO:BIE$5?GJZUDW^EZL\72=@F$&R^T M[:*229I&\=9V=?4/#R)"BHLX0@0^[X@\2'1%XGQ()-YL[BR6J_[R#S)A'?XVM: M?)7Z10_S+M^NF_K=@#L)UJ&]Y>R^)#[3E>MX[EKZS,46B%B`AQ#U(B=C&!5Q61#'>QU$.D@UD&B@U0'V0188,O@ M#53?C_"&R3!OY*P""29F:4;(")D2ZF"O@T@'L0X2':0ZR"9`,0+NJA]A!).! M[6!2),3UU)D'/(9M.$,E+=20W1`RN(/('I$(D1B1!)$4D6Q*%)-@R_D1)C$9 MN!EA5QD,<+RY:D$@@AZY-(0,+B&R1R1")$8D021%))L2Q248,G+)@8U6;G@? MWG&84.^3G%\@".S#@W/$7:G.[88@F18BLD M.(SN++X+9RH_:9F(:@DG4TL0"3EQ5_QHMHEV-N^'WP^31S5 MXW3X7:IF4PW%&^B!%&_N>`!=D32!1:LF<,(:IW'-Y[8ZGIT(\H;B"049#^>] M(-RIQ9/M:<=/A%)B))N@F/1;LMDT17&&=67?84T?KGHCD`.7F)B#FB]V'3B> M^\<#T7X)Q)MSUI'MA9;K])4$33V9KS2;(QDSIL42C>*)1&-4*A&^,%9*^LS$$BK(^UNV,))2TZ(1>=.B0>JI3.3J<]=9D:6V^;%W,_TV.BD:_JZ%/W97 MM#G1';U<6J.HW]A[%+A+M^L!\Y<\@>=#"P65H?%PZ4/#<8>O?#C",4]6/AS" MF,-+I&?G#@_8RZ5[W/'AX1#K!*X/#T28/\_]9S`"_Q#,?7@VN,,7/C3'P*UA MQO!2Z9:?Z&]YHAK^6XE^Z^@8FPJNENH/72?V_9WA]2.&T MLMESQ;&N._F%76!X(;G]%P``__\#`%!+`P04``8`"````"$`1)[4&UL(*($`2B@``$````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````G)%12\,P%(7?!?]#R7N;IALBI* M;S&YZX)-&G*CW?Z]6=?5B3X)>0GGW"_GGE2+G6F33_"H.UL3EN4D`2L[I6U3 MDZ?U,KTF"09AE6@["S79`Y(%O[RHI"MEY^'!=PY\T(!))%DLI:O)-@174HIR M"T9@%ATVBIO.&Q'BU3?4"?DN&J!%GE]1`T$H$00]`%,W$Q[Y[\VV"N*WH;ZU2^4QW4EYGMW>K9>$%SF;IWF1LOFZ8&4^C^>UHB?7.,\GH!D#_)MX`O`A]\\_ MYU\```#__P,`4$L#!!0`!@`(````(0!`D*U.Y0(```D)```0``@!9&]C4')O M<',O87!P+GAM;""B!`$HH``!```````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````)Q634_C,!"]K[3_("AFMP%BAU2@^.AS$$2BN,Z&>1_']XO+@9QQ9 MQU3&I%8PBM=@X[/T^S`<8-XNG+_"YII[OG9A\6Z1,(I M.2]+*3AS&&5Z*[C15N&>'6Z8`D[4\RYTS"&('3G$D+ M)-EMD"M@7K09$\:F9.5.5\"=-I$5?U&VXSAZ8A8\G5&\8D8PY9"6-VL^ZK4L MK3/IHS8O=@G@+$G0H-FLEVW;]EH,TY-A;8&KKJ5':)C@09?C0C@)]BZ?,>," ME$^&;6^@V\VT,8ZVLEB)C#C)ZP213'.C\ M0Z1?L:8*MRP6SHL:<&;"( M7^=5$/P7_*'GG.L*!5+/%)-2X9HWK((>-]I:BI6%PC`39GRM5GBI-NL@0.V' M#%'CL2ZP".U^>FA0"-=(Y-\1M?`\L0-@70?1+S&_Z0.3%=!;8+8R/:&@.CD8 M@T0F8B4R+/,P9LUXJ66&;8A.7RM,I>#=OT'6J>,3=DT7AF%HW)=TT'I>/5EX MK5`I.O5Z!8VZ:M,%>\*2"%IN1>\SVJ-]G\L>0?M<`GKUF;^+<0*."?E9D'U6 M^Z*<8^?/JJ!Z_2Y'09_>Y*1!EWUB-M$$70))2C\-OINLOLX*K7PG#%X1>J]& M*PDTW"I#+H_,8,IC,YM\^9;S+!.^0!A.N6WWVK6^O055*Q!T>5]5(:TZ,^?= ME+D1ZL7>EPL]P5+>C-'N)JF#SW#`;,YW&^0*)ZB1'F2\9-BILHW-QP,_]!^: M/YOT:'@X.!G@/&_MD63W#Y/^`P``__\#`%!+`0(M`!0`!@`(````(0`:,QE5 MV@$``#$6```3``````````````````````!;0V]N=&5N=%]4>7!E&UL M4$L!`BT`%``&``@````A`+55,"/U````3`(```L`````````````````$P0` M`%]R96QS+RYR96QS4$L!`BT`%``&``@````A`/Y[WY32`0``'!4``!H````` M````````````.0<``'AL+U]R96QS+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`+N'!,70`@``1`@``!D`````````````````\R,``'AL M+W=O&PO=V]R:W-H965T<,.P(``"X%```9```````````````` M`/XI``!X;"]W;W)K&UL4$L!`BT`%``&``@````A M`!-&&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&$SH!`(!```DPX` M`!D`````````````````Y3H``'AL+W=O&PO=V]R:W-H965T```8``````````````````A"``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`(VB+/<;)```(G<``!0`````````````````NDT``'AL+W-H87)E9%-T&UL4$L!`BT`%``&``@````A`-;8C"Y>#```_7,```T````````````` M````!W(``'AL+W-T>6QE&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M M`!0`!@`(````(0!:..\150,```,+```9`````````````````%6%``!X;"]W M;W)K&UL4$L!`BT`%``&``@````A`%8LQY9[`P`` MNPL``!@`````````````````X8@``'AL+W=O&UL4$L!`BT`%``&``@````A`,.B MO#3I'```HIT``!D`````````````````9(\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,IPYE*R!0``XQ4``!@` M````````````````4\```'AL+W=O&PO=V]R:W-H965T&UL M4$L!`BT`%``&``@````A`#X.'9?D`P``&0T``!@`````````````````%M`` M`'AL+W=O&PO=V]R:W-H965T``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`)4@75CD(```!KL``!D````` M````````````O^4``'AL+W=OF(C(&```&&```&0````````````````#:!@$`>&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`"(/!LCH`@``1`@``!D`````````````````&1H! M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`(G!8;OQ`@``10@``!D`````````````````]B4!`'AL+W=O&UL4$L%!@`````K`"L`GPL` '`'DU`0`````` ` end XML 12 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8

Related Party Transaction (Details) (Affiliated Entity [Member], USD $)
6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Affiliated Entity [Member]

Related Party Transaction [Line Items]

Maintenance costs $ 9,720 $ 8,960

Software implementation costs $ 6,000

X

- Definition

The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfPropertyRepairsAndMaintenance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_RelatedPartyTransactionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.

+ References

No definition available.

+ Details

Name: us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8

Share-Based Compensation (Schedule of Stock Option Activity) (Details) (USD $)
0 Months Ended 6 Months Ended

Sep. 05, 2013

Sep. 06, 2013

Dec. 31, 2013

Dec. 31, 2012

Number of Options

Outstanding at December 31, 2013 2,370,072

Vested and expected to vest at December 31, 2013 2,278,260

Vested and exercisable at December 31, 2013 2,080,064

Weighted Average Exercise Price

Outstanding at December 31, 2013 $ 1.79

Vested and expected to vest at December 31, 2013 $ 1.84

Vested and exercisable at December 31, 2013 $ 1.90

Weighted Average Remaining Contractual Term

Outstanding at December 31, 2013 4 years 6 months 26 days

Vested and expected to vest at December 31, 2013 4 years 6 months

Vested and exercisable at December 31, 2013 4 years 1 month 17 days

Average Intrinsic Value

Outstanding at December 31, 2013 $ 125,884

Vested and expected to vest at December 31, 2013 114,801

Vested and exercisable at December 31, 2013 125,784

Options exercised 31,700

Aggregate intrinsic value of option exercised 13,866

Stock options granted 50,000 15,000 65,000

Stock options issued, exercise price $ 0.58 $ 0.59

Fair value of stock options granted $ 25,150 $ 6,906

Exercise price $ 0.58 $ 0.59

Expected term 5 years 5 years

Volatility 132.31% 132.31%

Discount rate 1.85% 1.77%

X

- Details

Name: isr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract

Namespace Prefix: isr_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: isr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptonsOutstandingAggregateIntrinsicValueAbstract

Namespace Prefix: isr_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The total fair value of shares issued during the period under a deferred compensation arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.D.2)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section D

-Subsection 2

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

The risk-free interest rate assumption that is used in valuing an option on its own shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(iv)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Gross number of share options (or share units) granted during the period.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Number of options outstanding, including both vested and non-vested options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of fully vested and expected to vest options that are exercisable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Weighted average remaining contractual term for fully vested and expected to vest options that are exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount by which the current fair value of the underlying stock exceeds the exercise price of fully vested and expected to vest options outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of share options (or share units) exercised during the current period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 15 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8

Inventory
6 Months Ended

Dec. 31, 2013

Inventory [Abstract]

Inventory

4. Inventory

Inventory consisted of the following at December 31, 2013 and June 30, 2013:

December 31, June 30,

2013 2013

Raw materials $ 168,731 $ 167,671

Work in process 212,726 195,323

Finished goods 44,876 42,577

Total inventory $ 426,333 $ 405,571

X

- Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a, b, c

-Article 5

+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

EXCEL 16 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Q,3,X8S0U,5]E8SDP7S1A,3)?.3'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I% M>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-H87)E M0F%S961?0V]M<&5N#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!R969E#I7 M;W)K#I%>&-E;%=O5]4#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U8G-E<75E;G1?179E;G0\+W@Z3F%M93X-"B`@("`\>#I7;W)K M#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M5]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7 M;W)K#I%>&-E;%=O#I7;W)K#I7;W)K#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O5]#;VUM;VY?86YD/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U M#I%>&-E;%=O5]38VAE9'5L95]O/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O5]787)R86YT#I%>&-E;%=O5]!9&1I=&EO;F%L/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O5]4#I%>&-E;%=O#I%>&-E;%=O#I!8W1I=F53:&5E=#XP M/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^1&5C(#,Q+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)TES M;U)A>2P@26YC+CQS<&%N/CPO2!#96YT3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)S`P,#`W,C@S.#<\2!&:6QE3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)U-M86QL97(@4F5P;W)T:6YG($-O M;7!A;GD\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,3,X M8S0U,5]E8SDP7S1A,3)?.3'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&5D(&%SF%T:6]N/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XQ+#,T.2PT-CD\2P@;F]N+6-U'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XT-BPY-S,\7)O;&P@86YD(')E;&%T960@=&%X97,\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N M/CPO3H\+W-TF5D.CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF5D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#`P,2PV-S$\F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ.3(L.3DX+#,R.3QS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'!E;G-E'!E;G-E*3H\+W-T'0^)SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS M<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO MF%T:6]N(&]F(&9I>&5D(&%S'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R M8VES92!O9B!W87)R86YT&5R8VES92!O9B!O M<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO&AT;6PQ+T141"]X:'1M M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T9/3E0M M4U193$4Z(&YO"<^(%1H92!A8V-O;7!A;GEI;F<@8V]N M2!A8V-O=6YT65A65A2!T;R!P2P@ M:6X@86QL(&UA=&5R:6%L(')E2P@26YC+B!A;F0@:71S('=H;VQL>2UO=VYE9"!S=6)S M:61I87)I97,N)FYB2!B92!A;65N9&5D(&9R;VT@=&EM92!T M;R!T:6UE+CPO<#X@/'`@3L@ M1D].5#H@,3!P="!4:6UE#L@5$585"U!3$E'3CH@:G5S=&EF>2<^(%1H92!R97-U;'1S M(&]F(&]P97)A=&EO;G,@9F]R('1H92!P97)I;V1S('!R97-E;G1E9"!M87D@ M;F]T(&)E(&EN9&EC871I=F4@;V8@=&AO65A2!I;F-L=61E9"!I;B!F:6YA;F-I86P@3L@1D]. M5#H@,3!P="!4:6UE#L@5$585"U!3$E'3CH@:G5S=&EF>2<^(%1H92!P3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,3,X M8S0U,5]E8SDP7S1A,3)?.3'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6QE/3-$)U=)1%1(.B`P<'@G/B9N M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=724142#H@,"XU:6X[(%1%6%0M04Q) M1TXZ(&QE9G0G/CQS=')O;F<^,BX\+W-T2<^/'-T6QE/3-$)U1%6%0M04Q)1TXZ(&IU"<^(#QS=')O;F<^)FYB2!T:&4@1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A2!U2!I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A&AT;6PQ+T14 M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM M4W1A2<^(#QT9"!S='EL93TS M1"=724142#H@,'!X)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&IU"<^($)A M2!P;W1E;G1I86QL>2!D:6QU=&EV92!C;VUM M;VX@28C,SD[6QE/3-$)U1%6%0M04Q)1TXZ M(&IU"<^("9N8G-P.SPO<#X@/'`@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U9%4E1)0T%, M+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P M=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED M.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R/C(P,3(\+W1D/B`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`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E' M3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/ M33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/ M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(#(L M,S$R+#`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`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`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)U=)1%1(.B`P<'@G/B9N8G-P.SPO M=&0^(#QT9"!S='EL93TS1"=724142#H@,"XU:6X[(%1%6%0M04Q)1TXZ(&QE M9G0G/CQS=')O;F<^-"X\+W-T2<^/'-T"<^($EN=F5N=&]R M>2!C;VYS:7-T960@;V8@=&AE(&9O;&QO=VEN9R!A="!$96-E;6)E6QE/3-$)T9/3E0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Y M,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE M/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$,CX@1&5C96UB97(@ M,S$L/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N M=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@ M8V5N=&5R)SX@)FYB6QE/3-$)U9%4E1) M0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L M,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF M;F)S<#L\+W1D/B`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`\=&0@7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@ M/&1I=CX\(2TM4W1A2<^(#QT M9"!S='EL93TS1"=724142#H@,"XU:6X[(%1%6%0M04Q)1TXZ(&QE9G0G/CQS M=')O;F<^-2X\+W-T2<^/'-T"<^(%1H92!F;VQL;W=I;F<@=&%B;&4@ M<')E'!E;G-E M(')E8V]G;FEZ960@9'5R:6YG('1H92!T:')E92!A;F0@6QE M/3-$)U1%6%0M04Q)1TXZ(&IU"<^("9N8G-P M.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Y,"4[($)/4D1%4BU#3TQ, M05!313H@8V]L;&%P6QE/3-$)U9%4E1)0T%,+4%, M24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$-CY3:7@@;6]N=&AS/"]T9#X@ M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N M=&5R)R!C;VQS<&%N/3-$-CYE;F1E9"!$96-E;6)E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E. M1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!4 M15A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R/C(P,3,\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU" M3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA M8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R M/C(P,3(\+W1D/B`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`R,#$S+"!T;W1A;"!U;G)E8V]G;FEZ M960@8V]M<&5N2`P+C@R('EE87)S+CPO M<#X@/'`@3L@1D].5#H@,3!P M="!4:6UE28C,SD[6EN9R!V97-T:6YG('!E2!T:&4@0F]A6QE/3-$)U1%6%0M04Q)1TXZ M(&IU"<^("9N8G-P.SPO<#X@/'`@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&IU"<^("9N8G-P.SPO<#X@ M/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Y,"4[($)/4D1%4BU#3TQ,05!313H@ M8V]L;&%P6QE/3-$)U9%4E1)0T%,+4%,24=..B!B M;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R M)R!C;VQS<&%N/3-$,CX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R M)R!C;VQS<&%N/3-$,CX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\ M+W1R/B`\='(@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U9%4E1) M0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S M<#L\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF>2<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF>2<@ M8V]L6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF>2<@8V]L6QE/3-$)U=)1%1(.B`S-B4[(%!!1$1)3D3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U=)1%1(.B`R)3L@4$%$1$E.1RU" M3U143TTZ(#(N-7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)U=)1%1(.B`Q M)3L@0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%, M24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)U=)1%1(.B`Q,B4[ M($)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E' M3CH@6QE/3-$)U=)1%1(.B`Q,B4[($)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U=)1%1(.B`Q)3L@4$%$1$E.1RU"3U14 M3TTZ(#(N-7!T.R!415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`R)3L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`Q)3L@0D]21$52+4)/5%1/33H@ M8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`Q,B4[($)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U=)1%1(.B`Q)3L@4$%$1$E.1RU"3U143TTZ(#(N-7!T M.R!415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)U=) M1%1(.B`R)3L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`Q)3L@0D]21$52+4)/5%1/33H@8FQA8VL@,BXU M<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T.R!&3TY4.B`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`@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU"<^(%1H97)E('=E&5C=71I=F4@3V9F:6-E&5R M8VES92!P3L@1D].5#H@,3!P="!4:6UE&5R8VES92!P2!O9B!G&5R8VES92!P2!O9B`Q,S(N,S$E(&%N9"!A(&1I3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,3,X8S0U,5]E8SDP7S1A M,3)?.3'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO M"<@8V5L;'-P M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U9%4E1) M0T%,+4%,24=..B!T;W`[(%1%6%0M04Q)1TXZ(&IU6QE/3-$)U=) M1%1(.B`P+C5I;CL@5$585"U!3$E'3CH@;&5F="<^/'-T3L@1D].5#H@,3!P="!4:6UE"<^ M(%1H92!#;VUP86YY(&ES('1H92!H;VQD97(@;V8@86X@97AC;'5S:79E(&QI M8V5N2!B>2!T:&4@3&%W M6UE;G0@;V8@82!R;WEA;'1Y(&)A2!386QE"<^(%1H92!L:6-E;G-O2!P M87)T:6-I<&%T960@:6X@;F]N8FEN9&EN9R!M961I871I;VX@2!43X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\Q,3,X8S0U,5]E8SDP7S1A,3)?.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO"<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$ M)U9%4E1)0T%,+4%,24=..B!T;W`[(%1%6%0M04Q)1TXZ(&IU6QE M/3-$)U=)1%1(.B`P+C5I;CL@5$585"U!3$E'3CH@;&5F="<^/'-T3L@1D].5#H@,3!P="!4:6UE28C,SD[6QE/3-$)U9%4E1)0T%, M+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$,CY"86QA;F-E(&%T/"]T9#X@/'1D M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R M)SXF;F)S<#L\+W1D/B`\=&0@2<^($1E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$ M1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED M.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R/D1E8V5M8F5R(#,Q M+"`R,#$S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$ M1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU" M3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@ M8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X] M,T0R/DIU;F4@,S`L(#(P,3,\+W1D/B`\=&0@2!,979E;#PO=&0^(#PO='(^(#QT6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@:G5S=&EF>2<^07-S971S.CPO=&0^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&IU6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S M<#L\+W1D/B`\+W1R/B`\='(@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$ M5$@Z(#(E)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5TE$5$@Z(#$R)3L@5$585"U!3$E'3CH@8V5N=&5R)SY,979E;"`Q/"]T M9#X@/"]T6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`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`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM' M4D]53D0M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF>3L@4$%$1$E.1RU,1494.B`P+C(U M:6XG/B!787)R86YT(&QI86)I;&ET>3PO=&0^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B0\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E' M3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@;&5F="<^)#PO=&0^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SXQ,#0L,#`P/"]T9#X@ M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F M="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)SY,979E;"`R/"]T9#X@/"]T7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA&AT;6PQ+T141"]X:'1M;#$M=')A;G-I M=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)U=)1%1(.B`P+C5I;CL@5$585"U!3$E'3CH@ M;&5F="<^/'-T"<^($]N($1E8V5M8F5R(#$Y+"`R,#$S+"!T:&4@0F]A6%B;&4@86YD(&%C8W)U M960@;W5T2!T:&4@0F]A3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,3,X8S0U,5]E8SDP7S1A M,3)?.3'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@ M/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=..B!T;W`[(%1%6%0M04Q)1TXZ M(&IU6QE M/3-$)U1%6%0M04Q)1TXZ(&IU"<^(#QS=')O;F<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&IU"<^("9N8G-P.SPO<#X@/'`@3L@1D].5#H@,3!P="!4:6UE2!E;G1E28C,SD[2`D,RPR-SDL,CDR(&EN(&-A"<^ M(#QU/E-E2!A9F9E8W0@=&AE(%-E6QE/3-$ M)U1%6%0M04Q)1TXZ(&IU"<^("9N8G-P.SPO M<#X@/'`@3L@1D].5#H@,3!P M="!4:6UE2!A(&AO M;&1E2!P3L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\ M=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SXD/"]T9#X@/'1D M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$R)3L@5$585"U! M3$E'3CH@6QE/3-$)U9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U M+#(P-"DG/B`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`\+W1R/B`\='(@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB3L@1D].5#H@,3!P="!4:6UE"<^($)A2!A="!F86ER('9A;'5E+B!4:&4@0V]M<&%N>2!D971E2!D971EF5D(&$@8VAA M;F=E(&EN(&9A:7(@=F%L=64@87,@9&5S8W)I8F5D(&EN('1H92!T86)L92!B M96QO=SH\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU"<^("9N8G-P.SPO<#X@/'`@3L@1D].5#H@,3!P="!4:6UE2X\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&IU"<^("9N8G-P.SPO<#X@/'1A8FQE('-T M>6QE/3-$)U=)1%1(.B`Y,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF>2<@;F]W6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF>2<@8V]L6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF>2<@8V]L6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<@;F]W M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M4$%$1$E.1RU"3U143TTZ(#%P="<@;F]W6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]5 M3D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L M969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$ M5$@Z(#$R)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SXD/"]T M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$R)3L@ M5$585"U!3$E'3CH@"<^ M($-H86YG92!I;B!F86ER('9A;'5E(&]F('1H92!D97)I=F%T:79E('=A6QE/3-$)U1% M6%0M04Q)1TXZ(&IU"<^("9N8G-P.SPO<#X@ M/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Y,"4[($)/4D1%4BU#3TQ,05!313H@ M8V]L;&%P6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@ M8V5N=&5R)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED M.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0V/D1E8V5M8F5R(#,Q M+"`R,#$S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$ M1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU" M3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@ M8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X] M,T0V/D1E8V5M8F5R(#,Q+"`R,#$R/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@ M8V5N=&5R)SX@)FYB6QE/3-$)U9%4E1) M0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@3QS M=7`^,3PO6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P M=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%, M24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5TE$5$@Z(#$P)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z M(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%, M24=..B!L969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5TE$5$@Z(#$P)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!4 M15A4+4%,24=..B!L969T)SX@)FYB6QE M/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z M('=H:71E)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@:G5S=&EF>2<^0VAA;F=E(&EN(&9A:7(@=F%L=64\+W1D/B`\=&0@ M&5R8VES960\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E' M3CH@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)#PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT M)SXR,3@L,#`P/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@;&5F="<^)FYB3L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E' M3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S M<#L\+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E' M3CH@8V5N=&5R)SX@)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R/E%U86YT:71Y/'-U<#XQ/"]S M=7`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`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E M)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z M(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$P)3L@5$585"U!3$E'3CH@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM' M4D]53D0M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF>2<^0VAA;F=E(&EN(&9A:7(@=F%L M=64\+W1D/B`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`P,#PO=&0^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M M04Q)1TXZ(')I9VAT)SXV,RPU.3@\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@ M6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5D525$E#04PM04Q)1TXZ('1O<#L@4$%$1$E.1RU"3U143TTZ M(#(N-7!T.R!415A4+4%,24=..B!L969T)SX@5&]T86P@9F%I6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D M/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!4 M15A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/ M5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^ M(#(S+#`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`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$,CY3:7@@;6]N=&AS M(&5N9&5D/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U9%4E1)0T%,+4%,24=. M.B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#8X)3L@ M5$585"U!3$E'3CH@:G5S=&EF>2<^0VAA;F=E(&EN(&9A:7(@=F%L=64\+W1D M/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4 M+4%,24=..B!L969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5TE$5$@Z(#$R)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E M.R!415A4+4%,24=..B!L969T)SXI/"]T9#X@/"]T3L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@"!M;VYT:',@96YD960\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$-CY3:7@@;6]N=&AS M(&5N9&5D/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ M(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@ M,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0V/D1E M8V5M8F5R(#,Q+"`R,#$S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52 M+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G M(&-O;'-P86X],T0V/D1E8V5M8F5R(#,Q+"`R,#$R/"]T9#X@/'1D('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE M/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@3QS=7`^,3PO6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU" M3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)! M0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E M.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$P)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S M<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!4 M15A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$P)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\ M+W1D/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F M="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@&5R8VES960\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F M="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)#PO=&0^ M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I M9VAT)SXR,3@L,#`P/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@;&5F="<^)FYB3L@1D].5#H@,3!P M="!4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@ M"!M;VYT:',@96YD960\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$-CY3:7@@ M;6]N=&AS(&5N9&5D/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU" M3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@ M8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X] M,T0V/D1E8V5M8F5R(#,Q+"`R,#$S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@ M8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C M96YT97(G(&-O;'-P86X],T0V/D1E8V5M8F5R(#,Q+"`R,#$R/"]T9#X@/'1D M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P M=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@3QS=7`^,3PO6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$ M1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T M;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$ M5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$P)3L@5$585"U!3$E' M3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S M<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z M(#$E.R!415A4+4%,24=..B!L969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$P)3L@5$585"U!3$E'3CH@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^*3PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M M04Q)1TXZ(')I9VAT)SXV,RPU.3@\+W1D/B`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`P,#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(')I9VAT)SXV,RPU.3@\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=..B!J=7-T:69Y M)SX@5&]T86P@9F%I6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U14 M3TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$ M1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU" M3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE M.R!415A4+4%,24=..B!R:6=H="<^(#(S+#`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`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P M="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U=) M1%1(.B`Q,B4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`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`@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&IU"<^(#QS=')O;F<^)FYB M6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T M;VTG/B`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!4&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T M9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)U=)1%1(.B`P+C5I;CL@5$585"U!3$E'3CH@;&5F="<^(#QS M=')O;F<^,3`N/"]S=')O;F<^/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&IU6QE/3-$)U1% M6%0M04Q)1TXZ(&IU"<^("9N8G-P.SPO<#X@ M/'`@3L@1D].5#H@,3!P="!4 M:6UE2!C;VYT:6YU960@=&\@96YG86=E M('1H92!S97)V:6-E&5C=71I=F4@3V9F:6-E28C,SD[7-T96US+B!-"!M;VYT:',@96YD960@ M1&5C96UB97(@,S$L(#(P,3,@86YD(#(P,3(@9G)O;2!!4$58($1A=&$@4WES M=&5M"!M;VYT:',@96YD960@1&5C96UB97(@,S$L(#(P,3,N/"]P/B`\(2TM16YD M1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\Q,3,X8S0U,5]E8SDP7S1A,3)?.3'0O:'1M;#L@8VAA"<@8V5L;'-P86-I M;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U9%4E1)0T%, M+4%,24=..B!T;W`[(%1%6%0M04Q)1TXZ(&IU2<^/'-T3L@1D].5#H@,3!P="!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,3,X8S0U,5]E8SDP M7S1A,3)?.3'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SPA M+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@ M5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^ M/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E' M3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG M/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@ M8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C M96YT97(G(&-O;'-P86X],T0R/C(P,3(\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$R M)3L@5$585"U!3$E'3CH@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L M969T)SX@)FYB6QE/3-$)U9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z('=H:71E)SX@/'1D M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF M>2<^4V5R:65S($0@<')E9F5R6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@;&5F="<^)FYB6QE/3-$ M)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G M8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@ M;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(#(L,S$R+#`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`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@ M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^(#0L,S(X+#$W,#PO=&0^ M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,3,X8S0U,5]E M8SDP7S1A,3)?.3'0O:'1M;#L@8VAA2`H5&%B;&5S*3QB2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/'`@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$,CY*=6YE M(#,P+#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$ M)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU" M3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ M(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@ M,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R/C(P M,3,\+W1D/B`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`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`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@3L@1D].5#H@,3!P="!4:6UE3L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R M)R!C;VQS<&%N/3-$-CY4:')E92!M;VYT:',\+W1D/B`\=&0@"!M;VYT:',\+W1D/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$-CYE;F1E M9"!$96-E;6)E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E' M3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/ M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O M;'-P86X],T0R/C(P,3,\+W1D/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#,V)3L@5$585"U!3$E'3CH@:G5S M=&EF>2<^0V]S="!O9B!P6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4 M+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SXD M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$R M)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SXD/"]T9#X@ M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$R)3L@5$58 M5"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@;&5F="<^)FYB6QE/3-$)U9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R M,#0L,C4U+#(P-"DG/B`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`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R M)R!C;VQS<&%N/3-$,CX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E' M3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N M=&5R)R!C;VQS<&%N/3-$,CX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D M/B`\+W1R/B`\='(@6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$,CX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R M)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U9%4E1)0T%, M+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T M;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@:G5S M=&EF>2<@8V]L6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T], M3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)U=)1%1(.B`Q,B4[($)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U=)1%1(.B`Q)3L@4$%$1$E. M1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=..B!L969T.R!&3TY4.B`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`\=&0@3L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T M(&1O=6)L93L@5$585"U!3$E'3CH@6QE M/3-$)U!!1$1)3D3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,3,X M8S0U,5]E8SDP7S1A,3)?.3'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPO6QE/3-$)U1%6%0M04Q)1TXZ(&IU M"<^(%1H92!T86)L92!B96QO=R!S971S(&9O M2P@86YD('1H92!F M86ER('9A;'5E(&-A;&-U;&%T:6]N(&EN<'5T(&AI97)A2!L979E;"!T M:&4@0V]M<&%N>2!H87,@9&5T97)M:6YE9"!A<'!L:65S('1O(&5A8V@@87-S M970@86YD(&QI86)I;&ET>2!C871E9V]R>2XF;F)S<#LF;F)S<#L\+W`^(#QP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU"<^ M("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Q,#`E.R!"3U)$ M15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@8V5N=&5R)SY);G!U=#PO=&0^(#PO='(^(#QT6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED M.R!415A4+4%,24=..B!J=7-T:69Y)SX@1&5S8W)I<'1I;VX\+W1D/B`\=&0@ M6QE/3-$)U9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\ M=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@:G5S=&EF>2<@8V]L6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E M.R!415A4+4%,24=..B!L969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5TE$5$@Z(#$P)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$ M5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D M/B`\+W1R/B`\='(@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@;&5F="<^)#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SXR,RPP,#`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Q,3,X8S0U,5]E8SDP7S1A,3)?.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($)!0TM'4D]53D0M0T],3U(Z('=H:71E)SX@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF>2<^3&ES=&EN9R!E>'!E M;G-E/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E' M3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@&AT;6PQ+T141"]X M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A M3L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%, M24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<@;F]W6QE/3-$)T9/3E0M4TE: M13H@,3!P="<@;F]W6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@:G5S=&EF>2<@;F]W M2<@8V]L6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M4$%$1$E.1RU"3U143TTZ(#%P="<@;F]W2<@8V]L6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<@ M;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T M)SXI/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z M(#(E)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&IU M"<^("9N8G-P.SPO<#X@/'`@3L@1D].5#H@,3!P="!4:6UE3L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9% M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)R!C;VQS<&%N/3-$-CY4:')E92!M;VYT:',@96YD M960\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R M)R!C;VQS<&%N/3-$-CY4:')E92!M;VYT:',@96YD960\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@ M8V5N=&5R)SX@)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!C96YT97(G(&-O;'-P86X],T0R/E%U86YT:71Y/'-U<#XQ/"]S=7`^ M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU" M3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ M(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@ M,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R/D%M M;W5N=#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%!!1$1) M3D3QS=7`^,3PO6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%,24=..B!L969T)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$ M5$@Z(#$P)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4+4%, M24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M5$585"U!3$E'3CH@;&5F="<^*3PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SXV-3`L M,#`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`Y,"4[($)/4D1%4BU#3TQ, M05!313H@8V]L;&%P6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P M=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T M('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0V/D1E8V5M M8F5R(#,Q+"`R,#$S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$ M1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/ M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O M;'-P86X],T0V/D1E8V5M8F5R(#,Q+"`R,#$R/"]T9#X@/'1D('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U! M3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$ M)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@3QS=7`^,3PO6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U14 M3TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM' M4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!4 M15A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$P)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z M(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`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`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@ M8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/ M33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("T\+W1D M/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]2 M1$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("T\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU" M3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("T\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@ M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("T\+W1D/B`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`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U14 M3TTZ(#(N-7!T.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#(N M-7!T)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU" M3U143TTZ(#(N-7!T.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ M(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4 M+4%,24=..B!R:6=H="<^(#(T,"PP,#`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&IU"<^("9N8G-P.SPO<#X@/'`@3L@1D].5#H@,3!P="!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S M<#L\+W1D/B`\=&0@"!M;VYT:',@96YD960\+W1D M/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)R!C;VQS M<&%N/3-$,CY3:7@@;6]N=&AS(&5N9&5D/"]T9#X@/'1D('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D M/B`\+W1R/B`\='(@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]2 M1$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT M97(G(&-O;'-P86X],T0R/D1E8V5M8F5R(#,Q+"`R,#$S/"]T9#X@/'1D('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@ M5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U! M3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!4 M15A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R/D1E8V5M8F5R(#,Q+"`R M,#$R/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E. M1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!415A4 M+4%,24=..B!L969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@5TE$5$@Z(#$R)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E M.R!415A4+4%,24=..B!L969T)SXI/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\=&0@"<^($-H86YG92!I;B!F86ER('9A;'5E(&]F('1H92!D97)I=F%T:79E('=A M6QE/3-$ M)U1%6%0M04Q)1TXZ(&IU"<^("9N8G-P.SPO M<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Y,"4[($)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%P6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S M<#L\+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S M<#L\+W1D/B`\=&0@"!M;VYT:',@96YD960\+W1D M/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$58 M5"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R/E%U86YT:71Y/'-U M<#XQ/"]S=7`^/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E. M1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/ M33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P M86X],T0R/D%M;W5N=#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[(%!!1$1)3D3QS=7`^,3PO6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!4 M15A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`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`Y,"4[($)/4D1%4BU# M3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R M)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R M)SXF;F)S<#L\+W1D/B`\=&0@"!M;VYT:',@96YD M960\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P M=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!C96YT97(G(&-O;'-P86X],T0R/E%U86YT M:71Y/'-U<#XQ/"]S=7`^/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M4$%$1$E.1RU"3U143TTZ(#%P=#L@5$585"U!3$E'3CH@8V5N=&5R)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52 M+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G M(&-O;'-P86X],T0R/D%M;W5N=#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[(%!!1$1)3D3QS=7`^,3PO6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#$E.R!4 M15A4+4%,24=..B!L969T)SXD/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@5TE$5$@Z(#$P)3L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z M(#$E.R!415A4+4%,24=..B!L969T)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@5TE$5$@Z(#(E)SXF;F)S<#L\+W1D/B`\ M=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@6QE/3-$)U9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R M,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@ M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA M8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("T\+W1D/B`\=&0@ M6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/ M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52 M+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^ M("T\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ M(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^("T\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$ M1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("T\+W1D/B`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`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=..B!L M969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!415A4+4%,24=. M.B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T)SXF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/5%1/33H@8FQA M8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^(#(T,"PP,#`\ M+W1D/B`\=&0@"<^(#QS=7`^,3PO2!O9B!W87)R86YT&AT;6PQ M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\ M(2TM4W1A&5R8VES M960@86YD('=A3L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG M/B`\=&0@6QE/3-$)T9/3E0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@8V5N=&5R)SXF M;F)S<#L\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S M;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E&5R8VES92!P M6QE/3-$)U9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG/B`\ M=&0@3L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)U=)1%1(.B`Q M)3L@5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U=)1%1(.B`Q)3L@5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P M="!4:6UE6QE/3-$)U=)1%1(.B`Q)3L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@ M5$585"U!3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE6QE M/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z M(')G8B@R,#0L,C4U+#(P-"DG/B`\=&0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@;&5F M=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&IU"<^(#QE;3Y787)R86YT6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+4)/ M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G(&-O M;'-P86X],T0R/E%U86YT:71Y/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P M="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C M96YT97(G/B!%>'!I2`R-RP@,C`Q-3PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(&QE9G0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)SXR+C`P/"]T9#X@/'1D M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^ M)FYB6QE/3-$)U9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"DG M/B`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`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`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ M(#%P=#L@5$585"U!3$E'3CH@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ M(#%P="<^)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^(#`N.3@\+W1D/B`\=&0@6QE/3-$)U9%4E1)0T%,+4%, M24=..B!B;W1T;VT[($)!0TM'4D]53D0M0T],3U(Z('=H:71E)SX@/'1D('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<^)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@5$585"U! M3$E'3CH@'1087)T M7S$Q,SAC-#4Q7V5C.3!?-&$Q,E\Y-S4W7V8X-34R.30U865D90T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Q,3,X8S0U,5]E8SDP7S1A,3)?.3'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&-L=61E9"!F&-L=61E9"!F'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E*2`H1&5T86EL'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO MF5D(%!E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E(%-E'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!0'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'!E8W1E9"!T;R!V97-T(&%T($1E8V5M8F5R(#,Q+"`R M,#$S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO7,\'0^ M)S0@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES86)L92!A="!$96-E;6)E M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO&5R8VES960\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO&5R M8VES92!P'0^)SQS<&%N/CPO'0^)S4@>65A'0^)SQS<&%N/CPO3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Q,3,X8S0U,5]E8SDP7S1A,3)?.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO6%L='D@<&%Y;65N="!O;B!N M970@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,3,X M8S0U,5]E8SDP7S1A,3)?.3'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@("`@("`@/'1D(&-L87-S M/3-$;G5M/B@Q.#0L-3$T*3QS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES960\+W1D/@T*("`@("`@("`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`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO2!4 M'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,3,X8S0U,5]E M8SDP7S1A,3)?.3&UL#0I#;VYT96YT+51R86YS9F5R M+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E M>'0O:'1M;#L@8VAA&UL;G,Z;STS M1")U&UL/@T*+2TM+2TM/5]. M97AT4&%R=%\Q,3,X8S0U,5]E8SDP7S1A,3)?.3 XML 17 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8

Shareholders' Equity (Common and Preferred Stock Transactions) (Details) (USD $)
0 Months Ended 3 Months Ended 6 Months Ended 0 Months Ended

Aug. 29, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

Aug. 29, 2013

Common Unit Warrants [Member]

Aug. 29, 2013

Preferred Unit Warrants [Member]

Aug. 29, 2013

Common Stock [Member]

Oct. 13, 2011

Common Stock [Member]

Aug. 29, 2013

Series D Preferred Stock [Member]

Class of Stock [Line Items]

Sale of common stock 3,800,985 2,500,000 1,670

Number of shares covered by each warrant 0.816

Number of shares number of shares covered by warrant 1,525.23

Stock issued, price per share $ 0.535 $ 1,000

Exercise price 0.89 0.89 1.38 0.72 0.72

Warrant term 24 months 24 months

Number of common shares issuable upon conversion 1,869.15

Ownership percentage 9.99%

Beneficial conversion feature       $ 726,378

Gross proceeds from public offering 3,703,527

Underwriting discount (185,176)

Legal and accounting expense (184,514)

Listing expense (48,500)

Other expense (6,045)

Net proceeds $ 3,279,292

X

- Definition

Class Of Warrant Or Right, Term.

+ References

No definition available.

+ Details

Name: isr_ClassOfWarrantOrRightTerm

Namespace Prefix: isr_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Convertible Preferred Stock, Maximum Ownership Interest.

+ References

No definition available.

+ Details

Name: isr_ConvertiblePreferredStockMaximumOwnershipInterest

Namespace Prefix: isr_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

Gross Proceeds From Issuance Of Stock.

+ References

No definition available.

+ Details

Name: isr_GrossProceedsFromIssuanceOfStock

Namespace Prefix: isr_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Payments For Underwriting Fees Costs.

+ References

No definition available.

+ Details

Name: isr_PaymentsForUnderwritingFeesCosts

Namespace Prefix: isr_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for legal and accounting expense expense incurred directly with the issuance of an equity security.

+ References

No definition available.

+ Details

Name: isr_PaymentsOfStockIssuanceCostsLegalAndAccountingExpense

Namespace Prefix: isr_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for Listing expense incurred directly with the issuance of an equity security.

+ References

No definition available.

+ Details

Name: isr_PaymentsOfStockIssuanceCostsListingExpense

Namespace Prefix: isr_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for other expense incurred directly with the issuance of an equity security.

+ References

No definition available.

+ Details

Name: isr_PaymentsOfStockIssuanceCostsOtherExpenses

Namespace Prefix: isr_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_ClassOfStockLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(4))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Subparagraph 4

-Article 4

+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: us-types:perUnitItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.

+ References

No definition available.

+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(2))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Subparagraph 2

-Article 4

+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares issued for each share of convertible preferred stock that is converted.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

+ Details

Name: us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The excess of (1) fair value of the consideration transferred to the holders of the preferred stock over (2) the carrying amount of the preferred stock in the registrant's balance sheet, during the accounting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section S99

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=27010884&loc=d3e42851-122695

+ Details

Name: us-gaap_PreferredStockRedemptionPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOrSaleOfEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount per share or per unit of equity securities issued by non-development stage entity.

+ References

No definition available.

+ Details

Name: us-gaap_SharesIssuedPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 18 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8

Preferred Dividends (Details) (USD $)
6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dividends Payable [Line Items]

Preferred dividends paid $ 10,632 $ 10,632

Series B Preferred Stock [Member]

Dividends Payable [Line Items]

Preferred dividends paid 10,632 10,632

Dividends declared $ 10,632 $ 10,632

X

- Details

Name: us-gaap_DividendsPayableLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 405

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817

+ Details

Name: us-gaap_DividendsPreferredStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 19 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8

Shareholders' Equity (Schedule of Inputs for Fair Value Model) (Details) (USD $)
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Class of Warrant or Right [Line Items]

Balance, beginning of period 1,957,033

Balance, end of period 7,605,771 7,605,771

Value of warrants issued:

Change in fair value of warrant derivative liability $ (117,000) $ 55,000 $ (81,000) $ (74,000)

Balance, end of period 23,000 240,000 23,000 240,000

Common Stock Purchaser Warrants [Member]

Class of Warrant or Right [Line Items]

Balance, beginning of period 650,003 ^[1] 650,003 ^[1] 650,003 ^[1] 650,003 ^[1]

Warrants exercised    ^[1]    ^[1]    ^[1]    ^[1]

Balance, end of period 650,003 ^[1] 650,003 ^[1] 650,003 ^[1] 650,003 ^[1]

Value of warrants issued:

Balance, beginning of period 127,000 168,000 94,000 286,000

Change in fair value of warrant derivative liability (107,000) 50,000 (74,000) (68,000)

Balance, end of period 20,000 218,000 20,000 218,000

Over Allotment Warrants [Member]

Class of Warrant or Right [Line Items]

Balance, beginning of period 63,598 ^[1] 63,598 ^[1] 63,598 ^[1] 63,598 ^[1]

Warrants exercised    ^[1]    ^[1]    ^[1]    ^[1]

Balance, end of period 63,598 ^[1] 63,598 ^[1] 63,598 ^[1] 63,598 ^[1]

Value of warrants issued:

Balance, beginning of period 13,000 17,000 10,000 28,000

Change in fair value of warrant derivative liability (10,000) 5,000 (7,000) (6,000)

Balance, end of period $ 3,000 $ 22,000 $ 3,000 $ 22,000

[1] Quantity of warrants either issued or outstanding as of the date of valuation.

X

- Definition

Issuance of Common Stock in Connection with Warrant Exercises, Net of Issuance Costs, Shares.

+ References

No definition available.

+ Details

Name: isr_IssuanceOfCommonStockInConnectionWithWarrantExercisesNetOfIssuanceCostsShares

Namespace Prefix: isr_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: isr_WarrantsValueAbstract

Namespace Prefix: isr_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ClassOfWarrantOrRightLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

+ Details

Name: us-gaap_ClassOfWarrantOrRightOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_UnrealizedGainLossOnDerivatives

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

+ Details

Name: us-gaap_WarrantsAndRightsOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 20 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8

Shareholders' Equity (Warrants) (Details)
6 Months Ended

Dec. 31, 2013

Warrants

Balance, beginning of period 1,957,033

Warrants issued 5,648,738

Balance, end of period 7,605,771

Weighted average exercise price

Beginning balance outstanding 1.38

Warrants issued 0.72

Ending balance outstanding 0.89

X

- Definition

Class Of Warrant Or Right, Issued.

+ References

No definition available.

+ Details

Name: isr_ClassOfWarrantOrRightIssued

Namespace Prefix: isr_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Class of Warrant or Right Issued In Period, Weighted Average Exercise Price of Warrants or Rights

+ References

No definition available.

+ Details

Name: isr_ClassOfWarrantOrRightIssuedInPeriodExercisePriceOfWarrantsOrRights

Namespace Prefix: isr_

Data Type: us-types:perUnitItemType

Balance Type: na

Period Type: duration

X

- Details

Name: isr_ClassOfWarrantOrRightOutstandingAbstract

Namespace Prefix: isr_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: isr_ClassOfWarrantOrRightWeightedAverageExercisePriceAbstract

Namespace Prefix: isr_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(4))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Subparagraph 4

-Article 4

+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: us-types:perUnitItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

+ Details

Name: us-gaap_ClassOfWarrantOrRightOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 21 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8

Loss per Share
6 Months Ended

Dec. 31, 2013

Loss per Share [Abstract]

Loss per Share

3. Loss per Share

Basic earnings per share is calculated by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding, and does not include the impact of any potentially dilutive common stock equivalents. Common stock equivalents, including warrants and options to purchase the Company's common stock, are excluded from the calculations when their effect is antidilutive. At December 31, 2013 and 2012, the calculation of diluted weighted average shares did not include preferred stock, common stock warrants, or options that are potentially convertible into common stock as those would be antidilutive due to the Company's net loss position.

Securities, presented on an as-converted to common stock basis, not considered in the calculation of diluted weighted average shares, but that could be dilutive in the future as of December 31, 2013 and 2012, were as follows:

December 31,

2013 2012

Series B preferred stock 59,065 59,065

Series D preferred stock 3,121,480 -

Common stock warrants 7,605,771 1,957,033

Common stock options 2,370,072 2,312,072

Total potential dilutive securities 13,156,388 4,328,170

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for earnings per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8

Shareholders' Equity (Additional Information about Warrants) (Details)
6 Months Ended

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2013

Range of Exercise Price One [Member]

Dec. 31, 2013

Range of Exercise Price Two [Member]

Dec. 31, 2013

Range of Exercise Price Three [Member]

Dec. 31, 2013

Range of Exercise Price Four [Member]

Dec. 31, 2013

Range of Exercise Price Five [Member]

Dec. 31, 2013

Range of Exercise Price Six [Member]

Dec. 31, 2013

Range of Exercise Price Seven [Member]

Class of Warrant or Right [Line Items]

Quantity 7,605,771 1,957,033 6,000 25,000 5,648,738 1,207,832 650,003 63,198 5,000

Expiration date Jun. 08, 2015 Jul. 27, 2015 Aug. 25, 2015 Nov. 21, 2015 Oct. 19, 2016 Dec. 07, 2016 Jun. 27, 2017

Exercise price 0.89 1.38 1.18 2.00 0.72 1.56 1.043 1.043 0.98

X

- Definition

Warrants Expiration, Date.

+ References

No definition available.

+ Details

Name: isr_WarrantsExpirationDate

Namespace Prefix: isr_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(4))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Subparagraph 4

-Article 4

+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: us-types:perUnitItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_ClassOfWarrantOrRightLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

+ Details

Name: us-gaap_ClassOfWarrantOrRightOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 23 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8

Consolidated Balance Sheets (USD $)

Dec. 31, 2013

Jun. 30, 2013

Current assets:

Cash and cash equivalents $ 4,414,572 $ 2,899,927

Accounts receivable, net of allowance for doubtful accounts of $32,515 and $52,598, respectively 917,222 923,780

Inventory 426,333 405,571

Other receivables 10,064 11,502

Prepaid expenses and other current assets 156,365 202,880

Total current assets 5,924,556 4,443,660

Fixed assets, net of accumulated depreciation and amortization 1,349,469 1,684,282

Restricted cash 181,181 181,149

Inventory, non-current 469,758 469,758

Other assets, net of accumulated amortization 262,698 276,507

Total assets 8,187,662 7,055,356

Current liabilities:

Accounts payable and accrued liabilities 430,293 432,566

Accrued protocol expense 46,973 25,305

Accrued radioactive waste disposal 124,000 100,000

Accrued payroll and related taxes 141,082 127,419

Accrued vacation 104,932 107,578

Total current liabilities 847,280 792,868

Warrant derivative liability 23,000 104,000

Asset retirement obligation 828,568 792,242

Total liabilities 1,698,848 1,689,110

Commitments and contingencies (Note 6)

Shareholders' equity:

Preferred stock, $.001 par value; 7,001,671 shares authorized: 61 59

Common stock, $.001 par value; 192,998,329 & 193,000,000 shares authorized; 38,419,502 and 34,618,517 shares issued and outstanding 38,420 34,618

Treasury stock, at cost 13,200 shares (8,390) (8,390)

Additional paid-in capital 60,747,935 57,431,293

Accumulated deficit (54,289,212) (52,091,334)

Total shareholders' equity 6,488,814 5,366,246

Total liabilities and shareholders' equity 8,187,662 7,055,356

Series A Preferred Stock [Member]

Shareholders' equity:

Preferred stock, $.001 par value; 7,001,671 shares authorized:

Series B Preferred Stock [Member]

Shareholders' equity:

Preferred stock, $.001 par value; 7,001,671 shares authorized: 59 59

Series C Preferred Stock [Member]

Shareholders' equity:

Preferred stock, $.001 par value; 7,001,671 shares authorized:

Series D Preferred Stock [Member]

Shareholders' equity:

Preferred stock, $.001 par value; 7,001,671 shares authorized: $ 2

X

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 710

-SubTopic 10

-Section 25

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361

+ Details

Name: us-gaap_AccruedVacationCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Noncurrent portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 410

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849

+ Details

Name: us-gaap_AssetRetirementObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 25

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 7

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 17

-Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),19)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13433-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13495-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=20225523&loc=SL20225862-175312

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

+ Details

Name: us-gaap_DerivativeLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(d))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph d

-Article 5

+ Details

Name: us-gaap_InventoryNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

+ Details

Name: us-gaap_OtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6904-107765

+ Details

Name: us-gaap_OtherLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amounts of other receivables due within one year of the balance sheet date (or one operating cycle, if longer) from third parties or arising from transactions not separately disclosed.

+ References

No definition available.

+ Details

Name: us-gaap_OtherReceivablesGrossCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Cash and equivalents whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RestrictedCashAndCashEquivalentsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656

+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 24 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8

Basis of Presentation
6 Months Ended

Dec. 31, 2013

Basis of Presentation [Abstract]

Basis of Presentation

1. Basis of Presentation

The accompanying consolidated financial statements are those of IsoRay, Inc., and its wholly-owned subsidiaries (IsoRay or the Company). All significant intercompany accounts and transactions have been eliminated in consolidation. Certain amounts in the prior-year financial statements have been reclassified to conform to the current year presentation.

In the opinion of management, the accompanying unaudited interim consolidated financial statements and notes to the interim consolidated financial statements contain all adjustments, consisting of normal recurring items, necessary to present fairly, in all material respects, the financial position of IsoRay, Inc. and its wholly-owned subsidiaries.  These unaudited interim consolidated financial statements should be read in conjunction with our audited consolidated financial statements and related footnotes as set forth in the Company's annual report filed on Form 10-K for the year ended June 30, 2013, as it may be amended from time to time.

The results of operations for the periods presented may not be indicative of those which may be expected for a full year.  The unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures are adequate for the information not to be misleading.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, the reported amounts of revenues and expenses during the reporting period and the disclosures of contingent liabilities.  Accordingly, ultimate results could differ materially from those estimates.

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28200181&loc=SL6228881-111685

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 720

-SubTopic 15

-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7668296&loc=d3e288-107754

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 235

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122150

+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8

Loss per Share (Details)
6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Antidilutive securities excluded from computation of earnings per share, amount 13,156,388 4,328,170

Series B Preferred Stock [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Antidilutive securities excluded from computation of earnings per share, amount 59,065 59,065

Series D Preferred Stock [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Antidilutive securities excluded from computation of earnings per share, amount 3,121,480

Warrant [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Antidilutive securities excluded from computation of earnings per share, amount 7,605,771 1,957,033

Employee Stock Option [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Antidilutive securities excluded from computation of earnings per share, amount 2,670,072 2,312,072

X

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8

Share-Based Compensation (Schedule of Share-Based Compensation Expense) (Details) (USD $)
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]

Share-based compensation $ 13,432 $ 28,826 $ 51,784 $ 57,789

Unrecognized compensation expense related to stock-based options and awards 42,626 42,626

Unrecognized compensation expense related to stock-based options and awards, weighted-average recognition period 9 months 26 days

Stock options, maximum term 10 years

Cost of Product Sales [Member]

Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]

Share-based compensation 4,499 10,164 8,921 20,328

Research and Development Expenses [Member]

Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]

Share-based compensation 3,482 8,717 6,965 17,435

Sales and Marketing Expenses [Member]

Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]

Share-based compensation 879 1,523 1,757 3,182

General and Administration Expenses [Member]

Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]

Share-based compensation $ 4,572 $ 8,422 $ 34,141 $ 16,844

X

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.F)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section F

+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Unrecognized cost of unvested options awarded to employees as compensation.

+ References

No definition available.

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

XML 27 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 28 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8

New Accounting Pronouncements
6 Months Ended

Dec. 31, 2013

New Accounting Pronouncements [Abstract]

New Accounting Pronouncements

2. New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the "FASB") or other standards setting bodies that are adopted by us as of the specified effective dates. Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.

X

- Definition

The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section S99

-Paragraph 5

-Subparagraph (SAB TOPIC 11.M)

-URI http://asc.fasb.org/extlink&oid=26874127&loc=d3e31137-122693

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 11

-Section M

+ Details

Name: us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8

Consolidated Balance Sheets (Parenthetical) (USD $)

Dec. 31, 2013

Jun. 30, 2013

Accounts receivable, allowance for doubtful accounts $ 32,515 $ 52,598

Preferred stock, par or stated value per share $ 0.001 $ 0.001

Preferred stock, shares authorized 7,001,671

Common stock, par value per share $ 0.001 $ 0.001

Common stock, shares authorized 192,998,329 193,000,000

Common stock, shares issued 38,419,502 34,618,517

Common stock, shares outstanding 38,419,502 34,618,517

Treasury stock, shares 13,200 13,200

Series A Preferred Stock [Member]

Preferred stock, par or stated value per share $ 0.001 $ 0.001

Preferred stock, shares authorized 1,000,000 1,000,000

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Series B Preferred Stock [Member]

Preferred stock, par or stated value per share $ 0.001 $ 0.001

Preferred stock, shares authorized 5,000,000 5,000,000

Preferred stock, shares issued 59,065 59,065

Preferred stock, shares outstanding 59,065 59,065

Series C Preferred Stock [Member]

Preferred stock, par or stated value per share $ 0.001 $ 0.001

Preferred stock, shares authorized 1,000,000 1,000,000

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Series D Preferred Stock [Member]

Preferred stock, par or stated value per share $ 0.001 $ 0.001

Preferred stock, shares authorized 1,671 0

Preferred stock, shares issued 1,670 0

Preferred stock, shares outstanding 1,670 0

X

- Definition

A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5074-111524

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 30 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8

Loss per Share (Tables)
6 Months Ended

Dec. 31, 2013

Loss per Share [Abstract]

Schedule of Antidilutive Securities Excluded from Computation of Loss per Share

Securities, presented on an as-converted to common stock basis, not considered in the calculation of diluted weighted average shares, but that could be dilutive in the future as of December 31, 2013 and 2012, were as follows:

December 31,

2013 2012

Series B preferred stock 59,065 59,065

Series D preferred stock 3,121,480 -

Common stock warrants 7,605,771 1,957,033

Common stock options 2,370,072 2,312,072

Total potential dilutive securities 13,156,388 4,328,170

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8

Document and Entity Information
6 Months Ended

Dec. 31, 2013

Feb. 06, 2014

Document and Entity Information [Abstract]

Document Type 10-Q

Amendment Flag false

Document Period End Date Dec. 31, 2013

Entity Registrant Name IsoRay, Inc.

Entity Central Index Key 0000728387

Current Fiscal Year End Date --06-30

Document Fiscal Year Focus 2014

Document Fiscal Period Focus Q2

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 41,540,982

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: isr_DocumentAndEntityInformationAbstract

Namespace Prefix: isr_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8

Inventory (Tables)
6 Months Ended

Dec. 31, 2013

Inventory [Abstract]

Schedule of Components of Inventory

Inventory consisted of the following at December 31, 2013 and June 30, 2013:

December 31, June 30,

2013 2013

Raw materials $ 168,731 $ 167,671

Work in process 212,726 195,323

Finished goods 44,876 42,577

Total inventory $ 426,333 $ 405,571

X

- Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 2

-Paragraph 6

-Subparagraph a,b,c

-Article 5

+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8

Consolidated Statements of Operations (USD $)
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Consolidated Statements of Operations [Abstract]

Product sales $ 1,085,408 $ 975,457 $ 2,135,323 $ 2,031,689

Cost of product sales 1,119,314 1,134,083 2,246,537 2,210,740

Gross loss (33,906) (158,626) (111,214) (179,051)

Operating expenses:

Research and development expenses 170,030 149,176 317,020 290,648

Sales and marketing expenses 326,467 322,094 685,652 638,150

General and administrative expenses 513,964 469,559 1,165,000 1,114,412

Total operating expenses 1,010,461 940,829 2,167,672 2,043,210

Operating loss (1,044,367) (1,099,455) (2,278,886) (2,222,261)

Non-operating income (expense):

Interest income 481 128 835 272

Change in fair value of warrant derivative liability 117,000 (55,000) 81,000 74,000

Financing and interest expense (86)    (827) (6)

Non-operating income / (expense), net 117,395 (54,872) 81,008 74,266

Net loss (926,972) (1,154,327) (2,197,878) (2,147,995)

Preferred stock deemed dividends (Note 9)       (726,378)

Preferred stock dividends (2,658) (2,658) (5,316) (5,316)

Net loss applicable to common shareholders $ (929,630) $ (1,156,985) $ (2,929,572) $ (2,153,311)

Basic and diluted loss per share $ (0.02) $ (0.03) $ (0.08) $ (0.06)

Weighted average shares used in computing net loss per share:

Basic and diluted 38,419,502 34,604,605 37,133,875 34,238,401

X

- Definition

Total costs related to goods produced and sold during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 2

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfGoodsSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Interest and debt related expenses associated with nonoperating financing activities of the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

+ Details

Name: us-gaap_InterestAndDebtExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 7

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(b))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256

+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 7

-Article 5

+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.

+ References

No definition available.

+ Details

Name: us-gaap_PreferredStockDividendsIncomeStatementImpact

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The excess of (1) fair value of the consideration transferred to the holders of the preferred stock over (2) the carrying amount of the preferred stock in the registrant's balance sheet, during the accounting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section S99

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=27010884&loc=d3e42851-122695

+ Details

Name: us-gaap_PreferredStockRedemptionPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_SalesRevenueGoodsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate total amount of expenses directly related to the marketing or selling of products or services.

+ References

No definition available.

+ Details

Name: us-gaap_SellingAndMarketingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_UnrealizedGainLossOnDerivatives

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).

+ References

No definition available.

+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8

Fair Value Measurements
6 Months Ended

Dec. 31, 2013

Fair Value Measurements [Abstract]

Fair Value Measurements

7. Fair Value Measurements

The table below sets forth the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2013 and June 30, 2013, respectively, and the fair value calculation input hierarchy level the Company has determined applies to each asset and liability category.

Balance at Balance at Input

Description December 31, 2013 June 30, 2013 Hierarchy Level

Assets:

Cash and cash equivalents $ 4,414,572 $ 2,899,927 Level 1

Restricted cash 181,181 181,149 Level 1

Liabilities:

Warrant liability $ 23,000 $ 104,000 Level 2

X

- Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13433-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13504-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8

Commitments and Contingencies
6 Months Ended

Dec. 31, 2013

Commitments and Contingencies [Abstract]

Commitments and Contingencies

6. Commitments and Contingencies

Patent and Know-How Royalty License Agreement

The Company is the holder of an exclusive license to use certain "know-how" developed by one of the founders of a predecessor to the Company and licensed to the Company by the Lawrence Family Trust, a Company shareholder. The terms of this license agreement require the payment of a royalty based on the Net Factory Sales Price, as defined in the agreement, of licensed product sales. Because the licensor's patent application was ultimately abandoned, only a 1% "know-how" royalty based on Net Factory Sales Price, as defined in the agreement, remains applicable. To date, management believes that there have been no product sales incorporating the "know-how" and therefore no royalty is due pursuant to the terms of the agreement. Management believes that ultimately no royalties should be paid under this agreement as there is no intent to use this "know-how" in the future.

The licensor of the "know-how" has disputed management's contention that it is not using this "know-how". On September 25, 2007 and again on October 31, 2007, the Company participated in nonbinding mediation regarding this matter; however, no settlement was reached with the Lawrence Family Trust. After additional settlement discussions, which ended in April 2008, the parties failed to reach a settlement. The parties may demand binding arbitration at any time.

X

- Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8

Inventory (Details) (USD $)

Dec. 31, 2013

Jun. 30, 2013

Inventory [Abstract]

Raw materials $ 168,731 $ 167,671

Work in process 212,726 195,323

Finished goods 44,876 42,577

Total inventory $ 426,333 $ 405,571

X

- Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryFinishedGoods

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(4))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryRawMaterials

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryWorkInProcess

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 37 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8

Share-Based Compensation (Tables)
6 Months Ended

Dec. 31, 2013

Share-Based Compensation [Abstract]

Schedule of Share-Based Compensation Expense

The following table presents the share-based compensation expense recognized during the three and six months ended December 31, 2013 and 2012:

Three months Six months

ended December 31, ended December 31,

2013 2012 2013 2012

Cost of product sales $ 4,499 $ 10,164 $ 8,921 $ 20,328

Research and development expenses 3,482 8,717 6,965 17,435

Sales and marketing expenses 879 1,523 1,757 3,182

General and administrative expenses 4,572 8,422 34,141 16,844

Total share-based compensation $ 13,432 $ 28,826 $ 51,784 $ 57,789

Schedule of Stock Option within Share-based Compensation Plans

A summary of stock options within the Company's share-based compensation plans as of December 31, 2013 was as follows:

Weighted

Weighted Average

Average Remaining Aggregate

Number of Exercise Contractual Intrinsic

Options Price Term Value

Outstanding at December 31, 2013 2,370,072 $ 1.79 4.57 $ 125,884

Vested and expected to vest at

December 31, 2013 2,278,260 $ 1.84 4.50 $ 114,801

Vested and exercisable at

December 31, 2013 2,080,064 $ 1.90 4.13 $ 125,784

X

- Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.F)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section F

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the following for fully vested share options (or share units) and share options expected to vest at the date of the latest statement of financial position: the number, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or share units) outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8

Related Party Transaction
6 Months Ended

Dec. 31, 2013

Related Party Transaction [Abstract]

Related Party Transaction

10. Related Party Transaction

During the six months ended December 31, 2013 and 2012, the Company continued to engage the services of APEX Data Systems, Inc., owned by Dwight Babcock, the Company's Chairman and Chief Executive Officer, to modify and maintain the Company's web interfaced data collection application to aggregate patient data in a controlled environment. The Audit Committee and Board of Directors approved the use of the ongoing services of APEX Data Systems. Mr. Babcock recused himself from the Board vote due to his conflict of interest. The cost recorded during the six months ended December 31, 2013 and 2012 from APEX Data Systems, Inc. for the maintenance of the web interfaced data collection application was $9,720 and $8,960, respectively. An additional $6,000 was spent on the implementation of Customer Relationship Management software in the six months ended December 31, 2013.

X

- Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8

Preferred Dividends
6 Months Ended

Dec. 31, 2013

Preferred Dividends [Abstract]

Preferred Dividends

8. Preferred Dividends

On December 19, 2013, the Board of Directors declared a dividend on the Series B Preferred Stock of all currently payable and accrued outstanding and cumulative dividends through December 31, 2013 in the amount of $10,632. Dividends on the Series B Preferred Stock were last paid on December 31, 2012 as declared by the Board of Directors on December 21, 2012 in the amount of $10,632. The dividends outstanding and cumulative through December 31, 2013 of $10,632 and through December 31, 2012 of $10,632 were paid as of those dates.

X

- Details

Name: us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.

+ References

No definition available.

+ Details

Name: us-gaap_PreferredStockTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8

Shareholders' Equity
6 Months Ended

Dec. 31, 2013

Shareholders' Equity [Abstract]

Shareholders' Equity

9. Shareholders' Equity

Common and preferred stock transactions

On August 29, 2013, the Company entered into an agreement to sell 3,800,985 common units, each consisting of 1 share of common stock and a warrant to purchase 0.816 shares of common stock (the "Common Units"), and 1,670 preferred units, each consisting of 1 share of Series D Convertible Preferred Stock and a warrant to purchase 1,525.23 shares of common stock (the "Preferred Units") on a firm commitment underwritten basis. The Common Units were sold at an initial per unit purchase price of $0.535 and the Preferred Units were sold at an initial per unit purchase price of $1,000. The warrants are all exercisable at $0.72 per share, are callable, and have a twenty-four month term, with the exercise price and term subject to reduction if shareholder approval is obtained, and are not exercisable until March 1, 2014. Each share of the Series D Convertible Preferred Stock is convertible into 1,869.15 shares of common stock at any time at the option of the holder, subject to adjustment, provided that the holder will be prohibited from converting Series D Convertible Preferred Stock into shares of the Company's common stock if, as a result of such conversion, the holder, together with affiliates, would own more than 9.99% of the total shares of the Company's common stock then issued and outstanding. The preferred shares which are convertible into shares of common stock contain a beneficial conversion feature of $726,378 which was recognized as a deemed dividend to the Series D preferred shareholders on the date of issuance. This public offering resulted in gross proceeds of $3.7 million. The offering yielded approximately $3,279,292 in cash after expenses.

Series D

Series D convertible preferred shares are entitled to dividends in the same form as dividends actually paid on shares of common stock. Series D convertible preferred shares are convertible into shares of common stock at the rate of 1,869.15 shares of common stock for each share of Series D convertible preferred stock (subject to adjustment as provided in the certificate of designation for the Series D Convertible Preferred Stock), and are subject to conversion limitations if the conversion would result in the holder together with its affiliates, beneficially owning more than 9.99% of the total number of shares of our common stock then issued and outstanding. Series D convertible preferred shareholders shall not have the right to vote on any matter other than those set forth in the Certificate of Designation with the potential to specifically adversely affect the Series D Convertible Preferred Stock.

Upon the execution of a fundamental transaction which effects a merger or other change of control transaction of the Company a holder will have the right to receive, upon any subsequent conversion of a share of Series D Convertible Preferred Stock (in lieu of conversion shares) for each issuable conversion share, the same kind and amount of securities, cash or property as it would have been entitled to receive upon the occurrence of such fundamental transaction if it had been, immediately prior to such fundamental transaction, the holder of the shares of common stock into which such holder's shares of Series D Convertible Preferred Stock is then convertible.

Gross proceeds from public offering $ 3,703,527

Underwriting discount (185,176 )

Legal and accounting expense (184,514 )

Listing expense (48,500 )

Other expense (6,045 )

Net proceeds 3,279,292

Warrant liability and related offering cost deferral

Based on the guidance contained in ASC 815 "Derivatives and Hedging", management has concluded that the warrants issued in the October 13, 2011 underwritten registered offering of 2,500,000 shares of common stock should be classified as a derivative liability and has recorded a liability at fair value. The Company determined the fair value of the warrants using the Black-Scholes fair value model. The Company determined the fair value of the warrants on the date of the offering to be as disclosed in the tables below. The Company has recognized a change in fair value as described in the table below:

Change in fair value of the derivative warrant liability for the three months ended December 31, 2013 and 2012, respectively.

Three months ended Three months ended

December 31, 2013 December 31, 2012

Change in fair value $ (117,000 ) $ 55,000

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on October 19, 2011.

Three months ended Three months ended

December 31, 2013 December 31, 2012

Quantity¹ Amount Quantity¹ Amount

Balance, beginning of period 650,003 $ 127,000 650,003 $ 168,000

Change in fair value 650,003 (107,000 ) 650,003 50,000

Warrants exercised - - - -

Balance, end of period 650,003 $ 20,000 650,003 $ 218,000

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on December 7, 2011.

Three months ended Three months ended

December 31, 2013 December 31, 2012

Quantity¹ Amount Quantity¹ Amount

Balance, beginning of period 63,598 $ 13,000 63,598 $ 17,000

Change in fair value 63,598 (10,000 ) 63,598 5,000

Warrants exercised - - - -

Balance, end of period 63,598 $ 3,000 63,598 $ 22,000

Total fair value of warrant derivative liability at
December 31, 2013 and 2012 $ 23,000 $ 240,000

Change in fair value of the derivative warrant liability for the six months ended December 31, 2013 and 2012, respectively.

Six months ended Six months ended

December 31, 2013 December 31, 2012

Change in fair value $ (81,000 ) $ (74,000 )

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on October 19, 2011.

Six months ended Six months ended

December 31, 2013 December 31, 2012

Quantity¹ Amount Quantity¹ Amount

Balance, beginning of period 650,003 $ 94,000 650,003 $ 286,000

Change in fair value 650,003 (74,000 ) 650,003 (68,000 )

Warrants exercised - - - -

Balance, end of period 650,003 $ 20,000 650,003 $ 218,000

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on December 7, 2011.

Six months ended Six months ended

December 31, 2013 December 31, 2012

Quantity¹ Amount Quantity¹ Amount

Balance, beginning of period 63,598 $ 10,000 63,598 $ 28,000

Change in fair value 63,598 (7,000 ) 63,598 (6,000 )

Warrants exercised - - - -

Balance, end of period 63,598 $ 3,000 63,598 $ 22,000

Total fair value of warrant derivative liability at
December 31, 2013 and 2012 $ 23,000 $ 240,000

¹ Quantity of warrants either issued or outstanding as of the date of valuation.

Warrants

The following table summarizes the warrants outstanding as of the beginning of the fiscal year, warrants exercised and warrants issued during the year and weighted average prices for each category.

Weighted average

Warrants exercise price

Outstanding as of June 30, 2013 1,957,033 $ 1.38

Warrants issued 5,648,738 0.72

Outstanding as of December 31, 2013 7,605,771 $ 0.89

Warrants outstanding as of December 31, 2013

Quantity Expiration date Exercise price

6,000 June 8, 2015 $ 1.18

25,000 July 27, 2015 2.00

5,648,738 August 25, 2015 0.72

1,207,832 November 21, 2015 1.56

650,003 October 19, 2016 1.043

63,198 December 7, 2016 1.043

5,000 June 27, 2017 0.98

7,605,771 $ 0.89

X

- Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8

Subsequent Event
6 Months Ended

Dec. 31, 2013

Subsequent Event [Abstract]

Subsequent Event

11. Subsequent Event

In January 2014, the holder of the 1,670 shares of Series D convertible preferred stock fully exercised its right to convert the 1,670 shares of Series D convertible preferred stock into 3,121,480 shares of common stock which resulted in an increase in shares of common stock outstanding from 38,419,502 to 41,540,982. Subsequent to the conversion, no shares of Series D convertible preferred stock remain outstanding.

X

- Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

No definition available.

+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8

Subsequent Event (Details)
1 Months Ended

Dec. 31, 2013

Jun. 30, 2013

Jan. 31, 2014

Subsequent Event [Member]

Jan. 31, 2014

Common Stock [Member]

Subsequent Event [Member]

Jan. 31, 2014

Series D Preferred Stock [Member]

Subsequent Event [Member]

Subsequent Event [Line Items]

Number of shares converted 1,670

Number of common shares issued upon conversion 3,121,480

Common stock, shares outstanding 38,419,502 34,618,517 41,540,982

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_ConversionOfStockSharesConverted1

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_ConversionOfStockSharesIssued1

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SubsequentEventLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8

Shareholders' Equity (Tables)
6 Months Ended

Dec. 31, 2013

Shareholders' Equity [Abstract]

Schedule of Proceeds from Common Stock Offering

Gross proceeds from public offering $ 3,703,527

Underwriting discount (185,176 )

Legal and accounting expense (184,514 )

Listing expense (48,500 )

Other expense (6,045 )

Net proceeds 3,279,292

Schedule of Fair Value of Warrants

Change in fair value of the derivative warrant liability for the three months ended December 31, 2013 and 2012, respectively.

Three months ended Three months ended

December 31, 2013 December 31, 2012

Change in fair value $ (117,000 ) $ 55,000

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on October 19, 2011.

Three months ended Three months ended

December 31, 2013 December 31, 2012

Quantity¹ Amount Quantity¹ Amount

Balance, beginning of period 650,003 $ 127,000 650,003 $ 168,000

Change in fair value 650,003 (107,000 ) 650,003 50,000

Warrants exercised - - - -

Balance, end of period 650,003 $ 20,000 650,003 $ 218,000

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on December 7, 2011.

Three months ended Three months ended

December 31, 2013 December 31, 2012

Quantity¹ Amount Quantity¹ Amount

Balance, beginning of period 63,598 $ 13,000 63,598 $ 17,000

Change in fair value 63,598 (10,000 ) 63,598 5,000

Warrants exercised - - - -

Balance, end of period 63,598 $ 3,000 63,598 $ 22,000

Total fair value of warrant derivative liability at
December 31, 2013 and 2012 $ 23,000 $ 240,000

Change in fair value of the derivative warrant liability for the six months ended December 31, 2013 and 2012, respectively.

Six months ended Six months ended

December 31, 2013 December 31, 2012

Change in fair value $ (81,000 ) $ (74,000 )

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on October 19, 2011.

Six months ended Six months ended

December 31, 2013 December 31, 2012

Quantity¹ Amount Quantity¹ Amount

Balance, beginning of period 650,003 $ 94,000 650,003 $ 286,000

Change in fair value 650,003 (74,000 ) 650,003 (68,000 )

Warrants exercised - - - -

Balance, end of period 650,003 $ 20,000 650,003 $ 218,000

Change in fair value of the derivative warrant liability for purchaser warrants and underwriter warrants contained in an equity transaction on December 7, 2011.

Six months ended Six months ended

December 31, 2013 December 31, 2012

Quantity¹ Amount Quantity¹ Amount

Balance, beginning of period 63,598 $ 10,000 63,598 $ 28,000

Change in fair value 63,598 (7,000 ) 63,598 (6,000 )

Warrants exercised - - - -

Balance, end of period 63,598 $ 3,000 63,598 $ 22,000

Total fair value of warrant derivative liability at
December 31, 2013 and 2012 $ 23,000 $ 240,000

¹ Quantity of warrants either issued or outstanding as of the date of valuation.

Schedule of Warrants Activity

The following table summarizes the warrants outstanding as of the beginning of the fiscal year, warrants exercised and warrants issued during the year and weighted average prices for each category.

Weighted average

Warrants exercise price

Outstanding as of June 30, 2013 1,957,033 $ 1.38

Warrants issued 5,648,738 0.72

Outstanding as of December 31, 2013 7,605,771 $ 0.89

Warrants outstanding as of December 31, 2013

Quantity Expiration date Exercise price

6,000 June 8, 2015 $ 1.18

25,000 July 27, 2015 2.00

5,648,738 August 25, 2015 0.72

1,207,832 November 21, 2015 1.56

650,003 October 19, 2016 1.043

63,198 December 7, 2016 1.043

5,000 June 27, 2017 0.98

7,605,771 $ 0.89

X

- Definition

Tabular disclosure of proceeds from common stock offering.

+ References

No definition available.

+ Details

Name: isr_ScheduleOfProceedsFromCommonStockOfferingTableTextBlock

Namespace Prefix: isr_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of quantitative information about the inputs used in the fair value measurement of liabilities. This disclosure may include, but is not limited to, the fair value of the liability, valuation technique used to measure fair value, the inputs used to measure fair value, the ranges of the inputs, and the weighted averages of the inputs.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (bbb)

-URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 28

-Article 5

+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8

Commitments and Contingencies (Details) (Patent Rights Know-how and License Agreements [Member])

Dec. 31, 2013

Patent Rights Know-how and License Agreements [Member]

Finite-Lived Intangible Assets [Line Items]

Percentage of royalty payment on net sales 1.00%

X

- Definition

Percentage of Royalty Rate Payable on Net Sales

+ References

No definition available.

+ Details

Name: isr_PercentageOfRoyaltyRatePayableOnNetSales

Namespace Prefix: isr_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 45 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8

Consolidated Statements of Cash Flows (USD $)
6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss $ (2,197,878) $ (2,147,995)

Adjustments to reconcile net loss to net cash used by operating activities:

Allowance for doubtful accounts (20,083) (13,477)

Depreciation and amortization of fixed assets 349,232 388,171

Amortization of deferred financing costs and other assets 15,371 14,024

Change in fair value of warrant derivative liability (81,000) (74,000)

Accretion of asset retirement obligation 36,326 33,211

Share-based compensation 51,786 57,789

Changes in operating assets and liabilities:

Accounts receivable, gross 26,641 222,365

Inventory (20,762) 41,433

Other receivables 1,438 1,914

Prepaid expenses and other current assets 46,515 (84,252)

Accounts payable and accrued expenses (2,273) 4,120

Accrued protocol expense 21,668 13,750

Accrued radioactive waste disposal 24,000 24,000

Accrued payroll and related taxes 13,663 9,181

Accrued vacation (2,646) (3,230)

Net cash used by operating activities (1,738,002) (1,512,996)

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchases of fixed assets (14,419)

Additions to licenses and other assets (1,562) (13,407)

Change in restricted cash (32) (84)

Net cash used by investing activities (16,013) (13,491)

CASH FLOWS FROM FINANCING ACTIVITIES:

Preferred dividends paid (10,632) (10,632)

Proceeds from sales of preferred stock, pursuant to underwritten offering, net 1,478,712

Proceeds from sales of common stock, pursuant to underwritten offering, net 1,800,580

Proceeds from sales of common stock, pursuant to registered direct offering, net    3,291,977

Proceeds from sales of common stock, pursuant to exercise of warrants, net    1,825

Proceeds from sales of common stock, pursuant to exercise of options    11,309

Net cash provided by financing activities 3,268,660 3,294,479

Net increase in cash and cash equivalents 1,514,645 1,767,992

Cash and cash equivalents, beginning of period 2,899,927 2,672,711

CASH AND CASH EQUIVALENTS, END OF PERIOD $ 4,414,572 $ 4,440,703

X

- Definition

Provision for (Reduction of) Doubtful Accounts.

+ References

No definition available.

+ Details

Name: isr_ProvisionForReductionOfDoubtfulAccounts

Namespace Prefix: isr_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_AdjustmentForAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 410

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 410

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)(3)

-URI http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849

+ Details

Name: us-gaap_AssetRetirementObligationAccretionExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other expenses incurred but not yet paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other current operating liabilities not separately disclosed in the statement of cash flows.

+ References

No definition available.

+ Details

Name: us-gaap_IncreaseDecreaseInOtherCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Change in carrying value during the period of obligations incurred through and payable within one year (or in the operating cycle if longer) for employer-related costs not otherwise specified in the taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other amounts due to the reporting entity, which are not otherwise defined in the taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_IncreaseDecreaseInRestrictedCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfPrivatePlacement

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the amount received from holders exercising their stock warrants.

+ References

No definition available.

+ Details

Name: us-gaap_ProceedsFromWarrantExercises

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_UnrealizedGainLossOnDerivatives

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 46 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8

Share-Based Compensation
6 Months Ended

Dec. 31, 2013

Share-Based Compensation [Abstract]

Share-Based Compensation

5. Share-Based Compensation

The following table presents the share-based compensation expense recognized during the three and six months ended December 31, 2013 and 2012:

Three months Six months

ended December 31, ended December 31,

2013 2012 2013 2012

Cost of product sales $ 4,499 $ 10,164 $ 8,921 $ 20,328

Research and development expenses 3,482 8,717 6,965 17,435

Sales and marketing expenses 879 1,523 1,757 3,182

General and administrative expenses 4,572 8,422 34,141 16,844

Total share-based compensation $ 13,432 $ 28,826 $ 51,784 $ 57,789

As of December 31, 2013, total unrecognized compensation expense related to stock-based options was $42,626 and the related weighted-average period over which it is expected to be recognized is approximately 0.82 years.

The Company currently provides stock-based compensation under three equity incentive plans approved by the Board of Directors. Options granted under each of the plans have a ten year maximum term, an exercise price equal to at least the fair market value of the Company's common stock on the date of the grant, and varying vesting periods as determined by the Board. For stock options with graded vesting terms, the Company recognizes compensation cost on a straight-line basis over the requisite service period for the entire award.

A summary of stock options within the Company's share-based compensation plans as of December 31, 2013 was as follows:

Weighted

Weighted Average

Average Remaining Aggregate

Number of Exercise Contractual Intrinsic

Options Price Term Value

Outstanding at December 31, 2013 2,370,072 $ 1.79 4.57 $ 125,884

Vested and expected to vest at

December 31, 2013 2,278,260 $ 1.84 4.50 $ 114,801

Vested and exercisable at

December 31, 2013 2,080,064 $ 1.90 4.13 $ 125,784

There were no options exercised during the six months ended December 31, 2013 and 31,700 options exercised during the six months ended December 31, 2012. The Company's current policy is to issue new shares to satisfy option exercises. The intrinsic value of the employee options exercised during the six months ended December 31, 2012 was $13,866.

There were 65,000 stock option awards granted and no stock option awards granted during the six months ended December 31, 2013 and 2012, respectively.

There were 50,000 director stock options issued to the Chief Executive Officer and Chairman on September 5, 2013 with an exercise price of $0.58 per share which was the closing price of the Company common stock on the day of issuance. The fair value of the stock options issued on September 5, 2013 using a Black Scholes model is $25,150 utilizing the closing price on the day of grant of $0.58 per share as the grant and exercise price, a five year term, volatility of 132.31% and a discount rate of 1.85%.

There were 15,000 employee stock options issued to three members of management on September 6, 2013 with an exercise price of $0.59 per share which was the closing price of the Company common stock on the day of issuance. The fair value of the stock options issued on September 6, 2013 using a Black Scholes model is $6,906 utilizing the closing price on the day of grant of $0.59 per share as the grant and exercise price, a five year term, volatility of 132.31% and a discount rate of 1.77%.

X

- Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8

Fair Value Measurements (Details) (Fair Value, Measurements, Recurring [Member], USD $)

Dec. 31, 2013

Jun. 30, 2013

Level 1 [Member]

Assets:

Cash and cash equivalents $ 4,414,572 $ 2,899,927

Restricted cash 181,181 181,149

Level 2 [Member]

Liabilities:

Warrant liability $ 23,000 $ 104,000

X

- Details

Name: us-gaap_AssetsFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13433-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13495-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=20225523&loc=SL20225862-175312

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 55

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=28370219&loc=SL20226008-175313

+ Details

Name: us-gaap_DerivativeLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. This element is for unclassified presentations; for classified presentations there is a separate and distinct element.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RestrictedCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 101 170 1 true 30 0 false 5 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.isoray.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - Consolidated Balance Sheets Sheet http://www.isoray.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.isoray.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 004 - Statement - Consolidated Statements of Operations Sheet http://www.isoray.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations false false R5.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.isoray.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R6.htm 101 - Disclosure - Basis of Presentation Sheet http://www.isoray.com/role/BasisOfPresentation Basis of Presentation false false R7.htm 102 - Disclosure - New Accounting Pronouncements Sheet http://www.isoray.com/role/NewAccountingPronouncements New Accounting Pronouncements false false R8.htm 103 - Disclosure - Loss per Share Sheet http://www.isoray.com/role/LossPerShare Loss per Share false false R9.htm 104 - Disclosure - Inventory Sheet http://www.isoray.com/role/Inventory Inventory false false R10.htm 105 - Disclosure - Share-Based Compensation Sheet http://www.isoray.com/role/SharebasedCompensation Share-Based Compensation false false R11.htm 106 - Disclosure - Commitments and Contingencies Sheet http://www.isoray.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R12.htm 107 - Disclosure - Fair Value Measurements Sheet http://www.isoray.com/role/FairValueMeasurements Fair Value Measurements false false R13.htm 108 - Disclosure - Preferred Dividends Sheet http://www.isoray.com/role/PreferredDividends Preferred Dividends false false R14.htm 109 - Disclosure - Shareholders' Equity Sheet http://www.isoray.com/role/ShareholdersEquity Shareholders' Equity false false R15.htm 110 - Disclosure - Related Party Transaction Sheet http://www.isoray.com/role/RelatedPartyTransaction Related Party Transaction false false R16.htm 111 - Disclosure - Subsequent Event Sheet http://www.isoray.com/role/SubsequentEvent Subsequent Event false false R17.htm 303 - Disclosure - Loss per Share (Tables) Sheet http://www.isoray.com/role/LossPerShareTables Loss per Share (Tables) false false R18.htm 304 - Disclosure - Inventory (Tables) Sheet http://www.isoray.com/role/InventoryTables Inventory (Tables) false false R19.htm 305 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.isoray.com/role/SharebasedCompensationTables Share-Based Compensation (Tables) false false R20.htm 307 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.isoray.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) false false R21.htm 309 - Disclosure - Shareholders' Equity (Tables) Sheet http://www.isoray.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) false false R22.htm 40301 - Disclosure - Loss per Share (Details) Sheet http://www.isoray.com/role/LossPerShareDetails Loss per Share (Details) false false R23.htm 40401 - Disclosure - Inventory (Details) Sheet http://www.isoray.com/role/InventoryDetails Inventory (Details) false false R24.htm 40501 - Disclosure - Share-Based Compensation (Schedule of Share-Based Compensation Expense) (Details) Sheet http://www.isoray.com/role/SharebasedCompensationScheduleOfSharebasedCompensationExpenseDetails Share-Based Compensation (Schedule of Share-Based Compensation Expense) (Details) false false R25.htm 40502 - Disclosure - Share-Based Compensation (Schedule of Stock Option Activity) (Details) Sheet http://www.isoray.com/role/SharebasedCompensationScheduleOfStockOptionActivityDetails Share-Based Compensation (Schedule of Stock Option Activity) (Details) false false R26.htm 40601 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.isoray.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R27.htm 40701 - Disclosure - Fair Value Measurements (Details) Sheet http://www.isoray.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) false false R28.htm 40801 - Disclosure - Preferred Dividends (Details) Sheet http://www.isoray.com/role/PreferredDividendsDetails Preferred Dividends (Details) false false R29.htm 40901 - Disclosure - Shareholders' Equity (Common and Preferred Stock Transactions) (Details) Sheet http://www.isoray.com/role/ShareholdersEquityCommonAndPreferredStockTransactionsDetails Shareholders' Equity (Common and Preferred Stock Transactions) (Details) false false R30.htm 40903 - Disclosure - Shareholders' Equity (Schedule of Inputs for Fair Value Model) (Details) Sheet http://www.isoray.com/role/ShareholdersEquityScheduleOfInputsForFairValueModelDetails Shareholders' Equity (Schedule of Inputs for Fair Value Model) (Details) false false R31.htm 40905 - Disclosure - Shareholders' Equity (Warrants) (Details) Sheet http://www.isoray.com/role/ShareholdersEquityWarrantsDetails Shareholders' Equity (Warrants) (Details) false false R32.htm 40906 - Disclosure - Shareholders' Equity (Additional Information about Warrants) (Details) Sheet http://www.isoray.com/role/ShareholdersEquityAdditionalInformationAboutWarrantsDetails Shareholders' Equity (Additional Information about Warrants) (Details) false false R33.htm 41001 - Disclosure - Related Party Transaction (Details) Sheet http://www.isoray.com/role/RelatedPartyTransactionDetails Related Party Transaction (Details) false false R34.htm 41101 - Disclosure - Subsequent Event (Details) Sheet http://www.isoray.com/role/SubsequentEventDetails Subsequent Event (Details) false false All Reports Book All Reports Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights had a mix of decimals attribute values: 2 3. Process Flow-Through: 002 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Jun. 30, 2012' Process Flow-Through: 003 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 004 - Statement - Consolidated Statements of Operations Process Flow-Through: 005 - Statement - Consolidated Statements of Cash Flows isr-20131231.xml isr-20131231.xsd isr-20131231_cal.xml isr-20131231_def.xml isr-20131231_lab.xml isr-20131231_pre.xml true true ZIP 49 0001144204-14-009735-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-14-009735-xbrl.zip M4$L#!!0````(`%J`3D2)OL160FD```V.!@`0`!P`:7-R+3(P,3,Q,C,Q+GAM M;%54"0`#?(3^4GR$_E)U>`L``00E#@``!#D!``#L76MSXCBZ_GZJ]C]HLV>F M9JH"L>5[NGMVZ5QZJ$F';)*>RW[9,E@$G3&VU[([R?[Z\THV8(,Q-M@TZ71/ M306P)#_/HU>O[M+;OS]-7?29A(SZWKLCN2L=(>*-?(=Z#^^./MUU>G=G_?X1 M8I'M.;;K>^3=D>4A>^.)E$4G)ZK]F0O+D^GZX0.$E)03_GAH,S(+SI_2DO#4X_1& MB_"3:.KFPC\J(K1L6=:)>#H/N@(E%Y0_G05UR`*#>#\CH^Z#__D$'@B&'4GN M+#C&K/-@V\$\RMAF0Y%R^J`@"BBF8MDH8YJ$2"-4D00R":&WG,X?Q`XO/.<<[%J`6_>P<9R=CJ1W%"E!NNZM M"]#G_BB>SH/^\9UD#FK=8#GSQJ'RUU1$>#Y M&U?A)ERR-E'XI`VHZ>,\X-Q;5^'>0[',H>0_-`Y.ECK_S,/BKUF@N?`B&CV? MP>^A[?8]ASS]0IX%K,(GC>.3X)^!3<4T$I2%;UV!ZT^GOG<7^:,_[R9V2-@@ MCD3-![5A%GM)L*YFZM)Z(C;K^./.K#Z4])7@/$+LT20T$ZD?(8>,Z!3(!S_,YDGN]\9SY`X80/KHE@1^&'%% M`7-@>\]9&CD(R[AOR0-ED']>=&U/209X_D'CR/O,O[6?CU'?&W6S8/.O3=!" MU7=ZYMJ,#<:_V2%_-@AOZ<,DZC,60VM(5"GKGS>-?:,M:;IJ&HKY]F0#\$KL M^E[JFYY(.**,W(1T1.9!61J6;1*A8C+M:?7I[OS?`0G__9B^,:L:!M_2-?!& MP2J2V*#K/0FGZ^7B3SD3K:M@Q92ZLB1;&\4P.UB?B\&_64D24E$B/]U@]6,) M5XZ@00IR$Q3DG2CX'O2&(CIT(]:/]1*?Q=/#H06=I0H,^((," M%274ZL9*\&H2AAI`-I0=&!>D,;?C(`Y)UG95;KL2]$Q2.>JB7LCT(?09NPG] M$2$.NP2K%1&),M'&-1FBMU2=H'9K2H!PS]2/GD]X]7=Z+;V%ETLD]>E+S6 M]O)"&[E(7NN;O'-Y<;$4%>3%.>O%A;SR]O)FK3_])N_<]VXE[P;?^TW>N>_=4MY2W[L/>6_L9SZFQR[] M\)/GD/`QI'S(YI(0)E@*Q38%VF?[7C:A#Z0GS?M-N%9IINW^7$9>D0?;[7E. M;S3R8X\GZM:594B;):TN2"[U,/U=0DJ8(<.8#5 M-!A$$Q*F,=A&"7*A]ZF`+JG:9@%R\#+\P>$1,<,[&-_ZS[8;/=_:$8&4[*%+ M!AXXPCO;G=&O&)C[-,Q;DR;4](HL%XLP'S-?U.,02RJ,MW;H0PQV0A`Y5:`B MPHP`H?^9\EER\"JWQ(E%E3`8G_OQ,!K';EI\4O[5PK8Z@+F4^>#T327E7@U= MV]2QM)EZ:4.CLB=45,/8DCJO(YT8+&*<'2[*-!`&XS$)P6'<<[NY!_SOW=GP MUY9Q&Y^^^-Z-WORUTSD?G-W_<7.!^/(%=//I_57_#!UU3DY^4\Y.3L[OS]'O M/]]_O$)0F-`]M'$8Y=K8[LG)Q?41*FA&W-\F2R%D'CG]V(DR,;M.Y!RA3N?[ MA^@-Q^#0S_PCRGQ.H=U%=AA=AO8#]TI)!!$JXL(@%CV[Y-W1;_WS^Y]/D2E] M]P:]']R>7]QVS@975[V;NXM34,AU[8"1-^AR<'U_BF0IB-`]G8)#NB:/Z-:? MVMYQ\L,QN@/5QZ`J<5T6V".QU$5*O@>VXZ3?%RC"&81?+V[O^V>]JT[OJO_A M^A0-_2CRIP"G=_;+A]O!I^MS#FEP>XK"A^$/6%*/L:8=P]\?,ZDYL]0XTLY= M_U\7"=PW:,90!8;W%[_?SU[S?S'42>-GD888ND1!:E"(6P,*XJ%+1\A/S8F_ MY21R:KP1?R?2_MZ>!F^\(0O>U$]"7L+LDG$D$OW?+=+"2XF%?)P^D5`Y-B3E M6,-&@Q#1>N(G4;B3'3Q.:$0J9?ZZ#,^V8)%#F?!0E%]&/36;95T5V7>Z)UC6S/0?:\?8U(TKKZ.C)1/89NQL%EXN[E+NT( M?$V9I9K'T`#C_!K65XBT:FIG96%;]D^5])& MRRRMH6M#0Q%21,QWJ5._;FKH59G*]0?]&/J(N^FSCLB=3[_"LWX"\_)-^)%L&RS?_8EZ8UMV4%:],YFBVDNG@(: MVKS7,5^B6?PHZ1^I6-=PM94FZ[M8!8GP%9L:7\4KI>NIBD$T@E]I`K]2B-_H MS-9)M(A?;0*_6HC?[&"M=?Q:$_BU(ORRW,%RZ_B7IQ"VPJ^OXM?YW(5LM8Y_ M>?IY*_Q&(7X^Z-0Z?K,)_.8J?H/[GRKE-]U&H22-A2&I3@EHP(_D`,3N'-K,#5E2+077Y.`XZ4CWC4V=OG=F M!S2RW81$\;.6U.^S>2_ M(O]2*FN>[G,>3M840\[26H.I*6+[FV53):S6)^9"CXYO(1;+9M[;C#A\5Q#Q MF`B<7590+6B2'S*&OH'HH&V?HP5IE-`W+9S-UDI8]R"%55V*DA5S]:105;[! MX-"DP(4T:A>'>E)@2<'F`6HA5]>B9"E:/2V@JZ*KAZ<%[X]IAK*KMRA(HZQ^ MLW3M`*6PJDM1XBWJ2:&H)CX\*7`AC=K>HIX4,C3?#M`LH*Q7UJ+$6]33PC1D MX_"D@*(.37)M5V=1D$:I66B'*(5578H29U%/"M,XS)9%125*?44])13Y(-VF M7%V*$E=1LWQH6#D\*?C>(-70=W45!6F45J:R>IC=D,I:E&W'6$(* M:=3?9%-+"EDWU0-L>O,=,E6U*-L14TL+4\4':!9[&W_29,,\0%-8S&)MZ1LJ M#U,IJG*`^;^W83K-,,Q#;$/)5?B7.(&J_+%I8GUW_H]\O\RE'R[O'%C,WN2F M-.K$:'N.`&O6TI!496C[UJ'-*08%:[+6C`Y>1!WJQA']3.[(*`[%-.O%T\B- M'>*D2YJ".+*3S287=NA1[X'=D%`876_*7Y+HTT1*:3=5T\$TC%U6&*PF47*8 M%"AJZ!)XEVSSLPDZAZXU+A*J?N>OIM:RI1F2HKPRK?G,CLD/S=O)KE>3*-<: MZP8_2_"5:8V+A*H_75)7:T7&KT_KO1WY)QK`LJ8KIOG*)&ZI@5TH,?0P3-F0 M7IG"8FR<[TK?K=&QDD2YUIHEY:;27H/2N$BF+<:;ORE=S:9W;7"L)E&N--2! MLFJ^-O^!BX3:]3"B"M+O=%;.7$[&""0;T9#P-4^#H4L?!&&^D)"L#(M4#;W/ MD4%%5W(C(U4Q[DN(O0V1*0J6Y?:$8->^-\H.BE0(V/*8D&%AK.(*E#.0VF7; MYLB/B4U--W=FRQ9\6-OY(VF:HBT73K895*LRRJ:AZ\M64PCJ;-D`]K5#1%45 M79>6(1:/XFU$VJ:8FH55;36'"Y&>V6S2\QS^Y^(_,?ULN_PLIUYT9H?A,U2M MO]ING-Y=4B4D%]6HP`PO\L"HP0SK!C:R_K02J-89MVAUV+0L"QL'QKC5;4BJ MG)]M/PS&2@7&F3:"4HNQ*AF2T@+C2YN&(O`Y92/79W%8QKH@=&*N6%;,KFQ9 M\$F29?ADFM4M?6WDW:V^`/"^5.%'S=54)7_>W!:J5"P96ZJ2W##1]Z`=:C-R M3I*_)<(41]CO_A=9U55MDR#%0/>KR?ZVSABZ`66G$4V*;KC8^CJ6S1>P-%J/ MEMVY(G>53)-]&[1?5JA&J]_RRVFRZSM>GE"2M?$RFZQAI0>A2CQH4;QZ=_J\ M>-G*+M`IDVTYWFN1#;&RE9WT4R;;VDL&RF13N&R2JGP% MNI6=,%2FV]J+<5Z);F4G&Y7IMARONG>SVJ]+K^/ID(2#\6*"\XS?9NJ\?[ZP M1Y-\V/4:UDFEQ:;PFJM`H><@;W)X=1CL)&MUPZR>1HO-Y#62RAK6NGA3J:[. MH(*DRU<6;PK4:"=^G0S+JU4W@6J'9W-]\#4\5U9`?QF>DE%X0UN569U*-[LM ML=8AKO3%,USTG#WBR6=W)Y2E?3R[2DOE;12Q[QSTSLOEK2I%]_DN,Z\ M+6'>/-;+):U+4@WSQBEI$>OEDDZ]]^H=;]6\=X6[X99)*]K&]O-^G'=%SBO. M^X5R%KZ[,N<_](CFGCKNZ#\L[[A?)N;VI MA'6Z[OE@_'=C0]=KRO4N_@Q?SJEXF!=QI<(^>)*,>*- M:'KW:LGS@J&^DOTU6RR#;60KS6X$E\?XJA&LNNJU;8*+Y7_YJT3K16EZ/=_7 ME0TC$MB0!)IX+50#KRXC1QEOO)P3Q3:.V]XPH0Q%\G?BN0T+DCT$N1/CF M4D8_$^2F,D4^BN'/B(2133UT]"?7<^(_\JKW,W']@#AH^(Q\C_`D>()C/^8W MJS*1)`I"`G4T8
5I1!@#/GO0USO(S2))_O;(?0[!I@B[M*76?P?N!$,>0 M["R<:`P(T3.UCR(^J`CXB M!+_([M(>17[XC));V,5,-R!@P'],/0A*DZ#S5QSS].:\@M#GMV$C)JYE1^_) MR.9Z\AA)&#\4IO`WQ7K#`%%BN$$`#Y-["![A5;$;02LG(J"`/0390&T'7N/Q M[TC^+ILK*S2VHQ!"10OU[`P)^`B0UT<.@#A&8&WV0R+GD+@4[(";DAWQ1$#: MB0WV,R3$0YZ?YP\O&OEAX/,KDZ`-R=^9@<[M0:0P]B$5B#OC`AGIQ)!=<>.'3?S8!3/F%D$=),PWL9^%W=@L90>_0F3J MB8Q*2X<(FV&2ZCF.([Y!XG6XE9DUSS(D(\>$FQIE01R!K2V,)V/WHA7E"7L7 M.46C1&?(,Y982D[@+AIX`"B(")_?1U@[1M!&-)+K@!^XGX*$!F#S_*DB)T^/ MX(3]>[XWI$G79DH@W51;PPI(7M^]THV'7X7=Y,9D=LS!O!F_ M(5PK>RI$]5.PW@LEX<3?R0_I=;?I[M\O/]++51 M)/&OD.(RHB:IM;ZZ1K:P99D*MIJ@UF;:/W%)473:U[$T':\`TP:;U M#%),5;8@XJYL5@;P2@(<2"Z5#M?M0NX0,JTE4C54!1 M1)**HFTBJLJ:*EGFKD0S^]"7?FSY6`%AA87@B_:65P3!A46-9\C9WS5P=J4-E96 MNI'CO@%W)3$2YUFJ1!HD@2]+IM&,#&M3VNA=EH\R*\==)$-$H5M_`]UM$H;$ M68GS*?"]1:(9;6K%2Q9Y+W)[8PG.K@POB%:B"]]99.I6-WOZ]!:(EZ5BT6#\ MP?<==N>[LY9`[K=][O+'6-4U)5=AYK!L!7YO5P3(T(B6U4;![^TL`8QER5"E M9L'OZW!^6594R51J@;\)?>CL1<^W)+!IR/ON'VTQ[,7GWC*$2L,E]JW)2E>% M1L(.!60UB;(KH`V\DE&E,-ODCXO`US]OL0Y_T])WX7^>.LKLA0T]/H>>C-O] M1J-)']IRGZD3V^[\A!6H=I:[3$TDQ`U`K^1=K8ZDSHV'?]-6XFXJXYJL981K M`OZ!*UMR/EF9LOI*W`W*ZI:DMRML$,+[DI0\9^4FYY+G^ZR^%=7"V=57);": MY+>_$SY-4\YNTZK!+Z2?;7[2[16UA]05F_529@5/YD=Q6;LL.(FV&7IN#`%6R;#T[ M-@IID)P;?4T>T_MXJ/<`K00//HZ$'X;XT1\DZCE^$,WKG2UB?ELV57'9%`1* MEQ;)DO3=]FNHHB^UABJ=$&YE#15N>@T5%W-AORAOP(>ZABK'8$GG);A[FOSG M!]&+^6*Q+@/^'B,/$K`7R@8Y99&8ODR:LNDRGTO*>R'4=K/Y<<<'C.W08>B] M#W_0#V)5P67O[OW1CXBO,^#K,1";A^(3WCS>T'?H;,4'?Y6=NB]X5\SX.HYT M@0(+P)V.*3PAXS$9<=P+OKDN82QY`V/E)'9E#Q?=?-(9JM*1"IT"H5, M+"&"A@[0^$A=5_PL%LW8?(D!2`U"S-+UD!^'W%TR MWZ6.6*TPGJL5^(EGXNMU6.Q&@AOOYB6G;(OU$".;3=#8]1\9B@,^P<_EX,W" M9F;WMZH0EFJC^2J`P3C;([@E+N?+NZ]L<8O@3;)HB^77\>Z8QK<:ZK744)6K M&ZWIZD:87T?8'\J::`,US8M=-#;V^>V08H&5,#OH+3)11P@'+01+%C*.,H(A MDEYT`1[7?_#$*@HG#F+M:$R8H(QKN[ MIP>Q2"]7]E*+M7@Q>S^X/;^X[9P-KJYZ-W<7IZ"'Z]H!(UN4P*N+R_NT(#11 M"(=^%/G3HB+'D77N^O^Z2.#E2QVO*TE8N;6XE-:V\0HQ<#%!`^_=D2[2O1<& ME!A.ZXA:97(W+P!-XWD=]*7@'Z`6^)L6W^QB[W91QV,!H][9+Q]N M!Y^NSWES;/#_[%UM;]LXMOY^@?L?=(,IT`%D6Z+>BVV!-$EGLDC;W"2SG?FT M4&0Z%D:6#$F.F_WU2U*2+=F2+-D2)=O$SJ*QK9=S'AZ2A^3#AP\?./_E^3T0 M9!XH"H_^_;52JQ9G=Y+ZKG@(@T>M>$2?V4-3`XKX'>#=_N67#/;>%8R9?MGC M66#C83[>EAV!)O.R831HWF:J?:JXB0(OJC(#KC9P.F\`D>%6&S<@\!+0Z0!W M:/N\G-HAK)UJIAOB!QA`T\?;JMQQLN^5;-6*9R+:'R8635D=^J1UD4J\K-?I M9YNRI[^(Z+PF:@R1%"(J;Z@*0R2%B*CQLM0B))WDID7-8+1]'+>!,]/_&Y+5 MMA-J`76M3NIY!K'-*Z#.*/0<$-$4UB-DLP:QS:R!7NJ7,VU0LK;X&W2A;SJ1 MX,!X9KMV0#;0O\+Z#6*',RX'#EOJO"HSR%>T`V=T&G7CS.#7>1DP^#N#7Y)Y M4:XSY<#P;Q1_4>5UN.MEX0UO44-Y+F0 M=(@+-T4S+*`A$HXQIK\'6%H@[CTCFG5`9.%^D0&O`C61.%S=LH2XK.%X8+ZB M\>0+Y.;D*'K.0Q]CZ;=("@^_RXI?\IQA/MI$I-'W?B;2AL)0!]P;-/W@3)0' M$TF_>*L3@@#!\6J/L;)CJCPR99=H/&*F'U8$Q2J3+B8@X"'\W#'=&-77]2:% M:!<"#A4;P1]Z"%_N>US&+UA@'";2D42!+]YE$#TK9O>'T"4EP\U,5%R+&9&P MY"/AU>@@362Z;1&34.BALC9#5&/-((ST)$W;CZ=>N5'PU_3<\D_L*@VBW!@G!(-('Q082B=`T"$/NB^HJ=B6EGR)"+0F95=7`5ND"T/BU`=7*Q;&/HFKA0#![T7RYBB`"?5(:HW MJ*P"&_D10/\5(Q57F(D778!+$._Y6&(S3S_\+[E@,4,1\8;+=;M`8AW2[?`H MI%;'H9_?))*F#/T7L;8#QID^*LYTZ\_:)&[ME]@QAZL;N7UK]=BN;O%!;]G$ MZ$><\73MU)G$2J_9V*<).:N>73O5#727T1"N:Y_.I);UJ6%CP7I&U?R!G(R! MXFGM`\:J>Z@0X? MD>*;5K@PG:/VJQOT;A%XMAO85C=>L2;WH-*+%U2.VJ=ND".GNAVU1]W@]@3] MV5$[U`UL1)'W!)O8C'Y35TS]Q(@FA@W,$^9)9Y[0H+VFE10VZ4]@J!1X7[:UWQ3G]IMG<@^*S:` M8RDY@X7!GTNMEH=[M*.L ML(^K0@.E7(2JT['1!\T03CP46"8 M5@$BT,0:./%9[7//L2U\+"]>AB2'\Y(#BHD&"OD.:Y\$D[?8CI490?1@.]E0 MD-7<@;.YX[U!>*CUD3Z4*/&ZJIZ!8DTJB%2%%U#IIV5K(N&>M9X2#A+7*[VD M?M1AU,F)R?/H$&;G[;QP5P2"^SB6L>*RND'QZ=7X+&]5H^*E_6BJ@?8;M-UX)1I25269GZFNMEKN4+\GZ3^TPZ ML4=KZN%C#V;>&#JX$?D%=4.B(G`($,?^3Q)[&V9G3".AFN=Y['+T>VJJ+0:+ M1T9,,.I$,RS2"GOU'!._."1/%B4PE,1WD0XY.:4<'[[-^;'2ESC4E7?G%=QB MU*BL6N?BX":'O)*2)VI7Z%WF"SFK/!L5:J5X-GH8SVK%>%9Y0U#W#6>#:CAK MVE8X[WMN_6$'QF^>8(_E!MUQ<._#"419Q_@Q7)],G_M;=&J\(@!CJ(B:=,"Y M\SG/6+AV](`_'J\ON#&T[)GI!%B<[),HJ!)(PY!K71/N@5S3\MP#&??`RCT@ M4''OQO2QGD-P#_VDQ&WKTAU?V\X"9QC8S1W7)&4A'%".F;O3+OX;U;!_DQJ6 M=A9IIYX)T7!"3/(M&ZX^%5)J6.,LLG%9Z# M<=U-Y9THB;5,QUI$FMK/;RAS1-T^3E]=&&)=9V\&N?@K'B,AP*QT'&BS,TERMQN(@:3N0L-'=8;`R,]Y;&'OG4]\F)G,8;D M<3;*]RV2-..T?^Z%6*C8=!QLJQ,-K3-C`:QSC-)]G',.\6@A]Q<^?@7V=&GZ M..V.CN=+1@7(Q?G"MZ8HA:V@$XW,]_'Y5<3J,8<;NV@L$&,;R0I/(1D,H.$( MG$R@1=3)T8OMQ(\A=YFS/3(U\;+Q2(S)..Z*MD"/,1[;XPRB\R2;2PS/8)=` MP7.>OX9B:H;$OS3VJ&U'+PIM'`ZVFPH(\APRG/$0=$MOX8RQ['K:3VZ\@*M9 MDBU<<>`YI-9Z49-\!J/P1V@M?.0LO@Z54`#)_!R>L4/_!8,8[&CXG0&:B'SS MI(3110'*V''1QN+5]4*%YYX785385E)JJQ*+GSA9A(MHM)HK9J"W]O)F.U(!HM:-W__J6VH::.S39+UK2NVWS^7^< M8O!"K=/`6[640=AR-:I^E.Z.^G*]=WWI+QE6XD4@\K)>0C@[0XKPH#U;.ND4 MB@+[*F_T>0+EI_&JH/":5N>TVM./:I$W%(T7I#H)9%\V+M?/T3)3J9E`]W9) M=59YV?Z%T_^3ABM(4-4OC^,_-I-R$8B@BR+H5?]T4LTOVXYUM-NQVNJ6HI/+ M5Q/[ZPG?8#4CS9K(HB921&,71>4E76?=5%=E(/,2T'E1JS-\;/NDYSUY=874 MB@U^1LS/C.EV=[;YC%F`J*9>Q:Q]PM/8==50$802OH89#+Q)3-A0!Y*P=?DN M-AG09-%(.;?+GK:^3!CO].Z9;?O/"OR`R,CG9^IZ<[/O%\^.O\'5B!C$ZKVR<$W1O?`7J]3;@ M=-RA5'J$9YDNNM93?]G-_2MO/KBAMLDS=+PE&LZ$F(SBA],"UM'$=DW7PD,@,R`78RZ+L^[`(V),1&NQR-X*S//R M?*QHG]YAXG(FY^.Q$]E:1^@YI729?RYS#L5\!<^FP[>455'Q.I("4GGX2^^[18W M'X=,5%6*\#KC^DQ/?0T#R[=))G<,TQ\%@51#LHAQI_(AS'21O7*NE_"1Q_Z^ M2@KN<%+0ZS662Y)P?:#,4WL.64N+<4BE@,FY+U:V5ZJ[,8$H2 M:PO_D=IX4@,9"O2\$EFBPF<)Q:0\F9=%F5=JK1D?+;6Q8>P`KQL&;X"2HW2. M#[M-`F>J@I-^B=OB1_6E9RJKW`\P"'V;G,Z"JS?E1K(58I8N\NC_'5C4HY)^W7M<%[S204,H]><*BQ4\M)&QU2II6?:`RL60PR6GE6M@SJJLDSP M1[1C8;U\TE50U1F,Y,<2D+#ZV]'&48-(B*@1/F8HMA*_K>%X\]RU4NI$`0^# MK#\$J9[J_Q=8)2(T\?+GK3OQ_!E9YWS"!A8P-?9[!N-RK*YJ=0GW:FJZ+T0\ M8EN$<8SN>R7%E.S[2BU"XX5U?%$L-7F\PK1M2D[T8*F:<[VE;\X_7D3_[C_M MG/>@5B;&\U[TM!5EU`T_%P!:U=]H.BKS5Y.;>_H^2^.[BK+A]6:&95IPGJZW MO57OR.O6:T#3T[69$K&)]Z*HU1P2[++PUY,&3%$:AHN=)-)$2ITH&OI9S<,% MZO']I6^'Z1_P@,@DK%&;R-#A-6ST&#+Z,*U(4\[EOENAAUM(T2`MI,BR[A:S M[IYS"C=%W0[(*IG?K;N>5)%Q5@__OM%,VD#D_>B4+=A/7!VO;]8L/C8QB0Z M?[<]@SI)5^LI]OU()NA7AV8?EM7O7T3]%X>KHZ+-=/D8]`QZ!OUQ0=]]=KZ: M1X'X]+S:,RC]S35.)O]J8&]`RVD7BXZCC@ZQ[G3$`5DY8_A09OBLEG8UQO!A M#!_&\*'O]WDQ&QC#YR@@9`P?QJLXZVK!&#XL$EDD,H9/C4=TP+&0>,6HFK0=Y^9GRZSYT2RK\.I&R>B^(6FYQ"NT'-2;@X*7K.FI83'2'W[',CIVS9>D#Z2IVSD<70&PL&=AOQWV3.LHDI'61*4C7P4NK>PA/;;S.*^'NV;8R)AS-\N.BO2;GEA_3]YKE MQVQ+6>\@['E^?/SU@&WDZ7>U8%O*6"2R2.QVUH)M*6.RO2WMZS&:GM'H+7`L M^'H7?$!7V:ZRXV@8]->B[3\I/=T/9J>1=3"J:14>KT<&DHD^8T\.DHAFGIP_LEO/T M^KRX#(S3GQB.85._1L"IJ*YH>+7`L]OH6 M>X`=`G\"<\,G(C?6*)^'T7E81B9AY%Y>K>VSJ!GT#/H&?34H.\^(3]= M,L^)9%U,'9K%1GNQ<9+JT!64/#,Y.=.";ND-3!2W9Z*X3`N:A?T9ACW3@J;R M5B=_=9]+EO]3_6K`03N)UQ\3_!G^-GQK+\__>__<-P_DH?] M!EWHF\ZE.[XX"3 MCQ<3WYL-<&HQ$+2!(`Y"+_HD@H$D;MV+[UZX=G3K'X_7%RB-L>R9Z028S/I) M%%4%U8^-['#R*_U9YHU<8!*#(CIZ%S; M4NZ_1:.P"`I"K-^GXSFSO>&X0/T$&Y M>(6Z47P#U2174M72%J383+J(4(L.0]1+J\7^@-RZKVCLY?G%"*2NH!D$0-!4 M4.9SRJZFG:17ZV51EDI#O8:7W_&HO'(W6'`UU2(6554O<[[`1EI`T!O\29I2 MF@,<`L35PO=1"%4$8OMJJA$A9R8W*MM("PAJ$=$J$+4[P1UW44X1974G,/OW MAVT!1*]+D8"T.W(.!&B=@I8BDKJ,[M2,+.WN5U+&M>H!!Z-L6:GVNS&!:@$SV(II!(Y4"D+6K'5>.0UX0VOZ7E?;=X9:Q-'P96/:_V=@?W!MY^-%B`91S:X" M_)PY;O`!O>#CQ30,YQ]&H^5R.5Q*0\]_&0%!$$=_?KU[M*9P9@YL%Z^46\B" MT::/T4#_[=H.+,<+%OYZR3KVM/B"IJO5IWAY_OK[U=-?]S?<-)PYW/T?G^]N MK[B+P6CT0[H:C:Z?KKD_?W_Z>L/*<)W:G0FY=0&[,\E]CJA+%1A>N3W#)4;+>(_8EY'Z'ON2_X MDQP1--9?%#^[R.KL`U6E9M MZ-TP&;?C0:VWIY4_F$MN9B(/;#2$J(%+3T5%2H[=%E6=UR2Q00-/2HZE%#F- M5S5*R'6__?.'Y_^-U5CFOF?!H'JEZ._>/B`"7@-J!Q;U%Q/14'@)M"A=WHMM M?N7"&U\P)7B*1DDOGC>NT_J?V1YX6>9UK4[U81H$S>(/>$73:./??4]T4@UN MIT9U;T&7L!Q!5Q3M-[O&6S2A.H\I+4Z,CU^/L@&K@+"NI[ZHQ] M&N][-B;N]]S<6;;*5;!@EJ2'O^'L,+M4EOEIJ`A"R2*9&0R\2;Q*I@XD8>OR M7?LX`.K\C5 M]:QL%52@2EF.]VXK/=>*J)T;QJZ^;QM9U=`4/<_FE06'F-XJW'N;_F`NOR93 MC%GCT[^TC+RH:FIN3*=M.-2!-O$755V3]G0`3VEA03 M+5Z7K(NT?**W>T$#U'RBM;M;!'I=GS;W#61W!+3;B^B&**:V`102_,MM;+>C M,'1=UNO9>.F.'T,T%)AZSACZP4UT"N*&X;D7M8RXAG)125%SOS+U=O$IEB-M?MUU2!M#5_+"[RLL/Z]C=*ORR!O3\*IUK-QI>8,(V MZNE?[3$-Y4P7LZDNK=!^C6Y'5MKN`GWW?0Y](ID4-0:'/8(N M6U_5536%SF&F]P]):GVW!`Q9U@RJ2$;=Z4%(5GP$W6UH*KIW)Y`5+>\?D!3W MMDFR(5(%,K[\$"`K/H)N1&J2+@A@)Y05;>\?E!1C4A&!8:BM01D-+.Z\8(7, M^ANZ&ZY%0],U/>/HVI3:=E.3.S.`:FB@(;,IZ@")J/FQY(?#8#V]KV;/<]=*N(`0RE,-9V&]L).A0KHJ%* MPE&!0[.Z*Y(DBL>%#LU&137THL:P-CJ>ZR6]J93J^;9*N&-?XT2DZUO*0N- M:6K:E2UK]G:!6OT11$%6Q19<2JB/Y<.F.[WT80#[2V&A/5H-;VN-P^O$"RW=4U-AH2$XC8M`^_75W\X%S\=$BSFH#8215L+IG M+70A5E?4V'Y\CJ`&'M20\U72`;SC%57$-8Y21^-I"CG30BW*W'3?L&:&M:KE M<,Q-DDJ-3$AJ-6?ZD`NG7D#.I;D-O`?SC>=0JS3DB;:&C2Y9HO&C\S;PEBYZ M2+!X#NRQ;1+EX/?1#?C`&ZS5<16]^-3=Z`:F&IA5->$_-5\@]0^ART+%GR%QLMNVFW,!GYG!7T`]-]+4YBYZ#_L2O MG_NVYP_>H.GGN[I^N@\MQPP"9-U_V_O6YL:-H]WOI^K\![R*4V57010NQ(5. MO%7:E=91LKM2=N7XS?GB@L@AB1@$:%QTR:\_W0.`!$D`!$AZ9YN:-]WL'TLC8,?L:$X7),VM4S@:KM<3\NI6#)N+AW1<\X]C[N0R<[2 MM($3B!9HSIA1WO+TIPWD!;813,Q0?ACBN"B"1<"#[?@PWD@0Q5_%=8="`H!G M3'#@]'L^3BB#0X(AAVH$Y0\BQN]@A`MXRB88^V>X;]AS)'%:0]&"V1`U&U^V MA[>])1ECXS1!S6HX2R=<3[9GTOZ)-$C(>O4))C/,RD/XZ,V=P)H`U&&H1CR! M_A/8=);!<;V!;_0/?IZ_2V4;L"=G*Z,-C1Z8/_']#DHQ% M^`Q:%YP/8*9@@7\W-#GW71CLUJS%%0'P&E@^722=M7,Q9GM8(]F+40^<14:# MA)'9ICT!!4X+AM)\3+A.P&C'\U@:Y!6G`H4%`(J;!C!14)!9B$[@>3_LU@I[ MB=DU77AN&;@>EC2+-80;8/+9$)^SP(IHBW)'?<-I'@;RX1.WK^.Y8<\H2!I5*SH@'U":A*=X)9 M[\+I.`O+/5ET<21+Y$BT2J*2@H4-6EO2-+OA-/O%IBRDUCDLPQ<_7U\_7/R0 M8!@P=X+;[[`8W<+T_1WFH2Q3V0<3SH*?@]F<>\'F+),\HY%@^&$1NP3U:#T8 M$_)'@(7M8D0E^88X@MX`*9 M5C`,(\S3BZ]:B=#8W:J&FZOA>LQ\9M,N`,L.HG&1^$QK$M"E>?T2G0-4384F MXQ8(H:$QC1^8(=&),:;.[FLZ]>!A7-I!+U+.K'3DF*Z<$Q-8XJY6?)B6X6I# MY\R*FQ45;ZQZ5[YUD)!>)R$9MYG_2,VQIY(B"\F#D=RQ5$]:W?>NY&-(HQ-O MZ_I8ZB]URTA3%4';IF1K#,<24.O5'U521WIY`O)0U?A,$05AHP)&QBBJ(*/6 M2PY;A3R*DY%(U4_K".[0DO%`W7(1E63\8-Y(JB6J5BD)0K+.;'&B'HPWNC#= M3V],C/JS)QXL8F%2?!J,$*YJ\`4!ZY=^0VD]X+TF'42BH";3WQ\PVC;9U%S9 MIEZS"1`!](X&BJC)1V`JI8V399F42FYI?'6#98_.]9CNHN[`Y+9G)M8671H5-^M2#NMSF>DN^R(NO1%80 MLQB2-=;Z60&[UN*LV-CJGAPK*CW$Z!_YE1YW](]\8>_F-$*4"<4 M9,6V3C@M5H2HT`]#Q?9K_69%B(J"K-A&Q6FQ(D2%>A@JME_K-RM"5!1DQ38J MNL**KV1"0I<]?+\P@T4*#W:>:7+_J4FJK&6:TSM#JX76K:UE@;.'0W>:-9P] M'$IUOT]<#J:Z9Y5,-RFBT]V[#ORYXYK_Q8"P':*W'ZEM3T@5F+>CP4)?LY`U MH;>'5SVU]6S[NDIM/;9]!K5*V]368[YWE=IZ+/2N(KD>([S#U&;:5^6.)#(H MU&"!V4A^W0YZJ]Y)9%#;.FZKWB9DX;92D=YY7I!#9OASTP;$'E&&@ZJ.MD;- MA89I:]8X&`FJTH;LFC('FJ>O40.@E7G7T'+?RKSKQM)7C]R:6^XJ(N\^\'&' M/:$W-S-H3#S3L44O,;(Z2.W2&E@SJ5U;$AN1;'=6R$:DVXT%LQ')=F/];$2J MW5A.&Y%J9U;7@M1NY@K*^*UJI]+)IOQY/3SES^O>E#_%LOSDW#9.3_V#.7NR M2M1N)-W1BR?QR:R0O-'@"FW<*O2N@AP^[61EJ:/7>YN[(6.R>"(N)X[BO!AX M$?J]8[@3O`)]8[ID[#NNAPK",I"7!C>)N(D9-\*,"#1OSWMNS7`ZO^D];\N* M,]]8;]S2>*/XIC?&PTNKG)/0A/C].%C0G`'/9-417BEW:>J`U7AE,1QOG+L@ MO/^-/7XG"KPJ2X.UT/>.\X6XA+,,SXOFHFOLZ0]*R0)36R&NMB##[6CT418`Z4B.ET\-P8'- MD9"^`3IL_N0%MK4X?PXCKDS47EOS)],V/O:>>;USILBP#[I)KF:ZNBJ:)]L; MIL/F25ZH7XOSI(;`Q>U[,.7$@[9(E-KYVIXD$FDD$Q<4>*[FR2*!>O$KBRISIB0B?<1-N]X$H_@O9\FZD=$A.YY*N5HH%`,YF'A MIQ7-R*HH;[(8H3C2DE>A]XVN",F;,S\K0\!!KU9]8I1_15K3-5':QYQ]0VZ? M8_T+ZTTGU'R&G>J#98S)^D)YH4<;18TN",KF8E%DB/5SX"10X'XS+"`O4;1Y M_V,H0:60]/5+25U)'_\:[;R[5Z%J(VFT3V=L#"^;:CI_[\/DBK>OQ!V;WLH= MO^>IGB^?QU'>7!X1419&Z;).'5LVP;\:KFO8?ORDMT/K]@,]%_`A]#8G5EU2 MTJ6Z/:H=`M.3F7PA*UV=^4#-6QA1U8>2OJF8,L=2+5FU;E?DX6BHC@XAZVN8 M@OS!@*^37/TZ^Y79U$J-JS&6&0HR#D$BAD_LU$KS?KE,^> M^U$Q@%U'&GK/<*W@DR4'HAS005C1@]@S8T;"!HG[;([#/-'7#[?_ MR]T8OL%]>_/"T@]AK9.P)L/3&W?S8L[F/O?>>!J#6N`SBAI\F!NF"\31H7R8 MFV3*P0HS#J@'\'XZA?YD@=SIC-7#+#S-5+^`YW%O0%3"U/&>'BFQ-@P[,)"*/[ M">K"O,;D^V$"?-\GH7LWQ3D*O;G.,PES;0?>*KTW@-5!0>7R=,!]=@CZTY+J)B MJP,=50P`@UMN` MNX9W0.V%.IO[3N4%0:!OPD/H>0Y18BZ6%MT,KG+"?X`)YRR`-*I7<#&;FTON M\SKGN^=,_1=Z2]XNR)R*_,@E%MM"J_HW6!I`PC^'E1'`+KB>+$S;!(U)_>QQ M>4&T\9+=_6KZ\V2+>89`15V$Z[\"G!PJPV,,B-TF\OPJ&S??ZJ5P6V`>,=SQ M')J[(0!GAUIKR6*MN4\T>;0CBQIL)))LRAE8Y50V5@E5$P2Y+2J;*Y8Z$M2A MWA:53:6E$X!$HWR`[=YCU4`X;V;*4;^R!#Z5<%^NB?*OX0O'' MZS[<*"GOK#(-==)?ZRE(2:EGTX];"C*Y-5P;%GKO>AR%(A)0%[`-,6.Z]SU6 ML[PO%4D8B;(\3)*\;TSUD5JG:"^5H:2/I*0;LBRIZ&SPOH;%D7YVG(D7G]NE M_="D/04*3I&E1%&;M`$=24MS]>-UL+7U.FEIL)"\+*KZJ%9:&JLHKRE#12M% MRGA.)@'ZYZYMWYR8%CV'65?_NWT-2_/A-@U.*YI\`/"^R-XW*L,8;B%J>! M'V`%17J.EG?.2:\!&%BTT[*<%^_'3M0AWG`41&?M(^'/?^'>WW^]N?V*11,_ M73]\N_V1GI092^^`THF7GVX_/L;EQ"MP'SPYON\LTIP%8;7QN_]W&PYOTU\P M1@2Y)0NC-]<6,ACX8O]TH4;GZ0DLU3G,I)>B9TL(WR M8CU$0(\[>+(,T"'0#4>+..X1E40[QHG>*9KZPC6I>9K*H#VM^JP[>_I>$H:\ MI"@\_/N'0C,B4JRJ_N=LO^?JNMQR=5V.KFDRK MTE:S+JZZ8;O*B!=4I2LC92RL>1HEBS@77TU2YLO-P?.EFM5[?;OZV);6DI1Y M41+YH2ZT,*;N2<@/XU7!877-)&A.L$5D1\I M&B_(90S(AM%=7%?OM=$V`KTV@.Z$0;O'&82'"Z>,/7OD2EZFJ\3J+O&R)O"" M5JG-?"0IYR<"46I#!)U:GTY*_;8ZJ/9'T"9;NKHL/3J^87%+QR>V;\*GU8&O MMSJ19BHR2T6*L'=15%[6=;9,M26#(2]+.B]J9;:/E2]36_'N!P:D5N^^R_(Z MWBZ6EO-&H&T:%4U?>F]X9(+-$MNC[5Y;T$34PU'/DP'GO-\+\OY M6''KS`>Y>JI6MQF&K(?N.AJG3GUED2_2"R.S49"73RA)=$*N1,F1*"[17WNS]TH;K]$W#MS&/;*85BK<_"1`B@$3NTCJI62;ZL)4-5X.NS/K)63N_JC MW\BHCYX.(Z1%8[4VY_9)\>+(LY^3X@7#15.X:#-J059SHA9P7X*!;TO7F01C MX!D&>I9@10/^]N\.:"O'RS[DAZ-1A4W4&$<2 M'%'Y4:D8N-/GB*CQ0[E&EG3*.4TO&D6I6MS?B8\GKB>D`76MC.EY!MCF%:G& MR*E>85XABYTA07:M<=^G1]*C/VM ML5\>\N*PS)$#XW^U050JKP_+')7U-\CTD-"\K*"+?@&JS&G7X<%X0YGIT:;9 M+NF\+JF,[0VS78&MC]ZXUF1LUX#M94XE.A]J6G&P9E;$Z4?#=&E]KK"LT[4] M^60:3Z9%`UL_$P/3K4[N[:\8[(J1@^\QK\DCDIH595I!BRRR=/54[9&E82CE M$[&<%P[EA;F+_7E&:NFIB;F,\3Z"085+]_766KQAEIHPQ\QXC*5OP3K"9,CP M[11PP3W36G68/X>FUE MX'-SD[CHF7J#B0VO;>3[GM,ZOSYQ%YA:+4S!C+0X'#'0EX6D;E#Z!AWX9.:X M;X.$QNS9V(S>$&_LFLN^[#PS@+2C]:NTY,XCD='&$MDIXCK)/MKLWU9& MP2&%[IX!-MH.T1.[2[9IT-)Y?GTCG,(1K:EDI%6;#W_ MX_M4$EZHHBUC:FIJ6(_Q`UDGJ2[!F8Z&!`JYL;MB6=?>6853YO!.XO71B!]) M98(+.L^[[?#1Q`2GZQ*WXP7KRLJ4-[G7B>CI]&Y82=82U:*+//R_A1%UG"?# M_L:#U3_7CH^J/BG`L%PWI\J61NS22O=4"<=$TQLKAB'&EHY-K:,6JCQ+,*J< MO7:?M`6J,IN1="Q),M;7["V.*N2$"$JXSZS8,?QVMN-U>O?3O[&<8 MD^.^?0C+?.4ZZ_,?9G[XU5.U.G%74@AKQ7BTQDQ8+GB=^,GPBSC',_,S->EG M9JF8NN"=;:QV2W=(CJ="5\RLQB'625\;JU337ZYUME+-5^.%6QA`@6E8)^`O MRLM9HNJ\)K/D&X=P3N/54J4>>IU]XU?'_1T+`BY=9TR\4[AI+HD2KY6ZQ="M M368M'I>1PLMUWC?OP16LCWB1&/:PW`S+N!ZW*C83^-;2#>(AKVOL$E![_)=X M12L3J]").Y3,8WEJ_H.^LJ4'2U%X&]B,3_#ZI0L;N)DWE%1>+E58[`S6H";X M+BBP]C2>/Z%.ITF^LR++'Y)QW+[BI?.R.31P:_N`]_S#1M/G7,]+$UWSWPVJZ=J]=E</H5RLQB'4L+:,^\!?EBT-]"=Y#'JG`PUT^NZZ>+@SPI@G=? M+7%[MO"(C^IEFT>_$K0.R*1MHLX$*YWV$YXFR]GT;)NH=EAW_4S`^B-MTW0F MLZQ+BHV!]8RF^5>R,$PLJ-EKJEI"W6SFDIGAMXX[IB29DMP/UR\!/?YPIKVF MJAW>W;X2=VQZK<_T'O2RS;H/CNV[QM@/C)UD(+VBJQWNW0'S3-LSQ^U0Q53N M4=*+_`V]IJD=SCVXYIAIV_)\>R3NHM<$M<,V>F_L!%5L)P*(3B=-%*/DK"EI M(G0J69MW.WI$&BB95\7+J:-$J$/J)454VL1$;9LV(;.&:2,[8PMO1C`U=$5[*]W'E9?1(OZ`(OJ,S./W73;S!BYOVY MS.KAX``]RH3=KPDM*;S6J?.9.O/,-)VR)3-S#685F3O6A+C>[1^!Z;]]<7P2 M5=/P[MVO*$HO,_%,N;=9WIC54[5F4WG<2.H?I5"AF63,_V+1>?CY)9(1YR0C MW[RX),`3F9DV7H-B&^B<$5Y1Y988V(Y)9UR.&.-YHNH]SJ!33C_3VU0S![^W'9):=]^%%X'6 M$C'$TZ!V.KIT<2DU"5Q#)E-N/OQC!!KIOM:I/D7FQLM,N%BT1'N#P>Y910F. MBFJG:_M&'9]L1B9"$6N-.6PZU/3X30H_4C1>R,LUV@YYG1=5P=C/"LZ%9+UE MX306F)25-;@L*;]N&NZ]6EP:/=;*2XE;=A`*KPZQZ$H.6@MERST3(Z*W;>4&A9Q7UUN6?8,\[:U>F:K\:J@\%I>"G!V.'\*A_/"0,^Y6=>ED_G:BY'6 M>Q`)'9!%\D`AY8`V7>F%KS4]6,]W'7N6<6U M)5HK5)$L#7G[NC1=Z@#C)KGI`SLW_*R\:/M.JBH@I,VJF?54?92%[#*+:LE" M\%TO3REGEY2D9W0ZU>Q**V.KLG1FGDS%@9BS^:U2I.U4*ZNE6J52CB6)4.GBG3!0]'T`K8*@$Y)+CH;?DHNZ M\W@9N>Q5'#7)Y9!IF-Y/=`&,^(?9KA[%?W7FW7?97-\O"?O[E6-",!1NCKX9?BWI*ZZ?J^;!66LM@ M4U<-+]Z)`UF2Q=JT51I])RVX*F?2&0GNJ^G]_M$EY`X#((GGUR.VM%X:G6WP M@*@K-0DMC;J3%5EC\PQ%IFG]$]G]AL&(!X=1:>JC1)35*FZNI4*V]6HO+F5* M@=K47E(.=U\^7KR3!%T0U&$%HLBBHC;6QYDYKL/$'!7N>LKU5:F8\K9`F$BO M%D'E45>+^(AW%QU//#J^8:U*1=.I7*7LM>15*[F?J?\B M[NYGU_&\2@25TFY]UL.N$L0S20'^4YUH4@CJM23J,0I2)2$J3!(YDJC'Z9!A M&*@]DT7BQGD-RTEFZU4O_MLS0E)TO4+K+)..VH11H8&\TVHC!K*L"8(FU2*" M.@SD1/.U&\@%^VK00-:J\!&4HZZB$^N]G7XE"\/$1)\?@'>N,?8#P\(S6^FX MH^S#^ZW>`SK\M_I94F\J..@^G*IJ9V-&\M_$WNMZ-G/)S/!)#:O6P;W7OZII M5:YJ!]-9[=S=/XR"(#S2.U7Y<.J8Z>)G4:MPIE=';",*(*&86E``^WNO6P&( M0UVHPL]R+)U-"[M":[AH9XT8R9*F2VJ%V\6BQ#4MO]I-ZN.&T*"EW<#ZW8H! M7GHLK2SB!PRG'G.]]A7\`$I+*@6OU-'5\1J@NO[J.RBO,$*R.G+/2J[U'+M7 M&&%9JUR].YK?F/X,#=#OUE)(^Q7H%D8#4="U@2)J\MX%4-`OI5'XDI#VVGZ6 M46U@C2*NYZ``B3NW(,*:=OY&L>7LRXER5$O M96'G\7TW#F15E89)U^O."`X?>)U[)'6HZ[HX/&;@>//LQO3&EN,%[KK"5`8] M&4^S4E#K&XC)A)AAHLW5%5IA^5H^3>?EX_T#?;6*=)B^L\R^%+IU@S+*T`:S MR;2SKD]:R9RAH[#*TU:NT+WE=S;NI6XT2%5&A#]Z4_-/\N@O7(C$/5T5R2D; MW3'^TV@HJ_+PZ#*R%695;2@K+:S:"\>FE;R6+ID2UR4H(9S^=%*`O8RK-!U< M"PEI6\G9>V]SSFO?XT`O(JG^@KU>_,#3QD1>U82$D`L-"=D$O=P`[3:8 M9+Z)FNUAU<:W/4,5>452!I*]&`.40D-S7=!7W<]"ES`QN4P(MK^CZQ M.=@>FMZ`%L9+$LN]@&0P"0*,R$?9P,[/-PV+`[.%4KP>&TWHBB/ZCAIGE`H< MSM9H#FI1Q+PA6-?20HP9@@ZS/FK'%[S`M&VV,\HBGSXWA07P@E-S<>(9' M.?\%N/!V.74"EP."_3D',%SPW(N)'Z&KS:I*(4'P!.<%3_^!K3)*!L@*Z(SF MS&G88:A;.6.Y=)UG(,L$*3WYL&,FD[!W'(_M^!OC#FS?M+C/!A#.A8G%A@/N M%I&T0@X.J!!ZH,-QXF5\%*5[)P0R7QQODPE_$S]N70[43</*"-WZ#,=V8$_G9#\1O3J6F9AH^J M[<4)`*S.BPTH`5D`B38W&HQ&?XY'XF,08+G1P2-V7`4209'(81["/+%XA.V^ MS$T8/07SMG0SA(KF(N`.6/!$;#(UQSC+UN1S4V+X00BN[S1)Y65-CWIY`<:Y M9.S,;/._.$!DXP15\H0#BPT$C3/!V83DUH`C$P,U#SZ&6:NQ(R39L&&K#40" M4)?!DV6.X0=X%;$0RHHN!=R,QG4!<,:$3"AUW\D#C5L`HF#T(9=6+[Z9Q$+\ MT6GW"M:\3ZPW>(&7M!$OC21L<&QX*%B8PC#WZ(UTKQLU-"O+R`]M!=3(BX1" M^PGRC(Q>VA,KS"5GPLZ$P:E",'6\12A:8^1ZB`7$I&:X#A:!\55=Q%,Q*H1_H#%$4T! M:I!0R>-I'3+GV4&6VW15!F6&.LNAA-*A^W,'K!*/^"@&)#QDRH=-<=TDQ+6R M:9;0L$WM+83ADHSI"\@@8X(,1[4)/*0R*BC>CBG1.GK]91FM8V"TC8/8,`*3 M&FQH`V^2/`69V81W3$Y78BWYLX.4D0C31N*9P=/ZP5$%W6 ML8'MA_BUIOW=M,,)8RP$F-'A$>TDUMUC&TYQ([W#50IR@\A05L,7TJ8ANOWBEKX5`DE=$PWYF!:Y1J]M&+IYF?+ZBV1<*V;)2S2ZY*&+)1Y39!Y12J31+)W=2R2`O\E M/E5!:V-B>F-4=B>0D/9[45=X43LZ4_@/G4A%FR6]3V0&:IZN4F,J.91BM%L\ M#2$.>44<=DZ(Q\^[3]%YZPD):ZCSRO$U4[HQX8I69HX\!M1*+BO*LTL__+W* M"\,R);!*)"#NX!3_`AO>V)(Z@?F].IQL)>/N">[2UU[8*.\O[%V-)YKRAR[I M+K$,/%Q>G1J/'<_G)G1S95AGY9*ET6/QX?PL,"=X*!][#,(#P.MO'SA=5+B+ M&VCGV?!AI^U1-OZ-3&;`O0N>@]Z,,"H-=M+4[32V@@TWT,I;%QV812=5JZHC M,G5VB9N^2)?,8#&G+N&5J&!O+.%JB([`K'VV-Z>'!4]`B&5XGCDUU\Z+F(0M M2,PC3X=+G0?)'WUN:I@N]TRO9<1^47H>,R'H!:1L0EK6C\7'`"NB`P^'CE^] M1XU^^6T,6W\8>.*5A3,AUJ'M;SE7_*1'Q'>0$?1DF\86K9E/]8`'OUK.RV;/ M\RV_3WQ.!2\F1H%M$F_LFD];;89-_GCZL^=#&ELB`22@]K*CA>)3Q>H[3\O MRVQ`*J"VS;K9 MU''$J)N(#K4GZTUE\H>-/:YAYK;*8(K.Z:[2ZQS0`O!K3L(:V MULNI>JQ5R>@N/-9:+>ICN;7W'#W10?UV7X:\*C:9*R:PERP\TE(^A,#SF@?[ M9%9.;TFTXW\&!@:-T>MM7D!7T[#B9/1'IT#;\6D1V]8Z,O#Z/>9:=N1[VQ)LT%T:V]^&&CB5H7L7;JJH)NPC+E3ZU"[ M=KZ1PSE1JOH\J+.<8^CK'OI4O9WCM7;"F8XZ;NYN6%-Y_'>KIGL]<;="6<5Z MY.EZ=WG!\+'+$\J2H]'1,7.U7,COK_$!?9QUH8RU>F9QOY=5;GB.)(&QGK&> ML9ZQOEK6MV^=K\Y1,-E)^1.4[MH:)V-_E=E]IK-"JMGL8NCH-3K$LL<1['9. M?R)\5JY=C47XL`@?%N'3/-WG%=G`(GQZP4(6X&>E=&6F?0BQD%M_#L-<2]AJ,+6O??W"JT3UET=_1X^%J@WM8;`]# M1U9H#XOL89$]W76T,]8SUC/6,]8WQOKV+?/3C>PY$>OK^-"-LJ<<'64$PT8= M83W2"5KDJ45IM_6U-%"R-?8CK8"T&9H3Q^*DIT^EA_)/+G=%W\_.7WG$"D-' M7)WS,I4R\Y6EHV9ALX>&CX:A&M^V0-2=D9X*U><5*EA' M.!$+F:VNE;'$T M4=4G&IUE'`-?Y\`GZ2J[5=;_Z,13R3I6Y;6RTB?%IWNMC,%C%QZED^67]QZP M"V45;D;.Y'X'8SUC/6,]8WUCK&_?*#_="V6G8G>Q5-$,';6B@Z6*/N&8'I8J MFL7T="&ZY3RI/J]8!A;3TPL6LI@>%DEQUM."Q?0P)#(DLIB>$DVP5+V]B:HH MG=&TMXQCV.L:]B16!/X$SH9/)-U8I?$\+)R'@2,SFH<%\[!@GL[YUAGK&>L9 MZQGK&V-]^P;YZ0;SG(C5Q;)#,VS4AXV3S`Y=()/GADW.P9)J>%Q#8>;B<$_B>#PLG>FX- M;Q7_:OAT/<:%V<`(U6:C4:$#LDB9%]&7K0PE/D)L:R"M@.L1L#!U+,MY07Q$ MP<#!8F&XYG^A,83*"EKI2-J("\`OIJ8W!KOOC1@NG\!E?"Y+C;C5UQ%.)X%+ M^X?7\;WP&8*J!E]X)JXQ(]S2-<^!33A9V!?JOXH,J@,Z.3$Y=7:7FGB[;(B9&1&_E+`RT'-=&PR)NPH@I[E$ZWIXI<7TQ8U@- M(2K_@+<#PS@(VQJO"@JO:6)IMK>AQ?HL\1SSJ0E!"P-]U"$9%_$5]/+D=O?@ M.N6`-EWIM7/*[OFN8\]23GX2/YSLD6H%=Q.3MSW;B#-L+6@Q>87R]G5INM1A M15U8/1K^MCAO"YY454!(F[=+Z[F()N==F3NQ2X=R=ATX>D:G4\VNM#*V*F_S MYEU@&H2Y=8;)VDE8=[=,%EI<'*AH76SK,`)6&_@ M?!W,P*KF8'J>"J#SSZW:!G1W-+(($TKC=;E&9C6&XB_.<[BSE,23P;$X4-3N MXKB3BKGOV5O7E&R5W"T.A"[C61C6*)K34UO M[);=._;JQO3>P28808]8HLVGUM:`NX\785!*?_;XEG<=.JZ`<[3C2U#RXNAL.27_Y_+RUIY\=(W9@MC^Y25M"!^;F,_K=Z(__GH5>).U.QK* M=4.O8#S0/`7?YH9+O"_DA?[D<>;DIXMBCPX4090'HJ!K`T74Y($0_O>"YLB' M,7PETY\NIJZSN,04^)>B<"E*E[ZS_DL.6Q#2V@AL,VS`HYU>&Y?UT MRY*4-O:Q1%2U.B%"?[Q?HHO2NUU=>MK+F]37D#QAD/AO.H>D2T&[%,2( M0Q).*5G<>;<07$2M\/Q)'?$6HX(GC_P1@"*[?89_>"LM%/(CZU<4KKZ?;'F# M;'E%]N:[\/:[2+'>W']X_/?#+3?W%Q;W\,O[3W/-]S_ M_NWQ\R<.=AS<(];N,)$VP[JZNOURP5W,?7_YX]75R\O+X$4>..[LZO'KU2NV M)>++T<=+/_'F8.)/+KBU$D_J\.AS-+1OON'ZFUI_-P0B#*U8&4W"\K5\8,;E MX_T#?;6*``C?6>;D?]A<,R.?'$Q9T\ZT]:QDF$A<(F4K/F3OE:L-6V2CQ37B M.`JY/YTA3V]CAB9%?+53Y$%W@;'"J3P/+>DO<_S1]+S2T`#[QBX>W;MK0BLR+DL@/]>3; M8V>Q<.SH*3#UQW,.?@DL?U6FQ[3'+C$\FC8UX[UD1!6J'4[6^:$XXD&WXNB' M(J\,!7ZD2P,N@2WX!>D)A^V!)N`YVRE+F$L6!@PL,8+M>ZZ'FHI9:G=3=S\B M;P+WC:KY4.-3K9WR/>A<(4=?&]ZE,XT4MGHI"SN/%UJU92FY,J6,XICA2U*A MX:\65JG1X?^+9L_9&3W]NE+>__+M)CER6#EU>90U;-K]X:.NCN7'COH7&QZP MS/^2R<\PXSXYGG=OWZSR$X6PV?-,U19++G'BQAYGS\AJ(754A%38S:61.BI! MJHCF:+NTUF1_[]*J#5LG52Q":E*L"5+%$J1>*DK;M,*,DU1AI,&>>HW(`R9M M6B.=%C(,M#CA.5.X).&BT(697)3RW`E=DG)5;YUPL03A.=.[).&7BM`VY726 MBX)Z_"S?;21OEK=.]Z@$W;F3O!3=8NL"E]+'?,`<+T6XVCK=8@FZ,DKFTAUW@,U[Q\D>8.NO)%43)1<@*B$S.0R1`V%EJ@2 MM+T+4(*XU3Y5*[_F2+K:%HW[#4@*H4T4C?*D^CVI(<0ZV: MO^9G:]52R[S4&HG[[?=LI7J,Z=JP4BU,XI92+45BBS9-"9QNZ=1R.)7:5*G% M<;JI4LOAM!TI1AJUN+;9U*CE2#QXT8@R95Z'B3*_!!@)?3^E[I7$2^\-SQQ# M:S>F%?A1:,9AK]9WZK_K1<()K(FRK&N)8)[#AMT!KM7C0$CGFCX41Z!/^L^U MQD*!D&M#"1@GB"?`M7J\&AE<4P7X7T4S]/7)MV(-<"RP!`& M&_BSX?Y.?/A\^[J$7DF+X(I$609,=SQ''=8Y)E8 MSA*;9?@JB:^4@[R>`BQ:K:.SQ7N7GBR6AA=N,^]A8W]M68Z/8XG/*AFDBD-J MQ]MV]I!*6($/`6@MPR,N0U9I9`TUE2V&*8OAS\0FKF'!6G@]69BVZ?DNC<]B MRV%)A(F2,F0(2]W&>CYLA0V+,'U5&$U)-T/S.#I!7@NC2V&XSAH`?ZG(:ZW_ MO*:4E>,U);])7F-Z!U$]6UXK-?*Z3#:,GJY(G?$OU+0R41F61!4*NA54R9*L MBVR/MK%'6V'I%]OLQK:_=Y`2&*12MOT,3X?@:3Q%4S(Y".P`J;B,O#IN>0_$I9&`[]_2&SAXXD-U;O98%G/2IY@3J?P]=JE% M<+&8DY[%G/0,7^QHJ/M'0[V#%#L:ZLG14-^0Q8Z&^G8TU#.$L5UXIW?A/4-3 MKW?A7>1U3N4;=L_\5.^92^6/@UH%(KMGWK-[YGT#&+MG?A;WS'L)2W;/G*&J M8E0Q7_T9W#/O'2R9SZ]//K]>@8OY_'KG\^L5OIC/KP\^OYY!BOG\>N/SZQ>R MF,^O?SZ_7B&,A8.?0SAXWT#)'-'==D3W"DT]=T1WC=3*8"D2;]58,KQ+9XKP&5X*$BU M_5(EI["J^T`5A"&>P4JB#O^0VN17-1,M>/+('P$>93W#/Q[?EN3P\]?-MIJ= M:IM8$!,:N'(LK.\[21)S/G;8^9C`Q-8EK08PH3-,9&#BP]EB@I5/[*0WN%5, MR`P3&9BX/D],L%3,G4W%W"XHF).K@XF4VX4$^X^&C:ID\^P9YQ_()UA3;(]#<312!]@J`-\TO5>(\OZT^_@WZP%LC;Y_PSLC!Y^&K]N[L9>![M#&I&$P.I.`S,;S`I7C\Z%*G M_OCP^_:K=A.M>E\QRM,U[=D9P5UG<#\4[B*#>[_@WN-@LOHY)8PN90'#[E@> MS'[LLJC`F@,$VV7U9)?5`"XP/E<0^YC3;9M3-<;GANTKR*F>1S)'E-3)*?T2 M(U8%8<2BTOH2E49EUA0F9$G61;;^;)[=Q$CXQ38[89`T#0B!`2+%(#E'-+!; M9MVZ9=8L$E2Z41$$G5U]Z;#(:Q@2[^M+] MJR^-8H*=A/?@)+Q90+"3\+Z*"Q8ZPD)'6O6E-PUW%CK"0D?.!>[]]M[5 MRJE$&,P-XZ+'*K5^3H7!5ZH@L#M/_5"I]49= M[0""J=2>J-3:<1%;J1I3%/U0%#4;XUN`8(JB+XJB25STVO:J@%.6:?_^X]1Q M?-O!FY7V[]PK_T99WCX+#S`30P8.GQ^-JR`YJ@? M_/5J@ZX-8BUGO$&GA8GM'3>F8^Z2Z4\7?[J#/@U[3.ZGB4EX9W]P;)O0X]6J#!P\!J/4W#;;*VD3Y_`WHON*M4^5^[FZPQ MW'$\1/BX1\+1$U=38^Q?)B0=]N`ZBT8)C,APT@#KN!/B_G0AH@"NNH"-40O8 M2.OSI+"136"?L"&E6D;U8B.USU/"1@Z!O<*&V`(VTOH\*6QD$]@G;-"E<6>+ MW8"]L=WG*6$CA\!>86/4`C;2^CPI;&03V"=L2*E',C1P">X4-L05L MI/5Y4MC()K!.;*0>4MZOCU?"X[>]YN6AS;0IP>/&W+90"IPC'=I,UX72SFE/ M@9%)4B5"26VFXT+)&7/;0I&K$4I:,UT72O:8VQ4*9NBI0"CIS71;*'EC;E4H M-%#C>*%D---IH>2.N>V%7MMO;!_:3*>%DCOFMH52X%3MT&:Z+I1VSKZ*FB#' M"R6UF8X+)6?,;0M%KD8H:OK6*%D---I MH>2.N9Q0MN)]/L$?\'T83P4?_C]02P,$%`````@`6H!.1+%!E^N=#@``[+P` M`!0`'`!I`L``00E M#@``!#D!``#=74MSVS@2OF_5_@>NY[`S!\FBWDI-=E;Q(^4J)W;9RMB`2 MLK&A"`U`VO'\^FV`#U,628$T01.9P\22:?;77S>`[L;KU]^^;SSK`3-.J/_^ MR.X/CBSL.]0E_MW[HZ^WO>7MR<7%D<4#Y+O(HSY^?^33H]_^]?>__?J/7N^$ M811@UUH]6;\3/T!WN->+?[5EU`T=^!WUK>'`'O<&PYX]LOYMS=[9$VOY*7K0 M(_ZW=^)_*\2Q!5A\_HYP]O[H/@BV[XZ/'Q\?^X13AI[Z#MTH17Y#B8/@K3MYQ^>4E=5`@F1;5Z#A5MO`)\:F7/-837_7L M86]D][]S-X&XITR^D"/@V+(BEAGU\`U>6^+?KS<7112+7Q]_0)SPJ_4UPQR# M685*(%F^YI[A]?LCL%$O,8;`]9/X8D6WR5/!TQ8\A9/-U@."CIN#<8H#1#RN MAL9M%LX)W6Q(L`$H?.F[)]0/H)5`:R%8!8^#G-;@J+,$J!IGR>?4(Z[H&#X@ M3S21VWN,`R4T*]X2F&O$@+A['!`'>6K(&G;N++1;<&XL+7FU/D'\_MRCCTI\ M<>JLVX%UM<5,MD!%7+196*?4"042\/0SH%D\%_X#(*#L29T4 MTC`E*005V9I$*UN`-,S_)>7\&K/;>^AR%<1[VX;'@*Q\=1<`&`T[01:'LC$` M1L/F^(P?EXY#0QDN7#/JPX^.)21M`!')JAMZ^&J=__NS[^+'"OTBA]B.0U[?,OB`.M^N MMN++);C@`P2`%2%3I`/R/?5"ATL MQPZ"`4@[<\^&OO"W8<#/*7N.(JF+O2J0.27KYJ/:Y@R5FJY(W/C;-4+CB^,\08I\S$24K88"/NJE9NBX1 M+15YF2QWN:)A4(1)X\`>#P=#J66EM M`G[.UBRLN,QC[1:=!.K7E:TBM/A[`&$A#'\2;8+7HT[\E(=6V'M_!%_\=\FA M%?&3D(E*4W\ZF(_[]K@_W24I6[E>([Z2-=R0]^X0VLIR]S'V`IY$_GL#>RX M&OQ3_/6NJ%W`GBA)4Y;P6XH8AHPM(FX<$\`8S:;:%%%`H*1> MQH&6+-%TS>A&R30!K<<'9="&Y2R*^._(>L3D[CZ(OCBRMHQ0!JT;//C("CF` MI]NHE2=R$7/V_'2WL!\_<>T">G*,+3B!X M>R+^G4QK^M/Y>*3-ODH06C1T94IBBT_,L'C$`J@_F6F.\>H'=YG8Y3/UG>=1 M;J@O+LV5V9S;[1.^,[*7*FM6K/8\X&6TL>BI8M@'Y;4;"0,>MD:.MK MNV6BV["OLNJ=C>M>24!A5&166)-4L@E^SHJ']E!?.KDOL'Z\`[D%"['[.XJ6 M9*99Q6RD#W^^S"::G)(I,FG5`=7-BG[.-EN//F$<3T?G<+&P%_HB[X/B6S=P M)4+,"IEDY)Y'QGA@:TY4.F!8%>W-"H.2$L\U>A+U'8@&XMXI1\O)=*RU;U8% M\A8==AV2.AL^E10@"O4"%Y\--%MQ(JO"!)%H'Z#`Q(M M4[Y:>>0N6N6>R4&G@Z'FLMX!!`V[9XYA=A*7"GR8%4>>8D8>X"4/.,-&1K'Y M:*+/7P\(;\_&%5CH;.C8"!$'>FRSXJR,,A`^R#5_.VN*A&HC?1.*A\37[Z+S M5)F-!OIJI37!J[NDJGT2/SW`@%E]<,FNQ?X,.-`W)7IX]^8;V5>1DA^@,Z[* M3%$_;E;7?"-61_K8/4/,!\MRB/O#32@K-Z=X31P"X\YT,-&WW.HP@"9:@%)' M_3P%5(D3L_JXY_6[UXBX%_X)VI(`>?V)SJ58!4);MZR"\IWMR7*M^87)?:Q/ MDH5HH8H]FVFTY+[`UHUX0.>B_K?730M&>V(RNLSLD;Y:\DMIK1NO3%VS2H:[ M>YAB/QQ/Y_K*,3D26[??(:T[5Q'\]?@E!Y?P67T_QZ1L/\?S(10675MBI8BU MN?KX.Y"1XW+F'=D-=%.&[=HTJ:+63$KM)7, MB,/"SBF[P6XH=Y1>K4]IN`K6H9=,9/6'T\$BS^YYF$47]II`]2QQDY"%4:G_:06F;'#3,WH1.29!Q]> MGO?2MZ>+@;XU0/E".^T*"CS%AI^987A(@D1I$9_BZ-\+?W\/:-^&[$!?B4<% M0J>=HC*'L8O,#1E,]O5+=H7)>4![-&W3.3*R#?.*(M9B=U@8ZPXOSVT0VLWT M39\>!F"88Y3RE]2C!L:Z1WQLRVE<1<\]O@54'FO<;UD/E&%N5)GGQ+7V:IW& MN);*0GW1F@8ZCURI`\HPUZK,<^):AJPI*.B3\Y4*-HZ)IS-L,B(JA&.8XBIPF MOM.=91MUNIMR92?Z2KN5\1CF157835S)D&)O`8NB/,'56)SH*PJ_#ES]93(0 MV487H]"E\V=(&"X\-`54'XTUKGA3!J*Q1=7WA73]13T^BU;?=#0CW=/RP@^0 M?T=$CA3GV^.1SO-Y#\DWRT=*V3-L=<[^D+)[S):HQ$S;#/!VQ7?:,2IQ9]CB M]P+2SHF/?$>)M''KHZ\BN/JC[PW>QGW!U?HS#7!2:.K;D_E(G[I%8C4VCOIV M?MZJI<"5:>,HHP[&+C\'^BXX#\5Q__*BTNALN?QN.TLE]CJW`T_9,^(+ MI,Z^8^80+NJ*X_E,7U98)MH8?RCES*QUMUFU,G#8U5=39':%O262=(E]G M4\>W)+).-]BYU.JU)PZ,U4\'(`7E%'9AT+0Y(&NB\BC$C MJ7Z=]19 M7*VE(K?4<_NST4S?-N\7PMHS6HF6ADT"[APSL7Q`Q!.5^B\TD\C&I]!\0)PX MHI.W]45R%='4[V9,/W/DE3;[\0X9R9;ITNI=I%LZH%YLMLB1%_`.]%F["I1N M.4-M$DV;WZ8^39*L2+ED=[0]&N6>0=-0/U`DMW$WR.G0TA:OI+Q9K?]J5Z&8 M@I,&LAOGCG_Q2P\XU#G4QIB%''KOTW5.\"E(J[*G69?YY0M^N$1^DP+!H M*1UK8EWD2*/SWJ67\NHG>1^Q#^_RQ%Y0=T-\P@,FVUAJE<%TH:\X<4!Z$QZJ M8IO$,ZN08=8H);*[X1%Y1'3V*$I5-DIK!NG@63`KT-F! MLE'MRSW'L`F/W2KG#7;Q1N*![S\+H9__%@ M/+"MGG5*N.-1'C(,'Y+ST9ZLGT_%=40>_T5YBC_]V_@O:T_HIR^2$\6VSAN" MLJ+JIV'I6\Y%VG&/73EO*J'K/)8O3V@3[>L`_]ERW@&M.SMZE)OQ#\J^B;.\ MJ(.Y5$CK27IY0M_"C,5:FY55I0K=H,=/*,",($_J,V^A'\G*?`LC%NK\@ZU7 M&P\6^Z.7/!HX'OK_:467"ED_1V&!A7S72L=[2P[XUA=(`#F2]U+P7VH,>5F! MD;A(6+J-)@DMLH)>.SSF[LM@8I75U3JY2&F\T+BO_3"`5U0TXSPD9^=)M.=D M.!WDMN/<6U0.O:V)%EK+'"_3+B5US1I-G_>:24T2Q<3",BZO=^7B:I@DXQ9W MP.25'O(OQZGRZC>W<7TBNI=RU+;X);Z+2O/1*9:9\JU0."\=K6SY0A&=]@`U M8@PK,Y8J3/A++?.&JNKFWWEOMVU>3(%I.VQ+M(R.;TL*:D+)O#GRRG;>>6VG MS5Q,@&%7V21*GE/V%8)4]@C@P'_/L=@G`XKV1\/\1?"EQBUZ6V=LJJ1NT6;7 M#I8%XU^(_ZT0Q_#-_P%02P,$%`````@`6H!.1/^.IJ*?'0``IO4!`!0`'`!I M`L``00E#@``!#D! M``#M75MWXSAR?L\Y^0^*]R&S#Y9%W35G.QOY-NL3=\O'[I[)/N70(F0S0Y$: M@+*M_/H`("E1$DB")(H$/=J'V;8LHRY?`2A4%0I_^_O'TFF](4QLS_UR9K0[ M9RWDSCW+=E^^G/UX.I\^7=W=G;6(;[J6Z7@N^G+F>F=__X]__9>__=OY^15& MIH^LUO.F]:OM^N8+.C\/?[7"GK6>T]]Y;JO;,?KGG>ZYT6O]9VOTLS%H3;\& M7W1L]_>?V7^>38):E!>7_&P3_.7LU?=7/U]]B*VSB-]A/ MY]'7SME'YT;WO&>T/X@5L7@DC)C(&=5QJQ5H&7L.>D2+%OO_'X]W22IFO[ZX M-(E-9HL'C`BBL#*1*&4^S"M&BR]G%*/S"`S&UU_8!\_>*OJ6OUE12R'VTO*2MDZEI7GNO364)GBXUD^)F;\\K8D=<2 MY4JYEESB.;;%%H9+TV%3Y.D5(5^*FV=2$3,/)J:*>T6^/3<=.3UUO'>I?1%O/FB&K9F*X3Y#)3DRU/+UK4W7S-.J*7?4$/W-W?N MPL-+V:7),I&MEJ%;T\:_FLX:?44F6>-`31*<+-Z6%3`BOP!0?A0O`$*&OIO/ MCM0R2?GQU?)SY[Y1#CR\D5>*K5@E6Q9D:`.1ED;`5JS_>X^0!X2?7NF2*T'> M62G>`^+TY4V`LJ'8".)\2(-!V5`,QS?T/IW/O35W%QZPY])_SJ67+]=4O`U2 MYVZ!,$;6M?UF6\BU]O/M@_]^:_SU;LPRDUP3?J`.9DV3,A6'[U'`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`9^XWY#^9])#)EJ])7W9!EQRT4LL6+>`%A`\-N]NX MM?MRL]O5&^TA'\5MM]`^7KW`A=VPPI:?"74T`8IK$-*%23]L M@$V%X9]M*E0OL"Y38:AH*@RA=X34D(;L3,CKP`T:X?&JF?1`LJJ>].GV7P)@ M"?-/41S@+I`9@(Q9_]\N!"$GR5A4I]-MG;>VI7$\$+4KF6N%58:M_9I'B>!3 M1M5D[IA3@,75&K-"Q^DS\;$Y]]M#`^S<(218?&:R.D@6AZ/_Q[(B;]2O9I$Y M_\K$>&.[+SPYV!Z.^STH@:0X4#`;I9"*YEU>M>@=.@HKD<@CFB,J"UU"Z!$J MU$1[,!P.P(PUA7#5D$HJ0>^#Y+;.D/+>-HPQW#H3IU0U5$E2AMCT],1FYK\B MO+,N\@OV2"1QV^B-AV,HK-(H5XV=K!9"+/MZ8OF`TZ`GP/MO#SE@01`5PV"K?]!+$#,$9Z@S.3K9N!Q:< M7&ZT##I)K`MA.<90;V_R`7OT#.AO'NCYB=\4H@[RBAW2^&X]Z-)3*-BBF$RY M,NQDQ=?;D7Q$5$I[3L_!XJ/.-\^=1VOZ8-+K0D$JST=E`!=3C=Z^Z0!\/#N2I@$,CIPD^687(F:)X1M1*;[=TC"NK1!IPL6%`AJLD&<`B=RETZP`Q2P%Z.[G1 ME3`FR,'1NM<9@L40DLD6WQFB9$58\T8/(?03O$;6,;'V8-B'RS;*\Z'`7G,` M>)C5R:#:AZEZ+W3A&O,KV;0B&Z[P(QZD"NQ@&1MBVZZ^'J'6$0+2]?H@D&GR_Q+ MEUOO,$L0)4KO3V@7D< M^1'Y=M"<KG%,&\R[J&31U@'$!+GU M]H13FC&T1U0*L"1*=H_G.K&44XO>#G.*V`/`T(/>SI.44O1.=V;I@"T^/;"" M_BSJ.H"<1T,AUB,]L=Y>?PHNB0V,80_L%N`>J1(I[6B<>.Z)7T\;&"-X[@^I M*K#'#!!V2TNVX)K%3.?S]7+-RPZO MJ:[FMM\VAIT!6%U_-OUZ<,VGEZ9EN.@"T^N`754&R784P#!=[MJS5^6ZOO7D MN[ZU?MI[7C;/$P1YGJO-W1*N\1<23PYGHQW.TZW2TZW2TZU2?4`\W2IM]*W2 M4Q'&J0CC5(1Q*L)(L+13$89^-CAU'.^='>MN/7SMK9_]Q=HY;O^[O;8X@2MT MSL5)Q54G!96DM\NU[VK0`_T,V M+P]GGDS7_BME\?^0Q?K0=@#;4*;1KA/7-#WH';00R7%'R)K+,!0]<0:'94"W M?AR/Y=<[("^28;;VB6^ZENV^,&,TP"YI9Q"O'\T$3=0>KY>M%DG<,T9&#_2B M6`;]:I'-IQ"]KY?$9#G:.$9&OXJJH'HW3SD%A"".&P)BN&M0(P1+UR30K!F\ M(\%#X"8-`2Z^08P`3]IIA&N&4*R"**32T1/(O4*G0`Y6Z=0!*X05$*P6MPR) M([QT3:V=[FPTIFK^=&>C<=9WNK-1ZYV-,N57K&F8T3IO7=N$Y2O6&-$?;DT; MM_@!I_65+_M<8:3UTS6K)72(?-T5&XD/%!\G'*5PM55P>7([]([UW7W*#EBD M-Y-XB>DE?'M$0*H]'`_`HBK27"B8C+F13'^L,UU5>E?_9#U!PQZ>@6L%G$6] M3JSS:$;O3-5QKDUDL8-A'ZS62XJ#.L'.JR*]6UUN>;_MVO;)97;KR)G=VE,M]ZNPLQY:1)T^L,P:J>Y5AHC&GDUJC>]W&% MCQ:VQ[T1F","T7N/D!8]9[?X38`"=:%L M@.CR7.ER4->W+=M9,P">V)3D^K_YF#MK.L`M1?G*6U*OGK^O.%M$?3`C\KMY M.QB#>;RJ>"SN[#[-7Y&U=M!L49*7P+/JCT8CL"8O2EE54*V"0]UFM.@4H!@)O2-/8FF_F4L4AMT& M8[`6S5FTB\^FWTR,3=>/>A<.X`+\>Y3`K#L9C\AJDR1NHO5)S[7+C7B`X$X8 M]>&!*N(`V5:]@QQ83J4*R3F309?]/*:2OA.(-*I_[2"T^H"J\)H[TRI52*-F MFJ!Z45ZCVM17.\!&.WN0,/#R>=\7J4M%MH;\8&Z8MQ=68`W'8+ZSD&()*_QT3ZC(0?+97E(YE'J7K#&&DP%4TCJ1 M:G(&O(B%4)=#E(=G6U&3(_FDRVQFJ@:JD@K?6:[J:7*.Y8S(GQ]Q\I2"P MYDW_1"9N3SH&6-%@#C[@+5M4+59(3[7[T3F>`0BRU[/%L8][1W6(J6"$OW`` M]BQE;G9J,8122M/\60ASP^_AS!8[M>Q+ZUK!!XB]Q,L^H<+U##B+R,]0/391 M3G%Z)^I/79B;TP?WU(6Y<=9WZL*L;T(W836G#EX7K*HL@6;-3F^2_+6_558J M4&QTC@/%C\AA#P6U'DSL;UK?L>D2<\[^OD"X.!R+#Q4;J6S,.&'8'9[]`=R] M_RSBQ5?(A)&?D$._^?(+I)3:TEA93=[F&ICYN/%9WIB+!\<^ROR&^V M_QH?L6T,1B.PDSDL[PHF?VZ;V?5QK@H5O0_+5Q[AYSQOA2C?CVAEVIA=.?Q* M!Z8SE[W/VA[UQF#S3H)^G6:23SUZGWCDE``4S(5;7W=E00DTR.5F[S=!]<]X M!/!&.*K/RU"M?Q53X:>+?<2%#O[X_Z(-=%SDF5Z+D<+&P'9L-=^-21W`3 M)6SAPEABBHKM.`&%;;%>AM1Z9ZGE9AL_B5(%@#6&E6=#C1<]#@F4CD]O:8H3?[#D*[GD7/:.]P.BT%LLC!#KR62,.V`A.\6\ECB7"Q&9LDO=+_SL=[G9?25,-4_? M36Q1T&S,OQPPU#:&70/L#*:,304K%[2=;<_[$-#H702R6RG4*#G:-(P!O*>@ MD./BT_G.I6LQVCW2'1+C&U]W..A"J2&%KE)?`=(LHGDGI\,F]"//E`3H7%_6 M&O(($W5I'H[`7@U,I:S`O//`E&&D1]K0/EJ1*3S06;XN&ZU6G.IL5!"6D-6& M_A$*"4F`'-_RN*8DE)],A_6J#>Y?=@=P%_\.J<$99`(D^YEBL=RZ9R$(HM]E M=?[7[*D!;\7$#H_.H2S]P0@LCR1!OS94\^E&[_Q_6-O"JQ?P[\BG_]X7A/J; M8&&)+.*U(9Q#*WI7\F34+$7OA_1'8&T!I#BH#>B\^JF]!K3ZD"10/8P^(4FX MTSYX*5'50:`:(I6IE4DPB'V:RB4I]7SSW#=$?&3Q8"[Y[OFF$_\]4]$WS_\G M\G?*B_53(>U)UZ@W<5%6`EU-/ZVA346(ZNW=@&DCP.36P^%'['L&4PO8F;5: M44X6GXVQWJY>J%DZ<84*"?W7]F!B@/4FDF.A0::66Z>U'^W+U7),$FHY7CV' MRD7^O77SQYI*T_J):F'IN2W3M6*]Q?B.$;\T1@J7<(0$`W(!L>TM\N@B7IR0 MRD9D,;/H&'`W6D04BY]9'K`W1\CB5X[N"%FS*RG']2F\3MK>.B^W")$^%K6[G6%CYC9 M!'/(C&X(&/T@<[#JH?5WE[_!;DZGT"V3I6$K M[P\*(P%H@BM+6D0=58FI>Q=!B9;)KTS,8WOFOG96@OG[IHIV4U8 MUPS1KIR6<7^YX?)',;-)!:5N1W1++'&B)817%=#-"JP-:")5I<5JV?`<="I) MU4(3"LXRY(!M-U,0S6)N1)6B*"OBD8A!_\*RK2.2X!`+ZLK$1\KD<6KR\R4ET]S58CLX"UX@ZWK-GFT/PI<\ M1D:^H7?^*VJEHRYB"V1G`U7>B":Y1)"17/81EY`^A'3<,VOCF M\F/%JHW8%]EIO3WJ#<#J;PKPHX\Y2.DLM(>1GO;P"_8($98=!-II=X>=L<#5 M%L[LK,$J1RZ/="%.$SUQVKU8L0TB,#EXJ0%+#]N$Q*J[J%@3V5QWKI%K*[/( M+7<4.=$T=)(FUSUZ"6[SS.?LL9K=O2TNGW1XLP@%K?"5TD.$LZ:!CE3Y;'(H ME*R[*S^L7H@F2AS!J&GL(4VHF?^*<-0_G@]"]><;FU!1OXX*5[600K_X4)*^,+;*C7K\W;N`MRI[<+/6KZ:S1JVOGH4<-;9"KXSX.G;1@MP*2 MR2JN=;O`,8L$THKM,X9FE>(H#EW(PI1>(7"@ MBD_3OT=&2546]T#9\HQN4+[I6K;[PFIOP)RD+.(5V;5LY8M8+7I7&FZ=C"DA MZ\#E(WOE5NW)L`=6<)A)O3Z$\RA&[T)$L20K-/>1Q8NU)D.XB^]9Q'4#6*@6 MO4O8T@3YU7-,WW8HKX_T=-^>]$5]`>"1WF=#3\P35:5W59-(I$>;_'Z+$8IJ M]@*!AATP[T.6";V0SU"3WM6-41%T(-0S:X0[]]O=H=$1I,R$*7GA"/4AE"F0 MWE5KNW*[6&KOCM5)NHAWP6+/RXK(X*J5<'_Y@ M"FS@];!F=R3BR#VL\?S5)`@?7.YE132REIT]')2Y2G4IDI53[WS^[`UAUDG1 M9W&4(R&,CFQ%=,HX-:$D*5D#UX=3SY2&]*8X]4QIOEV>>J8TJF=*M-!/72NX M'AH/RQICRC642Y5&60&DDB>^P_-4EA[T]DY^N!B9#FL-_0L=ZMZC)NI>(VR_ M\6=?6`.1L0&6?\@@7CVF.;11NU=3MDJC6Z1*@XYG.JU0JZU[VWSF$3WU-1J< M4$AG2Z9LC0;OAO^=_A5?J-FU2J"]9X]0\:TSH;/[[@EJ$KY!?7GX!O6.`==Z M<$SWF[E$X5XS8-<4H4K_`!A6L`JDXK[7$@-.V=4XG&4V]F,M`9T8M)\=4%79 M39D=@E,5L+*K<7M5'\>:6=YWC#<0\_GGN?(JO@193X5[^A0[G0KW/G_A'MSN M`=FIK8ZM6JB^;0XDEON031L<_*T"BZ\$S.V]B631=0^LA"^YQ%@W1$]'"U$[ M^NNFX98J?N-C)P.YV$D4?5(3'HE&.]U4.=U4R70E/NE-E4]6W1^+2'?*]:<4 M#*IO];Y(;+UW]?J>B-+M+(M2T0SJO(K1N[[_=!#7 MQ`6H_2#^"7H`?:IJ2#;HU7%=H/S;C((!ZJIXS)"E@=OCJ8BN(<5*IR*ZYMOE MJ8BN445T?\IKWU('W^(WP)NT-P:-WN_S67)P<%?['C%9'NXY\RCKY[P[&723%/+ ML@,Y6G?NPL-+GMAKF<_>VH]J=17EH':D8I2FC-`I.W7*3OWILE.G$$=#CI*G M$$?S[?(4XFA^B*.IJ89'5B,U6^P?%%P4QNG[W>%`-GN?.E)-R0=IZ?0^-HO$ M^/[NQ<203<2GCJ012$+I:C_VY`>)0A&WMGX9F'9CZ0246$*]>U>*!+GUUC@F MAVP]:_I0&@$EED_O`A6A'/9;W-YDJ\73A]())Z%\>C]/+9+CR?Z(B2';N"EU M)(U0$DJG=[=/H1CH#;DQ0<9E8-J-I1-08@GU;LUY*LS3)/I9>V%>[W,6YMU_ MZN+W3UGCD`S9GZ.PX92E+F4'N3/1FAY)(L9O/E8VYDG":];\F;D6LH4LXB'J MPRM;I-H#+Z7RS8;1,8[RS>MG@OY8TUVR=?/&_EL@A[P=@H^@*#V<]@2L!B\! MBED_O;_;A&WM]&)K,=48H?R0$O-05HBH;U$7KC@N MD2J`+2;!DK*F'&E`_]:TJ5)#G<@J-L;JQ*C&&$5-9"4TH'TGV`PAH%SD4C#* M"!*YN5U#D-X&$4)=9SMI2!(L\4AVS4-4^]SO8M=4@!%4CCB)J+H%<>=752." MJ@2W-!Q)Z^"!X)^G[6NJ8JI99!38Z97GOB',-H[0G0_>0`P^]I%EM$>]/EAP M)),ZN`4+P_OR*M$[7)(@27";E(D!]SI[.FF-8#U6AMZ%R['D4R#`7GF%,81+ M%Z80K@=/*4747DN0E+@./V?_>38)HI_\/U!+`P04````"`!:@$Y$_,AM2[QQ M``!;'@<`%``<`&ES&UL550)``-\A/Y2?(3^4G5X M"P`!!"4.```$.0$``.V];7/<.)8N^'TC]C]@:R=VNB-D59),)LF^,[Q7EN4: MQ759&MM5O1T5&Q-T)B5S*D6J2:9M]:]?O/$EQ3<`!$"DJC_,M$N)E^>`SSDX M``X._NU_?G_8@Z]Q7B19^N\_6.>K'T"<;K-=DM[_^P^_?'QU\?'R^OH'4)11 MNHOV61K_^P]I]L/_#/_/_^/?_J]7KR[S."KC'?C\!'Y-TC*ZCU^]HC\]YMGN ML(6_92FP5];ZU__/@C^L_S++__T5ZMW!_)CS]415'5NN2W;]_.OSFXK!4$P8_X MU[IHD?05A(U:/_Z_/[_[N/T2/T2ODA1)NHUAK2+Y2X'_^"[;1B4>GE;U-BKG MQUJ"P1+HOUY5Q5ZA/[VR[%>.=?Z]V%40.\+T=_(#'#@`R-#EV3[^$-\!]+^_ M?+BN:]]%Q6=<\U"\NH^BQQ]1@1_WT>=X_V/T/2G>Q'?188_&$3?S)8_OC@>\ MTP#\ALZ/\;XLT%]0:\4K]*=7*XM*\7_WM%L^/4+"%,G#XQX.Z8\S@6^_1.E] M_`[]&W9M2P4_T+9<`>[RZ/XA3LLWV?:`_A?32JH8HSVH$0:/F1(ACEI6225' M(94<<0&>FX"`2+"+'_-XB^SN\-`?5=WG^?.:R`(%R`)9&XQYH$T%F-_`_Z<" M=Z==:=C3^%YDL&FUYXC[6I,-]3;.DVQWE4K&W-^L&O`?RR@?,2WB\+L-RQ;@ M4U9&>[G0NTW*!OT^ECS:SQN4/LK09^4V)!.CW&E2(FB!X2V[.%G'%,]R[^"_ M:$G4XHAK269&XBVW6HZ_EW&ZBW?$XZS;SK:T%.[EWW^`?_BOF_P^2I-_8'_C M,DN+;)_L\']>BS*-M>>YX4%++ M.M^(3LCH+\_G8_IG.1"/!VB/E@997HW]T>A?Y-4PW>79@])1*C/8?/194O-6 ML/8"]]RV-X[K_P"R?!?G<&GX`WB$]C-/RJ=__P&N$@\%E#][1,U%-2&C?#O! M-%KBQVT&5UF/Y:M]E\^P2.^`/B.=*GDY%*:+'7::'7*\?GS80ZAH%1VGKW[Y M^`-(=NI`AZ^C(BE`=@?:+8#?JN+_W[_]V(R=8F5^DQ3;?58<\O@3M!^O87N_ MGUO.9FV;J=@]Z'/M;;,5C=1D51/R8*XPKH>(!4! MK`E053SQTLJ@J:U<:91,C`8K36P MS#9YQ"?)<:U."5&G$JH3K!B#.SA+00_U*8YR?*#,ITB7V<-#4I(U=+HCL.YC M.!'&K>FO65VOH(:KFH"XH,Q3IYE25QK%V4RP]E=D:\(W>RZ:)9?J"6D.N+!5 M&:_XCJH+[PLQ06I\2,^R764S$A\6#6HT(C>7'AWYX/Z*^."^??J*-"B8EOEI M%L1Q?=*B1,M-1%.>V`SFE2ITX@,S3I5D2 M5XK$TXAG^_B3K@.S3P2%95*M0J+`0E+Q%:X)FJJ`U$61M[@VP-6A9P<;D*<^ M[Y(TOB[C!\2BE;J3>18$RA1F1$8&36EJ>[9GD:]F]M$9OS`+ZD8_HBFE^`U5 M`[B>/%UHE/1]]!"_R1ZB)$644;=1P`E&F8:P2;:+/ZR[,GNS8)9< M"ZK0)+@);3H[FF!0&^`WT@JG;MU&)?0"/R3W7\KB?Z?9MR_9-^A-ODNV<5K$ M%_=Y3$ZC?HX?/LP/J`-@*8%\!MI0X^*/+\+9N^7S9*+74EVP[>`U"A+#?)865)ZYO8Y)NX+T@-&I'T.$9BX)[I0$YUX#%Z M0NJ(Z)]"^A?\]$?I/78'V//=R$[9)X3M?.WYZ@[T^BP,*J(KW',WHL@NMS+B`NMMOL`-4ASZ%^GKN;]499P!<'D'FZ,TOB2GEX&D%W+=;8(8;?U&CUF2&5 MEFE''%]85463#?:UT#(\(K7!OJFN7GN43#Q&:T]GZN%IQ%FOR4]DN*I+J MB4<05Z,OMRU]H55!J^X9H+7%%.=#O(V3KZ@#Z#(VO-FH"RP>ZUF.:K#)]%P7 M>FLA(T9.31VD"BSR+XY]YEHN5I%_<>&_`_\,-E4\DJLN^R<%NJ%T%EE(-P;GB=Y: M3D!G=[.WLYAET#433`%IM.%#2QM@67%3CR:-7R.29K/^Z)ZC=#'1T^=L"C/) MT2)O7WED>FR/#+;9D81L`N@RYM-0PLH]^4J+2>6I*H.KFZ=]1K:WO$TM@MD1 MX0SH-1C6"0@U,ZLRHJ9TMTO(:-]&R>XZO8P>DS+:G[N^I="6]G=JWK0(6- MYY!A-CLJF@6^"C$5;:5_B,LDQV$Y-Y_WR3U):_`>#B>U M[)L5=#J4T98!P4P."\E8$YJEMK5:V^3;F!VHR2^,N1,'TI.*$Z+OE69H=CBHBCQU?A!T9U(F]T(JMK":A!`4G@ M*K;X,V-HAG`>D;6`/SEDB]\S_#2E!ZX6RWO<)^$1[YG@\:<(3H0RP1!ET#DJ M=;0,/[WN!OL,J_$/5Y\^BG#MLG:M_;XK*3*Y)F='?1SU,=7JLPG+IC.!X1OHPZCU&+6^ MKL/J;KK8-GGO]U+HB"EDV8!;=A3EYI-A,_PT<0RW1B>M'P'UU>ARW MHB_*RRC/GY+T_M=H?XC/-S[L3UG*618(\_@K*&6=&Y.I.O;3R?F`;_:>LY`\ M6@@O@BQ$I7$0Z!;](V[JJ50%-8EC35.%;II8INJVY9/P,-,3+/-+H]HUX8?4 M\!__HU7K#$0EJ"H"7)-3)5!RLIN[CV6V_9VF.+-6MKK-@VY_,\G.@+]F=K>L M[3ITE,T^MIF"KIRSX_V'),===@=P"<$\=R/9DE%6:VN)E/@SV;G(: M2QU#L_?T.:30XW9=[^T_NLC,'FS_*YK3M3O7IN\^2@1]G/J4$Q M^S2460;E1ID1B.Q'&+(46WGBIWCH5%^E86[W-I^QX]C;-#TJB2T$78^8?>HP M!5V;L1T!$9+?08$*G(%_.5^M+/`8Y>`K*OP_@!789T'@GSEV`/Z?Z.$1_<4Y M6ZU6Z/]`\26"$$!T*+_`H?]'O/L?P/'/UE9PYJYLS&]G?;:Q_#/7\JK"25&@ M6P+HQ^Q0%B7\!U0`2=179KNPQ8/]E[Q_2/A M.RYP!JXQ)_DX^";.X=(/W7UMW11O1>OYCJMNVWFB\WD,Y9:L(NQ416QZR,V+ MP.QC$TY)M%AR/DSA7Z,\C](2[.IJ=0H0SKO:K'Q08GR-8'K'-$]57&\L.L6: M?6#-)8=JP\T#)FP*'V?J$+T+XOA#O$>/>/9D#@FL0-U%@,GNYQ%= M0+KZ*=K)JMCPD"B#P.PM:&Y9M!AV7E3U3=O'Z`GVO<>^=$XJH[=F>1>2[.10 M\YBY*=3O/ET^6=5U`V*2`K-/V3DE46WI^>"$5?%7% M^:[I>)I]%,>`7K.I&\+19F6:I:^$%E6CGU:Q%=3!SA&;V)0.-G2[/3#[,&T2 MNSX+V0_@R%`*+O-;GN.Y95L;=?-QJZ=Y#!R'7#'OJ-3*HE'_@=D'!<.@57-M ML.>P]8L$:BFYD*.66IW;.$>ET$X$N1]G^#/:(Z@YIECQFSC#_=-[.,()N5LM M7Z0[?)+U)=O##U&@<,3R"7U*1UT"U:GNI5&25;@>G@Y475D!/2`Q>UN>4Q*- MQI(!3MN"XJU)4D@5QU5;V$4Y/F:+!ZJB=*%X-G,,?XR:5Q3=5IL%5->48\;C M4!=:[U_Q)0G9_*_O)SDK/3[L*`JUZC`L*ZM6M&X=6B2AGF/X$]2"$BT]$_3# M&I@1A*]Y%X77J''%/$`FWTL,8E=HV'O!=`VX8)'KF,?4[43KYR-8X[Z412'1T;4 M[*/8:?"ZG?%^&,\RFLC847E^_Q].J^KRT@WW*YNIP_(,$[;MS*WIF)M]A,$L M@WYSV@^DUZS*\(N'/KMJ3U@WC<>\W;Y4'IL5&7JSCXG9A=#MT8[#J=.CM"PQ M9XZ4F_)+G(^\>+E>>>KL\7CG\\C,+5C%Z*F*SBJ@]L3LPSXN.50;:!XP(2XL M\6%(5BHH,=8F<+QCM2E=DVVX/X^V.< M%IRY3$B?.$=6.V[&\17F,^GM4P:?I\4XIG&GO+U946-B]K$C"WP]AGD40V6/ M:=)`T5"@B8^KT/CJY.B`J>V41WN1Q`I89A\;,N'7:%C'D5"N1I2KU7N[V^WA MX4#N,D0/65XF_Q!XMP,WW3_-6HK-K!+'@4F4(QKW[L@%-AU]LT_XV`308FZG M4%`22W)\QSZS.J.KG;']AG=H2S,@8VWVL1NC!/J,[R26VIW-HUV21?BIM>&=1!#6)21DCAK]M$ILK%YV=BQJ;VFD\"X97[,/XQC0:[&?TSA:+!W* MY^>=P3^<;3RKF[N/\Z`.]H7>2[\BV\,7Z:ZU'=(LACQ/7;09`X+9+!<0L<5Z MAMKV:D,^G]F'=_S":+#9?(A"6@/0*C@2^7@K6+F/WB9XT?XJ+,DRULM?_-G/8!J!LXMC(+SPYDGE[,$KC2$KY& MZ(4YV^QS2V&95,\,HL#"IB(8>=U)-,Q$A$A*YA"3-:A90%X%*:,DC7=749XFZ7UQTEX'LNY)*K8/5;)\FR7FAZS#W#9A5!MT)F1A*0DN`#/3G;!;Z0X MY]5+TMSKH8\?**9S;\=+J71^,_3QU84H MC'0L@\Z,$AW3N;^2[?FNX3=_6.#KH?`HAHJ\;V21MX1>-CH":+_\??$]*%X;DBDA6WVV?XD=FV<'``0U@7`;Z@(P&5$ MV7AS]S9)HW2;1/O;K$C0T-?)3*`%4A>:PH)`$F.Y9.QP>*PVSGY+%M&.XJ!K')W2W`IDU#6X$[DL2 MP0=P=ZA,RB%K0LZJ'+./UD=Q:R-G3^=M$XQ_YB9<-X^VYZS418G(SMC.)$!# MOVYA'^V8X=$T^XAZ$KMZ&HX#"-L%_K7*)'U1EGGR^5`B;H(R`[<1?Z#&V#=6 MDI]4)TD[^4F'4MO3@3;[('D:/,>QF7A^TDD8-#_I_.<`1K)(NRK?YE65U9Q' MGF'&-CZ3OZ)WHQVSSW^99=!O9ON!\)C;&?[H)!N4Q#TLR.Y.F,-4GGBR-^X8 M?A#,+(26L`9F..'''@O->1_R4QY'Q2%_:M_.]#R%#_YV.YS'6B8!*KKV%?8W M-%+*,?M\=Q*[:N,[!2"L"AQ=-I='1]<^=3XV$@P3$JHW#EHBN]J.V8>T+/`9 M:!D06J;Q/=HO$K.:#%`:@M)[YE$)MEE1`LLY@RCHW7(^PE[L]]DWM+OU-LO? M9(?/Y=UA?['=9H>T+)JL(=5-1C>PU=VVXH(RC^0SI:[8S]<,SAI`WC!SS#Z< MF"67%A]C#L*P*MC*=`-UJ6H1W&4YV-$VT<4N7%:'5BGQ5XS7JHZ3P]>,3Q-Q M.&8?18L+I=HM$D867ARI3%47U.KUH:5>0CD>+K.'ARS%,R)#]\AR?' MVSC'JX=SSW+4*0\#@'DJ(R1AI2@LE>WJK;.UV0>'W+*H5@M>0"&I4*T=8!TX MW(#4(BL)`.L!7%&=%BAQS(S2@HX3QE#9PQX`C=M=FWT:*2*.%I=+`%BE$W2Y M4B?$`H]0$XI9FH#[*R[J-%J0'VMU44XC'4MC_K1$/8SO5+*K_;6UV2>>S#)H MM/.C0)[9=U(6-(7E,UFU+=?/Y#';_;P2M24D&_K:[(-1'C%TV^HI0,]L="<_ MX4Q>DTR=:/96MR4_T*ED/@]),LAE6L'V'#K89A^2,N'7;HU[0/1:8K&)#.[>',JBC-)=DM[#S[[1 MZ$.T>I;,XE&9!JGYK/5&X5LV;"#FT5Q8T/ZT M]2,-K'QRI+B`"JOL:@\1-;E[::'BPP0S]F'C68;@!=.9-0J+7 M9D<;B`FDQ0,2@M9]#^*1Z$E!]&36%O@QHLY.F[7V5BKS?(]U+E,O&`3KUX>> MBBOZI*)K]@DHEQQZYX=Q,-UY8>;F."L5-,P!RW!\PN9W*Z*U&,D2YYI]NLDG MR`(V?@)2U[;/W##OZYUNW4$7(%"WT!WN6#['!P4:XW==:>61;0;7[!--9AF6 ML-U]0`;M]OS7U?H_NS9[K8O'3':ZJH3L"(D6T5M0M-/NLDT^0)0SV()I!JRUI:W*$#]KL MMWZJ,UGRSO$'"0YRS3XEY91D,9L^C&G0L`N?+QU=MB+=HUMN*W57^GMZG$=M M-A%Z[^E5I?V-2T(U7;./CZ;!J[;0DP@Z=T<_"MS%&_VD2HRO7E9VC&Q/:1(O MX9),"*[9!_8L\+684P8@G;NC0I=%=_]]*$J4D.IMEE^T7C4[=WW'475SED*:^FC98!8VVCVOARLXJU\\C7,/D=A$T"UQ\"$XHC4HCPM/F4?8C1R MR3Y^'Y?7Z39[B-]E!?P[>DGL-L^^)KMX]_KIER+>7:PJU82.T,FDKR\:_EF[RGJ$%_S?*5,D+#5!TKS ME5>]X,=F][`']%?T;_3J'_J\._#Y"615!R"J>^!,IJ12(Q1/FW\$HS(R5TOL MC*9!MGRSC]N4RZ[/0U`CP',S4G>!GF`'I!/P)]3-G]'/^.G=JBMD3_Z$>@-) M^F=0=PB:'H6S#EX@I_Q#7"8YR9_<8__G8KO-8_2/J^^/<5K$YQN5[]$Q MPYAI#L2EK96V%-OJ+9!SC",NEQB`71A8UJ9'=DJP;DC1)E=3N<-X=ZW]"^ M*"^C/'^"4QC):+CQUY@_S=M54N\0L6"8IRJB8M;7BICJX[3:*_+%S#XB$I*' M73^@`Y1DNX]EE)=B6B*"+\0N&=K.Q.N\N*EW!C[']TF*'@U&RD/0*=43ZX^A M)]8,/;'(=S/[R$I('EX]N4H%,9N()_O7D+;J\^7-^\D:$?MU@^N'9"AVGQFYC\+^2/LU;V7@4/$A7*PBKS MN,H,M()WOJ@O;?8MI3EB<3ABXL]BS``8HAV!A):!_R`33M_,HT&)U%SK-EN) MNM>^>5JQ[;5+/J79-V'%A5*]]!=&UOAH^!]7;1^-5`=5??"GJH4_\VG1F_@Q MC[<)652ENZ/#1,B?0-FR?Z3C>3K")5&E$F.5H#E#(?GHHP1F[WUQ2*%E^0.S3WJ995!MTUF! M'/'Z#,#_VL M9W@DEMZK[GDZ5H M8/:V,[\PR^G,`*))#6GJJ50&-8_(F:8-W8?F6.J3!],V`8FO#LS>#!,3B$$M M9#Q&)P2N_UVM^SPK9D\/5P^/^^PICC_$>RS4L6?BJXM:YX$B6T&XA![6D[%F M4$0&/@6`O#DQ;6$7:Z&5#S/`L/*GX'('PMAC'RLGM4`9?9_O7;$P29.799;Z M,'A=(\WX/KV?%IA]="DNE'XOC!'9D#=650>TOLPURG7Z-4XA)RF#-CH7)ZV^ M9>O)N%C#BM&NYPYM*XOKEQ&CTD9[>MK,K:G\'T7=ARRZE+)HUV2X50U,?@6 M%64,=DGQF!717KFVZ)Q>#-`6UNFEIPW?\^B7.[4`$R:)%II>)F"-3R^TLO3I M9?R\S%6778(;CQ(%XA)_0I&FCGZ)(V&=VI$[IVQ+3D/,*.OIZ&NT%4@W,8-, M.B6UR MSNSY]$N=VCG^M#B+'>9/0@L)^7-YY+_-X\!IBK&+=$>V[_"1*"3* MVM$9V\@"2K:."`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`DYYE+Q'.MR ML&+UQ9G5'UOJV[QCW+S?*$4[T77:8N"].,>UM<^C(WB4*"&7_!-Z-]:69?EK MLN]KF[W/,ENVA29)9H!3\V/=D,+U(@OK=*X73=0ZUO7BZ(=':Q42:6";O9L_ M7[@EUXOL,#OKQ>OWOUY]_*1BO=@#:LB_(7R4J;140F77"]R8FW6BX>"J&Y2 M*ZSDM>+8V^+0:[-TSZ$C>)0H()?\$SHWUA9:KMC$83+[[LILV1::()D!3LV- M3:X8=6M%%M;I7"N:J'6L:\61MCRR4"%!&X[9MR\E2+?D:I$#9V>Y>'-[]>%" MR7*Q!]60>V7$5*?-[Q0?&'YM'%JG.&:'+\L1T)S9<`2ER)2HOTVWV$+_+"LRGC;H\;4=] MS=:;4=@M-6B7L_P-.4MRC`_\'(2M8:89ZAL3D/P(_H1^_C.X*,L\^7PH\1MB M909N(W3S10H'52V,%'.P;SW3+H=\9+)(=8P/@QS&K6L-,H@`S@R MT((V&W7IK@[RN"[CA_;Z=*/P9(D5QDR*BDM;LY>Y"0M^(/IY#-]H%A1)N>45 MPQ72>JW3'G05L8D5Q'7%M[:X.:3&<)NJ,5U[S]R$'?B!2_=+#(_E$Y5)SSPA MB`YISBNL.LF1ZO1%['%N5-U&3P_0$2IN[MXDR.=/=\5M3B\8?RRS[>\0(_E# M##\/_LNYM78L=1G$!!#-4R4Y0U!IE5!KCNN0Y(N.V6O9^<*IGIMF(PRK%D!V M!V[R'52Q_`G4C9V!NCF`:V-%;%HD?]2H@VINUY^6$G;OX(LTAVSNFEPZRKBI/Q]IV.C;KFH"H(068CKV*;O8_OV0Y/%U6D+`"7J MNG=E)ON7HSX\XCW7E9&ZCNL2-WYM]J$EKRBZ9B-&/,W<4V:`U@!-%:&D21S, M4#N5+,_\X6EBL#)-IQ.0K<6UV;NQ`M)HG@;8D847NUV"3Q60+NR3[?/<12(Y MBSHP;G-T,E$^W4+4)9R*KN!?'U$11)JUNO=5V8%(5@X>@0>59*01Q[7(,XIK ML_>,A672/F,P`NN=.JJZ<-&":I]A]:D;4*\[FB84@Y2'88H9;*5*W4:_J=F) M+>>(M=2DPPXQO(5M?XG0C)/=@;OD.UQ]"$TX>;:-XUWQ%I+JNB@.$1SYF[O+ M[.$A2^D:UETYZB*])ON?J2$"XM5Z,5UW[:[)G:ZUV9%9O*(HGT/X\(15>8"^ M+*AJ(.:3.D)[6NS44'(,8P[S.^/WYPXI_#S?X&G MHQO\;8NK[W&^38IXAYBE,!/(9/_RM(=5O#[%&:B[WM"D[6NS`S-Y1=$YB3#@ M>:8>Q)>B54!=1QGQE<\=RQ)_=,88J(N.OLB#AFNSXRNY9=$^2["@XI\?8MH2 M*D4^P8R=X+]&>0[;K="A$VK?4_=NQ%C7\K2"0:@^A>BIYOC44IV.VS0AA4[[ M/P[E&?-IX=KH*R&U&AA1QB:+?M$X#FF?5OI/%" MS.O_FA3PL[W-\@_Q[K!%G_#F[DUV^%S>'?87VVUV@"V?VYM5T'=M-2ERS'/+ MIBR'?V!M=#;9!9&W>,_4`OI4'CE@=8W?(!*12(.1%X`5UM4`K`?JBN#F#E15 M0557,>LM^V1I;W7C.C@^AT_"VES#8Z+$)&+G_2[;'M!V#N!IPK5H'G$5$GI`(]H4T\7X2XH*[A$;1B$ND*:!)"%U[L]]DW M?$Z`-&!743X2,OH?XL?Z2L?[K(R+V^@)Y50XMUS?4;>O.=3M/!W@$*;B_%@5 MFUPB<\V.W&.40+4[PP8C;(HA'QT7!+2D;.*JB59=BKE=NZ*"; M'6O'+H0FH\P,"'HB2;I-'J,]:"B=@A13^E&$TA^_1'G\.BKBW67V@!YWQH[5 MN;4)5NHL<7^G\]C,+$A%Y:$*WGI%+E.Y9H?-,>%7;8%90(2XT*O/J!1H%Y/+ M5"5;A$LPM;,MV%\!IR#=!"3!@VOV82>C!%HV`]FP')%V*TY:N%#%X04W=R@I MWEOH13<).EQKXZNSL2,]S^0OETPUB<=JX;$G>["NV8>7/&(H-[[L6,+++"VR M?;)#3@JH*V*'&"=)Q96%\R9]/#P^[G&+T;Z"(#UIF&'7`^4,=X-A`S MR2\J::T'C`U8OKTBA\VNV6>88@(IUPT15&&[5J,7H%51FXJH<6=,5)&NO\/Z M[8*U9U,WT^P344&)]/A#0MB.5667%-M]5AQR>EB*-.<.:4[2-,295.R7-(^C M??*/>/=3E*0H*>9-^B;&09O)5W1LZ_F6NDN/$[W/4Q!^T2K-F*SI^_1.WL;L MN5$I-O M,79\JGG"G#O^RK9=&!2(0\%L#W6]QX57EVYS(KRYNZG+-L5 M'[/][MQSO$"97C[K;)["32*O%.EY01PJA9T#R_#$=A/(M5!]'$.(?B9DS5!H M`F&O'`HJ629HH6!G%?"\H&.Y.%+#,CSEZ"ANU3[^6.@0-75L%V)R36"[1V3/%7179.W(BW#TW]R MR:':9/.`":O"`)8&N/@9:&A/J_#Q_*?#%-+BF.+14040DQJ< MWC,S+Y38=C,HWS'N4S4]WUN13V+V)B27'*J-.P^8(YX?%P>T/"?-<^C^W.;9 M75+"[^Z1U-Y*'EQM]323OJ.0:ZJV2T$?T*=K:[/#PT90YQ*959*&R?TUH'>_"KLL!7;WTG,815&;)Y!4N) MK7/(*Z'(:A.37S6+GCH/U"76&>IV+E>9A6G8.E0%[:,0=\SPZ^2L(FC9GF($ MT]`WP<5DDU:1>5V&M#TF=J!*L/$],L1F!QJP":#>S#*@")M2@!0[`U5!SJ?# M8]H/"J,[MQQ[XRK;5#KJ:QX_IV#7#WT?ET.;)&1[SO"$-*.XM6PNC2$(X8\" MFTM'35Y\C9(]NOC]*6N]3O$EV\-O4N`3,/19+76IYSG12.2KD.B]C&9IR:IG M.+.W^><)IMHLST*']854K\+NZR90'&/[K2':"CT%UJ1@ZLV]L0HV/F6PM(36 MZS[YU&:?',^43/^TPXVQGIA`]/BX3[:5@E5I,%%\!:W.J5E9FI&]P_2>X*OW M'!RG-[&E)!T:ZG>FMG"(4^O%#. MQF#?];&0XRK<=IGL7A&_AZ6;I'ES7@:-#-U*,/O4Q>QV/YYQ^RU\`LG. M#26[Y,8PO[-MSO!YD%FBW\?L$Q]N6;1LI/.BZC?\M=GGS*UP4S5$.T4;?ZZG M+M]?I[]YS&:!7U&YIZSMV.2@S?"D(5/051OIB?[#^O?J;))S*3CR&95XT/I8 MV/&8>\JB"SID'WAC]FG.)'8M'O(4BO`3:ALT)E(L_KW333-9;GQU3O!@MY(I M.BS-(%-;'IECDQ7UQNP3&$FFIUE'50LMA9_59V`(-3]R8?3;'@%ZOPSJ(HT5/_A"0 MXZQ`;Y*OR2Y.=\6SR/[KAT=LJ=?>2MW1&@^4>3R>*73SYA!7,ZN`!)%OS#Z3 MFR&5:DLM#BVLJ](GINO*9Y5-K^L#TH`./5)S-\5T1>I[O8N]'?28B>,%:_IM MS3X>G"<8@S[)>*"OQNN9>SJ] MR]02%M'Z]:*WYLKLS6=&"?3.'$,P.K-$4Q#0DHI(K6,B6(K54^:^6Q6GH#PE M+VE8A$5,^""0DG'7%_A'KE4K/-42/6P M-:_MR>TG6)%(ZHW9T2HJQ58]82G$'E9MTTNA=>N@U?P9J#I`X;JT"_QH*^GD M[.@%-D#Z,<)HJ'HZ\Z5;C;Y'.J5VA*YVD@C$C=FA/DKEUN00J)3AV(#L6@8D MCY.'SX>\P#W(L`9U^"IDJ_O&(L(H42I_`2`(E9^K+<[MSN#Y1#]D:DH_5,SNBB4L.+8?L/(B&K;A8R--'E&/_ M`VPF/<0X__G[N#RW-K:G+I--7Y?S*,TH1/W"7'_QM4M2JWIF!S@QH%=MDZ]WK*^)=5\TJB9GIV'T#L+8ZL``D(]\P.8&*!K\6L,@!! MS^6(/C7R,=[#/]U#H_USE/\>MX*DX+=%:9J5V<_!CF?2E$>@FJPCE3SZN*KE MF1W,Q"R#&9'?S$+H0> M^\L*ASH+B,P/-9G%W%GFYR:54-J,ES0[Y&9YZ)&F6_?,/K_CE$0+S?DP:7A& M\Z]Q90%B54-*AAG4>#_)6C+H>T&*AY M&B-M("I%$FTPL-?4V)D=]R1%/M5.D@R08=4(H*T`T@Q21-Q0`5I-S7Y*:"X1 ME4Q6IZB1G:E-F`SKC4^"X3RS3\/E"*AE(I0"M?M8G3Q5*UHHZGM,KNNI2X[( MBT:==K')SJ)6O2U!ZTI#%3RS3XEG2K;DY#8-CW=:HRHH?.%4F'#:)S2#E(UK M#AOXYFN/IL?QS#Y(GBO:XO,6`\A&Z2*J=`51-?@!T$L3*&OBXP'O::156L7Z MZ57.2[(7#W&Z0Z=];_?1_;FUGIJYBGA[?I]]_7$7)T2/X#^>JP_\TW&[\_1B M'&+%^>-2)$;%-ML3&X*L>DH8Z#>L_P[0#YS/I!_R'+68%-MH_[:B95,FPC\PM3B/ ME8*8*XXR5<>WA\D&AFWVI"\BCFH."V`*JSIX,4IJ@58U8:^Y:I?HRFT,O]_N M+?Q;`15JZJ%(5NL[V(<?699_L%`#S+Y.0R[GYU->7V#V8P4K" MZ]KUVTS=,.;EY%'[<%$DR\)-=R:%H3S"/*/K:-45N8/AF!TAQ2F))B(SPJE9 MW7K(ZZSGY$J$Y&^3?9Q?PMG^/LN1W9JZW\+'ZJ/69=!X'.XQ;X_+!F2+V#$[ MU&@"N1Y>#G5?\1#_#JH"(JS[$-\G:),H+=]'#]#O]V4MG_N:E\&["<#'Q'M> M>$5];;,/]3'B%3^?'IX7.V/[<\6:[E4;OS&#<. ML:+:<:D-'26SCVT&,:NFUE#'(?T!D%_XJ/0V2O)?49SRFZ38[K/BD+?R0-LK M5]U5T;&>YW&/3Z:*BZ.UK&#MKW!8@..;O9+F$4,U8SFPA*@LP(7!SW&$BJ+U MMWC"_+Z^/\7?R]?PQ]_/`V^M+GG%:-?RJ3TBU1BWFVH;9[TAW\'LM3N'%$LP MNQ]*F]BMPN`W5!S@\DJ8K20,;W%F=P+L1JMYQ,CXY%N8O;CG$X2=WS."Y[@@ M#1EP06Y?IX^'LGB'F9W.Y;$:Q:)$*O'*EAKR[+Q1J&[ M,M=+YI!`.8_9L83X-V"!W\C/G%;Y8KO-#I#O'^)MG'Q%KVKWJ,^YNUFKN_7# M!&%F!*B8E'5H*%-U._`#LKQQ+;,#2(3DT6*[19"%5260U[4$GAWFXX@2#]PX M3>@&23-5=S8;8I[,C@KD%T:U?\Z-J.'^AQ;W>WUW3FTHBK@L>GJO%\*;E:]. M$:9ZGZD$W,+5_)^L:5E.0"R3V8%:G)(H9SX7G)`4'V"Z\.8+,R_4^$&&D+[K M_DS5A(LJ)_#)TWNN979,&+\P>AP?7EA4!3AO:UU&!H)0`Q6B,KCVQ#X'ZV: M4KP@?@(IF1F,59?.5,'Q%1TOJ+ZCV?OWPC)IF3A$T36:LT7_B)NZG+''=7*H M=S0W5!(7YS[L2YDZ]'8Y,T"938HZ5+FW.!Y@ZJ.:'>K$A%\+?5F0A'^EB<@$ MLX^-?UPE#HYVBG:CZ7N+KUV/#JO9QTH,Z%4[)-,0PJ8(:)41/#HB_CPTY:VF MZ(G4[B;]$&\/>4YR5[[/TKSZ3Y2;J'B7I/%U&3_@6V7JWC:4"E72\92:4>L< MTTKI9N,X#N&.V=&("J76%N`@'7KKH/@,D-:Q]]1JOSI`WH$L!747N%2[$YRZ MKP"_H7X`[D@TDF*&D)_03O&Y%01309C+F@L,<"#`Q?<$Y?<-U)W- ML&&0I+.<(,QRF=T^ES89<279ML\_?F6701N<)($?6FY0]`_."#_NZMIN/KVX' M>:1C^70>E&B,SE4EJ`*V3SQ-V^QS10XIM.PLL^.A(;2V0A9K,\K:6,QDE.W: MCMATM,T.#F&680FCW`=DQ"C/IG.?<_,F>XB2]-Q>V1JVF8N]9DV6BXELD"1;YB<$@] MIB+#S6SL@'Y/LX\D9TBUA-JP01M2H./PJ=9>C3QMJO=&*\=B9>F=4YXC4*`[ MDS*.JLSSVNA]6/+AS(XNX1=F$0490S2B%\V>OIA_U3IQ&`O&=E8;3YDZL&&8 MIQ"BB)OJ?A[Q M!82K.,]2U:7;U6:?YW)*HGH2X(,3-L7!X.T+58Q78O!-87S'RD]7#;S-BIRO M&_YF!:\H6BP[)Z@V\]&E"3Z2?]Q^B7>'?7QSQQN%U(0=-9F%K(VC<`M6*M9Y MZJ-ZV"I=D]V/2YYV=GRSU^HJQ58];RG$'E9MHW=*A2-_::`O[@@()TY3I`%* MIM*7;S@ZD[3D?H*U;]'L9&;O9RB56\OTKU*"8P.2I%&Z3:+]D/F@65R@_;C+ M_ MRN6I$L]X"9YV?-6!"L'&69.1-3O*A@6^:M^1`4-8ESD#-4]QL3/P4YX5HG1] M'Y?XV^*[1(%2DL*N)%&S'W2'D+@85''R@,K:\/B7,=@<1C(KH_U,(]D%$'Y" MS8*D*B%(M@_1MY\C:,:A\X$M"GD<2^T4WNY3$OTFQ.CP\+@\&M@-&5BS5^-, M^/5.WR-(0O@;>*A^E$I0M7.W-H(.S]Q'Y>&H!F10S0Z!8D"O;=X>A-">MA%! MZU+S9NV_9OGOU^EMGFWC`G]A3UTFP/Y.)3%U2I`.59]50";`)X-M]I$RFP!Z MK>D8E!#]""=\.)+X9[E$56M1-1)UV*8>5P@VGD6&UNQ]-!;XVJSJ,(:V6:V( M2LO-,ZP]H11V8*E[P&FD8TG$99&H0]Z^B!+T4@7]`&9?9N200AN5)Z$TC!8. M5^OIK+4A;/GKJ;<5I=)8TL$)IU`C3&X]A+.QR=-"&[,C<]B%6(#'_4A:-&X' M8`H?-[)]?K5^[T*<'O:!>ZK1EX1PR+CCF1U]PR6'7H^8`5'#<-&#\[J!RT.> MPW]U#W<]=4<&K#!D'7=S"]L]R9YL@I[A.)[9?HF@1/H"5WA@'1TIM[QQ6E5B MG`DK@Q2'D)BE+B.!'^--$'-FD0G;,_MH3E@FS0$;?.B.-.WC,4A3>>:1' MG$^I1WF:I/?%;9Q__!*UEQC>1EU8YE"O\U2!79;ZJ?7!&L':"P+BF9I]],'7;Q["TF!_))#B:,X;^XZT\(# MB@\]WZPL=6M%HW1,?^E,OK2J)Q7YD,-VDZ!I$U2- M`L0^T&H6K0JZL]89((TOJ?5J7AU\:5K??;Y0#JG063V)#37\@3"?E>_:./ZZG8G98%]]E3''\LL^WO-_C; M5!G<_96ZG;#!;F=N^+)+4V_X#E9Q?=]LCW$*NO(#BO'^P^IW@`L`4D(PIV=S M,#USVB&/BZT]+>%(,K#*BL)0,V[=4`TI_5B;C48H[@;K2N^-B5F!Y#HF^-SM<=@RV:M:/]%V_ M@[[T)-4.CG/4\54^8%-FJY$!E#]E'463DJ#JC=E7XI3+?CI35[\`"J@?Q2\>$E[+>:ER,>;;F3DQ4V_B8ILGCP3R M^_@;S9('@=_F60K_N25OG?L;LDNHQ&0(09IG%22-0J7W M8LW9CA>X-!+.[*@G*?)IT5X92$-8#S05P7%-G>JF9`5P/%FEO[OD<^ ML=GWZR1(I]H5GP\Q;#6!IK11E0.P'?`4EX"V-"/:?00L2E7_!4H;%]=INTR2 M;I/'?5PT#\BX:W4[R1(`SM-5)2-4::Z,QO$E'DHDLX,&%4BK6K/E0QZ?384O M7;U)OB:[.-T5M]$36F*_BKU087W@+J1KGZ!6$7=4(V-&J9V`' M&U*O-VK<4)/UINMRRD(+*PK`EKS#*"ZH*H\3U7> M->%KFT!=$JK!;N6JP8@T0Z1OJKBV3YYU=975> M[ZN[W]#;I5S2#D@Q1%A2W+4WY`E)Q^S@+@;TNHG:A=!'4I$0C::GRL'!(6-P M!K;5'7X/="J+HQ.2=%EZ7,%U#4]D,PY<'S=[>F]H>08:EQD7D,M+Q6M(C;P< M61L^&V!K%=CK<\?=>([9MRH8)="\YAO#TC*G.R$G%1IAO)%R/4<*K M7\>]XNO*-W?U7VMTU^D%_.\HA\NI]290EVF;&\],W9(@?JU9`FU9)%6,ZYA] MQVBN:*I]IYGXPF@#%\\7%C.B^R0^M896@B[,3'O^SVPA_EEJ[@\61-_!G*)=V7V8I57 M%-4VF1-/2,L#7`&T:@A[%D,(>I^14Y.B$Y*?!^S-:CC(W&U@NP@26ZR,MMOFB&5%E]*'-^P M)G$F^+N[2_8):NDJ+>&GJW8)%3Z)V]_E/"5@%*-.X==?G#Z_L+',#D]F0*]Z M!IB&$#9%`"DCN(]YF17X="![C"'3/\2/49*CK9^?HR0MXS2"`WKNP>6R,KXR M`)A'7B$)*RJS5'9LP^/GV(5036QF)"$J28YY25E`"X,HW8%6<75L5^*W&,7V MCIO"4MGR;0>]">7YIM_.$I!&BUO"CRML_02VL/J,S1Z:[G7MKM5=]>_V)\\) M'\+?YVI7J6U=SW'(S&GVM9%)[#J7GGT`GOG%8HF`!]SR=_7EE+7KJ/,WIGI7 MLEP:31,6>:>V3'K:@!]P33_@:>[)3\JTU);C%+#G\X'`/(OE0!;9AFA2O;/X6?0C#]]2=%@E!FAD^+V<4NKF/>9JS-@&YLK1 M?I^>BR,!',_LC39=0Z#/?BB5X\C&-"^&D:Y(3O-7GU%GH-W;&6CZ(\:IZA&0 M+@'N4^*+"\IT2/'#"W\TDS3R#(/L/G&B<')SP3-[BU/;&&A98^B2YL@T$4OT MNF.)JLT.4;LR@!D]0W6/%S:OGYHB-!'&!5SZ[,ASBL6O<0'=+KBB0CBV\)^? M,O2GFT-9E%&Z@XLN;`*/-,52=V5K.<%D628#/DC7="T`:N.1QY"\4UF*+3Q& M^ORQ907ML8I=_PRTT*#58;L<100PI#/Z+"Q<1!)8>#^Y`@;*#/\9EFK`273J MEM-UQ5[?/XVO\`2,]\S^[*!.8.DV?-<6-QC(]Q^7AL=L"7IL&&^ MA8+Q/EM4W\RXN6NW1;?\L`^-^_O<$K9UA1`B5IC$=0ZV>69+]K@TJ3?GM8O2 M0#B$*6;G'Y0KJ&H'3"K:<'`]*?X&"B.\MDEJK7U]3V&BPIG@-.DIZ\AP*^I` MP^ZJLNAF'U!+E=,8-64`&[8NZ,*)]DA/JP,OW.!9WPJGF'&I5Q9G%66H?@': MW)/Q>E;#'K'P]&##],<%Y(JJQ?F6#'IP!N:\3$QVE^-=_XJ`[@Z?NX'"35X5D$;UO,@%YT)-(R?XAA"]NJL16>)LCUTH_1/BZJ3*BVJRZ55Z<[ M&?>71]$?WU9N%W4LDL9X;?@+>!/(5=OO\>[KJ_>XP*RT$GV?4>&U>@TD'+@R MWRJ*G#]T5Y8,YRG1XUUP?]5?J+IA)!CM/ M+92/7*54LCMRW<`E7#)[]TNIW*IG%97@0_GAFN]$+W,SR?D^2[^2C\#;+Z9]0.>L\L"UU\Z9>6318'X7CSF6RJ(BAK^D>6/-V@M$$),5)-0]]@FH&I@=+[_(>)RV&S@BF4SOSV3C=5K^ MW*D:+WW>VU'W[L8."*'-OL6XP&B;!N"4:H*[M)H?K,P^:6.!OQ!_VQC&&"SX"-_'7>)\] MHE:/I^RUJS!=(@.`>7P6DK#);SI=V7)]GTZ29L=(\@NCFO'N@\)%&47=@@->A)\SM9F7J+),!P;7:0IH@X6OQR`6"3&B'JDTM/U$63SBK< MDU8">9[::1I%9?GR:%Y9S_$)X:1$#HO_:?]Z?6[Z[,MAYY15#.?,Y M`2URSJN3VOK.>7GH3:HV'\+<6'I^09:F>!>2]*/@-_%=G.>#$PMZSN\ZW25? MD]TAVK^-DOS7:'^HLBD7UT5QB'?GGJ\P59H,A/.41LT8U4D,9;3N!);9Q]`2 MI52][I('-:R:&EYNX==UF^;.`&H0X!;KUQH*0!I=4+/5)"5]69K=34\JHW77 ML?U@<+:L`7$.@# M@7#U/"U;LBHE MD+%'V_(@6KVAO5O2'\`=:MJX[1>C46ZU>Z-XOL_#&'@BQ2J#6^M`'XCYQ[S'KT!6SCI%>@/&1=]`TV:EW;CEK MR_>)\VWV/HC&43#[:(I;GK!Y8E+,@LCSVPB.7[,];&8/V?4A*K'3[RD.2E$K M@5'+*<8A5K2NZN_=MVUSC^\TC\*)K;1&1-'B]#0]`]2UP=9+G2/T3^OU?(BU M6B\TF:[)9&IV"H4%1D.?JZ15KK#Y=4&+\R$I?G^;Q_%U"@[5"- MWR!KPSB\2FQ-?]]P6C4[:X6V,3@I+VE$$)4^$NH6H'Y!U?'2+M*X1IGO()VT MP5+K'/7WC29-!T^:JS^\X3H>B]-SC!BDPF\$9P=HFG)]AH9F5;S8[1)"H>9Q MU.;%<7?E>>8Y12S0%[(O8J,ZV[0P=6MYKD7R#*Y?Z+F\P#`8ZQ'QRR+#*;JI MO*"F7]#J&/Q6=2URUU*Y0IGE"KT4,R7/`V+C=+#9V#1+A+G!^]K'P6S/1T"B M\.90%F64[I+T7J\QH8%'*$'(-;V(5F.T-ZO>Z)^DR+&!L&QJ'N`?5`)9UC#P MC9`LNS#6*^8.S<#V0M=$_*-@NO/"+@KQ7<#K<=_E-?5=:+E^WP6T>@77U;WP MQ3P7)E7R_FEL6$=(F[$A?K7[0L^F^$?A)!P0=GG"7\F[%"BE3-S46LPXO#^0 ME$^;8*/N_4/I>(VQ'(/#I\!>5'W!Q;='Z'0",7X*13\A-Z0/O]1]DU9?9X#T M9HQ),7)[Y'1,BDH7I.H+3E$T0Z9K=O9BY;*?FKO1*\6`DP&B$KR)MSAI'7"L M,X!T:S$S\5?Z8O0%>3"ZX1$*,4QI@4SJ%68&C&$7CNBCK(9E_M7F9` M3LC/89=*G?=380`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`"_["*7>V1EK6BG.K8\EV:RV+SL`'F^@3!]JX]+&JD>6RO#7-4W M*#/\Y\6>(V'5+B/WZUZ$W9*^$S=)XKWL*'S.D3B)/38^F8ZS6C8V MYRO\LQ&&II6LL\X%U*N1Z)4 MO9=]"4/"Z)R^\S@EXOSGA^O7AZD9O&A[C9_HIE_[9>(:4O-&\0F91]E7+22,SNFO;Z=$7&!] M6T,R=WT[HL2&K&]?DEU<8GT[H!U+,I)+K&_[=<,C=]V]$[C$MNSHO)CU[92D85W`-!O52FU]RH&#)B0, MGS'8^BQ6D_;>H4NL;?SL8SRTE3?K%?$\'5\GZ3XTG]V!QZ-7#YV5,;Z MIX%:8K27,5#D7I+_1[^CT3\DO`;J*C5VZ=@K8`@!SS),GZ4P M,A'5/TT]PPU(DDM8_@;LF1@Z:OJMT)HI_\#C,U(J?O.?:)M9"C:%"HT(@RGJ@3>)J6;P$7KW4F MZ]#Y^P\9RSTY)"_$@>L5[N3]M8DGEEHUAIX*@42.$XF;"4[@$I:1@W;*H:?S MQ3=\`YE1JOJU-)1HQ]:5]Y(3W+);"_-'4M9>`B\21%B+7(\)3N`NU7(C8_HV M[CSQYN>X;#FG'"[G8D^Y"FNL]T_;)WLD%[5]Y+0W.(&[1+FW=F:-B9(%U:^ ME-H[?\6$9_@3+%D656+>\2"/C>^[RP5%RI-$L9E2.N3,ADHF"M^R3GP-*'\T M%O>UI(O$=`A;L)["DNZ;YP=T1R*JT,)EP@[_T(:/WT.3B<)9VROWW/97@77B M2TYUHV*&EZ9,OO!CF6U_!^3[0GM6%(<8&K.XLEV/`K8+M7B-&WIS@+[?/0&% M\1?X1PJZ?O?OW/*@UZC.]^(&--.2R!B`VB"(-!;XU!$W_-+N7-F4>RDS`4H- M_*KZ*(0?/9K!2S6^P0DI9G>F%F@,W3$DV!IH$OM`NJRUNK;*+#RC?4N8@3GD.IILA^M9 MP=J'U:!1=TR_F\$EB!;_EA4-<69IZ7\%I+SX86)OUV^28KO/BD,>?XJ_EZ]A MP=^A"^98NMG>@T,%\=G$'5>"WC;\E1.0[V9X^+J@2,LHQB2NL%VO5A%4%31U MP6^H-L#5U2N-NH6;D4K3OTQC:P-9.YM\2K-=-&&9]"W*!-#USB]\^G&YCXKB MY@XC>)>D\749/Q3GUDKA0S2]7M7&?AI" MB(N@1YG(=OEOJ!C`Y3@M..WKKQ%:<)0W^0>T4T]24$$$\?8`/TX2%Y?1?A_O M7C]=1=LOQV7/O96CG,WB\*0P7^;H/-.2&4VC+`JGH$JS1=2D;W-Q-DI)?X7? M!N#?JU226&'K]@!I$&VWHR8[M9929"4>VHM1Y(Y#)X$]GN_:9@>[8CL^<5V*P&06*-(!N5$=P'3RJ9F^Z M3X-?9%9J(Z`SSDTSX]S0^4/@&B[#!VZ.H8WD7P-ODH!H/Q6-H=D[V"SPV4FX MR[8'=$Z/C_+ED;'!,DS',\S'<^F$9+GXN!P?V7P&5,LA3O7_\!&NRE6_XQ#R. M7/FL/-I]2'ZN3D!("=[3#]S$+VE25EXI[0A9EKX8CWZ[-]"*#(8Q83MF6D\5 MI*V6X4N?*>QZV#8,H.(;*M%L(ZCB'9L#N!#Q>MR_@3K49;',CBYG0*_-^9N$ M(I>'*5Q)E\GG?7P+:1;G<%5-[&WT/7DX/-Q\2Z'W\"5YO$[A!!\7)>8`^-`VA>=O"'I'9][;%A5)O?`61A:V:H*Y*G0):&=2U055=FYHPVO%3 MT9,^R\_96+6*-?N&[QRQ],T5PAC'U.9L1&]X-Q;$F<:TX7`R>M/=H.!MBRRY M'=,7C,)2Z=G0$,87-KKP&,-.H,[><]ZA&>R<7`\DUP9_>VA2R\:F&U`:D.CC`^J!I0)]^J3F. M/R7]8I^A1AJ#KH6](DZ&8WB8]WSIEIVQF'&VSM.W9.>`GJ*CW"H14DJL=5M! MK?LISXKB-L^V<;PKWD(J(D@1_$(T@/W0HB`K;2AY&ZK8WJ M`=>\\S MX/0BBMDQRV(":;'J0M`HN1\K)44)%0"]FY46,6)# MP!Y)Q=[P/!+/$Z#B\W')`IN)M4,&WNP;81/(=?D6XS#"3U]BL(V*+R`[E'?[ M[!NXRW)`Z^#'TV`ED*3;`U[([I(\WI;[)_`M*;^`$M9-*I9#ESM*04QNW10,[`^8!P/L79SG=B'L#K4FAXT<6"L*3E;%!_1FGP`SRZ#: MC6`%$E8%`2P)VD4!*@MP855TY?(=EN9KUT^8JEO%E)CM^7)(H]EJS/]#FQW0 M6X:?I^T",@?>(YIQG;@;JQH1M`9E]9F"67+F=#!%QCP:L]BV87 M`S<`FA;`U1SWF9-:LS%J2$TU<+OY>&L7:YK]J'C3,ETNS=B,/NW M3[:-DIBT@S)"S-F;*&;HU[!;Q=30FGY>Z7&,KPLJ-)$C<4 MH5S[BW1WL<6.WK.M.4N&7S;8A<)=1@ZI6)1DN#U\8!>03V5VH)D4^9;TVUA! M3OMON"4`FP)-6_(]N:&M[MGZM/!6/9_F'#>"-Z&IXW`:^Z;\0BVJ(V/(&!2# M'@I(UX4;Z./E]5$$HA+SE3+F9M5IPA1Z%D5XU@::X2WR84YC,Y9;IB758`S8 MM!;@VI4."!XU<-!H]K)^62W@6\X?-5*M),E!O'L:N[H"4IFPC!^'V+^$S[`B MF+1Z'^#@[)7[LBK$MV(_:J1:+9+=2]?L^.,94AFP4A]'&-ZTE863\4=Q_A_B M74Q>=X)_?T@.#^?6>D,6K4HNK4ST/E,;N$6K56"BINVXZXU-WKHRG/9\DK#/ M%C/BD?DPA:_C-+Y+M@E<-C?71L!=')6'7)3L`_E&V/>4D0Z%Z5.S.>B+LK''"1^N5@6K&'Z^S"2`-M>:!8UT M)H+39[#IVU24Y1E,`9A+;0$!&X)/5W97AH<*LPNAWO8R M(@EOCZXCU7LG<+V(2J,EH,C#63Q<"%XZV0,!LF,;9/@1%+L4'$YP5D9[42>8 M%4_X/B[K>WB<+R9NO\2[P[ZZ+?7Z">=8_83N89^O_970C5YIH925B5;-Z.^_P$2#;IWW!YWA=`6VD(\*O3MW&. M_W9N>2M7(9V'^IU)9@YQ:BX/U_$=P\,V)[$K9^X$@/`H0V527Q?>1+$3#:+"GKTLC)#`_[&-]PH M M&6W,WBEA%4'7]C8P7 M$&[TK;!650L:M-5J'1"[YID=E\@O#/ND\4@&E_U7J:"]YX;6<#^&QE^0 M]?4Y5CNOY#5*%IQ"MPI^JK]"MXIBNOH>Y]ND0(N6\N;N:%(BBQF<8M%C370J MM>MYZJ%Z%'I>^B,S.TK,7#58?_MG6X:KE6O[Y*.;?=PE03HM"_+Y.,,Z5">F MU7@GFP;"+43[)2KB_'D$&W2V^UZ[''GH;:R]F?.'"-X>U@]6AN-J^*8KAQ2J M=US9H1R_@5D7GAMJ]C9*\E^C_2&^@/I#(H&+2H&PWIP'*.FVJBW6R>[GD5U` MNHKJTU71ZHW.X;[96ZK418TZH.@PJNB3![0UBKXQ/VL/#,+-%IU[0QGM.FMFAN; M9O#RS=[%YQ-D&8L^@&;$H),:DMG^:[:/RF0/O]X'J$OGP=I?QK(?XU"G`5/R MLNC"LS:P72*IMWRS$W.("[7X##`*+ZR5HRFF7$6T3PT+JPC7=/&LC3)K*`-6>KS0?DN+WMWD<5V_C$@IM5K;66:4/A7R%89-U M3%UZ6\"VC22)\,T^21,5:;'9A`%J+HK)7EE.SEGSAW]$QR/X@@9E\!4B.P M:CU5@CJL+]O?W(&C@\!K_(@Z;1J@MJL3P7KSN`#H#C.L^"S;(>G"")5GBE!_ M^3K?C6B7VA%._N=;-/C!-SL$1;'D[&9@7OR\6C$:NY`]LPO)D5WXUFL7SK!A MR)X;ANKV%F=\_E2`#;G:\BH@XN@RZ`#9%H5N_I'D<[9-_Q+N?HB1]EQ7%3?H&HO@* M!?N*[XSZ%KGCHV3';J+[>>H@(%NE"U-57<=W?7(`'9A]`,HI"8,&'-]F^B2^ M+<<'+;S\`AM!5_W`'=J0^(HW)*#C\8VZ)+NZ*M@GT6>!HQ^FN9W)TB_K?G1M M.RWYKAH7E+/JJ*D;S-(F)2'T$%?D\"`P^YQFIF2Z+/X\F)(=FZKZ1;K#UTJ* M]M4?RU^MU)UJCG4]3S,XA7JF&0/5`HOFZ`[,/L[GD$*UG\X.I;DV@:ZKDL*@ M55J,U&1_^W-1YM&VQ#:1>4.XMPDYK)Q"]9R.Q^7A3&BO2&!08/:Y!Q-^710< M`]&0CYQL_%:5$[2E`Q^8Y>:;?MIU_-W>\AX9,NJ!F7W^S":`EM-F)BCAK\_< MUX*F__J+BJE?RX\O)HW7PX%-WRMPM:QX1V*D\XR(R!R`IUX\9O[N2 M?!.+LWG%QV;J1IE[_,HC`B^;!9-*<$"2F$KB`IKXW2>([^)[4IP[;J!L=774 MTSS2CH.N_(;C4K9+@GZ(G"'WD?>ZCV@UO;_,QG M9<\JS^/--)(Z*_VSDBCXSB?ZMS%[M3V!7#6+QKL/F[,!P8=#AKX@6PI`+63J M>;&F;U`\,BAF+YDGD.O:H1R'H8Y5+"MD/:3J/B)W7!(.1A!L+#HF9J^'IZ!K M60E/@`BEG6+B6)/7L*7=9?:`4MUA%;A`;=['.+/AZZ>F#,UVB*?<9D9.=[=0 MB/?10_PF>XB2]-Q=^7U3J,04[Y(1SU,+/6-XE%=>=F^6YU;SH+G+(DW2JW9" MU(MPY!.3`MS!#9`!W^"7;]EZ=*K&Z!=WJL\-1YA&T\0?/"^+IV,2L[+ M";MJ:DX!"%L%A,-F!K\EDY>LCUI=3WE@>`(R/&9G:)G$KLM;G@*BEF,L/K,^ MBO5$3STK2ST_FC#/[+C!:?!:?.=)&$<,DY7`[3I]/)3%15'$>).T"E=)XN(_ M#[#]I,3Q5=?I798_8,7!;X!]BK^7KV$[O^-;",SSJZQ>YQ%;H>R=VXUSN\`A MH=A!<@P/RU(ELFK?01'N]AU*TC(@30/8-F@U#MJM@U;S]+D]@'H`N(O%=9S) MTWFI2M[UJ^12QR/4,7OK4I7(NKPX1?B'M3UBU';.:U/RZLR@Y-QM/W]%?P-HBY`2_5_SG;Q?I8BU@EY&7]4F M_SEE?9U:3',WO'$H#7,$6L4'&MS#6*[,W@B5)J/P@ M5@K,9F:\N0-50P"U=)P2I&IL>5UCVGTZ367K>91VSD=VR$[I-CNL^*08U_TL=(_Q*FC)Y_AKZ19S@VBV91DV0\Z367K/H8^ MY].NR:$)`FU+`#E8#U:^-T>J5?O]":J7;B5+]D>?OKB"K\T_3XKXVIM M25]Q+%HHT=TI=4&&HKADJ>3\X>@J)7^;ON<2'IA]9"I+1'T.YRR<1RK9;NE? M`6D+H,;.FM"&+*]R!,CS/84)JF2#]73U=602Y6S3PY9[0Q;$MDZ_<.9?P.\>7W2QUY*4)MK1Z/4W,TPA64/4UR.TV/Z!D;E^3 M79SN"AP,:-'+_F9'5$Y!U[6@FL`1XD\"+F?G=!S]LDQOZVIF6_?]W+[B>+3P MNG)C^+8:"WS5+@P#!JF$>_Z.^]$KCO6/M>$]]U:.IR[3@0@D"0R?/PA'&L#; M'.3,.O#)YS5[(2!#/'8-FI5001+<\'6=8^$S2;L`,M$\8/.XIB11SJDIG"5/ MX0+RB>Y8A'J_"">7CD00VO,)ZI4C7KG$>JW/'=@(^IZJ_(06*,(APE.^T MENWYKFMVH`\+?"TNUC@&ZF+=U&M(<$.W>``IJ(",[`O*Q=C875Z.5$.I8M%H MFGTEE$T`74M-)C3#Y#RC[.0\@F/Z]BS';,NRL[/3-U++(X-I]@8($WXM^W,L M2)JTI8E<$WF=WA*_9,J3V*Q\2\*TSMB?,D:+R\M`?.;&5RN7Y`3=&+[5+5_8 M!1T0,<23[@IZ1XTT7#^/!'#3K3I%78DSTE@FE6?.,B>GNCQS%AC84@VW.U#EW$7)R"LBUI&%L';GJ0>#Z]/N:' MU\$=G:GT#/PU1C_`OUU\C?/H/GX^N;;/H#.)DVLK-W`K@_[*[[NPPZ[!/:TJ MT%,V[*/*V-L$-*@D?]]F=8);8`PB+>*53N,:\3U;E84?L>A%5>D=5;LC'3\B ME3-+(5BZ4:`A@M*-J@Q;FXYO54R?D!#L]2RB>A97>O:(ZJEVZX1UR0"WKJ,I MDA^8APZ)C4-`-Y;9$69*Y=:B3RHEJ+=!.&/F#Y^+^.\'N(J\^HJR^S;/JME6 M7\8_21'Q`[W.#'AGEJ4.9Q^J8;N6`R;_;V]21VW81]#J##5'1!2?AJTO37 M57/U:#&R'KDMDW#^:_]YCQY."OP5L13FDE=(%N7NA0BJ#L,EN.'X!2QK9:E[ M#&VP6P6.>;\THTM6^@2839Y#\O,UTQ'.^2-+XNXP?DG-OJ,JV.]ZU`IT;D&M6>II[M M6N2Q(N\$+\,.B+&(1O1C&7/<4`V`J\APWMI/F$-3JFZ+:*IWM>==7=E8HY?. M+<=UUC;:S/!.(3<"ARC+.5;#H$*:GE85X)+T[+)\)H= M\<@L`SM3YUU[806DC;,0<(L*S*^LCK>E@+)C.$<9VU3$0VOVC2Y&"1:QJQT8 MPQR%115S5-RN:B8IHUVM:U8FP&P/E5F&1>UJ#R!=G+U)VS,L\^6^T:;D$W8, MY1A=FWHXEN?T?("N`$N8U`Z*07;"DFK)*6Q/];*3S9K6%2N]-WM_EE6$)6UI M#QY-9/T8?XW3%@^8GT2;:$P^7\>1CA&V71.-;F!VP!.K"$O8U!X<@T3%9553 M5=BRZNU]-S![H"+&);GZ,8IF?R72TYQ:VJ5G8R6M2J8J7X9@>9L8JPJ#7MXM%$ MUD^0D.UURWJ.+6TU)I^OXTC'"-NNB5<#9H<)L(JPA$WMP3%(5%Q6)E6_9:W/ MSYQP9[0I!30=03E*TKH>'M?3LZE=`18AZ',4P_3\E@F2LXK2O?K^F.1X$G@3 ME3'^WLQ9@?O;F$='9EP5#P)I"K9MYX]TV2S>9W@`K(I1F34[D$ MS[IN9+?&SUE:?KE(=W^+H\KI\HP_,FJCFWZ95I&$52O MC1AQA$TY1'%<\@R0LJ`NK(K>:BX'FD+O[O7`R:J6$WA^0.ZOG3K/G\FBQ07F M116^/R#[C:A?$,YOI7*>/N4&*>$HO$@UVK<2M@_*-4'UJIYC&1ZKRH1_(1M^ M!&+4@`N]7HM3$5792`I:U,#6AC#PPJGH*NV MT1/]]^0.?B>:<^-95W29"C]J7W2K$H+*V/!@E&*`FK2XY?LKL^,'1W%K)N51 MYSV,%-K$>-8'N>$-/Z.Z?8N^'J5R<4"&`2K2E`)0S"AR M[_]Y#Q`9SL+JV@K3H0YT*I>,@Y(,\;&J@/3<[-M5$\AUL_*X^RXQ40&A?+T] M'=',JM#(J$LW/=BM=((.23-"T2JY+QQKHB.%?_G]02P,$%`````@`6H!.1.P7E_32,0``K%P#`!0`'`!I M`L``00E#@``!#D! M``#L74MSXSB2OF_$_@>MY])SL$R*>G9,[:S*CU['N$H.VSV]>]J@2/A=-Y0]3#Q/URIG>U MLPYR+6)C]^7+V:^/Y]/'R]O;LX[GFZYM.L1%7\Y<I\JXB)A-_0;_Z7S[ MM7/^T;G>.S?T[H=G;TD\8B9YDC.&<:>S09D2!SV@>8?_]]>'VS2(^:\OOIH> M]F;S>XH\Q,3*66(S!\.\4C3_'BQ=!A` M%^K(N$*^B1U/C!I;+3F79+'`_H*1XDU=^Y*X/K,29BT8B=!CF59EY(BCQ*A2 MCI+K$0?;W#%\-1UN(H^O"/E"U#Q[%1%S;U(&W"ORL64Z8I0I5NXX:8],N5$@ MR=G\TO1>;QSR+H271ZQY-63-EH@&%BA(%U%+UA6Q5IP2ING73-']]:T[)W0A MZIIL$V&U!-V8F/[3=%;H&S*]%=W`)$#)_&U1`2'B#H#1H]@!)!+T9#X[0FZ2 MT>.KI>?6?6,4$+H6!P4KAB0B061NH*F%)8`5XW]'/.\>T<=7YG(%IG>6BM>` M^/SB*L#(4*P$<3J$A<'(4"R.[^A]:EED%80+]Y2X[)^6L/MR3<7+(`ONYHA2 M9%_A-VPCUY;P74M;L8B.B1&B0BT1#\CABR^+4/SU$S5=S[0$5SFZ5*PK*:2( M2XA1I!B=P'SXWH9%O(LE8B1QBH3MR;,40Y1,CQ`E51#"-ZOVRD&S>?+OKS_X M/R7\HL=B.X_MZRLFWB?6[[,E_W#*5/"-!8"2)!,3@N17XMB(>M=_K!A%(J0@ M:"+XKI"!Y-J1+PNPBUFOA(/UD&6R!0@AG.AW!YQD<3>)(-SD'BTA6E+:^*X:H=6S MA_Y8L=CGFD?)0C2P'Z&AF=HVYI9J.K%=[O29K/PBH)G8?+=U4.!DR!$A91G+ M^-VQ#[9_@'V'_86NZ9WSSA7V+(?P#2;[(<@4=LB\DY2RY!0737=N:$0?/@L& MV:(7T+BETB%6^"W'?$;.ES/VP?_-Z(OIXC^#07:Y%+QUR=$$L_D-=DW78GYC MEV:9/GL^95ZZ:XST85?O=4?[D,;SW'/3>PXROBOO_,4TET%R_`(YOK?])$#_ M7-/#W/%?PH_5D+@/D,,3WX1NI0B'T$[J3TPH7]EXOW=U8]CO-1.M!'*%@(L; MP)1N09Q3L@#5,I]4(")"F:<+SIKX_\XZ2XH)95[ORQG[8>4Q4,ARX_VV9)G4 M.K+A_0./\!L7RR"M>VZ]XL/%E'V#3Q7&1'<;=4P=+QC,9PX9!=^,O--%HGL2 M]EQ]3=1W=7X*?>I?RWBQ`[_\ZZ/@:#09R.4_`_Q5#]@1V+K@T/W4KL>+!CNG8G\;PRUZD(G'E*>Y6L M@\N(@TA)=&TT`3,;*5**>PFA:7:KY4CO#>IE66VT4E+@6Z]0',4?V#/TM>%Q MR)'I&PJ$'N*E"!4YB^$).XM=7HFMG=A'=VP=M&^9@-T7_.R@J>>A\#RUVQ^- M!V#LBM-1HY,8'CJ)8NC5Z"`$-"*#DV_FOPB]=$S/^VXNT!59F-CM]@P-;LF4 M)*:X'=RSD,_U'_#+J^_]PR7OK^2=*<8=MOB!Q?2%HDTT^0TMGA'M]H;:.(GI MI"R4W-!*M+NT"+?Z71R5$UX$BUH'6P[1+=MU>!Q/N#VH"`4E[`!1"P7%M;/Y M`UF;CK_FNZ%[<\V]V,S]COQ'TT$>%_:D+VP"@J-":W^&B"*5+P+`#ZCM7]<[ M5S+]P!Q170<+#R0(*:[[1=UFU1P77OE*6$Z^N+<&5`+%Q@1&>4"5B9H%<,H" MNS$8E5\>J[8;N>6Q9AU(A"L4?J\VX9=-$&A:KW/>B;*S079@5P+>":OF._LU M_`(9@9Q;`-*)@(T,+E>48Q+M`X>`1PN),Y9(`IK>*]_9LO_P8_XW%K+PO:Y_ M:5*Z9GO=H-JE.QSW#;C`+,1@8*Z'!;7P.CLYBEC26`V5 M<]A\Y22^Z<@JYPZ7G@:\$Y-21S'AIE*?*-4$O]76C<@])4M$_?4]V[H'EZ[9 MMFS)\P-!E#;H;9)?0$M2^M15BEX8@K;N01X00PA;/K*3]^??B6MM%^/!Q(`K MP18GI$K]*`A/6[)QSHUQ+^GP6>'& M]7#.*H6=SW2[]R"'``&&\*IV'2P&'XR`:054P90-1IRKMNXL@E/6\-)W>"2M M:QM#@RGL/)JO1/4FHAAYT_W;UV$UUD#K&7#EFND3JZG/%!!*5(0I!D*S#\XW M3'Q-8P*NSB1CXIHDF0M"[:?@`I*\3&-B#"S)Q(EKDF0N"#5N3P0DN>VMP#DY MR,D8VA`N`94^;XDH)3SB#.L8V0:2?4)7;$D]FJP[&/8!ZQS$"5&BM3)"/#P/ ME@2KK>FY8#N2P+K>UW3@75B#E$($A;8FYZX72X>L$0I;="6@,-$G([C[QGG3 MUZ844L"T-1D7.L=_FIM^U)%G'!F@RTC"G'6N&#D0M#5!)X`62$H$(DA*\NX] MO0=W`%Z?)SM*^.3P?CH)1[GLSR;5FAK=L<5]!!?H9T]>;Z0CADD4\@Z:KA:% MO1J+_H/=ZW[3M!B(<(N<*!6J-462Y707DJ1K;=TE72&*WTS>1R:&0^SX9FP, MX#0E9_*&*(@$1&W=207G*@_(QYM6];-G![]LF@O%SXN\]WD]GWRAY[)K>@84W4X(KY!%N,E:; MVQ.$YG2V9'+>+@.R`626L?'QM1@PIU.GH781Y%[3&-2V^C5O&Z7;Z[?#_0A8"7,WEPE2GFVX\2/V8/F#P-]5`'YA],JT><\0>P\FP#S M#2_@V;)P%S5N8.S"E9$=SU>/Q!+9;7B%3CKM0($%K*@RV-@OYTPH/&Y!-DXE M3D6"M+:FJB+<8GVU[XD7/!82"SQ'<%V_1"A0:TI2K![YPB.?V9@E2QB`_.@C MVJ5FE@,VAO-$U=ZO2]PT?-'[PS'-MX'3?74?B:!0P7QS-6I;T[ M?K;JF\=]\P]])AL5=M%+4",H?E88OX`LD%3RJ2U>2\! M$$[GB$3V2KS/HBID7YO4Q>Z+-[6LU6(5%)I>H3FVL-_5A]H`KH-3/@&UJ84D M-C_P60E(-AQBF4M*5H\,K5]?0[SW;^>G^X"F5^1CRW1D7@=*Z06\-]X^DS(O!)W\ M;?%/:SL):_N\]_]Y[__SWO_GO?_/>__52_*S?.2S?*0NG;O[+!]INJ,_C?*1 MY)2RXY!WOB>Z(?2*K)[]^T0?7QEU_!P9\$D!,2(J5Y8"V+3UX'4?BH!O;[KR7QES?R*;]]'7 M()LY9TU>LUID8M'\0TQUZG#K>:N`_6'B`Z)PJK"9N!%JD(!!6T\QD]B?K7S/ M-UT;NR_<#'2X%@LYLS="&=+0:.NA9:P@*76M'.D&[!7`'`(J5PQ)4$[G1+"P M;APMF".]7TFY7NV!@R`(IW-]JZ0.A*LE4W^XNJ>42>N7_3'SH=S'K9=[?&$< M0:98LF:N7P-28`C58-(V-=@K^-P@P"L^-;CB_(09*Y=Z'M?;O)+6-G%_7C/Z MO&9TNM>,RA=%#;**HJ)?>!TR[_`WGSHW#GDO]C3Z;K#9G`^U-Y)T)=34_M?* MVW0I>2(/R"),G8.'DV]=-CNZ(Q[[G$]S3\D;9F-^7?_J\7?N9TM$3=[29&KY M^&USUS)2?@WN82\(@HN?Q%PAIAC,`02FXMK3!:$^_C/XL3LV^A/`5G&I$RMQ M*$KR:#CP6-_/G:#>?Z<*+!I=22)ST]W1$`KZTY608G M#S?1%=K\-P9@>+\F0J\'V<5;G([34Z]B&+=U;[^#_H;0/3<]&!M&!6O^P;2G MIT]""$;'RBWKQPR)-,P5VF9%F[^ZS`ZE">(7*HW4';?-6!4)RF/50\;Y'D-GC^M6NS@P!L!N* M"`U*S*J49--W;'F(-3^OI,Y4MB_0!PW*=6-8J=K$)F^ROJ1BU/SZ3G6*3%T[]JP]0Z=O`.Z^BE'59-621[7YR4MU.B?R8BNW2*W*7*8( M476IG$"Z4AK3MM8D)L#+;6X7%`0PC,:5QHL'%#39=66C%2V-C4U9*MQN)+^L MQP'I#ZH\94FFH\'.2`2YR/\T5I.4^I_P\N$^&KT)W.T[83J:KD%J<61(:;`V">(7'>JV7J$"\\I&90!W#"!-3X-52P;)J!*\9?KU M'?E)J?"P=C8Q%6[T)W"E<_+T%$_?LDDLA&SOANG9;R:EINM??R!J88\+OS\> MP3GGK*F56(P*N<:..,1P:NMMRC@`097T+&##VZ)@=_6!-H"\89LS?Z-5)A^Q MMF8UXBCP.V:\V>K:FP\0;Z/)/V$F-9G`)=&*$=5H#2N(;7L;A"1# MPRMGT+UC6D&9`[=`#;([A`@1)Z-6&=@U_^"I\M`0)D5;96SX@);F.KS(\YWX M:)NB9Y(?&QH]J<91-/5\'W%_A3FM38++>1IBS3_.5[J2\U(:+Z7> MT1CT`%8)*9'E"?_)$IM8?*TP1FW6)J+]FT9SK,V?"'P-9;J*ZOM$'K+D2 MIP32CN2D?NB595%L?G!<=OV/$+EELG!?,*_C"$N%^L8(L,(UEX`3T*)LS)KO MC]75+3PP."FVV"@<;EYF-JRT>&]__N:ICAQBS<]$%]6<%%"S[BXP4.%B0GEZ MBB_E>WS@`X=Z(G8D@X]D1\^U-0-=@8\,_%F.GR)OT=,7/;A5J(['!M],/YD**G. MVQP]CUL4L.;OM`J^FRN"HJZ=ND5,F3.D=,W\7M`'G4FV;\!Q)D1#=4:P8S+; M"K)`.IG:I65@R@P7ZDM8P6JY=`(<36>+XZT[)W1A[G=4[0W@MN*"1-08JA6` MJ:U=R,0,3V^MWP3AK&E^4R_I-_43>EEAXS>O79D<+7$MAL1NI^;:T?8BZ%$> MV[`-`7>[HF34N_@>QOCUF/X%#4>DE,JD<",KKURWG=':W$FY=$)2'$52S#R#?%/96C*W* M0\!6.*G35J*^1SDO(12B<]66-1SYA3*;93'6'/M=71MMBKU!'%5LIGK<5!JK MIU-#(KD*$9?LK\#;%JJ[;?`$SLISIZ_'VJ50V44H+3/[:Y.Z#`!O^]#Z5]/# MUM2UK["S8I%\=Z*-X&I&NZ3SV:#O(>T!MR5^@70FR/179= M?=@;P34P2YJR'@7(93ZJ"FZ9U"^)Y\_F`3%:/J#,XCH0\ M:NI3((4;%V9B!':O3>V.9;_U0-21X&">V\62\Z;W1UKBFSBJKM^+TU*)GB>] MAE,4KJT=C-OW@M=>NF+Z9F*']TEY(K$V!*_,*S#["F(`GM#0X>J1):EI0(9' M$K*=)HW'#=6D8ONKWQ!^>66:-WUCVXD7]'VU>$9T-@^B1V^V\CW?=&U^4!%5 MW0Q&<`V^9*FI9^4M@]DN[&[9VBR^)87Q0$HVZG*<,0]A3`"3XFGSJCGEE)=7 M;O9A#Y"V9J0V911!R!'P?NLR2V&?='5]#)B)2INV8F5(:($M`$=;=YW"S\F" MJ$05S_.6T`P9<**;I8T-U*%71:"F6'#+XM;0>7H1/?O1$J`/!X#M")-GK5C5 MDSK)Y(,1Z7AC7_M:G`6AB!Q%RS+,OR"7 M0>;P!XWM!78QAXMG$B(,M"'@(V(YL]>E$S*@1(K1^#,L.<7(.H^)'<<<%D/I M8\V`TY=B1"E1H_)G>B(G78+(GG`;PO+7EO3.>>>*6*OPUE+T3P9;Y]IE7UMW M8BU=A.\K;LKHOY.W"1GACQ.P?A[;+/MH;5HDU%L1U:X(I;-9H M5@*RF3**;4[UC6.^L%`U266*"&=OW"9()XW1&K,C$J9SOVU#<\5BX!QP_H)8CR7/^[N6#$CP>*I)8T?!.$EL-VC=U"A&5V MB7C6Q[EE2_''/]":43]4*K2#\9LCM73&:^SQ*5).OJ)\B!OL6:;SO\BDD:\8 MJ#*WM"F:(#P!]FOL42FQPNTXN&&?>-V>IDI\*3,T07KYS-?8UD5:>)NU>LN! M*K^9.D?S!)@,0(WM0(27O1OL('K)_,8+H=SW&TH7O;W1FR"V;*9K;#`H'J?L M2N&/LD5=?:)JCYT_67/$*0C)=C^N-5.\3]3D!#^N%\_$Z>HC56YT;]PF""V- MT1I;'ZA))NK:B&<0V8K@$&]%$?OAQL2T$W3![7Q#)O\PZ%LDG$;D?Q_\>=)? M2^'\M9[/A*(5-=_-.9H)T(Y5@_A9,VW-G M+U4!%7O.\;B9.-O/3G2XZVQYTRLQ97GAQ8J5Q-%I:[U?,NL)<':'XP&'90$A`#R'9J0B34K#/2,+7UNEC$]M=U M;/F^H>B/%7*M]?0#,Y\[&8]S-F<*`LMT`A0$S$E#7Y&%B5T66O;R#AD5<)=. M@-K@64:,1S&T&$K-/N>/(1']\[\QHKP$>GW'"Z!#,":5Z'0K5VCN>*1+= M,"]+IE;!4TE1K>I2`L[2=B'P3D3OXVRQY6U%*79?OB%>)L>XT:OU=8<4J-4` M&:^>*?X,G$Y$ZIM0B(7!=]A\QD[0OSWDT)ZY$7_L"]^)2[<_\BI)[XF'/]Q> M\C*P"E2C+)EJ]4<]:$=:)NRDVJ]G=]A%P5M7/)M7@1M20>K)Z9MJ^32F:K!) M((L%V35N&<%B2-BS!64Q9#;'M^YRY7N!%]:W"[YNP&63,R8&BXSHNA!?U@5ID&[,:N:$V-D@H4D*W7T<:CV=F`7U*J6UQHI$.,Q_8$?2U_K')8R\SZ_+Y+HN M4+08_6W90L7=0,=K1F^BPWF,C(F+.XQHT`?S_9O)Y(A-Q^-]DS>7)&$9B<^I MQ("E9!/O'IT-P0G;H9CP?R/T]UOWGA(+>0'K@(^6)4_:`/&G@]#6%%?$^@WO MVL16L>`E)\ZZ#IJ M3'./^B6G,GPZJ:BC5LGEKZCU4Z-&^5CQ,TA,XR:V8=''_4&5_*C=\Y5;,_(` M.>'(L7PJ*-T2Y9,_T9^63/BTRS!WJ8=H^+!MRG%68007THF249_!%@+J!S9> M73,.C9<_GM-9(MH)6A`(&R[_L^U3T(6M]O!-Z4C@^F@(EZ!,F[6XO1Z.&+NX MK`&>I:1.J\0@Q863]D1X(@P_L/7U->,X^;EO?P4RH'%++'U;V_6QS3OMXC?T MR-/908J;=\4+JXH&FU[1(.?">9.76$\192-=[?>]#TN>!EH/KEX^8V(E-BHM MKUV_=R%$FEWZNF'B:QH3$V"Q)D[]?2 MW#:.A/^*;KM[6!4IB7HV`/0#!MK!7=!`ZY;A^-("-?J$XHINWI'+=8^3$%$2KW5 M(#5>-12',.ITL0HM7#`:K]*UMF.?*&K'8(!KLV'J0(.6.47J$.8,[LVS:;I5Q+C0Z M[]?2W%%;X^L1]]9F3+I`PJ/(8*9KXP(2K]%V.64#*<9R0`_3+-=#TY"Y@JM;4#JM$@GF9$LBQ#P8Z&T?.ZWAIXQ:L9A..2IHQ:MS'_>S#I-55)N=Y<*SG5L)HU@W,;E4S:O?I9 MBD&/JSLT=^"L.:RI#6RHTL;3!H=O"WJRLCN(@_:,UW$1W1,]OC"-HANT M=)=+.$-+>-+4(YH=-E*FL5C`)0H7YVN01??PX!P<,MREB]GP%OL!33@_$GM* MY=NUC!-)$&P=Y7J_@KA/)G`15'O7I&%M97-\>,O])0QU7D,Z/F66U.[U4Y'K M(0EC/Z4_3Q2U@6"(X&QX_.L`E0<>LEF*2?&,U(;M_+D2CLTWV7D#]H]X+PF/?H1?; M\8G!Y0L^Q[#";KL[-%W-UW"D<2P`\JBO8&!BVQ>#J,=V8ID=\`T=\#;.O6K=S*%I\QP+: M(F=Z'"#1//_-.K>ET'2??W^P`[2?D)0@C*<=FE)$,^'H2#_)0-EQ&N;$I6N] M><@.&W&7G&M!.G$J??WPUOZE6@! MVU^VOP\S/(,_4(`7BK<5V4@[_)_W'OGHYG0,CK:[QSNO4#-T80)&Q'=&F"*? MK5I9+;[;.^7W4.,44WB3)&CDOSH[5(+V@8H'S6FZ0SOOT77^QF`CC$;(XAQZ M*[A*8F#K[LEF@.36._:XF/PZ0D/58%0*%"H%W/-F[X:,]*]7@*'7#1>G]8&D M$/AW?.HL#*OHYRU_F\2WP,1[*/]6]#K\EX17F'U@G2EBA;]'$S;U'2N25*!, ML:[?/(JN_CL,+!",0DO7TK:HA.C67FVH"S)BI>K/S.YEK( M5\]]#=^NY#4;W)-F6MF_D\6$5232969*6073S`B6J@GUA97 MAVJ=``,RY.>5YT^9!%&X:-1V:1DW#!^?A^KLB[B"CPPFEI&R/K4V@!9M MOC7T2U+%<>WQN[:FPQY^,*(DU>YS!&T4035;KN"J-E9.W324XIM]0$%<_G-F M`=9Q.I].R4X09$L^1J*$]J&*\!V&$L]"ZE)CF!86"LXTR#' M`KH4"D%\AJJ%1G$8-&+(_Q.1$GYY#"P#\*U:-WN7`B*"S%`UK9KPG`B(&:0S ME&L)7Y'2$BSHI0E M1R7-F)@M+;AZRA43]V`+%NX.3AP[[$RJZL:0O'S9$E4#7_'&'NHCC^VM+H8- M9MU]U,*(E1/'IU\.A75J+FR'\ MG/2\EXTAP=[!FK,;HGH&Y1TB+PD,\4?/I?P\V8=[Y#\G[)TM38.E-CN!3_>! M.8MV`?Z@[<4-6OR;,&JHUOHFF.9/E.WCHX\>,8.O,9J.&SB[/^S#">709'D. ME8N]T+(&*_#RS.GQ6Q'TG-_N]TY(=\KOE(F6L8)[,($N?;!;0(AID=1;H]1S M90EG(03,`8==_*`E7X!QD>PO1]G/0QB]BH@_YCJRJF9N3&/#$GP0+;YB(8.6 M85X&1`*\&IP`$[OP=1"%B-,47I+=\ M-L,W$KOUX,1.S;8EO8)#0&EN0O[I05I7K`"[N+=`@MZBW38/H\VP&3>#E-&5 M8`G85+PE*M0$U&C@Q6C9Y)[C_NB=DBU850WQRC#@RGYV2]RX[^!D9?1[U3[. MZHZVA;ZF44XJQ@VF@/NC$ZV6KU]/8;+A<@/8U$WY>G7;'97160"J'8-KHQ(G M>S''8.(K6-\MP$O&N]P94CP>U:S:BS8]9B!-O*K7^RZW0#77!JT(R20OU"JX M9<%:,YKF`.R!;IY(:8:;F!3N!:$CANV#0D:M#9;Q?B@AO.?\#>/B0.]QDRZ[C*) M4!TE_0Z*`.)HK(,.3@F]B,8N@9.T7KO&FL"KL\>4CDCJ,L&`<$Q@UK/O!N_[WLPUJ MN1=O@C'[K]SQ=)[VL#(,N&K^8.ONW!K:M&`$0.16!6<'[3@$C>XIX2Q%MW?) MXO5TC?M*J60,VO^G'MV,]Z84W>5FK6_`F#1=X[Y3*AGOUHVGH@B!:?2@#$1' MQU(F.G[!PJHOQY!&X:R",MG>0P^L/1]H^Z'2_F>+QPBYPY'B_M MRF2'QXO9HWJ%X?%RZ>XU.URLV7BXE`G<_(`?_)5XT5>/-UF"36&%_3I`4 MP?9.D!J&ZF]\V(2'B4N?)?70)D6R8OV;-CO?[;R3>W3\!M3 MI.9H0:B+;S,%:.A?E%_V=54)CA.<(S)3(Q^Y@?43B@JZ]:]N#R$)1#]P@@#3 ME06%WYHD-+9V\E!#O?[=:B!$XN;XA/P(CX`",E[*8QHSZ_);0V%,XGKPJ%+QLZU!<4^BN-]0INZ>?3*9?@,@;$TEM)<(=/ M;Q[C2[X']XNH7 MT,(C9',NG8*P]*A.#.E<)?X"O?+\[RZF\1Y*-1_PC+AL_,'S8)'#C>^'>DH!>]ES%V&V@]JSAMY[I6-1*)UF%I?#/E M24A5)SB5HV)BE;N;1THKV5G$0F\U,K0K?'>=8T1'$)D7\.FT9K&3>0"7C0+' MFC*9R]M+:NC2FS6)T[Z$"I.7.Q4#=<<@7NKTUM2_(=]!P44^OB*BPC)F2[@G M6/G$K=LF.4'0G)-5?8J_HE_T3P'I3;P"K$O"M8@N8D@DX(GX;4Q7EJ8J;:-( MDOQQ%V9-83S1[D04?:SDVX<#VG]XN[1W3_GO3E?&'#P\2GYY78B74DP3P5L3 MR7NW@A=?JM$7`P(1*XZM$[$[7UP/A*X*ST3D-G,L<\,1N6P%8UK7%1_[]#-2 M3L8"KD['FK>3NX\+A%0$EOC<&8X(,'=)KM9O\L? MA9B(`)((Q6K>-WU"18;>G"]#+W;M3;R'R;7[3URK&50IM&3B]J1,@5:J2$\/V[&(*9+^^V==F.8>S!;?38DV4<;'L"X&C M?^DSN6=977LLC,$,KJI*W>P:R@<;&OV#0-6+QUGOJ,UBW8V@`/3P@A"9?>/RO;(ZNI16:AT+@1.AUD3X`7*TVI=F2(`U\0EZ"): MQ(WT'X]@BE\>P5=TO'G(U;@(78JTUA?W":ATZDY/3C@0$]$S-1<]%2=N'U)] M*O)<*-=O3_[NR0Z0?Y9U0,J^L$J(5&2\5(W7=>X+-ZUZ6Y-O7I&_/1R\(TFF M+%!A&JP4"R;'*@;JCE6\U&GCO1GSZ,9R#`+E&/A<8'JSMN;19<$^)9E+^N[Z MR#XX?Z/])[Q+/GL88_<":Y:OF(&O-`UG;9JLQ:D1N)KIE4@<-^JQJ`EAHK\A M/I]N?Z_4^,'525&QR,;#;=U]&.F2W=VU7FZ"LK4VZ`'=_>[#= MK_8SBIXI5E0_'T:]!UBQDL.DFO?<;80:`J[WXZ&G\;<0H8UEXM)#!A8-SF/0 MO-D&G4%+) M,$.U:;!B/YE,+_R\AVROAD!_PY)D(8C1OMUC^W;3Q^V(A_79K"80PQ`H8R8[3:>)&&K`&:I&6Y?TE`.C6:5,QJCZ M"48=Z4/ULPPL^88,^K&8@B+08(8Q0H<)-G7T:*-.C>D:HSMK>.XLQ5X2B>$28/(D?N@DZ0,KIL?)G+&N'L2;6OZ85_:H MYB>-MTU$BW=!BQTVU+!921^.S"6B?XR`JDLD;#QP[89-WNJ@(M"SBJ[S;S"A M^701-#X+ACR4O3G05=@V!/>XM!ZC\U'>GK+3DQW&J1&)`)ST5.I'H2@56E)X M`I'V(!M6[*/H*=V1=BQRVN9H[`_CKAWTPN7_&__%$' MR0]SOQ,/T,V/$V2,4B9@/\&261L$Y9Z-F(F&6#=5C:<8L-HT=/D0DF?7-^9VA@[L32N50>K&*36&''?!D.85> MD9NA9-V(5^E@FG&KA,H.6]PI\@B:IE'KF)?Q\N5=L8H<>-1(F?*/I1\I-3)D MYFM@B4MK0$429$8=NV"6?CZ=RIU4R0!&SZP]8!DSP).T?.+6KT!. M$/0V49W)86HCQ[((I[^4S=K%5<(!0*]8F'0\L&:`P44EDW;/0!;Y'79KEN-? M7!-\!ACL5SHM"`]+A;*"C444-+\5\R3$5\',9-E+0)BHLL@]OU26L+!(?Z_8 M5[P)VHBO%[L*2VP1[BOR`XQCI,B$3<3#CX]H;TY7\P5)_'(R$:8QD00F,/EQ%3/K9=4,`#I364/89%(+'DA[;E0)G.Y`!2(\ID[ M$P<^,'H`L``00E#@`` M!#D!``#M74MSVS@2OF_5_@>L+ILYR!+M.!F[XLPJ=KRE6B?RVDZRMRF(A"34 M4``#@);U[[@PWOGMX]__]N$?W>ZE(%@1#XV7 MZ#ME"D])MQN_"@3W0A?><8:.^\[;;O^XZYR@?Z'WY\XI&GR)!)^D=R[=&9EC MI+"8$O45SXD,L`OUS)0*SGN]Q6)Q1"47>'GD\GD/RCIQCD\I1I+[@D MD6>K>`IT5/+@/1`J`M21%`WT0ME5[^2*\T)EF.CE;PQT+I]IYN"JU%3 MOA;P;$YA<9)8XO3^]^7FWCB]`VV`D&D%S!A76`$-S+/D:1!0-N'Q(WCH4_;' MN?XSQI+3:"OW*0?;%9/1$N2 M>1O3DGM6W.61"66TOK=`_B_L+1^/B5_/42#Z%W94((B$J+E#-P2-/X6_-,(' M`(_TAV]WPW7C@G'3)RRI'$UN,][J(.I%KAGS8%>^GI%9M777'7> M^BI`4R(@4R'KU>*G2;-;9L,549CZ,D<*SR8KWO;K\@*]B<'\TC+D4`RYY/,Y M53H?E0/F77*F((.&VB'8I11QL6LW;KPK\B,#`T'&CG)`6G8TD!VE.`(DL1Q' MWI7CR$:>M/&D"8QADOO4T]/K3]C7\\[[&2$J2Y2QM,F3?O\8B'$/WC33:D.2 M%`.*0:`(14N,QA'C%@,(-2.*@KMS++&:K()@?9J@-SE4;3QI!&U6C06*NZ%N$$AL/T,2J99#-N%B7E@R\3"A=FEB1[\OCP/7L.-=@;<4)8\X+%/\B11-DER4CM\H#<1EI8A!V/(D#V"95PL4SY8 MS3$+M^7Q8E5Y.T(TB`G%48%:'A/6AX%V%#@X M"VZXE+=$W,^P("D%_,#JXKAC5CUS'-#UHH`(9&INV[\)[5\:$H`&E@>%D_*@ MD&=".S(TBQ/%P0$H87EXV!(:VC'BX'SX2A8#U^6AV>2^%9S!1[>X$L6PY5-= MQT5>``R4XD!Y("T[#L6.6U.=(-X5?:0>85Z&%';/=#G]7XN<6%6.5K6W3&@. M$TH91>!93BA^+2<4%9QHLXK#L^..^'H/\A8+M7P0F$GLYC>Y1&`ULW"Q&#J=?CAQK^='&C\,SQ$&B:?/B0 MED\'GQ;980!T/VD$*`NAI42S**%_G.>%/AE-JM]_?M(?RZL=TI5)-#UZ9RU4C'^7]J@]`H8J+C[QRC0#P$?+SSQ!Z;H88Q&Z" M=%;)B[CR?Z*H^I8*!Z-".);D9PC6?=;;K5D>.,<1'V,R=\!V,>JA]8P)RWXC2A))CBA>?835'.RK_`K`HAZ$V*.'LH&6&- M&26@VQ2ED6S3OY4$>C%OM2QK$LS,XDH5W5P<2,L+/D"WZIE8B6X19',4/EU+ MCM+B+.R6<$T@7'Z4JZ"2Y:CE5-PK4!SM6F(T@!BE2)3.RH01W(ZL7^4_JQ\Z*$Z$F7GY1%H!,-?[E"U!MY&HL83#GR%_3A5N:%X3/W* MI2!-N(5OG6[52T%;Z&8@)^D56H%NR=9(LI66@8CE9:!:T_UV":B!U-@PK5M8 M#S75JX4EFK2SMI>AS(=>\>+)^$G^@DIS/26=!UPHQ"HO#5UW>V=TW^@-=TUA M&U3TMVZBU]6/NLYQ]\0Y>M*'BGM[P5BQ<$<8B=Y>,$QY,"4]FO+'GD=H[G[1 M-3@J=?2';JJ\(X+8HE/SS5.U79`H:-M/]W1^]86L=0!D-;]&BAK(F6X$Y]VS MX>P'Y1DX<@U+V2.1:F<^9-3BSWNQ(GOQ[13CH#:.2L4>\95,GCP;3_DBWOT! MF;+V[S>)U]U0Z(BZU(4?[])<.<75MVY:S+Z`]$EFL=R9/EF]Y,OSW2-5('21 MSBY05DKF4S=5WS_(GT59#"-3?12K7L_VAK9\;W7!LE%Y]+'4EXFR<@7 M,A\3LC4)G+Y"F;#F+:;;&\4N/%*1RWOQ)0[;ZV/A`QWV)< M)/)"[$V4]L7_@^B_Q!L\$H&G)$>ZFHU7KXC&M:;9/S$;)K>A<&>0>(NU(;:& M;/,"K@&M^_%FLZHD&F@,I*!"4<"4WZ+[@I_H/)R/%@QF[C,:#)F".:G,M]5=L*ZBX85,/83==ME?MD/>FF=;_5ID:T8S"0DIB+R!/ZI,/C9CZP5Z)]IL_8KM*JJCA'RA+REO!74(\>2WX7"<'>I$B M/JZ9VKU=LMJ><72-)QA#QN8V!3L,@(A"%!;+&C:F0#,!=LB@PS)B=J]_4#6+ M0U,RJLBO1(TFB>8EETJ:M;M,;F6YV$.GG2.(7@/?Y^8JYW6A?*-0XZ+Y+FHKCXR/I@*$OU.REFZ3W-*G71CD#M.I$^AQ],EU*7,EN93ISQO*%M=4>Y7FW\#$WP?&IK\/ MW\D-&]1?ISNHW-T'!9U7:?A(S8B(3:CH]#54FFMVE.3"-'`TN>-+[*OE'41M M,$W#'3$89N^QG[.ZML;V@3C:R%$ODI2OY@Z;9E0;A9HW'@G^2'58A6'FCGBA M28Y&DRL>CM4D].,XDVVKN@K-Y6-$/@F7MO&[ZHI4T;;GUN<9^)U+O\#!/ MST%<^/C`]:.,#Y*NM=J_M.?IO2H_]++=RQL-2?B$`,*#>+RB\M?N\<(^YAW1 ML1JZE_['>;KOAMC76[GV(\G.%?^9H@O8G]W]GTZ%.1XS9+IR25VSI6/7YSM6 MV31OKU:$R[/8BE>-2VV291$(+32JZ`J`Q0````(`%J`3D2Q09?KG0X``.R\```4`!@```````$```"D M@8QI``!I`Q0````(`%J`3D3_CJ:BGQT``*;U`0`4`!@```````$```"D M@7=X``!I`Q0````(`%J`3D3\R&U+O'$``%L>!P`4`!@```````$```"D M@626``!I`Q0````(`%J`3D3L%Y?TTC$``*Q<`P`4`!@```````$```"D M@6X(`0!I`Q0````(`%J`3D05R$$)%@L```:"```0`!@```````$```"D M@8XZ`0!I'-D550%``-\A/Y2=7@+``$$)0X```0Y`0`` 64$L%!@`````&``8`%`(``.Y%`0`````` ` end XML 50 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8

Fair Value Measurements (Tables)
6 Months Ended

Dec. 31, 2013

Fair Value Measurements [Abstract]

Schedule of Financial Assets and Liabilities Accounted for at Fair Value on Recurring Basis and Fair Value Calculation Input Hierarchy Level

The table below sets forth the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2013 and June 30, 2013, respectively, and the fair value calculation input hierarchy level the Company has determined applies to each asset and liability category.

Balance at Balance at Input

Description December 31, 2013 June 30, 2013 Hierarchy Level

Assets:

Cash and cash equivalents $ 4,414,572 $ 2,899,927 Level 1

Restricted cash 181,181 181,149 Level 1

Liabilities:

Warrant liability $ 23,000 $ 104,000 Level 2

X

- Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19190-110258

+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Related Party Transaction (Details) (Affiliated Entity [Member], USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Affiliated Entity [Member]
Related Party Transaction [Line Items]
Maintenance costs	$ 9,720	$ 8,960
Software implementation costs	$ 6,000

Share-Based Compensation (Schedule of Stock Option Activity) (Details) (USD $)	0 Months Ended		6 Months Ended
	Sep. 05, 2013	Sep. 06, 2013	Dec. 31, 2013	Dec. 31, 2012
Number of Options
Outstanding at December 31, 2013			2,370,072
Vested and expected to vest at December 31, 2013			2,278,260
Vested and exercisable at December 31, 2013			2,080,064
Weighted Average Exercise Price
Outstanding at December 31, 2013			$ 1.79
Vested and expected to vest at December 31, 2013			$ 1.84
Vested and exercisable at December 31, 2013			$ 1.90
Weighted Average Remaining Contractual Term
Outstanding at December 31, 2013			4 years 6 months 26 days
Vested and expected to vest at December 31, 2013			4 years 6 months
Vested and exercisable at December 31, 2013			4 years 1 month 17 days
Average Intrinsic Value
Outstanding at December 31, 2013			$ 125,884
Vested and expected to vest at December 31, 2013			114,801
Vested and exercisable at December 31, 2013			125,784
Options exercised				31,700
Aggregate intrinsic value of option exercised				13,866
Stock options granted	50,000	15,000	65,000
Stock options issued, exercise price	$ 0.58	$ 0.59
Fair value of stock options granted	$ 25,150	$ 6,906
Exercise price	$ 0.58	$ 0.59
Expected term	5 years	5 years
Volatility	132.31%	132.31%
Discount rate	1.85%	1.77%

Shareholders' Equity (Common and Preferred Stock Transactions) (Details) (USD $)	0 Months Ended	3 Months Ended		6 Months Ended			0 Months Ended
	Aug. 29, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013	Aug. 29, 2013 Common Unit Warrants [Member]	Aug. 29, 2013 Preferred Unit Warrants [Member]	Aug. 29, 2013 Common Stock [Member]	Oct. 13, 2011 Common Stock [Member]	Aug. 29, 2013 Series D Preferred Stock [Member]
Class of Stock [Line Items]
Sale of common stock									3,800,985	2,500,000	1,670
Number of shares covered by each warrant							0.816
Number of shares number of shares covered by warrant								1,525.23
Stock issued, price per share									$ 0.535		$ 1,000
Exercise price		0.89		0.89		1.38	0.72	0.72
Warrant term							24 months	24 months
Number of common shares issuable upon conversion											1,869.15
Ownership percentage											9.99%
Beneficial conversion feature				$ 726,378
Gross proceeds from public offering	3,703,527
Underwriting discount	(185,176)
Legal and accounting expense	(184,514)
Listing expense	(48,500)
Other expense	(6,045)
Net proceeds	$ 3,279,292

Preferred Dividends (Details) (USD $)	6 Months Ended
Preferred Dividends (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Dividends Payable [Line Items]
Preferred dividends paid	$ 10,632	$ 10,632
Series B Preferred Stock [Member]
Dividends Payable [Line Items]
Preferred dividends paid	10,632	10,632
Dividends declared	$ 10,632	$ 10,632

Shareholders' Equity (Warrants) (Details)	6 Months Ended
Shareholders' Equity (Warrants) (Details)	Dec. 31, 2013
Warrants
Balance, beginning of period	1,957,033
Warrants issued	5,648,738
Balance, end of period	7,605,771
Weighted average exercise price
Beginning balance outstanding	1.38
Warrants issued	0.72
Ending balance outstanding	0.89

Shareholders' Equity (Additional Information about Warrants) (Details)			6 Months Ended
	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2013 Range of Exercise Price One [Member]	Dec. 31, 2013 Range of Exercise Price Two [Member]	Dec. 31, 2013 Range of Exercise Price Three [Member]	Dec. 31, 2013 Range of Exercise Price Four [Member]	Dec. 31, 2013 Range of Exercise Price Five [Member]	Dec. 31, 2013 Range of Exercise Price Six [Member]	Dec. 31, 2013 Range of Exercise Price Seven [Member]
Class of Warrant or Right [Line Items]
Quantity	7,605,771	1,957,033	6,000	25,000	5,648,738	1,207,832	650,003	63,198	5,000
Expiration date			Jun. 08, 2015	Jul. 27, 2015	Aug. 25, 2015	Nov. 21, 2015	Oct. 19, 2016	Dec. 07, 2016	Jun. 27, 2017
Exercise price	0.89	1.38	1.18	2.00	0.72	1.56	1.043	1.043	0.98

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Jun. 30, 2013
Current assets:
Cash and cash equivalents	$ 4,414,572	$ 2,899,927
Accounts receivable, net of allowance for doubtful accounts of $32,515 and $52,598, respectively	917,222	923,780
Inventory	426,333	405,571
Other receivables	10,064	11,502
Prepaid expenses and other current assets	156,365	202,880
Total current assets	5,924,556	4,443,660
Fixed assets, net of accumulated depreciation and amortization	1,349,469	1,684,282
Restricted cash	181,181	181,149
Inventory, non-current	469,758	469,758
Other assets, net of accumulated amortization	262,698	276,507
Total assets	8,187,662	7,055,356
Current liabilities:
Accounts payable and accrued liabilities	430,293	432,566
Accrued protocol expense	46,973	25,305
Accrued radioactive waste disposal	124,000	100,000
Accrued payroll and related taxes	141,082	127,419
Accrued vacation	104,932	107,578
Total current liabilities	847,280	792,868
Warrant derivative liability	23,000	104,000
Asset retirement obligation	828,568	792,242
Total liabilities	1,698,848	1,689,110
Commitments and contingencies (Note 6)
Shareholders' equity:
Preferred stock, $.001 par value; 7,001,671 shares authorized:	61	59
Common stock, $.001 par value; 192,998,329 & 193,000,000 shares authorized; 38,419,502 and 34,618,517 shares issued and outstanding	38,420	34,618
Treasury stock, at cost 13,200 shares	(8,390)	(8,390)
Additional paid-in capital	60,747,935	57,431,293
Accumulated deficit	(54,289,212)	(52,091,334)
Total shareholders' equity	6,488,814	5,366,246
Total liabilities and shareholders' equity	8,187,662	7,055,356
Series A Preferred Stock [Member]
Shareholders' equity:
Preferred stock, $.001 par value; 7,001,671 shares authorized:
Series B Preferred Stock [Member]
Shareholders' equity:
Preferred stock, $.001 par value; 7,001,671 shares authorized:	59	59
Series C Preferred Stock [Member]
Shareholders' equity:
Preferred stock, $.001 par value; 7,001,671 shares authorized:
Series D Preferred Stock [Member]
Shareholders' equity:
Preferred stock, $.001 par value; 7,001,671 shares authorized:	$ 2

Loss per Share (Details)	6 Months Ended
Loss per Share (Details)	Dec. 31, 2013	Dec. 31, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	13,156,388	4,328,170
Series B Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	59,065	59,065
Series D Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	3,121,480
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	7,605,771	1,957,033
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	2,670,072	2,312,072

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Accounts receivable, allowance for doubtful accounts	$ 32,515	$ 52,598
Preferred stock, par or stated value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	7,001,671
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	192,998,329	193,000,000
Common stock, shares issued	38,419,502	34,618,517
Common stock, shares outstanding	38,419,502	34,618,517
Treasury stock, shares	13,200	13,200
Series A Preferred Stock [Member]
Preferred stock, par or stated value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series B Preferred Stock [Member]
Preferred stock, par or stated value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	59,065	59,065
Preferred stock, shares outstanding	59,065	59,065
Series C Preferred Stock [Member]
Preferred stock, par or stated value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series D Preferred Stock [Member]
Preferred stock, par or stated value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,671	0
Preferred stock, shares issued	1,670	0
Preferred stock, shares outstanding	1,670	0

Document and Entity Information	6 Months Ended
Document and Entity Information	Dec. 31, 2013	Feb. 06, 2014
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 31, 2013
Entity Registrant Name	IsoRay, Inc.
Entity Central Index Key	0000728387
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q2
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		41,540,982

Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
Consolidated Statements of Operations (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Consolidated Statements of Operations [Abstract]
Product sales	$ 1,085,408	$ 975,457	$ 2,135,323	$ 2,031,689
Cost of product sales	1,119,314	1,134,083	2,246,537	2,210,740
Gross loss	(33,906)	(158,626)	(111,214)	(179,051)
Operating expenses:
Research and development expenses	170,030	149,176	317,020	290,648
Sales and marketing expenses	326,467	322,094	685,652	638,150
General and administrative expenses	513,964	469,559	1,165,000	1,114,412
Total operating expenses	1,010,461	940,829	2,167,672	2,043,210
Operating loss	(1,044,367)	(1,099,455)	(2,278,886)	(2,222,261)
Non-operating income (expense):
Interest income	481	128	835	272
Change in fair value of warrant derivative liability	117,000	(55,000)	81,000	74,000
Financing and interest expense	(86)		(827)	(6)
Non-operating income / (expense), net	117,395	(54,872)	81,008	74,266
Net loss	(926,972)	(1,154,327)	(2,197,878)	(2,147,995)
Preferred stock deemed dividends (Note 9)			(726,378)
Preferred stock dividends	(2,658)	(2,658)	(5,316)	(5,316)
Net loss applicable to common shareholders	$ (929,630)	$ (1,156,985)	$ (2,929,572)	$ (2,153,311)
Basic and diluted loss per share	$ (0.02)	$ (0.03)	$ (0.08)	$ (0.06)
Weighted average shares used in computing net loss per share:
Basic and diluted	38,419,502	34,604,605	37,133,875	34,238,401

Inventory (Details) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Inventory [Abstract]
Raw materials	$ 168,731	$ 167,671
Work in process	212,726	195,323
Finished goods	44,876	42,577
Total inventory	$ 426,333	$ 405,571

Subsequent Event (Details)				1 Months Ended
Subsequent Event (Details)	Dec. 31, 2013	Jun. 30, 2013	Jan. 31, 2014 Subsequent Event [Member]	Jan. 31, 2014 Common Stock [Member] Subsequent Event [Member]	Jan. 31, 2014 Series D Preferred Stock [Member] Subsequent Event [Member]
Subsequent Event [Line Items]
Number of shares converted					1,670
Number of common shares issued upon conversion				3,121,480
Common stock, shares outstanding	38,419,502	34,618,517	41,540,982

Commitments and Contingencies (Details) (Patent Rights Know-how and License Agreements [Member])	Dec. 31, 2013
Patent Rights Know-how and License Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of royalty payment on net sales	1.00%

Consolidated Statements of Cash Flows (USD $)	6 Months Ended
Consolidated Statements of Cash Flows (USD $)	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,197,878)	$ (2,147,995)
Adjustments to reconcile net loss to net cash used by operating activities:
Allowance for doubtful accounts	(20,083)	(13,477)
Depreciation and amortization of fixed assets	349,232	388,171
Amortization of deferred financing costs and other assets	15,371	14,024
Change in fair value of warrant derivative liability	(81,000)	(74,000)
Accretion of asset retirement obligation	36,326	33,211
Share-based compensation	51,786	57,789
Changes in operating assets and liabilities:
Accounts receivable, gross	26,641	222,365
Inventory	(20,762)	41,433
Other receivables	1,438	1,914
Prepaid expenses and other current assets	46,515	(84,252)
Accounts payable and accrued expenses	(2,273)	4,120
Accrued protocol expense	21,668	13,750
Accrued radioactive waste disposal	24,000	24,000
Accrued payroll and related taxes	13,663	9,181
Accrued vacation	(2,646)	(3,230)
Net cash used by operating activities	(1,738,002)	(1,512,996)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of fixed assets	(14,419)
Additions to licenses and other assets	(1,562)	(13,407)
Change in restricted cash	(32)	(84)
Net cash used by investing activities	(16,013)	(13,491)
CASH FLOWS FROM FINANCING ACTIVITIES:
Preferred dividends paid	(10,632)	(10,632)
Proceeds from sales of preferred stock, pursuant to underwritten offering, net	1,478,712
Proceeds from sales of common stock, pursuant to underwritten offering, net	1,800,580
Proceeds from sales of common stock, pursuant to registered direct offering, net		3,291,977
Proceeds from sales of common stock, pursuant to exercise of warrants, net		1,825
Proceeds from sales of common stock, pursuant to exercise of options		11,309
Net cash provided by financing activities	3,268,660	3,294,479
Net increase in cash and cash equivalents	1,514,645	1,767,992
Cash and cash equivalents, beginning of period	2,899,927	2,672,711
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 4,414,572	$ 4,440,703

Fair Value Measurements (Details) (Fair Value, Measurements, Recurring [Member], USD $)	Dec. 31, 2013	Jun. 30, 2013
Level 1 [Member]
Assets:
Cash and cash equivalents	$ 4,414,572	$ 2,899,927
Restricted cash	181,181	181,149
Level 2 [Member]
Liabilities:
Warrant liability	$ 23,000	$ 104,000